Query psy10487
Match_columns 610
No_of_seqs 524 out of 4263
Neff 9.2
Searched_HMMs 46136
Date Fri Aug 16 19:25:13 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy10487.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/10487hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG4194|consensus 100.0 5.7E-48 1.2E-52 390.5 21.8 332 151-491 390-747 (873)
2 KOG4194|consensus 100.0 2.1E-36 4.6E-41 306.7 11.6 386 54-464 316-802 (873)
3 KOG4237|consensus 100.0 4.4E-32 9.6E-37 264.4 9.0 235 22-260 35-404 (498)
4 KOG3513|consensus 99.9 4.8E-23 1E-27 226.2 13.0 209 231-460 304-516 (1051)
5 KOG3513|consensus 99.7 2.4E-17 5.2E-22 181.8 16.4 178 259-463 239-426 (1051)
6 KOG4237|consensus 99.7 7.8E-19 1.7E-23 172.2 -1.6 197 59-260 50-247 (498)
7 cd05762 Ig8_MLCK Eighth immuno 99.7 9.4E-16 2E-20 127.8 11.4 97 261-363 1-97 (98)
8 KOG4222|consensus 99.6 2.7E-16 5.9E-21 171.6 9.1 210 232-461 103-316 (1281)
9 cd05851 Ig3_Contactin-1 Third 99.6 2.7E-15 5.8E-20 122.6 10.1 87 260-356 1-87 (88)
10 KOG4221|consensus 99.6 8.4E-16 1.8E-20 168.7 8.6 206 231-459 203-417 (1381)
11 KOG4221|consensus 99.6 8.3E-15 1.8E-19 161.0 9.7 214 229-461 109-329 (1381)
12 PLN00113 leucine-rich repeat r 99.5 1.7E-14 3.6E-19 170.6 12.4 174 37-212 96-295 (968)
13 cd05892 Ig_Myotilin_C C-termin 99.5 2.9E-14 6.2E-19 112.2 9.4 75 278-356 1-75 (75)
14 cd05745 Ig3_Peroxidasin Third 99.5 2.6E-14 5.7E-19 112.7 8.8 74 274-356 1-74 (74)
15 cd05737 Ig_Myomesin_like_C C-t 99.5 6E-14 1.3E-18 115.8 11.1 86 266-356 7-92 (92)
16 cd05894 Ig_C5_MyBP-C C5 immuno 99.5 8.1E-14 1.8E-18 113.1 11.6 83 269-356 4-86 (86)
17 cd05747 Ig5_Titin_like M5, fif 99.5 6.3E-14 1.4E-18 115.7 10.9 89 260-354 3-91 (92)
18 cd05865 Ig1_NCAM-1 First immun 99.5 6.1E-14 1.3E-18 116.1 10.8 90 263-356 3-95 (96)
19 cd05735 Ig8_DSCAM Eight immuno 99.5 7.4E-14 1.6E-18 114.0 10.9 87 275-362 1-87 (88)
20 cd04975 Ig4_SCFR_like Fourth i 99.5 9.7E-14 2.1E-18 115.9 11.3 88 268-356 11-99 (101)
21 cd05728 Ig4_Contactin-2-like F 99.5 8E-14 1.7E-18 113.2 10.4 83 264-356 3-85 (85)
22 PLN00113 leucine-rich repeat r 99.5 3.7E-14 8.1E-19 167.7 12.1 157 55-213 164-320 (968)
23 cd04968 Ig3_Contactin_like Thi 99.5 1E-13 2.2E-18 113.4 10.9 87 260-356 1-87 (88)
24 cd05869 Ig5_NCAM-1 Fifth immun 99.5 1.6E-13 3.4E-18 114.5 12.1 93 260-356 2-97 (97)
25 cd05893 Ig_Palladin_C C-termin 99.5 6.4E-14 1.4E-18 110.3 9.1 75 278-356 1-75 (75)
26 cd05852 Ig5_Contactin-1 Fifth 99.5 5.6E-14 1.2E-18 110.1 8.7 73 275-356 1-73 (73)
27 cd05868 Ig4_NrCAM Fourth immun 99.5 9E-14 2E-18 110.1 9.7 75 275-356 1-75 (76)
28 cd05867 Ig4_L1-CAM_like Fourth 99.5 1.3E-13 2.7E-18 109.4 10.2 75 275-356 1-75 (76)
29 PHA02785 IL-beta-binding prote 99.5 8.4E-14 1.8E-18 142.5 11.6 205 230-448 91-317 (326)
30 cd05859 Ig4_PDGFR-alpha Fourth 99.5 1.3E-13 2.7E-18 115.4 10.5 88 269-356 12-99 (101)
31 PF07679 I-set: Immunoglobulin 99.5 1.7E-13 3.6E-18 112.7 11.1 90 261-356 1-90 (90)
32 cd05730 Ig3_NCAM-1_like Third 99.5 1.3E-13 2.9E-18 114.6 10.6 90 260-356 1-92 (95)
33 cd04972 Ig_TrkABC_d4 Fourth do 99.5 2.3E-13 5E-18 111.8 11.8 85 266-356 6-90 (90)
34 PHA02785 IL-beta-binding prote 99.5 4.4E-13 9.5E-18 137.2 15.0 164 271-451 37-205 (326)
35 KOG0444|consensus 99.5 4.2E-15 9.1E-20 153.4 0.1 185 38-227 107-298 (1255)
36 cd05744 Ig_Myotilin_C_like Imm 99.5 2.4E-13 5.2E-18 107.3 9.7 75 278-356 1-75 (75)
37 cd05723 Ig4_Neogenin Fourth im 99.5 3.4E-13 7.4E-18 105.3 10.3 71 277-356 1-71 (71)
38 KOG4222|consensus 99.5 2.8E-14 6E-19 156.1 5.2 215 229-456 195-409 (1281)
39 cd05855 Ig_TrkB_d5 Fifth domai 99.5 2.7E-13 5.9E-18 107.1 9.5 77 279-356 2-78 (79)
40 cd05863 Ig2_VEGFR-3 Second imm 99.5 1.8E-13 3.8E-18 104.7 8.1 65 278-356 1-65 (67)
41 cd04978 Ig4_L1-NrCAM_like Four 99.5 3.2E-13 7E-18 107.2 9.6 75 275-356 1-75 (76)
42 KOG0617|consensus 99.5 1.9E-15 4.1E-20 132.4 -3.8 148 41-194 40-190 (264)
43 PHA02826 IL-1 receptor-like pr 99.5 7.7E-14 1.7E-18 134.1 6.9 158 268-446 30-211 (227)
44 cd05870 Ig5_NCAM-2 Fifth immun 99.5 5.7E-13 1.2E-17 111.4 11.2 92 260-356 2-98 (98)
45 cd05732 Ig5_NCAM-1_like Fifth 99.5 5.6E-13 1.2E-17 111.1 11.0 92 260-356 2-96 (96)
46 cd05748 Ig_Titin_like Immunogl 99.4 5.6E-13 1.2E-17 105.2 10.0 74 277-356 1-74 (74)
47 cd07693 Ig1_Robo First immunog 99.4 7.2E-13 1.6E-17 111.2 11.1 94 260-356 1-99 (100)
48 cd05891 Ig_M-protein_C C-termi 99.4 7.6E-13 1.6E-17 109.0 10.8 86 266-356 7-92 (92)
49 cd04969 Ig5_Contactin_like Fif 99.4 6.5E-13 1.4E-17 104.5 9.5 73 275-356 1-73 (73)
50 cd05848 Ig1_Contactin-5 First 99.4 9.7E-13 2.1E-17 108.8 10.9 86 261-354 2-92 (94)
51 cd05857 Ig2_FGFR Second immuno 99.4 8.4E-13 1.8E-17 107.2 10.3 82 270-356 4-85 (85)
52 cd04971 Ig_TrKABC_d5 Fifth dom 99.4 7E-13 1.5E-17 106.1 9.5 78 279-356 2-80 (81)
53 cd05854 Ig6_Contactin-2 Sixth 99.4 1.2E-12 2.5E-17 106.1 10.1 79 276-358 1-83 (85)
54 cd05850 Ig1_Contactin-2 First 99.4 2.3E-12 5E-17 106.6 11.5 87 261-355 2-93 (94)
55 cd05864 Ig2_VEGFR-2 Second imm 99.4 7.1E-13 1.5E-17 102.6 7.7 68 278-356 1-68 (70)
56 cd05739 Ig3_RPTP_IIa_LAR_like 99.4 1.5E-12 3.2E-17 100.8 9.4 68 275-354 1-68 (69)
57 cd05773 Ig8_hNephrin_like Eigh 99.4 2.2E-12 4.7E-17 109.8 11.3 98 260-358 4-106 (109)
58 KOG0444|consensus 99.4 3.1E-14 6.7E-19 147.1 -0.2 172 37-214 81-258 (1255)
59 cd05876 Ig3_L1-CAM Third immun 99.4 1.1E-12 2.5E-17 102.3 8.3 70 278-356 1-70 (71)
60 cd05758 Ig5_KIRREL3-like Fifth 99.4 2.5E-12 5.4E-17 107.5 10.7 93 260-354 2-97 (98)
61 cd05743 Ig_Perlecan_D2_like Im 99.4 1.7E-12 3.7E-17 103.5 9.1 76 275-356 1-76 (78)
62 cd05866 Ig1_NCAM-2 First immun 99.4 4.2E-12 9.2E-17 104.0 11.4 87 263-356 3-91 (92)
63 cd05725 Ig3_Robo Third immunog 99.4 1.2E-12 2.6E-17 101.7 7.8 69 278-356 1-69 (69)
64 cd05856 Ig2_FGFRL1-like Second 99.4 1.7E-12 3.7E-17 104.6 8.9 79 270-356 4-82 (82)
65 cd05724 Ig2_Robo Second immuno 99.4 3E-12 6.6E-17 104.2 10.2 83 266-356 2-86 (86)
66 cd05760 Ig2_PTK7 Second immuno 99.4 2.4E-12 5.3E-17 102.2 9.2 72 278-356 1-74 (77)
67 cd05853 Ig6_Contactin-4 Sixth 99.4 1.7E-12 3.7E-17 104.1 8.3 79 276-358 1-83 (85)
68 cd04976 Ig2_VEGFR Second immun 99.4 2.1E-12 4.5E-17 100.8 8.6 69 278-356 1-69 (71)
69 cd05764 Ig_2 Subgroup of the i 99.4 3.1E-12 6.8E-17 100.9 9.7 73 275-356 1-74 (74)
70 KOG0618|consensus 99.4 2E-14 4.2E-19 155.2 -4.0 184 25-213 280-488 (1081)
71 cd04974 Ig3_FGFR Third immunog 99.4 1.8E-12 3.9E-17 106.4 8.5 82 275-356 1-89 (90)
72 cd05749 Ig2_Tyro3_like Second 99.4 2.4E-12 5.2E-17 102.7 8.9 76 265-354 3-80 (81)
73 cd05740 Ig_CEACAM_D4 Fourth im 99.4 3E-12 6.5E-17 105.0 9.7 80 267-356 10-90 (91)
74 KOG0617|consensus 99.4 9.8E-15 2.1E-19 127.9 -5.4 166 44-216 21-188 (264)
75 cd05746 Ig4_Peroxidasin Fourth 99.4 1.8E-12 4E-17 100.6 7.6 68 278-354 1-68 (69)
76 cd05722 Ig1_Neogenin First imm 99.4 5.6E-12 1.2E-16 104.7 10.9 86 264-356 3-95 (95)
77 cd05858 Ig3_FGFR-2 Third immun 99.4 3.5E-12 7.6E-17 104.7 9.3 82 275-356 1-89 (90)
78 cd05763 Ig_1 Subgroup of the i 99.4 3.1E-12 6.7E-17 101.2 8.5 73 278-356 1-74 (75)
79 cd04977 Ig1_NCAM-1_like First 99.4 9.4E-12 2E-16 102.5 11.6 88 263-356 3-92 (92)
80 cd04973 Ig1_FGFR First immunog 99.4 3.7E-12 7.9E-17 101.7 8.9 79 267-356 1-79 (79)
81 cd05849 Ig1_Contactin-1 First 99.4 5.3E-12 1.1E-16 104.0 10.0 86 261-355 2-92 (93)
82 cd05738 Ig2_RPTP_IIa_LAR_like 99.3 4E-12 8.7E-17 100.2 8.8 72 278-356 1-73 (74)
83 cd05726 Ig4_Robo Fhird immunog 99.3 3.2E-12 6.9E-17 105.0 8.4 83 275-358 1-83 (90)
84 cd04970 Ig6_Contactin_like Six 99.3 4.2E-12 9.2E-17 103.1 9.0 81 276-358 1-83 (85)
85 PRK15370 E3 ubiquitin-protein 99.3 4.2E-12 9.1E-17 142.0 11.9 160 36-215 180-339 (754)
86 PRK15387 E3 ubiquitin-protein 99.3 4.8E-12 1E-16 140.7 11.1 161 27-214 195-355 (788)
87 KOG0472|consensus 99.3 4.5E-14 9.8E-19 139.2 -4.5 178 42-228 145-330 (565)
88 KOG0472|consensus 99.3 3.5E-14 7.7E-19 139.9 -6.0 170 38-215 118-289 (565)
89 cd05731 Ig3_L1-CAM_like Third 99.3 7.5E-12 1.6E-16 97.8 8.0 70 278-356 1-70 (71)
90 cd05736 Ig2_Follistatin_like S 99.3 1.6E-11 3.6E-16 97.3 9.3 74 278-357 1-74 (76)
91 cd05765 Ig_3 Subgroup of the i 99.3 1.2E-11 2.7E-16 99.3 8.2 78 275-356 1-81 (81)
92 PRK15370 E3 ubiquitin-protein 99.3 7.1E-12 1.5E-16 140.1 9.1 119 36-168 201-319 (754)
93 cd05752 Ig1_FcgammaR_like Frst 99.3 1.6E-11 3.4E-16 97.4 8.2 77 261-356 1-78 (78)
94 cd04967 Ig1_Contactin First Ig 99.3 3.9E-11 8.4E-16 98.8 10.7 82 261-350 2-87 (91)
95 cd05750 Ig_Pro_neuregulin Immu 99.3 2E-11 4.4E-16 96.5 7.8 72 278-353 1-74 (75)
96 cd05756 Ig1_IL1R_like First im 99.2 2.5E-11 5.3E-16 100.1 8.4 83 268-356 7-94 (94)
97 PRK15387 E3 ubiquitin-protein 99.2 2.4E-11 5.2E-16 135.2 10.6 161 37-215 285-459 (788)
98 cd05734 Ig7_DSCAM Seventh immu 99.2 3E-11 6.5E-16 96.5 8.2 78 278-356 1-79 (79)
99 cd05733 Ig6_L1-CAM_like Sixth 99.2 3.6E-11 7.9E-16 95.4 8.4 71 278-354 1-76 (77)
100 PF14580 LRR_9: Leucine-rich r 99.2 7E-12 1.5E-16 114.9 4.7 123 56-183 20-146 (175)
101 cd05874 Ig6_NrCAM Sixth immuno 99.2 5.8E-11 1.2E-15 94.2 9.1 71 278-354 1-76 (77)
102 cd05742 Ig1_VEGFR_like First i 99.2 6.3E-11 1.4E-15 95.9 9.2 79 275-356 1-83 (84)
103 KOG0618|consensus 99.2 5.6E-13 1.2E-17 144.2 -4.3 158 53-214 239-443 (1081)
104 cd07702 Ig2_VEGFR-1 Second imm 99.2 5.7E-11 1.2E-15 92.2 7.9 67 278-353 1-67 (72)
105 cd05875 Ig6_hNeurofascin_like 99.2 1E-10 2.2E-15 92.8 9.1 67 278-350 1-71 (77)
106 cd05898 Ig5_KIRREL3 Fifth immu 99.2 1.4E-10 2.9E-15 95.7 9.9 93 260-354 2-97 (98)
107 cd05754 Ig3_Perlecan_like Thir 99.2 1E-10 2.2E-15 95.0 7.6 77 266-354 7-84 (85)
108 KOG1259|consensus 99.2 4.6E-12 9.9E-17 120.7 -0.4 131 56-194 285-416 (490)
109 cd05729 Ig2_FGFR_like Second i 99.1 4E-10 8.7E-15 91.2 10.9 82 270-356 4-85 (85)
110 PF14580 LRR_9: Leucine-rich r 99.1 7.3E-11 1.6E-15 108.2 6.7 111 103-217 17-129 (175)
111 cd05861 Ig1_PDGFR-alphabeta Fr 99.1 4.2E-10 9.1E-15 90.9 10.1 79 275-356 1-82 (84)
112 cd05882 Ig1_Necl-1 First (N-te 99.1 4.7E-10 1E-14 92.5 9.7 88 267-356 4-95 (95)
113 cd05895 Ig_Pro_neuregulin-1 Im 99.1 3.5E-10 7.5E-15 89.6 7.8 72 278-353 1-75 (76)
114 cd05873 Ig_Sema4D_like Immunog 99.1 7.6E-10 1.7E-14 89.1 8.9 70 266-345 2-71 (87)
115 cd04979 Ig_Semaphorin_C Immuno 99.0 9.2E-10 2E-14 90.1 8.5 82 267-357 3-87 (89)
116 cd05757 Ig2_IL1R_like Second i 99.0 1E-09 2.2E-14 90.0 7.9 78 269-356 4-86 (92)
117 cd07701 Ig1_Necl-3 First (N-te 99.0 2.2E-09 4.7E-14 88.8 9.6 88 267-356 4-95 (95)
118 cd05862 Ig1_VEGFR First immuno 99.0 3.2E-09 6.8E-14 86.1 9.2 80 275-357 1-85 (86)
119 cd05727 Ig2_Contactin-2-like S 99.0 1.2E-09 2.6E-14 89.4 6.2 75 268-348 11-86 (96)
120 cd05753 Ig2_FcgammaR_like Seco 99.0 2.2E-09 4.8E-14 86.4 7.4 77 266-356 5-83 (83)
121 PF13855 LRR_8: Leucine rich r 98.9 6.6E-10 1.4E-14 83.8 3.5 59 82-140 2-60 (61)
122 PF13895 Ig_2: Immunoglobulin 98.9 5.9E-09 1.3E-13 83.1 9.1 71 270-356 9-80 (80)
123 PHA02826 IL-1 receptor-like pr 98.9 2.1E-09 4.5E-14 103.5 6.4 100 231-346 108-212 (227)
124 smart00408 IGc2 Immunoglobulin 98.9 7.3E-09 1.6E-13 77.9 8.2 63 274-346 1-63 (63)
125 KOG1259|consensus 98.9 2.5E-10 5.3E-15 109.1 -0.2 131 81-217 284-415 (490)
126 PF13855 LRR_8: Leucine rich r 98.9 1.7E-09 3.7E-14 81.5 4.3 61 105-165 1-61 (61)
127 cd05845 Ig2_L1-CAM_like Second 98.9 4E-09 8.7E-14 86.1 6.4 73 267-347 10-84 (95)
128 cd05860 Ig4_SCFR Fourth immuno 98.9 3.1E-08 6.7E-13 81.1 11.1 88 268-356 11-99 (101)
129 cd05871 Ig_Semaphorin_classIII 98.8 1.7E-08 3.8E-13 82.6 9.4 82 269-357 5-89 (91)
130 cd00116 LRR_RI Leucine-rich re 98.8 9.3E-10 2E-14 113.1 2.3 157 56-214 52-234 (319)
131 KOG0532|consensus 98.8 1.5E-10 3.2E-15 119.6 -3.9 168 38-214 54-247 (722)
132 cd00116 LRR_RI Leucine-rich re 98.8 1.6E-09 3.6E-14 111.2 2.0 158 55-214 81-263 (319)
133 cd05885 Ig2_Necl-4 Second immu 98.8 5.5E-08 1.2E-12 76.7 9.7 67 278-348 2-69 (80)
134 cd05897 Ig2_IL1R2_like Second 98.8 2.9E-08 6.4E-13 81.3 8.0 80 270-356 5-93 (95)
135 cd05717 Ig1_Necl-1-3_like Firs 98.8 5.4E-08 1.2E-12 80.6 9.8 88 267-356 4-95 (95)
136 smart00410 IG_like Immunoglobu 98.8 1.2E-07 2.7E-12 75.9 11.7 83 268-356 2-85 (86)
137 smart00409 IG Immunoglobulin. 98.8 1.2E-07 2.7E-12 75.9 11.7 83 268-356 2-85 (86)
138 PLN03150 hypothetical protein; 98.8 2.4E-08 5.3E-13 111.3 10.0 107 56-164 419-526 (623)
139 cd07690 Ig1_CD4 First immunogl 98.8 2.2E-08 4.7E-13 82.1 6.9 79 270-348 2-91 (94)
140 cd05759 Ig2_KIRREL3-like Secon 98.8 7.2E-08 1.6E-12 77.5 9.9 78 278-356 2-82 (82)
141 COG4886 Leucine-rich repeat (L 98.8 6.4E-09 1.4E-13 110.3 4.8 169 37-214 119-290 (394)
142 PLN03210 Resistant to P. syrin 98.7 1E-07 2.2E-12 114.0 13.5 119 37-163 592-714 (1153)
143 KOG0532|consensus 98.7 1.3E-09 2.7E-14 112.8 -2.9 132 58-195 53-184 (722)
144 PLN03150 hypothetical protein; 98.7 3.2E-08 6.9E-13 110.3 7.7 109 107-215 420-529 (623)
145 PF00047 ig: Immunoglobulin do 98.6 5.8E-08 1.3E-12 73.8 6.0 63 275-341 1-64 (64)
146 PLN03210 Resistant to P. syrin 98.6 2.3E-07 4.9E-12 111.1 13.4 96 37-139 614-714 (1153)
147 KOG1859|consensus 98.6 1.4E-09 3E-14 115.2 -5.8 129 83-217 166-295 (1096)
148 KOG3207|consensus 98.6 1.3E-08 2.8E-13 102.4 0.4 160 55-214 146-314 (505)
149 PF13927 Ig_3: Immunoglobulin 98.5 1.6E-07 3.5E-12 73.6 6.1 74 260-343 1-75 (75)
150 cd05896 Ig1_IL1RAPL-1_like Fir 98.5 5.4E-07 1.2E-11 74.1 8.8 86 268-356 8-104 (104)
151 cd05774 Ig_CEACAM_D1 First imm 98.5 4.7E-07 1E-11 75.9 8.5 92 265-356 3-105 (105)
152 KOG3207|consensus 98.5 2.5E-08 5.4E-13 100.4 0.2 158 55-213 172-338 (505)
153 COG4886 Leucine-rich repeat (L 98.5 8.7E-08 1.9E-12 101.7 4.3 150 56-213 117-267 (394)
154 cd05872 Ig_Sema4B_like Immunog 98.4 8.6E-07 1.9E-11 70.9 7.5 71 268-350 4-74 (85)
155 cd05762 Ig8_MLCK Eighth immuno 98.4 4.3E-08 9.3E-13 81.6 -0.3 42 420-461 53-94 (98)
156 KOG1644|consensus 98.4 3E-07 6.6E-12 83.7 4.5 102 107-210 44-149 (233)
157 cd05881 Ig1_Necl-2 First (N-te 98.4 4E-06 8.6E-11 68.8 10.6 72 268-343 5-83 (95)
158 KOG0531|consensus 98.4 7.5E-08 1.6E-12 102.5 0.3 108 80-192 94-201 (414)
159 KOG1859|consensus 98.4 1.5E-08 3.4E-13 107.5 -4.9 127 56-190 165-292 (1096)
160 KOG0531|consensus 98.4 6E-08 1.3E-12 103.3 -0.6 164 41-214 79-245 (414)
161 cd00098 IgC Immunoglobulin Con 98.4 1.8E-06 3.8E-11 71.4 8.3 75 273-347 11-87 (95)
162 PF13306 LRR_5: Leucine rich r 98.4 8.1E-07 1.7E-11 78.0 6.4 126 70-203 3-128 (129)
163 cd05892 Ig_Myotilin_C C-termin 98.3 5.1E-07 1.1E-11 70.9 4.5 34 424-457 42-75 (75)
164 KOG4579|consensus 98.3 5.1E-08 1.1E-12 83.1 -1.8 133 84-219 30-164 (177)
165 cd05877 Ig_LP_like Immunoglobu 98.3 4.5E-06 9.7E-11 70.6 10.0 85 274-358 1-104 (106)
166 cd05854 Ig6_Contactin-2 Sixth 98.3 6.9E-07 1.5E-11 72.2 4.5 40 421-460 45-84 (85)
167 cd05714 Ig_CSPGs_LP Immunoglob 98.3 3.6E-06 7.9E-11 71.2 9.2 84 274-357 1-103 (106)
168 KOG1909|consensus 98.3 1.7E-07 3.7E-12 92.0 1.1 111 56-166 93-226 (382)
169 cd05771 IgC_Tapasin_R Tapasin- 98.3 2.2E-06 4.8E-11 76.4 7.9 112 232-345 12-131 (139)
170 cd05863 Ig2_VEGFR-3 Second imm 98.3 5.8E-07 1.3E-11 68.7 3.4 38 420-457 28-65 (67)
171 cd05879 Ig_P0 Immunoglobulin ( 98.3 6.8E-06 1.5E-10 70.3 10.1 91 266-356 4-116 (116)
172 cd05761 Ig2_Necl-1-4_like Seco 98.3 7.7E-06 1.7E-10 65.5 9.9 68 278-347 2-70 (82)
173 cd05751 Ig1_LILRB1_like First 98.3 2.2E-06 4.8E-11 70.2 6.8 73 261-344 3-75 (91)
174 KOG1644|consensus 98.3 1.1E-06 2.4E-11 80.0 5.2 127 56-187 20-150 (233)
175 cd05852 Ig5_Contactin-1 Fifth 98.2 1.2E-06 2.5E-11 68.5 4.4 37 421-457 37-73 (73)
176 cd05713 Ig_MOG_like Immunoglob 98.2 5.8E-06 1.2E-10 69.1 8.9 82 275-356 1-99 (100)
177 cd05741 Ig_CEACAM_D1_like Firs 98.2 3.5E-06 7.6E-11 69.2 7.5 82 275-356 1-92 (92)
178 cd05900 Ig_Aggrecan Immunoglob 98.2 8E-06 1.7E-10 69.4 9.4 85 274-358 1-110 (112)
179 cd05851 Ig3_Contactin-1 Third 98.2 2.7E-07 5.9E-12 75.1 0.3 37 421-457 51-87 (88)
180 cd05723 Ig4_Neogenin Fourth im 98.2 2.7E-06 6E-11 66.1 5.7 37 421-457 35-71 (71)
181 cd05876 Ig3_L1-CAM Third immun 98.2 2E-06 4.3E-11 66.9 4.9 38 420-457 33-70 (71)
182 cd05893 Ig_Palladin_C C-termin 98.2 1.7E-06 3.7E-11 68.0 4.5 34 424-457 42-75 (75)
183 cd04983 IgV_TCR_alpha_like Imm 98.2 5.4E-06 1.2E-10 70.5 7.7 81 265-346 3-94 (109)
184 KOG4579|consensus 98.2 1.7E-07 3.7E-12 79.9 -1.8 134 56-192 28-161 (177)
185 cd05853 Ig6_Contactin-4 Sixth 98.2 1.7E-06 3.6E-11 69.5 3.8 40 421-460 45-84 (85)
186 cd05735 Ig8_DSCAM Eight immuno 98.2 5.9E-07 1.3E-11 73.2 1.2 39 423-461 47-85 (88)
187 cd07705 Ig2_Necl-1 Second immu 98.2 2.4E-05 5.2E-10 62.7 10.5 68 278-347 2-71 (83)
188 cd05864 Ig2_VEGFR-2 Second imm 98.2 2.1E-06 4.6E-11 66.4 3.9 35 422-456 33-67 (70)
189 cd05745 Ig3_Peroxidasin Third 98.1 2.9E-06 6.3E-11 66.5 4.6 37 421-457 38-74 (74)
190 cd05878 Ig_Aggrecan_like Immun 98.1 1.6E-05 3.5E-10 67.6 9.5 84 274-357 1-107 (110)
191 cd05880 Ig_EVA1 Immunoglobulin 98.1 1.7E-05 3.6E-10 68.1 9.5 90 267-356 5-115 (115)
192 cd05718 Ig1_PVR_like First imm 98.1 1.5E-05 3.3E-10 66.2 8.8 81 276-356 1-97 (98)
193 cd04974 Ig3_FGFR Third immunog 98.1 3.1E-06 6.7E-11 69.3 4.5 36 422-457 54-89 (90)
194 TIGR00864 PCC polycystin catio 98.1 2.2E-06 4.9E-11 104.3 5.1 78 183-260 1-81 (2740)
195 cd05725 Ig3_Robo Third immunog 98.1 3.3E-06 7.2E-11 65.2 4.1 37 421-457 33-69 (69)
196 cd05899 IgV_TCR_beta Immunoglo 98.1 9.5E-06 2.1E-10 69.1 7.3 81 265-346 3-96 (110)
197 cd04970 Ig6_Contactin_like Six 98.1 3.1E-06 6.7E-11 68.4 4.0 41 420-460 44-84 (85)
198 cd05763 Ig_1 Subgroup of the i 98.1 4.3E-06 9.3E-11 65.8 4.5 38 420-457 37-74 (75)
199 PF13306 LRR_5: Leucine rich r 98.1 9.1E-06 2E-10 71.3 6.9 117 56-180 13-129 (129)
200 cd05867 Ig4_L1-CAM_like Fourth 98.1 5.6E-06 1.2E-10 65.3 5.0 38 421-458 39-76 (76)
201 cd05715 Ig_P0-like Immunoglobu 98.0 3.3E-05 7.2E-10 66.5 9.8 91 266-356 4-116 (116)
202 KOG4658|consensus 98.0 3E-06 6.4E-11 97.0 4.1 139 44-188 511-653 (889)
203 cd05869 Ig5_NCAM-1 Fifth immun 98.0 1E-06 2.2E-11 73.3 0.3 35 423-457 63-97 (97)
204 cd07698 IgC_MHC_I_alpha3 Class 98.0 4.6E-05 1E-09 62.7 9.8 81 260-346 2-84 (93)
205 cd05748 Ig_Titin_like Immunogl 98.0 8E-06 1.7E-10 64.0 4.7 38 420-457 37-74 (74)
206 cd05901 Ig_Versican Immunoglob 98.0 5.7E-05 1.2E-09 64.1 10.0 38 321-358 78-115 (117)
207 cd05755 Ig2_ICAM-1_like Second 98.0 3.8E-05 8.1E-10 63.4 8.7 81 262-347 3-87 (100)
208 cd05884 Ig2_Necl-3 Second immu 98.0 4.4E-05 9.6E-10 61.1 8.9 69 278-347 2-71 (83)
209 cd05746 Ig4_Peroxidasin Fourth 98.0 6.9E-06 1.5E-10 63.4 4.1 35 421-455 34-68 (69)
210 cd05730 Ig3_NCAM-1_like Third 98.0 1.7E-06 3.7E-11 71.6 0.6 39 420-458 55-93 (95)
211 cd05731 Ig3_L1-CAM_like Third 98.0 8.3E-06 1.8E-10 63.2 4.5 38 420-457 33-70 (71)
212 cd05868 Ig4_NrCAM Fourth immun 98.0 8.8E-06 1.9E-10 64.2 4.6 38 421-458 39-76 (76)
213 cd05744 Ig_Myotilin_C_like Imm 98.0 9.2E-06 2E-10 63.9 4.6 34 424-457 42-75 (75)
214 cd05747 Ig5_Titin_like M5, fif 98.0 1.6E-06 3.5E-11 71.2 0.3 35 422-456 58-92 (92)
215 cd04978 Ig4_L1-NrCAM_like Four 98.0 8.9E-06 1.9E-10 64.0 4.4 38 420-457 38-75 (76)
216 cd04968 Ig3_Contactin_like Thi 98.0 8.6E-06 1.9E-10 66.3 4.4 37 421-457 51-87 (88)
217 cd05886 Ig1_Nectin-1_like Firs 98.0 6.7E-05 1.5E-09 62.2 9.7 36 321-356 62-98 (99)
218 cd05883 Ig2_Necl-2 Second immu 98.0 7.4E-05 1.6E-09 59.2 9.4 76 278-356 2-79 (82)
219 PF07686 V-set: Immunoglobulin 98.0 2.4E-05 5.3E-10 66.6 7.3 94 263-356 4-114 (114)
220 cd05775 Ig_SLAM-CD84_like_N N- 98.0 3E-05 6.5E-10 64.3 7.5 84 273-356 2-96 (97)
221 cd05855 Ig_TrkB_d5 Fifth domai 97.9 4.1E-06 8.8E-11 66.2 2.0 34 422-455 43-76 (79)
222 cd05870 Ig5_NCAM-2 Fifth immun 97.9 3E-06 6.6E-11 70.5 1.4 36 422-457 63-98 (98)
223 cd00099 IgV Immunoglobulin var 97.9 2.2E-05 4.8E-10 66.1 6.6 76 271-346 2-91 (105)
224 cd05773 Ig8_hNephrin_like Eigh 97.9 2.1E-06 4.6E-11 73.0 0.2 40 422-461 68-108 (109)
225 cd04971 Ig_TrKABC_d5 Fifth dom 97.9 1.3E-05 2.9E-10 63.9 4.7 35 422-456 45-79 (81)
226 PF08205 C2-set_2: CD80-like C 97.9 8.5E-05 1.8E-09 60.5 9.6 72 275-347 14-86 (89)
227 cd05726 Ig4_Robo Fhird immunog 97.9 1.1E-05 2.4E-10 65.9 4.3 39 421-459 45-83 (90)
228 smart00407 IGc1 Immunoglobulin 97.9 7.6E-05 1.7E-09 58.6 8.9 68 278-345 2-71 (75)
229 KOG1909|consensus 97.9 4.4E-06 9.6E-11 82.3 2.0 159 55-215 30-227 (382)
230 cd05902 Ig_Neurocan Immunoglob 97.9 7.3E-05 1.6E-09 63.2 9.0 83 275-357 2-107 (110)
231 cd07699 IgC_L Immunoglobulin C 97.9 4.3E-05 9.3E-10 63.7 7.5 86 260-345 1-89 (100)
232 cd05858 Ig3_FGFR-2 Third immun 97.9 1.1E-05 2.4E-10 66.0 3.9 35 423-457 55-89 (90)
233 cd05888 Ig1_Nectin-4_like Frst 97.9 8.1E-05 1.7E-09 62.1 9.1 80 277-356 2-99 (100)
234 cd04969 Ig5_Contactin_like Fif 97.9 1.7E-05 3.8E-10 61.9 4.6 37 421-457 37-73 (73)
235 cd04980 IgV_L_kappa Immunoglob 97.9 3.9E-05 8.5E-10 64.8 7.1 82 263-344 3-93 (106)
236 cd05894 Ig_C5_MyBP-C C5 immuno 97.9 1.6E-05 3.5E-10 64.3 4.4 37 421-457 50-86 (86)
237 cd05771 IgC_Tapasin_R Tapasin- 97.9 9.7E-06 2.1E-10 72.3 3.3 36 323-358 2-37 (139)
238 cd05765 Ig_3 Subgroup of the i 97.9 1.8E-05 3.9E-10 63.1 4.5 36 422-457 46-81 (81)
239 PHA02987 Ig domain OX-2-like p 97.9 9.8E-05 2.1E-09 66.9 9.5 90 268-357 23-122 (189)
240 cd05732 Ig5_NCAM-1_like Fifth 97.8 3.2E-06 7E-11 70.0 -0.2 36 422-457 61-96 (96)
241 cd04982 IgV_TCR_gamma Immunogl 97.8 6.7E-05 1.4E-09 64.5 7.9 78 266-343 4-98 (116)
242 cd05764 Ig_2 Subgroup of the i 97.8 1.2E-05 2.6E-10 63.0 2.8 37 421-457 38-74 (74)
243 cd05736 Ig2_Follistatin_like S 97.8 2E-05 4.4E-10 62.0 4.1 39 420-458 36-74 (76)
244 cd05865 Ig1_NCAM-1 First immun 97.8 2.8E-05 6E-10 64.3 5.0 36 422-457 59-95 (96)
245 cd05859 Ig4_PDGFR-alpha Fourth 97.8 2.9E-05 6.2E-10 64.9 4.6 36 422-457 64-99 (101)
246 cd05846 Ig1_MRC-OX-2_like Firs 97.8 0.00012 2.7E-09 60.7 8.4 82 275-356 1-96 (97)
247 cd05760 Ig2_PTK7 Second immuno 97.8 2.7E-05 5.8E-10 61.6 4.2 35 420-454 35-69 (77)
248 PF12799 LRR_4: Leucine Rich r 97.8 3E-05 6.6E-10 53.6 3.8 38 82-120 2-39 (44)
249 cd07694 Ig2_CD4 Second immunog 97.8 0.00015 3.3E-09 57.3 8.2 76 269-356 8-85 (88)
250 cd04976 Ig2_VEGFR Second immun 97.8 3.1E-05 6.7E-10 60.1 4.4 37 420-456 32-68 (71)
251 cd04975 Ig4_SCFR_like Fourth i 97.8 3.7E-05 7.9E-10 64.2 4.8 36 422-457 64-99 (101)
252 cd05767 IgC_MHC_II_alpha Class 97.7 0.00035 7.6E-09 57.3 10.4 82 260-345 1-84 (94)
253 cd05766 IgC_MHC_II_beta Class 97.7 0.00041 8.9E-09 57.0 10.6 72 273-347 12-85 (94)
254 PF12799 LRR_4: Leucine Rich r 97.7 3.4E-05 7.4E-10 53.4 3.5 38 106-144 2-39 (44)
255 cd05887 Ig1_Nectin-3_like Firs 97.7 0.00021 4.6E-09 58.7 8.8 81 276-356 1-95 (96)
256 cd00096 Ig Immunoglobulin doma 97.7 0.0002 4.4E-09 54.1 8.2 68 278-347 1-68 (74)
257 cd05739 Ig3_RPTP_IIa_LAR_like 97.7 6.8E-05 1.5E-09 57.8 5.2 32 423-456 38-69 (69)
258 cd05770 IgC_beta2m Class I maj 97.7 0.00048 1.1E-08 56.3 10.1 80 261-345 2-83 (93)
259 cd04972 Ig_TrkABC_d4 Fourth do 97.7 7.3E-05 1.6E-09 61.1 5.4 36 422-457 55-90 (90)
260 cd05728 Ig4_Contactin-2-like F 97.7 6.4E-05 1.4E-09 60.7 4.9 37 421-457 49-85 (85)
261 cd05857 Ig2_FGFR Second immuno 97.7 4.9E-05 1.1E-09 61.3 4.0 37 421-457 49-85 (85)
262 PF07679 I-set: Immunoglobulin 97.7 3E-06 6.5E-11 69.2 -3.2 38 420-457 53-90 (90)
263 cd05738 Ig2_RPTP_IIa_LAR_like 97.6 6.5E-05 1.4E-09 58.8 4.5 36 421-456 36-72 (74)
264 cd05856 Ig2_FGFRL1-like Second 97.6 9.3E-05 2E-09 59.0 5.4 35 422-456 47-81 (82)
265 cd05737 Ig_Myomesin_like_C C-t 97.6 5.6E-05 1.2E-09 62.0 4.1 35 423-457 58-92 (92)
266 cd05711 Ig_FcalphaRI Immunoglo 97.6 0.00023 5E-09 58.6 7.7 74 261-342 2-75 (94)
267 KOG3515|consensus 97.6 4.9E-05 1.1E-09 83.3 4.5 80 267-357 14-95 (741)
268 KOG4658|consensus 97.6 7.1E-05 1.5E-09 85.9 5.9 124 37-164 526-653 (889)
269 cd05847 IgC_CH2_IgE CH2 domain 97.6 0.00041 8.8E-09 57.0 8.8 75 274-348 13-89 (94)
270 cd04984 IgV_L_lambda Immunoglo 97.6 0.00015 3.3E-09 60.2 6.4 74 271-344 2-85 (98)
271 KOG2982|consensus 97.6 3.4E-05 7.3E-10 74.5 2.6 159 55-213 71-236 (418)
272 cd05734 Ig7_DSCAM Seventh immu 97.6 8.1E-05 1.8E-09 59.1 4.5 29 421-449 42-70 (79)
273 cd05895 Ig_Pro_neuregulin-1 Im 97.6 6.9E-05 1.5E-09 59.0 3.7 34 421-454 42-75 (76)
274 cd05750 Ig_Pro_neuregulin Immu 97.6 4.2E-05 9.2E-10 59.9 2.4 34 421-454 41-74 (75)
275 cd05866 Ig1_NCAM-2 First immun 97.6 0.00011 2.3E-09 60.2 4.7 28 423-450 56-83 (92)
276 cd05743 Ig_Perlecan_D2_like Im 97.5 7.4E-05 1.6E-09 59.2 3.6 35 421-455 40-74 (78)
277 cd05719 Ig2_PVR_like Second im 97.5 0.00067 1.5E-08 55.8 9.1 77 275-355 15-94 (95)
278 cd05742 Ig1_VEGFR_like First i 97.5 0.00011 2.4E-09 59.1 4.2 37 421-457 47-83 (84)
279 cd05772 IgC_SIRP Signal-regula 97.5 0.0016 3.4E-08 55.2 11.3 74 271-347 17-94 (111)
280 cd07693 Ig1_Robo First immunog 97.5 3.5E-05 7.7E-10 64.0 1.2 27 431-457 72-99 (100)
281 cd05740 Ig_CEACAM_D4 Fourth im 97.5 0.00012 2.7E-09 59.8 4.2 32 420-451 52-83 (91)
282 cd07706 IgV_TCR_delta Immunogl 97.5 0.00048 1E-08 59.2 7.9 81 263-343 2-93 (116)
283 cd05758 Ig5_KIRREL3-like Fifth 97.5 2.2E-05 4.8E-10 65.3 -0.6 33 423-455 64-97 (98)
284 cd05850 Ig1_Contactin-2 First 97.4 4.2E-05 9.1E-10 63.0 1.0 31 421-451 56-87 (94)
285 cd05768 IgC_CH4 CH4 domain (fo 97.4 0.00047 1E-08 57.6 7.0 74 272-345 13-91 (102)
286 cd05756 Ig1_IL1R_like First im 97.4 0.00014 3E-09 59.8 3.5 37 421-457 58-94 (94)
287 PF07654 C1-set: Immunoglobuli 97.4 0.0018 3.8E-08 51.9 9.8 70 274-346 7-78 (83)
288 cd05769 IgC_TCR_beta T cell re 97.4 0.00096 2.1E-08 56.8 8.6 93 260-352 2-99 (115)
289 cd04973 Ig1_FGFR First immunog 97.4 0.00021 4.5E-09 56.8 4.3 36 422-457 44-79 (79)
290 cd05849 Ig1_Contactin-1 First 97.4 6.1E-05 1.3E-09 61.9 1.2 31 421-451 55-86 (93)
291 cd05716 Ig_pIgR Immunoglobulin 97.4 0.00074 1.6E-08 56.0 7.6 75 270-345 2-87 (98)
292 KOG3515|consensus 97.4 0.00027 5.9E-09 77.7 6.0 111 229-343 171-286 (741)
293 cd05875 Ig6_hNeurofascin_like 97.3 0.00023 5E-09 56.2 4.0 33 420-452 36-72 (77)
294 cd07703 Ig2_Nectin-2_like Seco 97.3 0.0017 3.7E-08 53.3 9.2 71 276-350 16-87 (95)
295 cd05724 Ig2_Robo Second immuno 97.3 6E-05 1.3E-09 60.8 0.5 30 422-451 50-79 (86)
296 cd05891 Ig_M-protein_C C-termi 97.3 0.00031 6.7E-09 57.6 4.7 35 423-457 58-92 (92)
297 cd05733 Ig6_L1-CAM_like Sixth 97.3 0.00021 4.6E-09 56.4 3.5 32 420-451 36-71 (77)
298 cd05848 Ig1_Contactin-5 First 97.3 0.00032 6.9E-09 57.8 4.6 31 421-451 56-87 (94)
299 PRK15386 type III secretion pr 97.3 0.00073 1.6E-08 70.0 8.0 129 37-187 55-187 (426)
300 COG5238 RNA1 Ran GTPase-activa 97.3 0.00024 5.3E-09 67.9 3.9 162 54-215 29-228 (388)
301 cd05722 Ig1_Neogenin First imm 97.3 0.00016 3.4E-09 59.7 2.3 34 422-455 53-93 (95)
302 cd07702 Ig2_VEGFR-1 Second imm 97.2 0.00033 7.2E-09 54.3 3.8 31 421-451 34-64 (72)
303 cd05889 Ig1_DNAM-1_like First 97.2 0.002 4.3E-08 53.0 8.4 79 276-354 1-93 (96)
304 cd04977 Ig1_NCAM-1_like First 97.2 0.00049 1.1E-08 56.4 4.8 35 422-456 56-91 (92)
305 KOG3665|consensus 97.2 0.00015 3.3E-09 81.1 2.4 131 56-190 123-263 (699)
306 KOG2982|consensus 97.2 0.00038 8.3E-09 67.4 4.7 81 37-119 74-160 (418)
307 cd07700 IgV_CD8_beta Immunoglo 97.2 0.0026 5.6E-08 53.7 9.3 73 271-343 2-93 (107)
308 cd05874 Ig6_NrCAM Sixth immuno 97.2 0.00039 8.5E-09 54.8 3.9 32 420-451 36-71 (77)
309 cd05861 Ig1_PDGFR-alphabeta Fr 97.2 0.00032 6.9E-09 56.4 3.4 38 421-458 44-83 (84)
310 cd04985 IgC_CH1 CH1 domain (fi 97.2 0.0031 6.8E-08 51.8 9.3 71 274-345 15-87 (95)
311 KOG2123|consensus 97.2 1.8E-05 3.9E-10 75.7 -4.6 82 80-165 18-100 (388)
312 cd07697 IgC_TCR_gamma T cell r 97.2 0.0021 4.5E-08 52.9 8.1 69 274-345 15-85 (96)
313 cd05712 Ig_Siglec_N Immunoglob 97.1 0.0027 5.8E-08 54.8 9.0 79 266-344 5-102 (119)
314 cd05862 Ig1_VEGFR First immuno 97.1 0.00023 4.9E-09 57.5 2.0 39 421-459 48-86 (86)
315 cd04967 Ig1_Contactin First Ig 97.1 0.00064 1.4E-08 55.5 4.7 32 420-451 55-87 (91)
316 PF01462 LRRNT: Leucine rich r 97.1 0.00034 7.4E-09 43.0 2.2 28 23-54 1-28 (28)
317 cd07696 IgC_CH3 CH3 domain (th 97.1 0.0022 4.7E-08 52.9 7.6 75 270-345 9-86 (96)
318 cd05754 Ig3_Perlecan_like Thir 97.1 0.00062 1.3E-08 54.8 4.3 35 421-455 50-84 (85)
319 cd05898 Ig5_KIRREL3 Fifth immu 97.1 0.00012 2.5E-09 60.5 -0.0 35 421-455 62-97 (98)
320 KOG2739|consensus 97.1 0.0003 6.5E-09 67.2 2.7 86 80-167 42-130 (260)
321 smart00082 LRRCT Leucine rich 97.1 0.00028 6E-09 50.7 1.8 49 211-260 1-51 (51)
322 smart00013 LRRNT Leucine rich 97.1 0.00065 1.4E-08 43.7 3.3 31 23-57 1-31 (33)
323 cd05749 Ig2_Tyro3_like Second 97.0 0.00074 1.6E-08 53.8 4.1 29 421-451 47-75 (81)
324 KOG3665|consensus 96.9 0.00056 1.2E-08 76.7 3.4 131 81-213 122-262 (699)
325 PRK15386 type III secretion pr 96.9 0.0035 7.5E-08 65.1 8.8 133 55-212 52-188 (426)
326 KOG2120|consensus 96.9 3.1E-05 6.8E-10 74.8 -5.7 129 82-211 186-323 (419)
327 cd04986 IgC_CH2 CH2 domain (se 96.9 0.0033 7E-08 51.8 6.8 85 259-346 2-90 (99)
328 cd05753 Ig2_FcgammaR_like Seco 96.9 0.00079 1.7E-08 53.9 2.9 28 421-448 46-73 (83)
329 cd05752 Ig1_FcgammaR_like Frst 96.8 0.0011 2.4E-08 52.3 3.3 24 421-445 45-68 (78)
330 cd05757 Ig2_IL1R_like Second i 96.8 0.00082 1.8E-08 55.0 2.6 35 421-455 50-84 (92)
331 cd04981 IgV_H Immunoglobulin ( 96.8 0.0049 1.1E-07 52.9 7.2 78 266-343 3-97 (117)
332 cd05729 Ig2_FGFR_like Second i 96.7 0.0017 3.6E-08 51.9 4.0 34 423-456 51-84 (85)
333 KOG2739|consensus 96.7 0.00059 1.3E-08 65.2 1.4 102 103-206 41-148 (260)
334 cd05720 Ig_CD8_alpha Immunoglo 96.7 0.0029 6.4E-08 53.1 5.5 73 271-343 2-90 (104)
335 KOG2123|consensus 96.7 0.00011 2.4E-09 70.4 -3.8 101 103-207 17-123 (388)
336 PHA03376 BARF1; Provisional 96.7 0.014 3E-07 52.9 9.3 80 269-348 20-113 (221)
337 cd07692 Ig_CD3_epsilon Immunog 96.6 0.003 6.5E-08 47.0 4.2 52 273-344 5-56 (65)
338 cd05871 Ig_Semaphorin_classIII 96.6 0.0034 7.3E-08 51.2 4.5 39 421-459 51-90 (91)
339 smart00406 IGv Immunoglobulin 96.5 0.0048 1E-07 48.7 5.2 65 277-341 1-81 (81)
340 KOG1026|consensus 96.5 0.003 6.6E-08 69.7 5.0 136 203-357 137-273 (774)
341 cd07704 Ig2_Nectin-3-4_like Se 96.4 0.025 5.4E-07 46.4 8.8 74 269-346 10-85 (97)
342 cd05727 Ig2_Contactin-2-like S 96.4 0.0025 5.4E-08 52.3 2.9 32 418-449 55-86 (96)
343 KOG2120|consensus 96.4 0.00042 9.1E-09 67.2 -2.2 153 56-210 186-347 (419)
344 COG5238 RNA1 Ran GTPase-activa 96.3 0.0051 1.1E-07 59.1 4.8 132 79-210 90-251 (388)
345 cd05886 Ig1_Nectin-1_like Firs 96.2 0.0036 7.9E-08 51.9 2.8 38 421-458 61-99 (99)
346 PHA02633 hypothetical protein; 96.2 0.0079 1.7E-07 43.9 4.0 41 421-461 16-56 (63)
347 cd05882 Ig1_Necl-1 First (N-te 96.1 0.0071 1.5E-07 49.7 4.2 23 422-444 61-83 (95)
348 cd04979 Ig_Semaphorin_C Immuno 96.0 0.0072 1.6E-07 49.0 3.8 38 422-459 50-88 (89)
349 KOG4597|consensus 95.9 0.0099 2.2E-07 61.0 4.7 90 263-356 199-291 (560)
350 cd05713 Ig_MOG_like Immunoglob 95.9 0.0058 1.3E-07 50.8 2.6 37 421-457 63-99 (100)
351 PHA02633 hypothetical protein; 95.8 0.019 4.1E-07 42.0 4.6 36 322-357 18-53 (63)
352 cd07691 Ig_CD3_gamma_delta Imm 95.8 0.023 5E-07 42.7 5.1 50 274-343 5-54 (69)
353 smart00408 IGc2 Immunoglobulin 95.8 0.0099 2.1E-07 43.7 3.3 28 420-447 36-63 (63)
354 cd07701 Ig1_Necl-3 First (N-te 95.7 0.015 3.2E-07 47.9 4.3 35 421-456 60-94 (95)
355 cd05888 Ig1_Nectin-4_like Frst 95.6 0.0092 2E-07 49.7 2.6 37 421-457 62-99 (100)
356 PHA03376 BARF1; Provisional 95.5 0.02 4.3E-07 52.0 4.7 48 421-470 85-132 (221)
357 cd07690 Ig1_CD4 First immunogl 95.5 0.012 2.6E-07 48.2 3.1 28 423-450 65-92 (94)
358 cd05897 Ig2_IL1R2_like Second 95.5 0.0099 2.1E-07 48.7 2.6 28 422-449 54-81 (95)
359 KOG1480|consensus 95.3 0.0028 6.1E-08 68.6 -1.6 86 262-356 131-220 (909)
360 cd05896 Ig1_IL1RAPL-1_like Fir 95.3 0.016 3.4E-07 47.9 3.1 37 420-456 67-103 (104)
361 cd05714 Ig_CSPGs_LP Immunoglob 95.3 0.011 2.4E-07 49.7 2.3 39 420-458 65-103 (106)
362 cd05877 Ig_LP_like Immunoglobu 95.1 0.013 2.8E-07 49.3 2.2 36 422-457 67-102 (106)
363 cd05887 Ig1_Nectin-3_like Firs 95.1 0.017 3.7E-07 47.5 2.8 38 420-457 57-95 (96)
364 PF00047 ig: Immunoglobulin do 95.1 0.022 4.7E-07 42.7 3.2 18 425-442 47-64 (64)
365 cd05717 Ig1_Necl-1-3_like Firs 94.9 0.019 4.2E-07 47.1 2.6 34 422-456 61-94 (95)
366 PF08204 V-set_CD47: CD47 immu 94.9 0.044 9.6E-07 47.2 4.7 83 274-357 26-120 (130)
367 cd05775 Ig_SLAM-CD84_like_N N- 94.7 0.022 4.7E-07 47.1 2.4 42 416-457 54-96 (97)
368 smart00409 IG Immunoglobulin. 94.7 0.059 1.3E-06 42.2 4.9 36 422-457 50-85 (86)
369 smart00410 IG_like Immunoglobu 94.7 0.059 1.3E-06 42.2 4.9 36 422-457 50-85 (86)
370 cd05718 Ig1_PVR_like First imm 94.6 0.027 5.9E-07 46.4 2.7 37 421-457 60-97 (98)
371 cd05774 Ig_CEACAM_D1 First imm 94.6 0.029 6.3E-07 47.0 2.8 36 420-455 67-103 (105)
372 cd05873 Ig_Sema4D_like Immunog 94.5 0.021 4.6E-07 46.0 1.9 26 421-446 46-71 (87)
373 cd05845 Ig2_L1-CAM_like Second 94.5 0.047 1E-06 44.7 3.9 31 418-448 53-84 (95)
374 PF13927 Ig_3: Immunoglobulin 94.4 0.02 4.2E-07 44.1 1.4 25 420-444 51-75 (75)
375 PF13895 Ig_2: Immunoglobulin 94.3 0.046 1E-06 42.7 3.4 23 425-447 47-69 (80)
376 cd05721 IgV_CTLA-4 Immunoglobu 94.3 0.23 5E-06 41.9 7.5 77 265-341 3-93 (115)
377 cd05860 Ig4_SCFR Fourth immuno 93.7 0.054 1.2E-06 44.7 2.8 36 422-457 64-99 (101)
378 cd05878 Ig_Aggrecan_like Immun 93.5 0.046 1E-06 46.3 2.2 38 420-457 69-106 (110)
379 PF00560 LRR_1: Leucine Rich R 93.4 0.048 1E-06 31.3 1.4 12 132-143 3-14 (22)
380 PF00560 LRR_1: Leucine Rich R 93.4 0.042 9.2E-07 31.5 1.2 14 83-96 2-15 (22)
381 PF05790 C2-set: Immunoglobuli 93.4 0.64 1.4E-05 36.7 8.2 52 289-356 26-78 (80)
382 cd05900 Ig_Aggrecan Immunoglob 93.3 0.068 1.5E-06 45.4 2.8 37 421-457 72-108 (112)
383 cd05741 Ig_CEACAM_D1_like Firs 93.0 0.077 1.7E-06 43.0 2.7 29 422-450 56-84 (92)
384 cd05885 Ig2_Necl-4 Second immu 93.0 0.18 3.9E-06 39.8 4.6 28 422-449 42-69 (80)
385 cd05879 Ig_P0 Immunoglobulin ( 92.9 0.064 1.4E-06 45.8 2.1 29 420-448 77-105 (116)
386 smart00369 LRR_TYP Leucine-ric 92.7 0.094 2E-06 31.4 2.1 21 105-125 2-22 (26)
387 smart00370 LRR Leucine-rich re 92.7 0.094 2E-06 31.4 2.1 21 105-125 2-22 (26)
388 cd05901 Ig_Versican Immunoglob 92.7 0.086 1.9E-06 44.9 2.5 37 421-457 77-113 (117)
389 cd05889 Ig1_DNAM-1_like First 92.4 0.1 2.3E-06 42.8 2.7 34 421-454 58-92 (96)
390 cd05846 Ig1_MRC-OX-2_like Firs 92.4 0.11 2.3E-06 42.8 2.8 37 421-457 59-96 (97)
391 PHA03042 CD47-like protein; Pr 92.2 0.56 1.2E-05 45.3 7.6 70 274-356 30-104 (286)
392 cd05902 Ig_Neurocan Immunoglob 92.2 0.082 1.8E-06 44.7 1.8 37 421-457 70-106 (110)
393 cd07689 Ig2_VCAM-1 Second immu 92.1 0.59 1.3E-05 38.3 6.5 70 272-344 12-85 (99)
394 cd05880 Ig_EVA1 Immunoglobulin 92.1 0.1 2.2E-06 44.7 2.2 28 421-448 77-104 (115)
395 smart00370 LRR Leucine-rich re 91.8 0.14 3E-06 30.7 2.0 22 81-102 2-23 (26)
396 smart00369 LRR_TYP Leucine-ric 91.8 0.14 3E-06 30.7 2.0 22 81-102 2-23 (26)
397 PF13504 LRR_7: Leucine rich r 91.3 0.13 2.9E-06 27.4 1.4 11 107-117 3-13 (17)
398 cd05715 Ig_P0-like Immunoglobu 91.2 0.15 3.2E-06 43.6 2.5 27 421-447 78-104 (116)
399 KOG3864|consensus 90.9 0.053 1.1E-06 50.2 -0.7 81 106-186 102-185 (221)
400 PHA02865 MHC-like TNF binding 90.7 1.1 2.4E-05 45.2 8.3 80 259-345 202-304 (338)
401 PF07354 Sp38: Zona-pellucida- 90.5 0.35 7.7E-06 46.5 4.3 49 288-345 11-60 (271)
402 cd05751 Ig1_LILRB1_like First 90.3 0.21 4.6E-06 40.5 2.5 26 420-445 50-75 (91)
403 KOG0473|consensus 88.9 0.022 4.7E-07 53.7 -4.9 84 127-213 40-123 (326)
404 KOG0473|consensus 88.3 0.0096 2.1E-07 56.0 -7.6 86 101-189 38-123 (326)
405 cd04983 IgV_TCR_alpha_like Imm 88.0 0.28 6.2E-06 41.1 1.7 27 421-447 68-94 (109)
406 cd05872 Ig_Sema4B_like Immunog 87.5 0.67 1.5E-05 37.1 3.4 31 423-454 47-77 (85)
407 cd00099 IgV Immunoglobulin var 87.3 0.26 5.7E-06 40.9 1.0 26 422-447 66-91 (105)
408 cd05890 Ig2_Nectin-1_like Seco 87.1 3 6.6E-05 33.7 6.7 73 277-355 22-97 (98)
409 PF07686 V-set: Immunoglobulin 87.0 0.36 7.7E-06 40.5 1.7 24 422-445 78-101 (114)
410 KOG3864|consensus 86.5 0.095 2.1E-06 48.6 -2.2 34 56-91 102-135 (221)
411 cd05759 Ig2_KIRREL3-like Secon 86.3 1 2.2E-05 35.5 4.0 25 424-448 47-71 (82)
412 PHA02982 hypothetical protein; 86.2 1.6 3.5E-05 40.4 5.4 81 268-348 32-126 (251)
413 KOG1480|consensus 85.7 0.28 6E-06 53.8 0.4 31 420-450 180-210 (909)
414 PF11465 Receptor_2B4: Natural 84.6 4.3 9.4E-05 33.5 6.7 35 322-356 71-106 (108)
415 cd05881 Ig1_Necl-2 First (N-te 84.5 0.49 1.1E-05 38.8 1.3 24 422-445 61-84 (95)
416 cd05899 IgV_TCR_beta Immunoglo 83.3 0.72 1.6E-05 38.9 1.9 26 422-447 71-96 (110)
417 cd00096 Ig Immunoglobulin doma 83.0 1.7 3.7E-05 31.6 3.8 28 420-447 40-67 (74)
418 PHA03270 envelope glycoprotein 82.1 15 0.00032 38.2 10.8 86 259-347 220-310 (466)
419 cd04984 IgV_L_lambda Immunoglo 80.0 0.91 2E-05 37.3 1.3 25 421-445 61-85 (98)
420 cd04980 IgV_L_kappa Immunoglob 79.5 0.84 1.8E-05 38.1 0.9 24 422-445 70-93 (106)
421 KOG4308|consensus 78.6 0.093 2E-06 56.5 -6.4 157 57-213 89-274 (478)
422 PHA02987 Ig domain OX-2-like p 78.0 4.6 9.9E-05 37.2 5.2 40 420-459 82-123 (189)
423 PHA03273 envelope glycoprotein 78.0 21 0.00046 37.4 10.5 86 260-347 237-327 (486)
424 smart00365 LRR_SD22 Leucine-ri 77.6 1.8 4E-05 25.9 1.7 16 105-120 2-17 (26)
425 PF03921 ICAM_N: Intercellular 77.3 37 0.0008 27.5 9.9 80 262-356 5-85 (91)
426 smart00406 IGv Immunoglobulin 76.6 0.95 2.1E-05 35.2 0.4 21 421-441 60-80 (81)
427 PHA03269 envelope glycoprotein 74.8 8.5 0.00018 40.5 6.7 87 260-348 329-420 (566)
428 cd05716 Ig_pIgR Immunoglobulin 74.7 1.3 2.9E-05 36.2 0.9 24 423-446 64-87 (98)
429 PF06832 BiPBP_C: Penicillin-B 74.5 27 0.00058 28.0 8.5 56 277-350 31-86 (89)
430 PF06328 Lep_receptor_Ig: Ig-l 74.1 11 0.00024 30.3 6.0 69 264-340 7-80 (89)
431 PHA03052 Hypothetical protein; 72.8 8.7 0.00019 28.8 4.5 37 267-303 4-43 (69)
432 cd04982 IgV_TCR_gamma Immunogl 72.8 1.7 3.8E-05 36.8 1.1 23 422-444 76-98 (116)
433 PF13516 LRR_6: Leucine Rich r 72.6 1.9 4E-05 25.1 0.9 16 153-168 2-17 (24)
434 cd05720 Ig_CD8_alpha Immunoglo 72.5 1.6 3.5E-05 36.4 0.8 24 421-444 67-90 (104)
435 smart00364 LRR_BAC Leucine-ric 71.5 2.4 5.3E-05 25.3 1.2 18 55-72 2-19 (26)
436 KOG0613|consensus 70.4 17 0.00036 43.1 8.5 37 423-459 393-429 (1205)
437 cd07691 Ig_CD3_gamma_delta Imm 70.0 5.2 0.00011 30.3 2.9 23 422-444 32-54 (69)
438 KOG1947|consensus 69.9 1.3 2.9E-05 47.8 -0.3 85 55-141 214-307 (482)
439 KOG4308|consensus 69.7 0.22 4.7E-06 53.7 -6.3 18 101-118 111-128 (478)
440 cd07700 IgV_CD8_beta Immunoglo 69.7 2 4.4E-05 35.9 0.8 22 423-444 72-93 (107)
441 cd05712 Ig_Siglec_N Immunoglob 67.0 3.2 6.9E-05 35.5 1.5 25 421-445 78-102 (119)
442 KOG1947|consensus 66.9 2.4 5.1E-05 45.9 0.9 108 80-187 187-305 (482)
443 cd07706 IgV_TCR_delta Immunogl 65.6 2.6 5.7E-05 35.8 0.7 23 422-444 71-93 (116)
444 PF11465 Receptor_2B4: Natural 64.5 5 0.00011 33.2 2.1 38 414-451 62-99 (108)
445 PHA02914 Immunoglobulin-like d 64.1 21 0.00045 36.7 6.7 89 268-356 272-380 (500)
446 KOG3763|consensus 62.9 3.8 8.3E-05 43.9 1.4 66 151-216 216-285 (585)
447 cd00098 IgC Immunoglobulin Con 59.1 12 0.00027 30.0 3.6 24 425-448 64-87 (95)
448 PHA03271 envelope glycoprotein 58.7 49 0.0011 34.3 8.3 85 260-346 247-336 (490)
449 PF02480 Herpes_gE: Alphaherpe 56.7 15 0.00033 39.2 4.6 21 323-343 270-290 (439)
450 PF02124 Marek_A: Marek's dise 56.2 60 0.0013 30.7 7.9 148 291-443 8-158 (211)
451 KOG4341|consensus 55.5 4.7 0.0001 41.8 0.6 37 79-115 292-330 (483)
452 KOG4597|consensus 54.7 15 0.00032 38.7 3.9 50 420-469 254-303 (560)
453 PF08204 V-set_CD47: CD47 immu 54.6 6.8 0.00015 33.9 1.4 37 420-457 83-119 (130)
454 KOG3763|consensus 54.5 7.7 0.00017 41.7 2.0 64 103-166 216-283 (585)
455 PHA03189 UL14 tegument protein 54.1 47 0.001 32.9 7.0 85 267-352 59-164 (348)
456 smart00368 LRR_RI Leucine rich 53.3 11 0.00023 22.9 1.7 13 106-118 3-15 (28)
457 KOG4341|consensus 52.8 8.9 0.00019 39.9 2.0 60 56-116 295-357 (483)
458 KOG1026|consensus 51.8 23 0.0005 40.1 5.2 67 285-357 297-363 (774)
459 cd04981 IgV_H Immunoglobulin ( 51.3 6.4 0.00014 33.5 0.7 21 424-444 77-97 (117)
460 cd05711 Ig_FcalphaRI Immunoglo 48.8 9.3 0.0002 31.0 1.3 22 422-443 54-75 (94)
461 PF12355 Dscam_C: Down syndrom 47.2 20 0.00043 29.5 2.8 21 561-581 35-55 (124)
462 cd07694 Ig2_CD4 Second immunog 46.8 19 0.0004 28.9 2.6 32 420-451 48-79 (88)
463 TIGR00864 PCC polycystin catio 46.5 13 0.00028 47.8 2.5 32 111-142 1-32 (2740)
464 PF05955 Herpes_gp2: Equine he 44.0 53 0.0011 29.8 5.2 63 281-343 113-177 (226)
465 PF01463 LRRCT: Leucine rich r 42.1 11 0.00025 22.2 0.6 24 236-260 2-25 (25)
466 PHA03282 envelope glycoprotein 41.4 1.2E+02 0.0026 32.1 8.0 21 323-343 334-354 (540)
467 PHA03273 envelope glycoprotein 39.6 5E+02 0.011 27.8 12.1 18 281-298 357-376 (486)
468 cd05883 Ig2_Necl-2 Second immu 37.8 39 0.00084 26.7 3.2 22 424-446 45-67 (82)
469 PF07354 Sp38: Zona-pellucida- 37.1 23 0.0005 34.5 2.1 27 420-446 34-60 (271)
470 PF05725 FNIP: FNIP Repeat; I 35.2 49 0.0011 22.4 3.0 34 52-89 9-42 (44)
471 PHA02982 hypothetical protein; 28.7 35 0.00076 31.9 1.7 58 412-470 89-147 (251)
472 PF05790 C2-set: Immunoglobuli 28.6 56 0.0012 25.7 2.6 30 422-451 42-72 (80)
473 PF02440 Adeno_E3_CR1: Adenovi 26.4 1.8E+02 0.004 21.7 4.9 21 272-296 2-22 (63)
474 PHA03240 envelope glycoprotein 26.3 91 0.002 29.2 3.9 69 269-337 32-120 (258)
475 PHA03283 envelope glycoprotein 25.2 1.4E+02 0.003 32.2 5.5 37 322-358 134-170 (542)
476 PF12885 TORC_M: Transducer of 23.3 94 0.002 27.4 3.2 23 570-592 89-111 (150)
477 PF15183 MRAP: Melanocortin-2 23.1 1.3E+02 0.0028 23.7 3.6 31 4-34 51-82 (90)
478 PHA03283 envelope glycoprotein 22.8 3.1E+02 0.0068 29.7 7.5 21 323-343 316-336 (542)
479 KOG0613|consensus 22.7 49 0.0011 39.4 1.9 85 268-356 342-427 (1205)
480 PHA03282 envelope glycoprotein 20.5 1.6E+02 0.0034 31.3 4.7 39 319-357 121-161 (540)
No 1
>KOG4194|consensus
Probab=100.00 E-value=5.7e-48 Score=390.48 Aligned_cols=332 Identities=22% Similarity=0.347 Sum_probs=228.8
Q ss_pred CCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCcccccCCchhhHHHHhhcc
Q psy10487 151 KLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPWCCDCHLRSFRNWLLKSK 230 (610)
Q Consensus 151 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~~~l~~~~ 230 (610)
.|++|+.|+|.+|+|+.|...+|..+..|++|||.+|.|.++.+++|.++ +|++|.+..-.|-|||++.|+..|+...+
T Consensus 390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~ 468 (873)
T KOG4194|consen 390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRK 468 (873)
T ss_pred cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcc
Confidence 34444444444444444444444455555555555555555555555544 45555555555799999999999999888
Q ss_pred CCCC-CCCCCCCCccCCCcccccccccccC----CCceeeeecceEeecCceEEEEEEEEe--cCCCeEEEEeCCEEecc
Q psy10487 231 LYSH-PLSCTEPGMLQTKHWDDVKAQEFAC----PPNVTIKESMVIREAGGNVTMSCYVYG--DPEPTILWLLNGQVLHN 303 (610)
Q Consensus 231 l~~~-~~~C~a~~~l~g~~~~~v~~~~~~c----~P~i~~~~~~~~v~~G~~v~l~C~~~g--~P~p~v~W~~~g~~l~~ 303 (610)
++.. ...|..|..+.+..+..+...++.| +|.|...|..+.+..|++++|+|.|.+ .-+-++.|.++......
T Consensus 469 lq~sv~a~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~sssasplsi~WR~dnevq~r 548 (873)
T KOG4194|consen 469 LQSSVIAKCAYPEPLADQSIVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNEVQPR 548 (873)
T ss_pred cccceeeeccCCcccccceeEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccCCCCCceeEeeeccccCcc
Confidence 7643 4589999999999999999999998 488999999999999999999999987 55668999997663221
Q ss_pred ---CCcc----ceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce-eEEEEEEcCccccccccccCCcceeeh
Q psy10487 304 ---SSFD----LLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA-SGEISLDLPEINLATTLSKTDSWYMLV 375 (610)
Q Consensus 304 ---~~~~----~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~L~V~~~~~~p~~~~~~~~~~~~ 375 (610)
.++. +...+..+....+.+.|.+.+|+..|+|.|+|++.|..|+. +..+.|+| ...|.+.+.|....+.
T Consensus 549 v~ved~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV---~~~PsFtktP~dltl~ 625 (873)
T KOG4194|consen 549 VDVEDFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTV---NQAPSFTKTPEDLTLR 625 (873)
T ss_pred cchhcchhhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhheeEEEe---eccCccccCcccceee
Confidence 1110 11111112223556799999999999999999999999986 55888988 6778999999999988
Q ss_pred hhhHHHHHHHHHhheeEEEEEEeeecc-cccccccCCccccccccccccceeeeeeeeccCcceeeeecCCCcceeeeee
Q psy10487 376 LGISVCVVSVIVSIGMSFCVCRAHEHK-NKRRKRKGKMKQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQ 454 (610)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 454 (610)
.+..+-+.|.+.+-+-+.+.|.+.+.+ .+. -...++.+..++..+.|.+|+.+|+|.|+|.|.|.+|+.+..+.
T Consensus 626 tg~mArl~CaAtG~P~PeIawqkdggtdFPA-----A~eRRl~Vmpedd~f~Itnvk~eD~GiYtC~A~n~AG~isanAt 700 (873)
T KOG4194|consen 626 TGQMARLECAATGHPRPEIAWQKDGGTDFPA-----ARERRLHVMPEDDVFFITNVKIEDQGIYTCTAQNVAGQISANAT 700 (873)
T ss_pred cccceeeeeeccCCCCcceeehhcCCCCCch-----hhhheeeecCCCCEEEEecccccccceeEEeeeccccceeeceE
Confidence 877776544444444333333333222 000 01122344566677999999999999999999999999999999
Q ss_pred cccccCCCcceeEecC---CCCCc-----ccccCCCc--ccccCCCC
Q psy10487 455 SLAMEQPPVHITIESH---AVDPQ-----VSVFPPPP--EFSSNHLP 491 (610)
Q Consensus 455 l~v~~~pp~~i~ie~~---~~~~l-----~~~~P~pp--ef~~~~~p 491 (610)
|+|.|.|...+-.|.. .++++ +++.|+-| +|...--|
T Consensus 701 L~V~e~p~f~~PL~~~~V~~get~vlqC~a~~~~a~pr~~W~k~d~p 747 (873)
T KOG4194|consen 701 LTVLETPSFSIPLEDQLVVVGETLVLQCLAEGAPADPRLEWFKEDKP 747 (873)
T ss_pred EEEecCCcccccccceEEEecceEEEEEecCCCCCCccccccCCCCc
Confidence 9999986544332221 12333 77777744 88865433
No 2
>KOG4194|consensus
Probab=100.00 E-value=2.1e-36 Score=306.72 Aligned_cols=386 Identities=22% Similarity=0.327 Sum_probs=283.1
Q ss_pred CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCC---cccccCCCC
Q psy10487 54 DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLH---QDTFLGNDR 130 (610)
Q Consensus 54 ~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~---~~~f~~l~~ 130 (610)
-..|++|+|++|+|+.++++.|. .|..|+.|+|++|+|..+..++|.++.+|++|||++|.|+... ...|.+|++
T Consensus 316 tqkL~~LdLs~N~i~~l~~~sf~--~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~ 393 (873)
T KOG4194|consen 316 TQKLKELDLSSNRITRLDEGSFR--VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPS 393 (873)
T ss_pred cccceeEeccccccccCChhHHH--HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchh
Confidence 35799999999999999999998 7899999999999999999999999999999999999987543 456899999
Q ss_pred CcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccccccccc------ccccccCcccc-------
Q psy10487 131 LKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNG------NRLKHLSESVF------- 197 (610)
Q Consensus 131 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~------n~l~~~~~~~~------- 197 (610)
|+.|.|.+|++..+...+|.++..|++|+|.+|.|..|.+++|..+ +|+.|.+.. +++..+.+...
T Consensus 394 LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq~s 472 (873)
T KOG4194|consen 394 LRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQSS 472 (873)
T ss_pred hhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHHHHHhcccccc
Confidence 9999999999999999999999999999999999999999999887 787776543 33332211000
Q ss_pred --------cCCCcccEEecCCCcccccC-------------------------------------------------Cch
Q psy10487 198 --------FPTPNLKTLSLDGNPWCCDC-------------------------------------------------HLR 220 (610)
Q Consensus 198 --------~~~~~L~~l~l~~N~~~c~c-------------------------------------------------~l~ 220 (610)
..+.....+.++.-.+.|+- ...
T Consensus 473 v~a~CayPe~Lad~~i~svd~~~lvC~DspkpqI~~qPe~~~al~g~nirftC~a~sssasplsi~WR~dnevq~rv~ve 552 (873)
T KOG4194|consen 473 VIAKCAYPEPLADQSIVSVDTANLVCDDSPKPQIVTQPETVSALIGENIRFTCNAYSSSASPLSIEWRKDNEVQPRVDVE 552 (873)
T ss_pred eeeeccCCcccccceeEeechhhceecCCCCcceecCchHhhhhhccceEEEEEeccCCCCCceeEeeeccccCcccchh
Confidence 01111112222222233321 111
Q ss_pred hhHHHHhhc---------------------cCCCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEE
Q psy10487 221 SFRNWLLKS---------------------KLYSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVT 279 (610)
Q Consensus 221 ~~~~~l~~~---------------------~l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~ 279 (610)
+|..+.... --+.+.|+|+..|.++....+.+.... .-.|.+...|.+.+...|+.+.
T Consensus 553 d~a~~~~q~r~~~~~e~~~~~~~L~L~nVt~td~grYQCVvtN~FGStysqk~KltV-~~~PsFtktP~dltl~tg~mAr 631 (873)
T KOG4194|consen 553 DFATFLSQNRNGTFGEREEYTAILHLDNVTFTDEGRYQCVVTNHFGSTYSQKAKLTV-NQAPSFTKTPEDLTLRTGQMAR 631 (873)
T ss_pred cchhhhhhhccCccchhhhhhheeeeeeeecccCceEEEEEecccCcchhheeEEEe-eccCccccCcccceeeccccee
Confidence 122211111 024568999999988887777666543 3569999999999999999999
Q ss_pred EEEEEEecCCCeEEEEeCCEE-eccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCc
Q psy10487 280 MSCYVYGDPEPTILWLLNGQV-LHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 280 l~C~~~g~P~p~v~W~~~g~~-l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
|.|.|.|.|.|+|.|.|+|.. +.....++...-.++ ....|.||+.+|.|.|+|.|.|.+|..++.++|.|.+
T Consensus 632 l~CaAtG~P~PeIawqkdggtdFPAA~eRRl~Vmped------d~f~Itnvk~eD~GiYtC~A~n~AG~isanAtL~V~e 705 (873)
T KOG4194|consen 632 LECAATGHPRPEIAWQKDGGTDFPAARERRLHVMPED------DVFFITNVKIEDQGIYTCTAQNVAGQISANATLTVLE 705 (873)
T ss_pred eeeeccCCCCcceeehhcCCCCCchhhhheeeecCCC------CEEEEecccccccceeEEeeeccccceeeceEEEEec
Confidence 999999999999999998765 554433333222221 2788999999999999999999999999999999954
Q ss_pred cccccccccCCcceeehhhhHHHHHHHHHhheeEEEEEEeeecccccccccCCcccccc------ccccccceeeeeeee
Q psy10487 359 INLATTLSKTDSWYMLVLGISVCVVSVIVSIGMSFCVCRAHEHKNKRRKRKGKMKQSVS------FNDQEKKLLDVSITT 432 (610)
Q Consensus 359 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~L~i~~v~~ 432 (610)
. |.+..+-+...+..+.. ....|.....+...+..|.+....+. +.+.+.-|.+.+...
T Consensus 706 ~---p~f~~PL~~~~V~~get------------~vlqC~a~~~~a~pr~~W~k~d~pil~t~rh~f~d~dQllvv~~~~~ 770 (873)
T KOG4194|consen 706 T---PSFSIPLEDQLVVVGET------------LVLQCLAEGAPADPRLEWFKEDKPILITERHTFPDGDQLLVVKENLV 770 (873)
T ss_pred C---CcccccccceEEEecce------------EEEEEecCCCCCCccccccCCCCceEEeecccCCCCCeEEEEEehhh
Confidence 3 33333333333333222 24456665555544466666666553 335666788888889
Q ss_pred ccCcceeeeecCCCcceeeeeecccccCCCcc
Q psy10487 433 TDRHTGSCEALGSQPDMELIEQSLAMEQPPVH 464 (610)
Q Consensus 433 ~D~G~Y~C~A~N~~G~~~~~~~l~v~~~pp~~ 464 (610)
+|+|.|+|+..|..|.......+.++.++--+
T Consensus 771 ~daG~yTcem~~~~~~~~~~i~l~~~~~~~~~ 802 (873)
T KOG4194|consen 771 EDAGIYTCEMSNTLGTERIHICLLVYQKKKCR 802 (873)
T ss_pred hhcceEEEEEEeeccceeeEEEEEEeecCCcc
Confidence 99999999999999988777777776554333
No 3
>KOG4237|consensus
Probab=99.97 E-value=4.4e-32 Score=264.37 Aligned_cols=235 Identities=28% Similarity=0.476 Sum_probs=205.0
Q ss_pred CCCCCCCeeCccCCCcEEEcCCCCCCccCcccCCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhh
Q psy10487 22 TDCPDTCRCKWTLGKKSALCKDANFTALPSTLDSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTF 101 (610)
Q Consensus 22 ~~Cp~~C~C~~~~~~~~~~C~~~~l~~lP~~l~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f 101 (610)
..||..|+|.... ...|+|++++|+++|..+|.+...|+|..|.|+.|++++|+ .+.+|+.|+|++|+|..|.+++|
T Consensus 35 ~~CP~pC~Cs~~~-g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~--~l~~LRrLdLS~N~Is~I~p~AF 111 (498)
T KOG4237|consen 35 SACPAPCTCSDVE-GGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFK--TLHRLRRLDLSKNNISFIAPDAF 111 (498)
T ss_pred ccCCCCcccCCCC-CceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhcc--chhhhceecccccchhhcChHhh
Confidence 4799999999765 58899999999999999999999999999999999999999 79999999999999999999999
Q ss_pred cCCCCCcEEEccC-CCCCCCCccc--------------------------------------------------------
Q psy10487 102 KYLTILVEVDLSD-NQIAWLHQDT-------------------------------------------------------- 124 (610)
Q Consensus 102 ~~l~~L~~LdLs~-n~l~~l~~~~-------------------------------------------------------- 124 (610)
.++++|.+|-+-+ |+|++++.+.
T Consensus 112 ~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~ 191 (498)
T KOG4237|consen 112 KGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIK 191 (498)
T ss_pred hhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccc
Confidence 9999987775544 8888765322
Q ss_pred ------------------------------------------------------------------------------cc
Q psy10487 125 ------------------------------------------------------------------------------FL 126 (610)
Q Consensus 125 ------------------------------------------------------------------------------f~ 126 (610)
|.
T Consensus 192 tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~ 271 (498)
T KOG4237|consen 192 TLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFK 271 (498)
T ss_pred hHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHh
Confidence 45
Q ss_pred CCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEE
Q psy10487 127 GNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTL 206 (610)
Q Consensus 127 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l 206 (610)
++++|+.|+|++|.|+.+...+|.++.+|+.|.|..|+|..+....|.++..|+.|+|.+|+|+.+.+..|..+..|.+|
T Consensus 272 ~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l 351 (498)
T KOG4237|consen 272 KLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTL 351 (498)
T ss_pred hcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeee
Confidence 56667777777777777777777777777777777777777777778888889999999999999999999999999999
Q ss_pred ecCCCcccccCCchhhHHHHhhccCCCCCCCCCCCCccCCCcccccccccccCC
Q psy10487 207 SLDGNPWCCDCHLRSFRNWLLKSKLYSHPLSCTEPGMLQTKHWDDVKAQEFACP 260 (610)
Q Consensus 207 ~l~~N~~~c~c~l~~~~~~l~~~~l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~ 260 (610)
.+-+|+|.|+|++.|+..|+..+. ..+...|..|..+++..+.++...+|.|.
T Consensus 352 ~l~~Np~~CnC~l~wl~~Wlr~~~-~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~ 404 (498)
T KOG4237|consen 352 NLLSNPFNCNCRLAWLGEWLRKKS-VVGNPRCQSPGFVRQIPISDVAFGDFRCG 404 (498)
T ss_pred ehccCcccCccchHHHHHHHhhCC-CCCCCCCCCCchhccccchhccccccccC
Confidence 999999999999999999999888 78889999999999999999999999886
No 4
>KOG3513|consensus
Probab=99.89 E-value=4.8e-23 Score=226.24 Aligned_cols=209 Identities=19% Similarity=0.225 Sum_probs=157.1
Q ss_pred CCCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCcccee
Q psy10487 231 LYSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLE 310 (610)
Q Consensus 231 l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~ 310 (610)
.+.+.|.|.+.|..+ . ........+..+|.+...+.+..+..|++++|.|.+.|.|.|+|+|++||.++....+....
T Consensus 304 ~D~G~Y~C~AeN~~G-~-~~~~~~v~v~a~P~w~~~~~d~~~~~gs~v~~eC~a~g~P~p~v~WlkNg~pl~~~~r~~~~ 381 (1051)
T KOG3513|consen 304 EDAGEYECIAENSRG-S-ATHSGHVTVYAPPYWLQKPQDTEADTGSNVTLECKASGKPNPTVKWLKNGEPLEPAERDPRY 381 (1051)
T ss_pred CCCeEEEEEEecccc-c-ceeeEEEEEecCchhhcccceeEecCCCCeEEEEEecCCCCCceEEeeCCeecCccCCCcce
Confidence 477899999998887 2 23333345678999999999999999999999999999999999999999999866543222
Q ss_pred eccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCccccccccccCCcceeehhhhHHHHHHHHHhhe
Q psy10487 311 EEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSVIVSIG 390 (610)
Q Consensus 311 ~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (610)
. ...+.|+|.+++.+|+|.|+|.|+|.+|...+.+.|.|. ..+|.+...+....+.......
T Consensus 382 ~-------i~~g~L~is~v~~~dsg~YQC~A~Nk~G~i~anA~L~V~--a~~P~f~~~p~~~~~~a~~g~~--------- 443 (1051)
T KOG3513|consen 382 K-------IDDGTLIISNVQESDSGVYQCIAENKYGTIYANAELKVL--ASAPVFPLNPVERKVMAVVGGT--------- 443 (1051)
T ss_pred E-------EeCCEEEEEecccccCeEEEeeeecccceEeeeeEEEEE--ccCCCCCCCccceEEEEEeCCe---------
Confidence 1 334599999999999999999999999999999999994 4556666665544322211111
Q ss_pred eEEEEEEee--ecccccccccCC--ccccccccccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccC
Q psy10487 391 MSFCVCRAH--EHKNKRRKRKGK--MKQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQ 460 (610)
Q Consensus 391 ~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~ 460 (610)
+.+.|.-+ +++...|.+... ..........+++|.|.+++.+|+|.|+|.|.|..|+++.+++|.|.+.
T Consensus 444 -v~i~C~~~asP~p~~~W~k~~~~~~~~~r~~i~edGtL~I~n~t~~DaG~YtC~A~N~~G~a~~~~~L~Vkd~ 516 (1051)
T KOG3513|consen 444 -VTIDCKPFASPKPKVSWLKGGEKLLQSGRIRILEDGTLEISNVTRSDAGKYTCVAENKLGKAESTGNLIVKDA 516 (1051)
T ss_pred -EEEeeccCCCCcceEEEEcCCcccccCceEEECCCCcEEecccCcccCcEEEEEEEcccCccceEEEEEEecC
Confidence 13334333 333434443332 1222233467889999999999999999999999999999999999884
No 5
>KOG3513|consensus
Probab=99.74 E-value=2.4e-17 Score=181.75 Aligned_cols=178 Identities=19% Similarity=0.271 Sum_probs=131.5
Q ss_pred CCCceeee-ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEE
Q psy10487 259 CPPNVTIK-ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEY 337 (610)
Q Consensus 259 c~P~i~~~-~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y 337 (610)
.+|.+... +.......|+.+.|.|.|.|+|.|+|.|.|.+....... .... .....|.|.+++.+|+|.|
T Consensus 239 ~~P~i~~~~p~~~~a~~G~~v~LECfA~G~P~P~i~W~k~~g~~~~~r---~~~~------~~~~vL~I~nv~~~D~G~Y 309 (1051)
T KOG3513|consen 239 YAPKILVPFPETETALKGQSVKLECFALGNPTPQIKWRKVDGKPPPRR---ATYS------NYGKVLKIPNVQYEDAGEY 309 (1051)
T ss_pred cCCccccCCCCcccccCCCeEEEEEEecCCCCCcEEEEeCCCCCCCcc---eeee------ccccEEEecccCcCCCeEE
Confidence 35766654 457778899999999999999999999999776422211 1111 2235899999999999999
Q ss_pred EEEeecCCcceeEEEEEEcCccccccccccCCcceeehhhhHHHHHHHHHhheeEEEEEEee--ecccccccccCCcccc
Q psy10487 338 TCYAENIRGNASGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSVIVSIGMSFCVCRAH--EHKNKRRKRKGKMKQS 415 (610)
Q Consensus 338 ~C~a~N~~G~~~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 415 (610)
+|.|+|..|...+.+.+.| ..+|...+.++...+..+..+ .+.|+.. +++..+|.+. ..+
T Consensus 310 ~C~AeN~~G~~~~~~~v~v---~a~P~w~~~~~d~~~~~gs~v------------~~eC~a~g~P~p~v~WlkN---g~p 371 (1051)
T KOG3513|consen 310 ECIAENSRGSATHSGHVTV---YAPPYWLQKPQDTEADTGSNV------------TLECKASGKPNPTVKWLKN---GEP 371 (1051)
T ss_pred EEEEecccccceeeEEEEE---ecCchhhcccceeEecCCCCe------------EEEEEecCCCCCceEEeeC---Cee
Confidence 9999999999999999998 555666666665555444432 3445444 4444444443 333
Q ss_pred cc-------ccccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCCCc
Q psy10487 416 VS-------FNDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQPPV 463 (610)
Q Consensus 416 ~~-------~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~pp~ 463 (610)
+. ..-+.+.|+|.+++..|+|.|.|.|+|..|..-..+.|.|+..+|.
T Consensus 372 l~~~~r~~~~~i~~g~L~is~v~~~dsg~YQC~A~Nk~G~i~anA~L~V~a~~P~ 426 (1051)
T KOG3513|consen 372 LEPAERDPRYKIDDGTLIISNVQESDSGVYQCIAENKYGTIYANAELKVLASAPV 426 (1051)
T ss_pred cCccCCCcceEEeCCEEEEEecccccCeEEEeeeecccceEeeeeEEEEEccCCC
Confidence 32 3356779999999999999999999999999999999998866444
No 6
>KOG4237|consensus
Probab=99.70 E-value=7.8e-19 Score=172.20 Aligned_cols=197 Identities=29% Similarity=0.454 Sum_probs=176.7
Q ss_pred EEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeC
Q psy10487 59 VLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNG 138 (610)
Q Consensus 59 ~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~ 138 (610)
.++-++-.+++++.+.= .+-..|+|..|+|+.|++++|+.+++|+.|||++|+|+.|.+++|.++.+|..|-+.+
T Consensus 50 ~VdCr~~GL~eVP~~LP-----~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg 124 (498)
T KOG4237|consen 50 IVDCRGKGLTEVPANLP-----PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYG 124 (498)
T ss_pred eEEccCCCcccCcccCC-----CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhc
Confidence 35667777777775432 2567899999999999999999999999999999999999999999999999888887
Q ss_pred -ccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCcccccC
Q psy10487 139 -NPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPWCCDC 217 (610)
Q Consensus 139 -N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~c~c 217 (610)
|+|+.++.+.|.+|..|+.|.+.-|++..+..+.|..+++|..|.+-.|.++.+....|..+..++.+.+..|++.|+|
T Consensus 125 ~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 125 NNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred CCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CchhhHHHHhhccCCCCCCCCCCCCccCCCcccccccccccCC
Q psy10487 218 HLRSFRNWLLKSKLYSHPLSCTEPGMLQTKHWDDVKAQEFACP 260 (610)
Q Consensus 218 ~l~~~~~~l~~~~l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~ 260 (610)
.+.|+.+.+.......+...|..+..+..+++..+....|.|.
T Consensus 205 nL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~ 247 (498)
T KOG4237|consen 205 NLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS 247 (498)
T ss_pred ccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh
Confidence 9999999888888888888998887777777777766666554
No 7
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=99.65 E-value=9.4e-16 Score=127.81 Aligned_cols=97 Identities=21% Similarity=0.255 Sum_probs=81.4
Q ss_pred CceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 261 PNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 261 P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
|.|...+..+.+..|+.+.|.|.+.|.|+|++.|+|+|..+....+...... ...+.|.|.++..+|+|.|+|.
T Consensus 1 p~~~~~p~~~~v~~G~~v~l~C~~~G~p~p~v~W~kdg~~l~~~~~~~~~~~------~~~s~L~I~~~~~~D~G~Ytc~ 74 (98)
T cd05762 1 PQIIQFPEDMKVRAGESVELFCKVTGTQPITCTWMKFRKQIQEGEGIKIENT------ENSSKLTITEGQQEHCGCYTLE 74 (98)
T ss_pred CceEECCcCEEEECCCEEEEEEEEcccCCCceEEEECCEEecCCCcEEEEec------CCeeEEEECCCChhhCEEEEEE
Confidence 5677788899999999999999999999999999999999975543222211 1235899999999999999999
Q ss_pred eecCCcceeEEEEEEcCcccccc
Q psy10487 341 AENIRGNASGEISLDLPEINLAT 363 (610)
Q Consensus 341 a~N~~G~~~~~~~L~V~~~~~~p 363 (610)
|.|..|.+.+++.|.|.+.+.+|
T Consensus 75 a~N~~G~~~~~~~l~V~~~P~pP 97 (98)
T cd05762 75 VENKLGSRQAQVNLTVVDKPDPP 97 (98)
T ss_pred EEcCCCceeEEEEEEEecCCCCC
Confidence 99999999999999997765554
No 8
>KOG4222|consensus
Probab=99.65 E-value=2.7e-16 Score=171.56 Aligned_cols=210 Identities=20% Similarity=0.245 Sum_probs=150.7
Q ss_pred CCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEEEEE-EecCCCeEEEEeCCEEeccCCcccee
Q psy10487 232 YSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLE 310 (610)
Q Consensus 232 ~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~ 310 (610)
+.+.|.|.+.+.++..-..........-+-.+.+.+..+.+..|+.++|.|.- .|.|.|.++|.|+|+++........
T Consensus 103 d~G~y~cvasn~~g~avSr~a~L~vavlrddfrv~prd~~~a~ge~avlEcgpP~ghpeptvSw~Kdg~pl~~~~~~~~- 181 (1281)
T KOG4222|consen 103 DHGVYSCVASNRLGEAVSRGASLIVAVLRDDFRVSPRDVQAAVGEEAVLECGPPRGHPEPTVSWVKDGKPLDHYDVPII- 181 (1281)
T ss_pred CCceeEeeecCccceeeecCceEEEEEechhcccCcccccccccceeEEeccCCCCCCCCcceeecCCCccccccceeE-
Confidence 78899999998887554444443333334566677788889999999999975 7999999999999999873322111
Q ss_pred eccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce-eEEEEEEcCccccccccccCCcceeehhhhHHHHHHHHHhh
Q psy10487 311 EEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA-SGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSVIVSI 389 (610)
Q Consensus 311 ~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (610)
.....|.|.|.+|..+|+|.|.|+|.|.+|.. +..+.|.| ...|.+.+.+....+..+..+.+
T Consensus 182 ------~lisgG~LlIsnvrksD~GtY~CVatNmvG~ReS~~A~lsv---~e~P~f~~rp~~~~v~~g~~~~f------- 245 (1281)
T KOG4222|consen 182 ------ALISGGNLLISNVRKSDEGTYACVATNMVGERESIPARLSV---QEKPWFWKRPKDLAVLVGAAAEF------- 245 (1281)
T ss_pred ------EEecCCcEEEeccccCCCceeeeeecccccccccccceeee---ccCCccccccccceeeccccccc-------
Confidence 12344699999999999999999999999986 45788888 44567777777666555444332
Q ss_pred eeEEEEEEeeecccccccccC--CccccccccccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCC
Q psy10487 390 GMSFCVCRAHEHKNKRRKRKG--KMKQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQP 461 (610)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~p 461 (610)
-|....++.+..+|++.. ....+.....++.+|.|.+++..|+|+|.|.|.|..|..+..+.++|...|
T Consensus 246 ---~c~v~GdP~P~Vrwkk~~~~~P~~ry~i~~d~qtl~i~r~tp~deg~y~C~a~n~vG~l~asa~ltV~apP 316 (1281)
T KOG4222|consen 246 ---DCRVGGDPQPTVRWKKDDPSLPRSRYSILDDTQTLRIDRVTPTDEGTYVCPAENLVGGLEASATLTVQAPP 316 (1281)
T ss_pred ---ccccCCCCCCceeeeccCCCCCccceeeeeccccccccccCCCcccceeeeccccccccccccceEEecCc
Confidence 222223333333333311 112223344566889999999999999999999999999999999987644
No 9
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.62 E-value=2.7e-15 Score=122.58 Aligned_cols=87 Identities=26% Similarity=0.531 Sum_probs=74.9
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C 339 (610)
+|.|...+.+..+.+|+.+.|.|.+.|+|.|.++|+|++..+....+ .. ...+.|.|.+++.+|+|.|+|
T Consensus 1 ~p~i~~~~~~~~~~~G~~v~l~C~~~G~P~P~v~W~k~~~~~~~~~~--~~--------~~~~~L~I~~v~~~D~G~Y~C 70 (88)
T cd05851 1 PADINVKFKDTYALKGQNVTLECFALGNPVPVIRWRKILEPMPATAE--IS--------MSGAVLKIFNIQPEDEGTYEC 70 (88)
T ss_pred CCceEEccccEEEeCCCcEEEEEEecccCCCEEEEEECCcCCCCCCE--Ee--------cCCCEEEECcCChhhCEEEEE
Confidence 57888899999999999999999999999999999999877654321 11 122489999999999999999
Q ss_pred EeecCCcceeEEEEEEc
Q psy10487 340 YAENIRGNASGEISLDL 356 (610)
Q Consensus 340 ~a~N~~G~~~~~~~L~V 356 (610)
.|.|..|.+.+.+.|.|
T Consensus 71 ~A~N~~G~~~~~~~l~V 87 (88)
T cd05851 71 EAENIKGKDKHQARVYV 87 (88)
T ss_pred EEEcCCCceEEEEEEEE
Confidence 99999999999999887
No 10
>KOG4221|consensus
Probab=99.61 E-value=8.4e-16 Score=168.71 Aligned_cols=206 Identities=18% Similarity=0.240 Sum_probs=139.0
Q ss_pred CCCCCCCCCCCCccCCCcccccccccccC-----CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCC
Q psy10487 231 LYSHPLSCTEPGMLQTKHWDDVKAQEFAC-----PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSS 305 (610)
Q Consensus 231 l~~~~~~C~a~~~l~g~~~~~v~~~~~~c-----~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~ 305 (610)
-+.+.|.|.+.+.......++.......- .-.|...|+...+.+|+.++|.|.+.|.|+|.|.|.+||..+..++
T Consensus 203 ~d~g~yrc~vt~g~~~r~S~~a~ltv~s~~~~~~~~~fl~~p~~~~v~~g~~v~leCvvs~~p~p~v~Wlrng~~i~~ds 282 (1381)
T KOG4221|consen 203 SDTGEYRCVVTGGASQRTSNEAELTVLSDPGALNKLVFLDEPSNAVVVEGDDVVLECVVSGVPKPSVKWLRNGEKISVDS 282 (1381)
T ss_pred CCCceEEEEEecCCcCCccceeEEEecCCcccccceeeecCCCccccccCCcEEEEEEecCCCCCceEEeeCCeeeeecc
Confidence 36778999887665544444333332211 1224567788999999999999999999999999999999987765
Q ss_pred ccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCccccccccccCCcceeehhhhHHHHHHH
Q psy10487 306 FDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSV 385 (610)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 385 (610)
.. ... ...+.|.|.+++..|+|.|+|+|.|......+.+.|.|. .+|.+...+...........
T Consensus 283 ~r-ivl-------~g~~slliS~a~~~dSg~YtC~Atn~~D~idasaev~V~---a~P~~~~~p~~l~A~e~~di----- 346 (1381)
T KOG4221|consen 283 YR-IVL-------VGGSSLLISNATDDDSGKYTCRATNTNDSIDASAEVTVL---APPGFTKAPTTLVAHESMDI----- 346 (1381)
T ss_pred eE-EEE-------ecccceEEeccccccCceEEEEecCCCcccccceEEEEE---cCCCCCCCCcceeeeeccce-----
Confidence 22 111 224589999999999999999999955555555556552 34667777666554442221
Q ss_pred HHhheeEEEEEEe--eecccccccccCCccc-cccc-cccccceeeeeeeeccCcceeeeecCCCcceeeeeeccccc
Q psy10487 386 IVSIGMSFCVCRA--HEHKNKRRKRKGKMKQ-SVSF-NDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAME 459 (610)
Q Consensus 386 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~-~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~ 459 (610)
.+.|.. ++.+..+|.+.+..-. +-.+ ...++.|+|..+-..|+|-|.|+|.|.+|.+...+++.++.
T Consensus 347 -------e~ec~~~g~p~p~v~w~kNgd~~ipsdy~ki~~~~~lrIlgi~~sdeg~yQcvaen~~G~a~a~a~l~vv~ 417 (1381)
T KOG4221|consen 347 -------EFECPVSGKPIPTVRWYKNGDRIIPSDYFKIVGGGNLRILGIVKSDEGFYQCVAENDAGSAQAAAQLEVVP 417 (1381)
T ss_pred -------eEeCCCCCCCcceEEEEecCcccCcccceEecCCCCcEEEEEecccchhhhhhhccCcccccchhhheecc
Confidence 334433 3333333433322111 1111 12333499999999999999999999999999999997663
No 11
>KOG4221|consensus
Probab=99.56 E-value=8.3e-15 Score=161.03 Aligned_cols=214 Identities=19% Similarity=0.205 Sum_probs=143.2
Q ss_pred ccCCCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccc
Q psy10487 229 SKLYSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDL 308 (610)
Q Consensus 229 ~~l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~ 308 (610)
++.+.+.|+|.+...-.+.-+.......+.-.+.+...+...++..|+++.|.|.+.+.|.|.+.|.+|..++..+.+ .
T Consensus 109 ~~~~eg~Yqc~atv~~~gsi~Sr~a~v~~a~~~~f~~~~~~~t~~~g~ta~f~c~vn~e~~p~i~w~kn~~pl~~~~r-~ 187 (1381)
T KOG4221|consen 109 NKVDEGVYQCLATVEDVGSILSRTAKVALAGLADFALQPESTTLLYGQTALFSCEVNAEPVPTIMWLKNDQPLPLDSR-V 187 (1381)
T ss_pred ccccCceEEEEEEccccceeecceEEEEecccCccccCccceeEecCCcEEEEEEEcCccCceeEEecccccccCCCc-E
Confidence 346778899988655333333333333344567777888899999999999999999999999999999997776652 2
Q ss_pred eeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce-eEEEEEEcCccc---cccccccCCcceeehhhhHHHHHH
Q psy10487 309 LEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA-SGEISLDLPEIN---LATTLSKTDSWYMLVLGISVCVVS 384 (610)
Q Consensus 309 ~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~L~V~~~~---~~p~~~~~~~~~~~~~~~~~~~~~ 384 (610)
.. ...|.|.|.+++..|.|.|.|.|++.+-.. +..+.|+|.... ..-.|...+.......+..+.+.|
T Consensus 188 i~--------lpsG~L~I~~~qp~d~g~yrc~vt~g~~~r~S~~a~ltv~s~~~~~~~~~fl~~p~~~~v~~g~~v~leC 259 (1381)
T KOG4221|consen 188 IV--------LPSGALEISGLQPSDTGEYRCVVTGGASQRTSNEAELTVLSDPGALNKLVFLDEPSNAVVVEGDDVVLEC 259 (1381)
T ss_pred EE--------cCCCcEEecccccCCCceEEEEEecCCcCCccceeEEEecCCcccccceeeecCCCccccccCCcEEEEE
Confidence 22 334699999999999999999999987543 557777774211 111234444444444444444333
Q ss_pred HHHhheeEEEEEEeeecccccccccCCc---cccccccccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCC
Q psy10487 385 VIVSIGMSFCVCRAHEHKNKRRKRKGKM---KQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQP 461 (610)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~p 461 (610)
++ ....++..+|.+.+.. +..+......+.|+|.+++..|+|.|+|.|+|......+++.+.|..+|
T Consensus 260 vv----------s~~p~p~v~Wlrng~~i~~ds~rivl~g~~slliS~a~~~dSg~YtC~Atn~~D~idasaev~V~a~P 329 (1381)
T KOG4221|consen 260 VV----------SGVPKPSVKWLRNGEKISVDSYRIVLVGGSSLLISNATDDDSGKYTCRATNTNDSIDASAEVTVLAPP 329 (1381)
T ss_pred Ee----------cCCCCCceEEeeCCeeeeecceEEEEecccceEEeccccccCceEEEEecCCCcccccceEEEEEcCC
Confidence 33 3334444444432211 1111122345679999999999999999999977777777888777653
No 12
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.55 E-value=1.7e-14 Score=170.62 Aligned_cols=174 Identities=20% Similarity=0.210 Sum_probs=88.8
Q ss_pred cEEEcCCCCCC-ccCcccC---CCccEEEeecCCCC----------------------CCChhhhcccCCCCccEEEccc
Q psy10487 37 KSALCKDANFT-ALPSTLD---SDIQVLDLNNNKIS----------------------YLTKEAFKSIGLLNLQRIYLKN 90 (610)
Q Consensus 37 ~~~~C~~~~l~-~lP~~l~---~~L~~L~L~~n~i~----------------------~l~~~~~~~~~l~~L~~L~L~~ 90 (610)
+.++..++++. .+|..+. .+|++|+|++|+++ ...+..+. ++.+|++|+|++
T Consensus 96 ~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~--~l~~L~~L~L~~ 173 (968)
T PLN00113 96 QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIG--SFSSLKVLDLGG 173 (968)
T ss_pred CEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHh--cCCCCCEEECcc
Confidence 45666666665 5665432 35566666655554 22233333 455566666666
Q ss_pred CCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCH
Q psy10487 91 SGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHK 170 (610)
Q Consensus 91 n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~ 170 (610)
|.+....+..|.++++|++|+|++|++....+..|..+.+|+.|+|++|.+....+..|.++++|+.|+|++|++....+
T Consensus 174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 55555445555555555555555555554444455555555555555555554444444555555555555555544444
Q ss_pred HHhhcCccccccccccccccccCcccccCCCcccEEecCCCc
Q psy10487 171 DALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNP 212 (610)
Q Consensus 171 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~ 212 (610)
..|.++.+|+.|++++|.+.+..+..+..+.+|+.|++++|.
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 295 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCe
Confidence 444455555555555554443333333334444444444443
No 13
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=99.55 E-value=2.9e-14 Score=112.18 Aligned_cols=75 Identities=28% Similarity=0.436 Sum_probs=59.9
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
+.|.|.+.|.|.|.|.|+|++..+.....+.....++. ...+|.|.+++.+|+|.|+|.|.|.+|.+..++.|.|
T Consensus 1 v~l~C~v~G~P~P~i~W~k~~~~i~~~~~r~~~~~~~~----g~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05892 1 VKLECQISAIPPPKIFWKRNNEMVQYNTDRISLYQDNS----GRVTLLIKNVNKKDAGWYTVSAVNEAGVATCHARLDV 75 (75)
T ss_pred CEEEEEEEecCCCeEEEEECCEECcCCCCeEEEEEcCC----CcEEEEECCCChhhCEEEEEEEEcCcCeEEEEEEEeC
Confidence 47999999999999999999998874332222212211 1137999999999999999999999999999999876
No 14
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.54 E-value=2.6e-14 Score=112.71 Aligned_cols=74 Identities=30% Similarity=0.469 Sum_probs=63.2
Q ss_pred cCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 274 AGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
+|+++.|.|.+.|+|.|.|+|+|++..+....+.. ....+.|.|.+++.+|+|.|+|.|.|..|..+.++.
T Consensus 1 eG~~v~l~C~~~g~P~p~i~W~k~g~~~~~~~~~~---------~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 71 (74)
T cd05745 1 EGQTVDFLCEAQGYPQPVIAWTKGGSQLSVDRRHL---------VLSSGTLRISRVALHDQGQYECQAVNIVGSQRTVAQ 71 (74)
T ss_pred CCCeEEEEeECCEecCCEEEEEECCEECCCCCCeE---------EccCCeEEEeeCCHHhCEEEEEEEEeCCCceeEEEE
Confidence 58999999999999999999999999876543211 122358999999999999999999999999999998
Q ss_pred EEc
Q psy10487 354 LDL 356 (610)
Q Consensus 354 L~V 356 (610)
|.|
T Consensus 72 L~V 74 (74)
T cd05745 72 LTV 74 (74)
T ss_pred EeC
Confidence 876
No 15
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=99.54 E-value=6e-14 Score=115.77 Aligned_cols=86 Identities=29% Similarity=0.539 Sum_probs=70.8
Q ss_pred eecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.|..+.+.+|+++.|.|.+.|.|.|++.|+|++..+....+.......+ ....|.|.+++.+|+|.|+|.|.|..
T Consensus 7 lp~~v~v~~G~~v~L~C~v~G~P~p~v~W~k~g~~l~~~~~~~~~~~~~-----~~~~L~I~~v~~~D~G~Y~C~a~N~~ 81 (92)
T cd05737 7 LPDVVTIMEGKTLNLTCTVFGDPDPEVSWLKNDQALALSDHYNVKVEQG-----KYASLTIKGVSSEDSGKYGIVVKNKY 81 (92)
T ss_pred CCceEEEeCCCcEEEEEEEEecCCCeEEEEECCEECccCCCEEEEEcCC-----CEEEEEEccCChhhCEEEEEEEEECC
Confidence 3556788999999999999999999999999999887654432222211 12479999999999999999999999
Q ss_pred cceeEEEEEEc
Q psy10487 346 GNASGEISLDL 356 (610)
Q Consensus 346 G~~~~~~~L~V 356 (610)
|.++..+.|.|
T Consensus 82 G~~~~~~~v~v 92 (92)
T cd05737 82 GGETVDVTVSV 92 (92)
T ss_pred CcceEEEEEeC
Confidence 99999988875
No 16
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=99.54 E-value=8.1e-14 Score=113.14 Aligned_cols=83 Identities=18% Similarity=0.319 Sum_probs=68.1
Q ss_pred ceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce
Q psy10487 269 MVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA 348 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 348 (610)
.+.+.+|+.+.|.|.+.|.|.|.+.|++++..+............ ...+.|.|.++..+|+|.|+|.|.|..|.+
T Consensus 4 ~~~v~~G~~v~l~c~~~G~P~P~v~W~k~~~~i~~~~~r~~~~~~-----~~~~~L~I~~~~~~D~G~Y~c~a~N~~G~~ 78 (86)
T cd05894 4 TIVVVAGNKLRLDVPISGEPAPTVTWSRGDKAFTETEGRVRVESY-----KDLSSFVIEGAEREDEGVYTITVTNPVGED 78 (86)
T ss_pred EEEEEcCCEEEEEeeEeecCCCeEEEEECCEECccCCCeEEEEEc-----CCeEEEEECCCccCcCEEEEEEEEeCCCcE
Confidence 467889999999999999999999999999988754321111111 123589999999999999999999999999
Q ss_pred eEEEEEEc
Q psy10487 349 SGEISLDL 356 (610)
Q Consensus 349 ~~~~~L~V 356 (610)
.+++.|.|
T Consensus 79 ~~~~~l~V 86 (86)
T cd05894 79 HASLFVKV 86 (86)
T ss_pred EEEEEEEC
Confidence 99998875
No 17
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=99.53 E-value=6.3e-14 Score=115.69 Aligned_cols=89 Identities=27% Similarity=0.506 Sum_probs=74.8
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C 339 (610)
+|.+...+....+.+|+.+.|.|.+.|+|.|.+.|+++|..+....+...... ...+.|.|.+++.+|+|.|+|
T Consensus 3 ~~~~~~~p~~~~~~~G~~~~L~C~~~g~P~p~v~W~k~g~~l~~~~~~~~~~~------~~~~~L~i~~~~~~D~G~Y~C 76 (92)
T cd05747 3 PATILTKPRSLTVSEGESARFSCDVDGEPAPTVTWMREGQIIVSSQRHQITST------EYKSTFEISKVQMSDEGNYTV 76 (92)
T ss_pred CCcccccCccEEEeCCCcEEEEEEEeecCCCEEEEEECCEECCCCCcEEEEEc------CCeeEEEECCCCcccCEeEEE
Confidence 67888888999999999999999999999999999999988765443222111 123689999999999999999
Q ss_pred EeecCCcceeEEEEE
Q psy10487 340 YAENIRGNASGEISL 354 (610)
Q Consensus 340 ~a~N~~G~~~~~~~L 354 (610)
.|.|..|.++.++.|
T Consensus 77 ~a~N~~G~~~~~~~l 91 (92)
T cd05747 77 VVENSEGKQEAQFTL 91 (92)
T ss_pred EEEcCCCCEeEEEEe
Confidence 999999999888876
No 18
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=99.53 E-value=6.1e-14 Score=116.10 Aligned_cols=90 Identities=24% Similarity=0.406 Sum_probs=70.0
Q ss_pred eeeeecceEeecCceEEEEEEEEecCC-CeEEEEe-CCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVYGDPE-PTILWLL-NGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~g~P~-p~v~W~~-~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
+...|....+.+|+.++|.|.+.|.|. |.+.|++ ++..+............. ...++|+|.+++.+|+|.|+|.
T Consensus 3 ~~~~p~~~~v~~G~~v~l~C~v~G~P~~p~i~W~~~~g~~l~~~~~r~~v~~~~----~~~~~L~I~~v~~~D~G~YtC~ 78 (96)
T cd05865 3 VDIVPSQGEISVGESKFFLCQVAGEAKDKDISWFSPNGEKLTPNQQRISVVRND----DYSSTLTIYNANIDDAGIYKCV 78 (96)
T ss_pred EEEeCCccEECCCCeEEEEEEEeCCCCCCEEEEECCCCcCccccCCeEEEEeCC----CCceEEEEeccChhhCEEEEEE
Confidence 455677778999999999999999995 7999998 776665433211111111 1246899999999999999999
Q ss_pred eecCC-cceeEEEEEEc
Q psy10487 341 AENIR-GNASGEISLDL 356 (610)
Q Consensus 341 a~N~~-G~~~~~~~L~V 356 (610)
|.|.+ |..++++.|.|
T Consensus 79 A~N~~~g~~~~s~~l~v 95 (96)
T cd05865 79 VSNEDEGESEATVNVKI 95 (96)
T ss_pred EEcCCCCcEEEEEEEEE
Confidence 99997 88999998876
No 19
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.53 E-value=7.4e-14 Score=113.99 Aligned_cols=87 Identities=21% Similarity=0.306 Sum_probs=67.8
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.++|.|.+.|.|+|.+.|++++..+.....++.......+ ....+.|.|.++..+|+|.|+|.|.|..|..++++.|
T Consensus 1 g~~~~l~C~~~g~p~~~i~W~k~~~~i~~~~~r~~~~~~~~~-~~~~s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L 79 (88)
T cd05735 1 GQKKEMSCTAHGEKPIIVRWEKEDRIINPEMSRYLVSTKEVG-DEVISTLQILPTVREDSGFFSCHAINSYGEDRGIIQL 79 (88)
T ss_pred CCeEEEEEEEECCCCCEEEEeeCCEECCCCCCcEEEEEecCC-CcEEEEEEECCCCcccCEEEEEEEEcCCCcceEEEEE
Confidence 788999999999999999999999887654322221111100 1234689999999999999999999999999999999
Q ss_pred EcCccccc
Q psy10487 355 DLPEINLA 362 (610)
Q Consensus 355 ~V~~~~~~ 362 (610)
.|.+.+.+
T Consensus 80 ~V~~~P~~ 87 (88)
T cd05735 80 TVQEPPDP 87 (88)
T ss_pred EEeCCCCC
Confidence 99665443
No 20
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=99.52 E-value=9.7e-14 Score=115.89 Aligned_cols=88 Identities=22% Similarity=0.390 Sum_probs=70.6
Q ss_pred cceEeecCceEEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 268 SMVIREAGGNVTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
..+.+.+|+++.|.|.+.| .|+|.+.|+|||.++............ .......+.|.|.++..+|+|.|+|.|.|..|
T Consensus 11 ~~~~v~~G~~v~L~c~v~g~~P~p~v~W~Kdg~~i~~~~~~~~~~~~-~~~~~~~~~L~i~~v~~~D~G~Ytc~A~N~~G 89 (101)
T cd04975 11 TTIFVNLGENLNLVVEVEAYPPPPHINWTYDNRTLTNKLTEIVTSEN-ESEYRYVSELKLVRLKESEAGTYTFLASNSDA 89 (101)
T ss_pred ceEEEECCCCEEEEEEEEecCCCCccEEEeCCeeCCCCcceeEEEec-cCcceEEEEEEEeecCHhhCeeEEEEEECCCc
Confidence 4677889999999999999 899999999999998754322111111 00113457899999999999999999999999
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.++.++.|.|
T Consensus 90 ~~~~t~~L~V 99 (101)
T cd04975 90 SKSLTFELYV 99 (101)
T ss_pred cEEEEEEEEE
Confidence 9999999887
No 21
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=99.52 E-value=8e-14 Score=113.15 Aligned_cols=83 Identities=27% Similarity=0.416 Sum_probs=70.9
Q ss_pred eeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeec
Q psy10487 264 TIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 264 ~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N 343 (610)
...|.+..+.+|+.+.|.|.+.|.|.|.+.|++++..+....+. . ...+.|.|.+++.+|+|.|+|.|.|
T Consensus 3 ~~~p~~~~~~~G~~~~l~C~~~g~p~p~v~W~k~g~~~~~~~~~--~--------~~~~~L~i~~~~~~D~G~Y~C~a~N 72 (85)
T cd05728 3 LKVISDTEADIGSSLRWECKASGNPRPAYRWLKNGQPLASENRI--E--------VEAGDLRITKLSLSDSGMYQCVAEN 72 (85)
T ss_pred cccCCccEEcCCCcEEEEEEeeEeCCCEEEEEECCEECCCCCeE--E--------EeCCEEEEeeCCHHHCEEEEEEEEC
Confidence 44677888999999999999999999999999999987654321 1 2235899999999999999999999
Q ss_pred CCcceeEEEEEEc
Q psy10487 344 IRGNASGEISLDL 356 (610)
Q Consensus 344 ~~G~~~~~~~L~V 356 (610)
..|...+++.|.|
T Consensus 73 ~~G~~~~~~~l~V 85 (85)
T cd05728 73 KHGTIYASAELAV 85 (85)
T ss_pred CCCeEEEEEEEEC
Confidence 9999999998875
No 22
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=99.52 E-value=3.7e-14 Score=167.69 Aligned_cols=157 Identities=21% Similarity=0.180 Sum_probs=115.6
Q ss_pred CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEE
Q psy10487 55 SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVL 134 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L 134 (610)
.+|++|+|++|.+....+..|. ++.+|++|+|++|.+....+..|+.+.+|++|+|++|++....+..|.++++|++|
T Consensus 164 ~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 241 (968)
T PLN00113 164 SSLKVLDLGGNVLVGKIPNSLT--NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHL 241 (968)
T ss_pred CCCCEEECccCcccccCChhhh--hCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEE
Confidence 4788888888888766666666 67888888888888877777778888888888888888877666777778888888
Q ss_pred EeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCcc
Q psy10487 135 YLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPW 213 (610)
Q Consensus 135 ~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~ 213 (610)
+|++|.+....+..|.++++|+.|+|++|++....+..+.++.+|+.|++++|.+....+..+..+++|+.|++.+|.+
T Consensus 242 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~ 320 (968)
T PLN00113 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320 (968)
T ss_pred ECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCcc
Confidence 8888877766666677777777777777777665566666677777777777766655555555556666666665554
No 23
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.52 E-value=1e-13 Score=113.42 Aligned_cols=87 Identities=25% Similarity=0.433 Sum_probs=72.6
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C 339 (610)
|+.+...+....+.+|+.+.|.|.+.|.|.|.+.|++++..+...... . ...+.|.|.+++.+|+|.|+|
T Consensus 1 p~~~~~~p~~~~~~~g~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~--~--------~~~~~L~i~~v~~~D~G~Y~C 70 (88)
T cd04968 1 PSIIVVFPKDTYALKGQNVTLECFALGNPVPQIKWRKVDGSMPSSAEI--S--------MSGAVLKIPNIQFEDEGTYEC 70 (88)
T ss_pred CCcEEECCCceEEeCCCcEEEEEEeeEeCCCEEEEEECCCcCCCccEE--E--------EeCCEEEECCCCcccCEEEEE
Confidence 355666788888999999999999999999999999988765433211 0 223589999999999999999
Q ss_pred EeecCCcceeEEEEEEc
Q psy10487 340 YAENIRGNASGEISLDL 356 (610)
Q Consensus 340 ~a~N~~G~~~~~~~L~V 356 (610)
.|.|..|....++.|.|
T Consensus 71 ~a~N~~G~~~~~~~l~V 87 (88)
T cd04968 71 EAENIKGKDTHQGRIYV 87 (88)
T ss_pred EEEECCCcEEEEEEEEE
Confidence 99999999999998877
No 24
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=99.52 E-value=1.6e-13 Score=114.54 Aligned_cols=93 Identities=28% Similarity=0.452 Sum_probs=72.4
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCcc---ceeeccCCceeeeeeEEEEEecCCCCCeE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFD---LLEEEEGDALFEKSVSITLFNVTDLDAGE 336 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~---~~~~~~~~~~~~~~~~L~I~~v~~~D~G~ 336 (610)
.|.|...+....+..|+.++|.|.+.|.|.|.++|++++..+...... ....... ...+.|.|.+++.+|+|.
T Consensus 2 ~p~i~~~~~~~~~~~g~~v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~~~~~~~v~~~----~~~~~L~I~~v~~~D~G~ 77 (97)
T cd05869 2 KPKITYVENQTAMELEEQITLTCEASGDPIPSITWRTSTRNISSEEKTLDGHIVVRSH----ARVSSLTLKYIQYTDAGE 77 (97)
T ss_pred CceEEEccCceEEEcCCCEEEEEEeeEeCCCEEEEEECCccccCCccccCccEEEEcC----ccEEEEEEecCccCcCEE
Confidence 467777776666777899999999999999999999998776533210 1111111 123689999999999999
Q ss_pred EEEEeecCCcceeEEEEEEc
Q psy10487 337 YTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 337 Y~C~a~N~~G~~~~~~~L~V 356 (610)
|+|.|.|..|.++.++.|.|
T Consensus 78 Y~C~A~N~~G~~~~~~~l~v 97 (97)
T cd05869 78 YLCTASNTIGQDSQSMYLEV 97 (97)
T ss_pred EEEEEecCCCCeeEEEEEEC
Confidence 99999999999999998876
No 25
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=99.52 E-value=6.4e-14 Score=110.34 Aligned_cols=75 Identities=28% Similarity=0.423 Sum_probs=59.6
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
++|.|.+.|.|.|.|.|+|++..+............+. ....|.|.+++.+|+|.|+|.|.|.+|.++.++.|.|
T Consensus 1 v~l~C~v~G~P~P~v~W~k~~~~l~~~~~~~~~~~~~~----~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05893 1 VRLECRVSGVPHPQIFWKKENESLTHNTDRVSMHQDNC----GYICLLIQGATKEDAGWYTVSAKNEAGIVSCTARLDV 75 (75)
T ss_pred CEEEEEEeEecCCEEEEEECCEECCCCCCeEEEEEcCC----CEEEEEECCCCHHHCEEEEEEEEcCCCEEEEEEEEeC
Confidence 47999999999999999999998865432222211111 1126999999999999999999999999999999876
No 26
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.51 E-value=5.6e-14 Score=110.11 Aligned_cols=73 Identities=36% Similarity=0.589 Sum_probs=61.7
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.+.|.|.+.|.|.|+|.|+|++..+....+. .. ...+.|.|.+++.+|+|.|+|.|.|..|.+..++.|
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~k~~~~l~~~~r~-~~--------~~~g~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 71 (73)
T cd05852 1 GGRVIIECKPKAAPKPKFSWSKGTELLVNNSRI-SI--------WDDGSLEILNITKLDEGSYTCFAENNRGKANSTGVL 71 (73)
T ss_pred CCeEEEEEecceeCCCEEEEEeCCEecccCCCE-EE--------cCCCEEEECcCChhHCEEEEEEEECCCCceeEEEEE
Confidence 678999999999999999999999876544321 11 123589999999999999999999999999999998
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.|
T Consensus 72 ~~ 73 (73)
T cd05852 72 SV 73 (73)
T ss_pred EC
Confidence 75
No 27
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.51 E-value=9e-14 Score=110.13 Aligned_cols=75 Identities=25% Similarity=0.451 Sum_probs=62.0
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.++|.|.+.|.|.|+|+|+++|.++.......... ...+.|.|.+++.+|+|.|+|.|.|.+|.+.+++.|
T Consensus 1 g~~~~l~C~a~G~P~P~i~W~k~g~~i~~~~~~~~~~-------~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 73 (76)
T cd05868 1 GEDGTLICRANGNPKPSISWLTNGVPIEIAPTDPSRK-------VDGDTIIFSKVQERSSAVYQCNASNEYGYLLANAFV 73 (76)
T ss_pred CCCEEEEEEeeEeCCCeEEEEECCEEccccCCCceEE-------ecCCEEEECCCCHhhCEEEEEEEEcCCCEEEEEEEE
Confidence 6789999999999999999999999885432211111 122479999999999999999999999999999999
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.|
T Consensus 74 ~v 75 (76)
T cd05868 74 NV 75 (76)
T ss_pred Ee
Confidence 87
No 28
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.51 E-value=1.3e-13 Score=109.44 Aligned_cols=75 Identities=28% Similarity=0.483 Sum_probs=62.8
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.++|.|.+.|.|.|+++|+++|..+......... ....+.|.|.+++.+|+|.|+|.|.|..|...+.+.|
T Consensus 1 G~~v~l~C~~~G~P~p~i~W~k~g~~i~~~~~~~~~-------~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l 73 (76)
T cd05867 1 GETARLDCQVEGIPTPNITWSINGAPIEGTDPDPRR-------HVSSGALILTDVQPSDTAVYQCEARNRHGNLLANAHV 73 (76)
T ss_pred CCeEEEEEEeeEeCCCeEEEEECCEECCCCCCCceE-------EeeCCEEEECCCChhhCEEEEEEEECCCCeEEEEEEE
Confidence 688999999999999999999999987654321111 1223589999999999999999999999999999998
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.|
T Consensus 74 ~V 75 (76)
T cd05867 74 HV 75 (76)
T ss_pred EE
Confidence 87
No 29
>PHA02785 IL-beta-binding protein; Provisional
Probab=99.51 E-value=8.4e-14 Score=142.46 Aligned_cols=205 Identities=16% Similarity=0.151 Sum_probs=114.0
Q ss_pred cCCCCCCCCCCCCccCCCccccccccccc-CCCceeeeecceEeecCceEEEEEE-----EEecCCCeEEEEeCCEEecc
Q psy10487 230 KLYSHPLSCTEPGMLQTKHWDDVKAQEFA-CPPNVTIKESMVIREAGGNVTMSCY-----VYGDPEPTILWLLNGQVLHN 303 (610)
Q Consensus 230 ~l~~~~~~C~a~~~l~g~~~~~v~~~~~~-c~P~i~~~~~~~~v~~G~~v~l~C~-----~~g~P~p~v~W~~~g~~l~~ 303 (610)
..+.+.|+|.+.|..+.... .+....+. -+|.+...+....+.+|..+.|.|. ..++|.|++.|+++.. +..
T Consensus 91 ~~DsG~Y~C~a~N~~g~~~~-s~~L~V~~~~~~~~~~~~~~~~~~~g~~~~i~C~~~~~~~~~~~~~~i~W~k~~~-~~~ 168 (326)
T PHA02785 91 QSDSGIYICITKNETYCDMM-SLNLTIVSVSESNIDLISYPQIVNERSTGEMVCPNINAFIASNVNADIIWSGHRR-LRN 168 (326)
T ss_pred cccCeEEEEEEECCCcceEE-EEEEEEEecCCCccceeeccceecccCcEEEECCChhhcccCCCCceEEEccCCc-cCC
Confidence 35788999999877643332 12211111 1233333345556779999999997 3578999999988642 211
Q ss_pred CCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeE----EEEEEcCccccccccccCCcceeehhhhH
Q psy10487 304 SSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASG----EISLDLPEINLATTLSKTDSWYMLVLGIS 379 (610)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~----~~~L~V~~~~~~p~~~~~~~~~~~~~~~~ 379 (610)
.+ .. ....+.|.|.+++.+|+|.|+|.|.|.+|.... .+.|.|.....+|.+. .+.......+..
T Consensus 169 -~r--~~-------~~~~~~L~i~~v~~~d~G~Y~C~~~n~~g~~~~~~t~~v~l~V~~~~~pp~~~-~p~~~~~~~G~~ 237 (326)
T PHA02785 169 -KR--LK-------QRTPGIITIEDVRKNDAGYYTCVLKYIYGDKTYNVTRIVKLEVRDRIIPPTMQ-LPEGVVTSIGSN 237 (326)
T ss_pred -cc--eE-------ecCCCeEEEeecChhhCeEEEEEEEeccCCEEEeEEEEEEEEEeccCCCceec-CCCcEEecCCCc
Confidence 11 00 112358999999999999999999999987543 4456564433343332 223333333333
Q ss_pred HHHHHHHHhheeE--EEEEEeeecccccccccCCccccccc----------cccccceeeeeeeeccCcceeeeecCCCc
Q psy10487 380 VCVVSVIVSIGMS--FCVCRAHEHKNKRRKRKGKMKQSVSF----------NDQEKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 380 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
+.+.|.+.+.+.. ..++|.+.+......... ....+.. ....+.|.|.+|+.+|+|.|+|.|.|..|
T Consensus 238 v~L~C~a~g~P~~~~~~v~W~kng~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~L~I~~V~~~D~G~Y~C~A~n~~~ 316 (326)
T PHA02785 238 LTIACRVSLRPPTTDADVFWISNGMYYEEDDED-GDGRISVANKIYTTDKRRVITSRLNINPVKEEDATTFTCMAFTIPS 316 (326)
T ss_pred EEEEEEEECCCCCCCceEEEEECCEECCCcCCC-CceeEEEecCccccccceeeeEEEEECCcchhcCeeeEEEEEeccC
Confidence 3333333322211 112222211111000000 0000000 01245799999999999999999999886
Q ss_pred c
Q psy10487 448 D 448 (610)
Q Consensus 448 ~ 448 (610)
.
T Consensus 317 ~ 317 (326)
T PHA02785 317 I 317 (326)
T ss_pred c
Confidence 4
No 30
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=99.50 E-value=1.3e-13 Score=115.38 Aligned_cols=88 Identities=19% Similarity=0.242 Sum_probs=69.9
Q ss_pred ceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce
Q psy10487 269 MVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA 348 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 348 (610)
...+..|+.+.|.|.+.|.|+|.+.|+|+|.++....................+.|+|.+++.+|+|.|+|.|.|..|.+
T Consensus 12 ~~~~~~~~~~~l~~~v~g~P~P~v~W~kdg~~l~~~~~~~~~~~~~~~~~~~~s~L~I~~v~~~D~G~Ytc~A~N~~g~~ 91 (101)
T cd05859 12 LEFANLHEVKEFVVEVEAYPPPQIRWLKDNRTLIENLTEITTSEHNVQETRYVSKLKLIRAKEEDSGLYTALAQNEDAVK 91 (101)
T ss_pred eEEEecCCcEEEEEEEEEeCCCceEEEECCEECcCCcceEEeccccccceeeccEEEEeeCCHHHCEEEEEEEEcCCceE
Confidence 56778899999999999999999999999999876543211111100011334689999999999999999999999999
Q ss_pred eEEEEEEc
Q psy10487 349 SGEISLDL 356 (610)
Q Consensus 349 ~~~~~L~V 356 (610)
+.++.|.|
T Consensus 92 ~~t~~l~V 99 (101)
T cd05859 92 SYTFALQI 99 (101)
T ss_pred EEEEEEEE
Confidence 99999887
No 31
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=99.50 E-value=1.7e-13 Score=112.75 Aligned_cols=90 Identities=40% Similarity=0.615 Sum_probs=78.1
Q ss_pred CceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 261 PNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 261 P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
|.|...+..+.+.+|++++|.|.+.|.|.|.+.|++++..+....+....... ....|.|.+++.+|+|.|+|.
T Consensus 1 P~~~~~~~~~~v~~G~~~~l~c~~~~~p~~~v~W~~~~~~l~~~~~~~~~~~~------~~~~L~I~~v~~~D~G~Y~C~ 74 (90)
T PF07679_consen 1 PVFTKKPKDVTVKEGESVTLECEVSGNPPPTVTWYKNGRPLTSSQRYQIESDG------GSSSLTIKNVTREDAGTYTCV 74 (90)
T ss_dssp EEEEEESSEEEEETTSEEEEEEEEEESSSSEEEEEETTEEEESSSSEEEEEET------TEEEEEESSESGGGSEEEEEE
T ss_pred CEEEEecCCEEEeCCCEEEEEEEEEeCCCCcccccccccceeeeeeeeeeccc------ceeEEccCCCChhhCEEEEEE
Confidence 56777889999999999999999999999999999999999886554433322 245899999999999999999
Q ss_pred eecCCcceeEEEEEEc
Q psy10487 341 AENIRGNASGEISLDL 356 (610)
Q Consensus 341 a~N~~G~~~~~~~L~V 356 (610)
|.|..|...+++.|.|
T Consensus 75 ~~n~~g~~~~~~~l~V 90 (90)
T PF07679_consen 75 ASNSSGEATASVNLTV 90 (90)
T ss_dssp EEETTEEEEEEEEEEE
T ss_pred EEECCCEEEEEEEEEC
Confidence 9999999999998876
No 32
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=99.50 E-value=1.3e-13 Score=114.55 Aligned_cols=90 Identities=32% Similarity=0.602 Sum_probs=71.4
Q ss_pred CCceeeee--cceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEE
Q psy10487 260 PPNVTIKE--SMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEY 337 (610)
Q Consensus 260 ~P~i~~~~--~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y 337 (610)
||.|.... .+..+..|+.+.|.|.+.|.|.|.+.|+++|..+........... ..+.|+|.+++.+|+|.|
T Consensus 1 pp~i~~~~~~~~~~~~~G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~~~~~~-------~~~~L~I~~v~~~D~G~Y 73 (95)
T cd05730 1 PPTIRARQSEVNATANLGQSVTLACDADGFPEPTMTWTKDGEPIESGEEKYSFNE-------DGSEMTILDVDKLDEAEY 73 (95)
T ss_pred CCccccCCcccceEEeCCCCEEEEEeccEeCCCEEEEEECCEECcCCCCEEEEeC-------CCCEEEECCCChhhCEEE
Confidence 34454433 455788999999999999999999999999998765422111111 124799999999999999
Q ss_pred EEEeecCCcceeEEEEEEc
Q psy10487 338 TCYAENIRGNASGEISLDL 356 (610)
Q Consensus 338 ~C~a~N~~G~~~~~~~L~V 356 (610)
+|.|.|..|....++.|.|
T Consensus 74 ~C~a~N~~G~~~~~~~L~V 92 (95)
T cd05730 74 TCIAENKAGEQEAEIHLKV 92 (95)
T ss_pred EEEEEcCCCeEEEEEEEEE
Confidence 9999999999999999987
No 33
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=99.50 E-value=2.3e-13 Score=111.81 Aligned_cols=85 Identities=26% Similarity=0.452 Sum_probs=68.9
Q ss_pred eecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.+....+.+|+.+.|.|.+.|.|.|.+.|+++|..+......... . ....+.|.|.+++.+|.|.|+|.|.|..
T Consensus 6 ~p~~~~v~~G~~v~l~C~~~G~P~p~v~W~~~g~~~~~~~~~~~~--~----~~~~~~L~I~~v~~~D~g~Y~C~A~N~~ 79 (90)
T cd04972 6 GPNATVVYEGGTATIRCTAEGSPLPKVEWIIAGLIVIQTRTDTLE--T----TVDIYNLQLSNITSETQTTVTCTAENPV 79 (90)
T ss_pred CCcCEEEcCCCcEEEEEEEEEcCCCeEEEEECCEEccCCccEEEE--e----cCCEEEEEEecCCcccCEEEEEEEECCC
Confidence 445666889999999999999999999999999887543321100 0 0223589999999999999999999999
Q ss_pred cceeEEEEEEc
Q psy10487 346 GNASGEISLDL 356 (610)
Q Consensus 346 G~~~~~~~L~V 356 (610)
|.+.+++.|.|
T Consensus 80 G~~~~~~~L~v 90 (90)
T cd04972 80 GQANVSVQVTV 90 (90)
T ss_pred CceeEEEEEeC
Confidence 99999998875
No 34
>PHA02785 IL-beta-binding protein; Provisional
Probab=99.48 E-value=4.4e-13 Score=137.20 Aligned_cols=164 Identities=12% Similarity=0.118 Sum_probs=93.9
Q ss_pred EeecCceEEEEEEE-----EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 271 IREAGGNVTMSCYV-----YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 271 ~v~~G~~v~l~C~~-----~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.+.+|+.+.|.|.+ .|.|.|++.|+|+|.... + ....+++ ..|.|.++..+|+|.|+|+|.|..
T Consensus 37 ~~~~ge~~~l~C~~~~~~~~g~p~~~i~W~K~g~~~~---~-~~~~~~g-------~~l~i~~~~~~DsG~Y~C~a~N~~ 105 (326)
T PHA02785 37 MELENEPVILPCPQINTLSSGYNILDILWEKRGADND---R-IIPIDNG-------SNMLILNPTQSDSGIYICITKNET 105 (326)
T ss_pred hhhcCCCEEEECCCccccccCCCCceEEEEECCCccc---e-EEEccCC-------ceEEEcccCcccCeEEEEEEECCC
Confidence 34569999999997 799999999999974311 1 1111111 258899999999999999999999
Q ss_pred cceeEEEEEEcCccccccccccCCcceeehhhhHHHHHHHHHhheeEEEEEEeeecccccccccCCccccccccccccce
Q psy10487 346 GNASGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSVIVSIGMSFCVCRAHEHKNKRRKRKGKMKQSVSFNDQEKKL 425 (610)
Q Consensus 346 G~~~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 425 (610)
|....++.|.|..... +.+...........+..+.+.|.... .+......+...|.+.............++.|
T Consensus 106 g~~~~s~~L~V~~~~~-~~~~~~~~~~~~~~g~~~~i~C~~~~-----~~~~~~~~~~i~W~k~~~~~~~r~~~~~~~~L 179 (326)
T PHA02785 106 YCDMMSLNLTIVSVSE-SNIDLISYPQIVNERSTGEMVCPNIN-----AFIASNVNADIIWSGHRRLRNKRLKQRTPGII 179 (326)
T ss_pred cceEEEEEEEEEecCC-CccceeeccceecccCcEEEECCChh-----hcccCCCCceEEEccCCccCCcceEecCCCeE
Confidence 9888888888743221 11111111111111111111111000 00001111122221111001111111234689
Q ss_pred eeeeeeeccCcceeeeecCCCcceee
Q psy10487 426 LDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 426 ~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.|.+++.+|+|.|+|.|.|..|....
T Consensus 180 ~i~~v~~~d~G~Y~C~~~n~~g~~~~ 205 (326)
T PHA02785 180 TIEDVRKNDAGYYTCVLKYIYGDKTY 205 (326)
T ss_pred EEeecChhhCeEEEEEEEeccCCEEE
Confidence 99999999999999999999887543
No 35
>KOG0444|consensus
Probab=99.48 E-value=4.2e-15 Score=153.42 Aligned_cols=185 Identities=23% Similarity=0.312 Sum_probs=83.5
Q ss_pred EEEcCCCCCCccCccc--CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCC
Q psy10487 38 SALCKDANFTALPSTL--DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDN 115 (610)
Q Consensus 38 ~~~C~~~~l~~lP~~l--~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n 115 (610)
.+|.+.++|+++|.++ .+++-+|+|++|+|..|+...|. +|..|-+|+|++|.+..++|. .+.|..|++|+|++|
T Consensus 107 ~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfi--nLtDLLfLDLS~NrLe~LPPQ-~RRL~~LqtL~Ls~N 183 (1255)
T KOG0444|consen 107 ILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFI--NLTDLLFLDLSNNRLEMLPPQ-IRRLSMLQTLKLSNN 183 (1255)
T ss_pred eeecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHH--hhHhHhhhccccchhhhcCHH-HHHHhhhhhhhcCCC
Confidence 3455555555555444 23555555555555555555554 455555555555555555443 344455555555555
Q ss_pred CCCCCCcccccCCCCCcEEEeeCccccc-cCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCc
Q psy10487 116 QIAWLHQDTFLGNDRLKVLYLNGNPITE-LRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSE 194 (610)
Q Consensus 116 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 194 (610)
.+....-..+-.+.+|+.|.+++.+-+- -.+..+..|.+|+.++|+.|++..+ |+.+-++.+|+.|+|++|+|+.+..
T Consensus 184 PL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~v-Pecly~l~~LrrLNLS~N~iteL~~ 262 (1255)
T KOG0444|consen 184 PLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIV-PECLYKLRNLRRLNLSGNKITELNM 262 (1255)
T ss_pred hhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcc-hHHHhhhhhhheeccCcCceeeeec
Confidence 4332211111112222222222211100 0011223334444455555555444 3444455555555666665555543
Q ss_pred ccccCCCcccEEecCCCcc----cccCCchhhHHHHh
Q psy10487 195 SVFFPTPNLKTLSLDGNPW----CCDCHLRSFRNWLL 227 (610)
Q Consensus 195 ~~~~~~~~L~~l~l~~N~~----~c~c~l~~~~~~l~ 227 (610)
. ...+.+|++|+++.|++ .|.|.+..+...+.
T Consensus 263 ~-~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 263 T-EGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred c-HHHHhhhhhhccccchhccchHHHhhhHHHHHHHh
Confidence 2 23344555556665554 23455555544443
No 36
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=99.48 E-value=2.4e-13 Score=107.33 Aligned_cols=75 Identities=28% Similarity=0.395 Sum_probs=59.6
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
++|.|.+.|.|.|.|.|+|++..+............+. ....|.|.+++.+|+|.|+|.|.|.+|.++.++.|.|
T Consensus 1 v~L~C~v~G~P~P~v~W~k~~~~i~~~~~r~~~~~~~~----~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 75 (75)
T cd05744 1 VRLECRVSAIPPPQIFWKKNNEMLTYNTDRISLYQDNC----GRICLLIQNANKEDAGWYTVSAVNEAGVVSCNARLDV 75 (75)
T ss_pred CEEEEEEeecCCCeEEEEECCEECCCCCCcEEEEEcCC----CeEEEEECCCCcccCEEEEEEEEcCCCcEEEEEEEeC
Confidence 47999999999999999999998875432222221211 1236999999999999999999999999999998875
No 37
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.47 E-value=3.4e-13 Score=105.34 Aligned_cols=71 Identities=31% Similarity=0.581 Sum_probs=59.4
Q ss_pred eEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 277 NVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 277 ~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
+++|.|.+.|.|.|.++|+|++..+....+.+. ...+.|.|.+++.+|+|.|+|.|.|..|.+++++.|.|
T Consensus 1 ~v~l~C~~~G~P~p~v~W~k~g~~~~~~~~~~~---------~~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 71 (71)
T cd05723 1 DVIFECEVTGKPTPTVKWVKNGDMVIPSDYFKI---------VKEHNLQVLGLVKSDEGFYQCIAENDVGNVQASAQLII 71 (71)
T ss_pred CEEEEEEEEEeCCCEEEEEECCeECCCCCCEEE---------EecCCEEEEcCCcccCEEEEEEEEcCCCEEEEEEEEEC
Confidence 478999999999999999999988765443211 22347899999999999999999999999999999875
No 38
>KOG4222|consensus
Probab=99.47 E-value=2.8e-14 Score=156.13 Aligned_cols=215 Identities=16% Similarity=0.169 Sum_probs=153.8
Q ss_pred ccCCCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccc
Q psy10487 229 SKLYSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDL 308 (610)
Q Consensus 229 ~~l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~ 308 (610)
.+.+.+.|.|++.|.++..........+ .-+|.+...+.+..+.+|..+.|.|++.|+|.|.|.|.+++..+.....
T Consensus 195 rksD~GtY~CVatNmvG~ReS~~A~lsv-~e~P~f~~rp~~~~v~~g~~~~f~c~v~GdP~P~Vrwkk~~~~~P~~ry-- 271 (1281)
T KOG4222|consen 195 RKSDEGTYACVATNMVGERESIPARLSV-QEKPWFWKRPKDLAVLVGAAAEFDCRVGGDPQPTVRWKKDDPSLPRSRY-- 271 (1281)
T ss_pred ccCCCceeeeeecccccccccccceeee-ccCCccccccccceeecccccccccccCCCCCCceeeeccCCCCCccce--
Confidence 3568899999999988776655444443 3789999999999999999999999999999999999997766654332
Q ss_pred eeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCccccccccccCCcceeehhhhHHHHHHHHHh
Q psy10487 309 LEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSVIVS 388 (610)
Q Consensus 309 ~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (610)
.+.++ .-+|.|.+++..|.|.|.|.|.|..|...+.+.++| ..+|.+.+.+....+..+..+.+.|.+.+
T Consensus 272 ~i~~d-------~qtl~i~r~tp~deg~y~C~a~n~vG~l~asa~ltV---~apP~f~kkp~dq~v~lg~~vt~pc~~~g 341 (1281)
T KOG4222|consen 272 SILDD-------TQTLRIDRVTPTDEGTYVCPAENLVGGLEASATLTV---QAPPSFGKKPRDQKVALGGTVTFPCETLG 341 (1281)
T ss_pred eeeec-------cccccccccCCCcccceeeeccccccccccccceEE---ecCcccccccCccccccCceEEeeeecCC
Confidence 22222 128999999999999999999999999999999988 44567777666666665556666666666
Q ss_pred heeEEEEEEeeecccccccccCCccccccccccccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 389 IGMSFCVCRAHEHKNKRRKRKGKMKQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
.+...++|.+.....-..................+.|.|.++...|.|.|.|.+.+++|+....+.+.
T Consensus 342 nP~PavfW~keg~q~llf~~~p~~~~~r~svs~~g~L~it~v~~~d~g~Yvcq~~~~~~ss~~~a~~~ 409 (1281)
T KOG4222|consen 342 NPPPAVFWLKEGSQDLLFSASPPSSNGRGSVSPTGTLTITNVRQSDEGYYVCQTQTSAGSSLTKAYLE 409 (1281)
T ss_pred CCCcceEEeccCcceecccCCCCCcCccceecCCCCcccccccccccceEeecccccccccccceeEE
Confidence 66544444333222110000000111111223445899999999999999999999988766555554
No 39
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=99.47 E-value=2.7e-13 Score=107.10 Aligned_cols=77 Identities=27% Similarity=0.393 Sum_probs=60.7
Q ss_pred EEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 279 TMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 279 ~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
.+.|.+.|+|.|+|+|+|||.++..+.+......... .....+.|+|.+++.+|+|.|+|+|+|..|.+++++.++.
T Consensus 2 ~i~~~v~G~P~Pti~W~kng~~l~~~~~~~~~~~~~~-~~~~~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~~f 78 (79)
T cd05855 2 CIPFTVKGNPKPTLQWFHEGAILNESEYICTKIHVIN-NTEYHGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSAHF 78 (79)
T ss_pred eEEEEEeEeCCCceEEEECCEECCCCcceeeeeEeec-ccceEEEEEECCCCcccCEEEEEEEEcCCcccceEEEeec
Confidence 4789999999999999999999986654322111100 1134578999999999999999999999999999988764
No 40
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=99.47 E-value=1.8e-13 Score=104.71 Aligned_cols=65 Identities=28% Similarity=0.443 Sum_probs=56.2
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
++|.|.+.|.|.|.+.|+|||..+.... ..+.|.|.++..+|+|.|+|+|.|..|..++++.+.|
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~~--------------~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~~l 65 (67)
T cd05863 1 VKLPVKVAAYPPPEFQWYKDGKLISGKH--------------SQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISLEL 65 (67)
T ss_pred CEEEEEEEEeCCCEEEEEECCEECcccC--------------CcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEEEE
Confidence 4799999999999999999999886321 1248999999999999999999999998888777765
No 41
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=99.46 E-value=3.2e-13 Score=107.16 Aligned_cols=75 Identities=28% Similarity=0.428 Sum_probs=63.2
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.++|.|.+.|.|.|.|.|+++|..+......... ....+.|.|.+++.+|+|.|+|.|.|..|...+.+.|
T Consensus 1 G~~~~l~C~~~g~P~p~i~W~~~g~~~~~~~~~~~~-------~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 73 (76)
T cd04978 1 GETGRLDCEAEGIPQPTITWRLNGVPIEELPPDPRR-------RVDGGTLILSNVQPNDTAVYQCNASNVHGYLLANAFV 73 (76)
T ss_pred CCeEEEEEEceeeCCCEEEEEECCEECCCCCCcceE-------EccCCEEEECCCChhhCEEEEEEEEccCCeEEEeEEE
Confidence 688999999999999999999999988655432111 1223589999999999999999999999999999998
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.|
T Consensus 74 ~V 75 (76)
T cd04978 74 HV 75 (76)
T ss_pred EE
Confidence 87
No 42
>KOG0617|consensus
Probab=99.46 E-value=1.9e-15 Score=132.36 Aligned_cols=148 Identities=25% Similarity=0.363 Sum_probs=80.9
Q ss_pred cCCCCCCccCcccC--CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCC
Q psy10487 41 CKDANFTALPSTLD--SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIA 118 (610)
Q Consensus 41 C~~~~l~~lP~~l~--~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~ 118 (610)
.+.++++.+|.++. .+|+.|++.+|+|++++...- .+++|+.|++.-|.+..++ ..|+.++.|+.|||+.|++.
T Consensus 40 LSHNKl~~vppnia~l~nlevln~~nnqie~lp~~is---sl~klr~lnvgmnrl~~lp-rgfgs~p~levldltynnl~ 115 (264)
T KOG0617|consen 40 LSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSIS---SLPKLRILNVGMNRLNILP-RGFGSFPALEVLDLTYNNLN 115 (264)
T ss_pred cccCceeecCCcHHHhhhhhhhhcccchhhhcChhhh---hchhhhheecchhhhhcCc-cccCCCchhhhhhccccccc
Confidence 34455555555543 255555555555555554332 3555555555555554443 23555555666666655553
Q ss_pred C-CCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCc
Q psy10487 119 W-LHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSE 194 (610)
Q Consensus 119 ~-l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 194 (610)
. .-|..|..+..|+-|+|+.|.+..++++ .+++++|+.|.+..|.+-.+ |..++.+..|+.|.+++|+++-+++
T Consensus 116 e~~lpgnff~m~tlralyl~dndfe~lp~d-vg~lt~lqil~lrdndll~l-pkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 116 ENSLPGNFFYMTTLRALYLGDNDFEILPPD-VGKLTNLQILSLRDNDLLSL-PKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred cccCCcchhHHHHHHHHHhcCCCcccCChh-hhhhcceeEEeeccCchhhC-cHHHHHHHHHHHHhcccceeeecCh
Confidence 2 2234445555556666666655555442 55666666666666666555 3445566666666666666666655
No 43
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=99.46 E-value=7.7e-14 Score=134.10 Aligned_cols=158 Identities=15% Similarity=0.207 Sum_probs=94.6
Q ss_pred cceEeecCceEEEEEEEEecCC-----------CeEEEEeCCEEe--ccC-CccceeeccCCceeeeeeEEEEEecCCCC
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPE-----------PTILWLLNGQVL--HNS-SFDLLEEEEGDALFEKSVSITLFNVTDLD 333 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~-----------p~v~W~~~g~~l--~~~-~~~~~~~~~~~~~~~~~~~L~I~~v~~~D 333 (610)
..+.+.+|+++.|.|.+.+.|+ ++|.|+|++... ... .+........+......+.|.|.+++.+|
T Consensus 30 ~~~~v~eGe~v~L~C~~~~~~~~~~~~~~~~~~~~V~W~k~~s~~~v~~~~~~~~~~~i~~~~~~~r~~~L~I~~v~~~D 109 (227)
T PHA02826 30 TPVYAKFGDPMVLLCTGKHYKKSIFFDKTFITSYNVTWSKTDSLAFVRDSGARTKIKKITHNEIGDRSENLWIGNVINID 109 (227)
T ss_pred ceEEecCCCCEEEEccccccccccccccccCCCccEEEEeCCeEEEEEcCCCccccccccccceecCCCeEEECCCChHH
Confidence 4567889999999999987654 489999987642 111 11000000000001124589999999999
Q ss_pred CeEEEEEeecCCcceeEEEEEEcCccccccccccCCcceeehhhhHHHHHHHHHhheeEEEEEEeee-------cccccc
Q psy10487 334 AGEYTCYAENIRGNASGEISLDLPEINLATTLSKTDSWYMLVLGISVCVVSVIVSIGMSFCVCRAHE-------HKNKRR 406 (610)
Q Consensus 334 ~G~Y~C~a~N~~G~~~~~~~L~V~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 406 (610)
+|.|+|+|.|..|....++.|.|..... ...+..+..+ .+.|.... .+...|
T Consensus 110 sG~Y~C~a~N~~~~~~~~i~L~V~~~~~---------~~~~~~G~~v------------~L~C~~~~~~~~~~p~p~I~W 168 (227)
T PHA02826 110 EGIYICTISSGNICEESTIRLTFDSGTI---------NYQFNSGKDS------------KLHCYGTDGISSTFKDYTLTW 168 (227)
T ss_pred CEEEEEEEEECCcceEEEEEEEEecCCc---------cceEecCCCE------------EEEeeCCCCccccCCCceEEE
Confidence 9999999999999988888888832110 0111111111 22332211 122222
Q ss_pred cccCCc---cccccccccccceeeeeeeeccCcceeeeecCCC
Q psy10487 407 KRKGKM---KQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQ 446 (610)
Q Consensus 407 ~~~~~~---~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~ 446 (610)
.+.... ...+.....++.|.|.+++.+|+|.|+|+|+...
T Consensus 169 yKng~~l~~~~r~~~~~~~~~L~I~~V~~~DsG~YtC~a~~~~ 211 (227)
T PHA02826 169 YKNGNIVLYTDRIQLRNNNSTLVIKSATHDDSGIYTCNLRFNK 211 (227)
T ss_pred EECCEECCCCCCEEEeCCCCEEEECcCCHHhCEEEEEEEEEeE
Confidence 222111 1122222345689999999999999999999854
No 44
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.46 E-value=5.7e-13 Score=111.37 Aligned_cols=92 Identities=24% Similarity=0.421 Sum_probs=69.1
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeC--CEEeccCCc---cceeeccCCceeeeeeEEEEEecCCCCC
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLN--GQVLHNSSF---DLLEEEEGDALFEKSVSITLFNVTDLDA 334 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~--g~~l~~~~~---~~~~~~~~~~~~~~~~~L~I~~v~~~D~ 334 (610)
+|.+. .+.++.+.+|+.++|.|.+.|.|.|.|.|+++ +..+..... .+...... ...+.|+|.+++.+|+
T Consensus 2 ~p~i~-~~~~~~~~~G~~v~l~C~~~G~P~p~i~W~k~~~g~~~~~~~~~~~~r~~v~~~----~~~~~L~I~~v~~~D~ 76 (98)
T cd05870 2 QPHII-QLKNETTVENGAATLSCKAEGEPIPEITWKRASDGHTFSEGDKSPDGRIEVKGQ----HGESSLHIKDVKLSDS 76 (98)
T ss_pred CCEEE-eeccEEEcCCCcEEEEEecccCCCCeEEEEECCCCceeccCCcCcCceEEEeec----CCeeEEEEeeCCcCCC
Confidence 45554 46788999999999999999999999999994 444332110 11111110 1235899999999999
Q ss_pred eEEEEEeecCCcceeEEEEEEc
Q psy10487 335 GEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 335 G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
|.|+|.|.|..|.+..++.|.|
T Consensus 77 G~Y~C~A~N~~G~~~~~~~l~~ 98 (98)
T cd05870 77 GRYDCEAASRIGGHQKSMYLDI 98 (98)
T ss_pred EEEEEEEeccCCcceeEEEEeC
Confidence 9999999999999999998875
No 45
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=99.46 E-value=5.6e-13 Score=111.05 Aligned_cols=92 Identities=25% Similarity=0.364 Sum_probs=71.1
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCc---cceeeccCCceeeeeeEEEEEecCCCCCeE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSF---DLLEEEEGDALFEKSVSITLFNVTDLDAGE 336 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~---~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~ 336 (610)
+|.|. .+.+..+.+|+.+.|.|.+.|.|.|.+.|++++..+..... ........ ...+.|+|.+++.+|+|.
T Consensus 2 ~P~i~-~~~~~~~~~g~~v~l~C~~~g~p~p~v~W~~~~~~~~~~~~~~~~~~~~~~~----~~~~~L~I~~v~~~D~G~ 76 (96)
T cd05732 2 QPKIT-YLENQTAVELEQITLTCEAEGDPIPEITWRRATRNFSEGDKSLDGRIVVRGH----ARVSSLTLKDVQLTDAGR 76 (96)
T ss_pred Cccce-ecCceeEecCCcEEEEEEEeEcCCCcEEEEECCcccCCCCccccceEEEeCC----ccEEEEEECcCCcCcCEE
Confidence 46664 45678889999999999999999999999999866543221 01111111 123689999999999999
Q ss_pred EEEEeecCCcceeEEEEEEc
Q psy10487 337 YTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 337 Y~C~a~N~~G~~~~~~~L~V 356 (610)
|+|.|.|..|.++.++.|.|
T Consensus 77 Y~C~a~N~~G~~~~s~~l~v 96 (96)
T cd05732 77 YDCEASNRIGGDQQSMYLEV 96 (96)
T ss_pred eEEEEEeCCCCcEEEEEEeC
Confidence 99999999999999998875
No 46
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=99.45 E-value=5.6e-13 Score=105.15 Aligned_cols=74 Identities=28% Similarity=0.452 Sum_probs=60.9
Q ss_pred eEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 277 NVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 277 ~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
.+.|.|.+.|.|.|.+.|+++|..+....+...... ...+.|.|.+++.+|+|.|+|.|.|..|.++.++.|.|
T Consensus 1 ~~~l~c~~~G~P~p~v~W~k~g~~l~~~~~~~~~~~------~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 74 (74)
T cd05748 1 SVRLEVPISGRPTPTVTWSKDGKPLKLSGRVQIETT------ASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATINVKV 74 (74)
T ss_pred CEEEEeeEeeeCCCeEEEEECCEEcCCCCeEEEEEC------CCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEEEEC
Confidence 378999999999999999999998855443222211 12358999999999999999999999999999998875
No 47
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=99.45 E-value=7.2e-13 Score=111.18 Aligned_cols=94 Identities=31% Similarity=0.465 Sum_probs=69.3
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCC----ccceeeccCCceeeeeeEEEEEecCCCCCe
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSS----FDLLEEEEGDALFEKSVSITLFNVTDLDAG 335 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~----~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G 335 (610)
+|.+...+..+.+.+|+.++|.|.+.|.|.|.+.|+|+|..+.... .......++. .....+.+..++.+|+|
T Consensus 1 ~P~i~~~p~~~~v~~G~~~~l~C~~~g~P~p~i~W~k~g~~l~~~~~~~~~~~~~~~~~~---~~~~~i~~~~~~~~D~G 77 (100)
T cd07693 1 PPRIVEHPSDLIVSKGDPATLNCKAEGRPTPTIQWLKNGQPLETDKDDPRSHRIVLPSGS---LFFLRVVHGRKGRSDEG 77 (100)
T ss_pred CCeEEecCceeEEcCCCeEEEEeeCCcCCCCEEEEEECCEECccccCCCCcceEEecCCc---EEEEEeeccCCCcCcCE
Confidence 5788888899999999999999999999999999999999886521 1111111221 00011222234789999
Q ss_pred EEEEEeecCCcc-eeEEEEEEc
Q psy10487 336 EYTCYAENIRGN-ASGEISLDL 356 (610)
Q Consensus 336 ~Y~C~a~N~~G~-~~~~~~L~V 356 (610)
.|+|.|.|..|. .+..+.|.|
T Consensus 78 ~Y~C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 78 VYVCVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred EEEEEEEccccceecceEEEEe
Confidence 999999999999 667888776
No 48
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=99.44 E-value=7.6e-13 Score=109.04 Aligned_cols=86 Identities=27% Similarity=0.540 Sum_probs=70.4
Q ss_pred eecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.|..+.+.+|+.+.|.|.+.|.|.|.+.|++++..+....+.......+ ..+.|.|.+++.+|+|.|+|.|.|..
T Consensus 7 ~p~~v~v~eG~~v~L~C~v~g~P~p~i~W~k~~~~~~~~~~~~~~~~~~-----~~~~L~I~~~~~~D~G~Y~C~a~N~~ 81 (92)
T cd05891 7 LPDVVTIMEGKTLNLTCTVFGNPDPEVIWFKNDQDIELSEHYSVKLEQG-----KYASLTIKGVTSEDSGKYSINVKNKY 81 (92)
T ss_pred CCCcEEEcCCCEEEEEEEEEEeCCCeEEEEECCEECCCCCCEEEEEcCC-----CEEEEEECCCChhhCEEEEEEEEeCC
Confidence 3567789999999999999999999999999998876544322222222 12479999999999999999999999
Q ss_pred cceeEEEEEEc
Q psy10487 346 GNASGEISLDL 356 (610)
Q Consensus 346 G~~~~~~~L~V 356 (610)
|.+..++.|.|
T Consensus 82 G~~~~~~~v~~ 92 (92)
T cd05891 82 GGETVDVTVSV 92 (92)
T ss_pred CceeeEEEEEC
Confidence 99999998875
No 49
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.44 E-value=6.5e-13 Score=104.46 Aligned_cols=73 Identities=40% Similarity=0.633 Sum_probs=62.1
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.+.|.|.+.|.|.|+++|++++..+....+.+. ...+.|.|.+++.+|+|.|+|.|.|..|..+.++.|
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~~~~~~~~~~~~~---------~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 71 (73)
T cd04969 1 GGDVIIECKPKAAPKPTISWSKGTELLTNSSRICI---------WPDGSLEILNVTKSDEGKYTCFAENFFGKANSTGSL 71 (73)
T ss_pred CCeEEEEEeeeEcCCCEEEEEECCEEcccCCCEEE---------CCCCeEEEccCChhHCEEEEEEEECCCCceEEEEEE
Confidence 67899999999999999999999998765443211 122479999999999999999999999999999988
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.|
T Consensus 72 ~V 73 (73)
T cd04969 72 SV 73 (73)
T ss_pred EC
Confidence 76
No 50
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=99.44 E-value=9.7e-13 Score=108.84 Aligned_cols=86 Identities=27% Similarity=0.369 Sum_probs=64.9
Q ss_pred CceeeeecceEee---cCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecC-CCCCeE
Q psy10487 261 PNVTIKESMVIRE---AGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVT-DLDAGE 336 (610)
Q Consensus 261 P~i~~~~~~~~v~---~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~-~~D~G~ 336 (610)
|.+...|.++.+. +|+.++|.|.+.|.|.|+|+|+|+|..+......... ...+.|.|.++. .+|+|.
T Consensus 2 P~f~~~p~~~~~~~~~~g~~v~l~C~~~G~P~P~i~W~k~g~~l~~~~~~~~~--------~~~g~L~i~~~~~~~D~G~ 73 (94)
T cd05848 2 PVFVQEPDDAIFPTDSDEKKVILNCEARGNPVPTYRWLRNGTEIDTESDYRYS--------LIDGNLIISNPSEVKDSGR 73 (94)
T ss_pred CeeEECCCcEEccCCCCCCEEEEEEEeeecCCCEEEEEECCeECccCCCceEE--------eeCCeEEEccCCccCcCEE
Confidence 5566666666554 4789999999999999999999999988643321111 223589999985 699999
Q ss_pred EEEEeecCCcceeE-EEEE
Q psy10487 337 YTCYAENIRGNASG-EISL 354 (610)
Q Consensus 337 Y~C~a~N~~G~~~~-~~~L 354 (610)
|+|.|.|.+|...+ .+.|
T Consensus 74 Y~C~A~N~~G~~~S~~~~l 92 (94)
T cd05848 74 YQCLATNSIGSILSREALL 92 (94)
T ss_pred EEEEEEcCCCeEEeccEEE
Confidence 99999999998743 4444
No 51
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=99.43 E-value=8.4e-13 Score=107.25 Aligned_cols=82 Identities=28% Similarity=0.418 Sum_probs=66.3
Q ss_pred eEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCccee
Q psy10487 270 VIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNAS 349 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 349 (610)
..+.+|+.+.|.|.+.|.|.|.+.|+|+|..+............ .....|.|.+++.+|+|.|+|.|.|..|.+.
T Consensus 4 ~~v~~G~~~~L~C~~~g~P~p~i~W~k~g~~l~~~~~~~~~~~~-----~~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~ 78 (85)
T cd05857 4 HAVPAANTVKFRCPAAGNPTPTMRWLKNGKEFKQEHRIGGYKVR-----NQHWSLIMESVVPSDKGNYTCVVENEYGSIN 78 (85)
T ss_pred EEcCCCCEEEEEEEcCCCCCCEEEEEECCEECCCCCceeeeEEe-----CCceEEEEccCCcccCEEEEEEEEeCCCEEE
Confidence 45778999999999999999999999999988654432111100 1134799999999999999999999999999
Q ss_pred EEEEEEc
Q psy10487 350 GEISLDL 356 (610)
Q Consensus 350 ~~~~L~V 356 (610)
+++.|.|
T Consensus 79 ~~~~l~v 85 (85)
T cd05857 79 HTYHLDV 85 (85)
T ss_pred EEEEEEC
Confidence 9998876
No 52
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=99.43 E-value=7e-13 Score=106.05 Aligned_cols=78 Identities=31% Similarity=0.414 Sum_probs=61.0
Q ss_pred EEEEEEEecCCCeEEEEeCCEEeccCCccceeeccC-CceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 279 TMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEG-DALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 279 ~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~-~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
.+.|.+.|.|.|+|+|+|+|..+............. .......+.|+|.+++.+|+|.|+|+|.|.+|.+++++.++.
T Consensus 2 ~i~~~v~G~P~P~v~W~k~g~~i~~~~~~~~~~~~~~~~~~~~~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~~~~ 80 (81)
T cd04971 2 CIPFTVRGNPKPTLTWYHNGAVLNESDYIRTEIHYEVTTPTEYHGCLQFDNPTHVNNGNYTLVASNEYGQDSKSISAHF 80 (81)
T ss_pred eEEEEeEeeCCCcEEEEECCEECcCCCceeEEEEeecccccccEEEEEECCCCcccCeEEEEEEEeCCCCeeeEEEeee
Confidence 378999999999999999999998665432221111 001134568999999999999999999999999999988765
No 53
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.42 E-value=1.2e-12 Score=106.07 Aligned_cols=79 Identities=25% Similarity=0.330 Sum_probs=62.0
Q ss_pred ceEEEEEEEEecCCC--eEEEEeCCEEeccCCccce--eeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEE
Q psy10487 276 GNVTMSCYVYGDPEP--TILWLLNGQVLHNSSFDLL--EEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGE 351 (610)
Q Consensus 276 ~~v~l~C~~~g~P~p--~v~W~~~g~~l~~~~~~~~--~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 351 (610)
++++|.|.+.|+|.| .+.|+++|..+........ .... ....+.|+|.+++..|+|.|+|.|.|.+|.++++
T Consensus 1 ~~~~L~C~a~g~P~p~~~v~W~~~g~~i~~~~~~~~~~~~~~----~~~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~ 76 (85)
T cd05854 1 ENLTLQCHASHDPTMDLTFTWSLDDFPIDLDKPNGHYRRMEV----KETIGDLVIVNAQLSHAGTYTCTAQTVVDSASAS 76 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEccccCCCCcEEEEEe----cceEeEEEEccCChhhCeEEEEEEecCCCCEEEE
Confidence 468999999999998 5899999988865321111 1100 0234699999999999999999999999999999
Q ss_pred EEEEcCc
Q psy10487 352 ISLDLPE 358 (610)
Q Consensus 352 ~~L~V~~ 358 (610)
+.|.|..
T Consensus 77 ~~L~V~~ 83 (85)
T cd05854 77 ATLVVRG 83 (85)
T ss_pred EEEEEEC
Confidence 9999853
No 54
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=99.41 E-value=2.3e-12 Score=106.61 Aligned_cols=87 Identities=25% Similarity=0.380 Sum_probs=65.9
Q ss_pred CceeeeecceEeecC---ceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecC-CCCCeE
Q psy10487 261 PNVTIKESMVIREAG---GNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVT-DLDAGE 336 (610)
Q Consensus 261 P~i~~~~~~~~v~~G---~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~-~~D~G~ 336 (610)
|.+...|..+.+.+| ++++|.|.+.|+|.|+|+|+++|..+......... ...+.|.|.++. ..|+|.
T Consensus 2 P~f~~~P~~~~~~~~~~g~~v~l~C~a~g~P~p~i~W~~~g~~l~~~~~~~~~--------~~~g~L~I~~~~~~~D~G~ 73 (94)
T cd05850 2 PVFEEQPSSLLFPEGSPEEKVTLGCRARASPPATYRWKMNGTEIKFAPESRYT--------LVAGNLVINNPQKARDAGS 73 (94)
T ss_pred CeeEECCCCEEecCCCCCCeEEEEeEceeCCCCEEEEEECCEECccCCCceEE--------EECCeEEEccCCccCcCEE
Confidence 556667777776655 58999999999999999999999988643321111 223589998865 599999
Q ss_pred EEEEeecCCcceeE-EEEEE
Q psy10487 337 YTCYAENIRGNASG-EISLD 355 (610)
Q Consensus 337 Y~C~a~N~~G~~~~-~~~L~ 355 (610)
|+|.|.|..|.... .+.|.
T Consensus 74 Y~C~A~N~~G~~~s~~a~l~ 93 (94)
T cd05850 74 YQCLAINRCGTVVSREANLR 93 (94)
T ss_pred EEEEEEcCcCcEEEEEEEEe
Confidence 99999999998754 66553
No 55
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.41 E-value=7.1e-13 Score=102.64 Aligned_cols=68 Identities=29% Similarity=0.514 Sum_probs=55.3
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
+.|.|.+.|.|.|.++|+|||.++..... . ...+.|.|.++..+|+|.|+|.|.|..|..+...++.+
T Consensus 1 ~~~~c~v~G~P~P~v~W~k~g~~l~~~~~---~--------~~~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~l 68 (70)
T cd05864 1 VKIPVKYYGYPPPEVKWYKNGQLIVLNHT---F--------KRGVHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQL 68 (70)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCCE---E--------ccCCEEEECcCCHHHCEEEEEEEEECCCceeeEEEEEE
Confidence 36899999999999999999999865421 1 11237999999999999999999999998766555544
No 56
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=99.41 E-value=1.5e-12 Score=100.83 Aligned_cols=68 Identities=25% Similarity=0.495 Sum_probs=55.3
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|++++|.|.+.|.|.|.|.|+|++..+...... . .....|+|.+++ |+|.|+|.|.|..|...+++.|
T Consensus 1 G~~v~L~C~a~G~P~P~v~W~k~g~~l~~~~~~--~--------~~~~~L~i~~~~--d~G~Y~C~A~N~~G~~~~~a~l 68 (69)
T cd05739 1 GGSVNLTCVAVGAPMPYVKWMKGGEELTKEDEM--P--------VGRNVLELTNIY--ESANYTCVAISSLGMIEATAQV 68 (69)
T ss_pred CCeEEEEEEeeecCCCEEEEEECCEECCCccce--e--------cCccEEEEeccc--cCeeEEEEEEeCCCEEEEEEEE
Confidence 678999999999999999999999887543321 1 112378898874 8999999999999999888876
No 57
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=99.40 E-value=2.2e-12 Score=109.79 Aligned_cols=98 Identities=24% Similarity=0.334 Sum_probs=71.1
Q ss_pred CCceeeeec--ceEe--ecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecC-CCCC
Q psy10487 260 PPNVTIKES--MVIR--EAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVT-DLDA 334 (610)
Q Consensus 260 ~P~i~~~~~--~~~v--~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~-~~D~ 334 (610)
+|.|...+. .+.. ..|..++|.|.+.|.|.|.+.|+++|..+.............. .....+.|+|.+++ .+|.
T Consensus 4 ~P~~~~~~~~~~~~~~~~~g~~v~L~C~a~G~P~p~i~W~k~g~~l~~~~~r~~~~~~~~-~~~~~s~L~I~~v~~~~D~ 82 (109)
T cd05773 4 APDLQKGPQLRKVASRGDGSSDANLVCQAQGVPRVQFRWAKNGVPLDLGNPRYEETTEHT-GTVHTSILTIINVSAALDY 82 (109)
T ss_pred ccccccCCceEEEEEecCCCCEEEEEEECcccCCCEEEEEECCEECCCCCCeEEEEeecc-CccceeEEEECcCCccCCC
Confidence 566655544 2222 3568899999999999999999999998865432221111110 01224689999997 5999
Q ss_pred eEEEEEeecCCcceeEEEEEEcCc
Q psy10487 335 GEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 335 G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
|.|+|.|.|..|.+..++.|.|.+
T Consensus 83 G~Y~C~A~N~~G~~~~~i~L~~~~ 106 (109)
T cd05773 83 ALFTCTAHNSLGEDSLDIQLVSTS 106 (109)
T ss_pred EEEEEEEEeCCccCcEEEEEEecC
Confidence 999999999999999999999854
No 58
>KOG0444|consensus
Probab=99.40 E-value=3.1e-14 Score=147.10 Aligned_cols=172 Identities=25% Similarity=0.402 Sum_probs=141.7
Q ss_pred cEEEcCCCCCC--ccCcccC--CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEc
Q psy10487 37 KSALCKDANFT--ALPSTLD--SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDL 112 (610)
Q Consensus 37 ~~~~C~~~~l~--~lP~~l~--~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdL 112 (610)
++++-+.++|+ .||..|- ..|++|||++|++++.+.+.- .-.++-.|+|++|+|..|+...|-+|..|-.|||
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE---~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLE---YAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhh---hhcCcEEEEcccCccccCCchHHHhhHhHhhhcc
Confidence 34555666665 5777663 589999999999998886543 2567889999999999999888999999999999
Q ss_pred cCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCcccc--ccCHHHhhcCcccccccccccccc
Q psy10487 113 SDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIH--SVHKDALIHLTALESLNLNGNRLK 190 (610)
Q Consensus 113 s~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~n~l~ 190 (610)
|+|++..++|+ ...+..|+.|.|++|++......++..+++|+.|.+++.+-+ .+ |..+..+.+|..+|++.|.+.
T Consensus 158 S~NrLe~LPPQ-~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~-Ptsld~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 158 SNNRLEMLPPQ-IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNI-PTSLDDLHNLRDVDLSENNLP 235 (1255)
T ss_pred ccchhhhcCHH-HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcC-CCchhhhhhhhhccccccCCC
Confidence 99999999986 577899999999999998887778888899999999887533 33 455677899999999999998
Q ss_pred ccCcccccCCCcccEEecCCCccc
Q psy10487 191 HLSESVFFPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 191 ~~~~~~~~~~~~L~~l~l~~N~~~ 214 (610)
.++. .+..+.+|+.|+|++|.++
T Consensus 236 ~vPe-cly~l~~LrrLNLS~N~it 258 (1255)
T KOG0444|consen 236 IVPE-CLYKLRNLRRLNLSGNKIT 258 (1255)
T ss_pred cchH-HHhhhhhhheeccCcCcee
Confidence 8766 5568999999999999875
No 59
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=99.39 E-value=1.1e-12 Score=102.34 Aligned_cols=70 Identities=27% Similarity=0.461 Sum_probs=57.9
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
+.|.|.+.|.|.|.+.|++++..+..... ... ...+.|+|.+++.+|+|.|+|.|.|..|.+++++.|.|
T Consensus 1 ~~L~C~~~G~P~P~v~W~k~~~~~~~~~~--~~~-------~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05876 1 LVLECIAEGLPTPEVHWDRIDGPLSPNRT--KKL-------NNNKTLQLDNVLESDDGEYVCTAENSEGSARHHYTVTV 70 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCcCCCCCce--eEE-------cCCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEEEE
Confidence 47999999999999999999876654321 111 12358999999999999999999999999999999887
No 60
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=99.39 E-value=2.5e-12 Score=107.48 Aligned_cols=93 Identities=25% Similarity=0.415 Sum_probs=69.0
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCC-eEEEEeCCEEeccCCc-cceeeccCCceeeeeeEEEEEecCCCC-CeE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEP-TILWLLNGQVLHNSSF-DLLEEEEGDALFEKSVSITLFNVTDLD-AGE 336 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p-~v~W~~~g~~l~~~~~-~~~~~~~~~~~~~~~~~L~I~~v~~~D-~G~ 336 (610)
||.+ ..+....+.+|+.+.|.|.+.|.|.| .|.|++++..+..... ......... .....+.|+|.+++.+| .|.
T Consensus 2 pp~i-~~~~~~~~~~G~~v~L~C~~~g~P~P~~v~W~~~~~~i~~~~~~r~~i~~~~~-~~~~~s~L~I~~v~~~d~~G~ 79 (98)
T cd05758 2 PPII-TSEATQYAILGDKGRVECFIFSTPPPDRIVWTWKENELESGSSGRYTVETDPS-PGGVLSTLTISNTQESDFQTS 79 (98)
T ss_pred CCeE-cCCCcEEEeCCCcEEEEEEEcccCCCCEeEEEECCEEccCCCCCCEEEEEecC-CCceEEEEEECCcccccccee
Confidence 3444 44566778999999999999999999 6999999998865431 111111110 01223589999999955 899
Q ss_pred EEEEeecCCcceeEEEEE
Q psy10487 337 YTCYAENIRGNASGEISL 354 (610)
Q Consensus 337 Y~C~a~N~~G~~~~~~~L 354 (610)
|+|.|.|..|.+.+.+.|
T Consensus 80 Y~C~A~N~~G~~~~~~~L 97 (98)
T cd05758 80 YNCTAWNSFGSGTAIISL 97 (98)
T ss_pred EEEEEEcCCCcccEEEEe
Confidence 999999999999888876
No 61
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=99.39 E-value=1.7e-12 Score=103.49 Aligned_cols=76 Identities=33% Similarity=0.442 Sum_probs=60.2
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|++++|.|.+.|.|.|.+.|++++..+....+....... ..+.|+|.+++.+|+|.|+|.|.|..|.....+.+
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~~~~~~~~~~~~~~~~~~~------~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~~ 74 (78)
T cd05743 1 GETVEFTCVATGVPTPIINWRLNWGHVPDSARVSITSEG------GYGTLTIRDVKESDQGAYTCEAINTRGMVFGIPDG 74 (78)
T ss_pred CCEEEEEEEEEEecCCEEEEEECCeECCCCCCEEEEECC------CEEEEEECCCChHHCEEEEEEEEecCCEEEecccE
Confidence 688999999999999999999998877654332211111 23589999999999999999999999998776655
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.+
T Consensus 75 ~~ 76 (78)
T cd05743 75 IL 76 (78)
T ss_pred EE
Confidence 43
No 62
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=99.39 E-value=4.2e-12 Score=104.02 Aligned_cols=87 Identities=29% Similarity=0.518 Sum_probs=67.2
Q ss_pred eeeeecceEeecCceEEEEEEEEecCCCeEEEEe-CCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEe
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVYGDPEPTILWLL-NGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYA 341 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~-~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a 341 (610)
+.+.+.+..+.+|+.+.|.|.+.|.|. .+.|++ ++..+....+.. ...++ ..+.|.|.++..+|+|.|+|.|
T Consensus 3 ~~~~~~~~~v~~G~~v~l~C~~~G~P~-~v~W~k~~g~~~~~~~r~~-~~~~g-----~~~~L~I~~v~~~D~G~Y~C~A 75 (92)
T cd05866 3 VSISLSKVELSVGESKFFTCTAIGEPE-SIDWYNPQGEKIVSSQRVV-VQKEG-----VRSRLTIYNANIEDAGIYRCQA 75 (92)
T ss_pred EEEEecceEEcCCCeEEEEEEEEEeCC-eEEEEeCCCeEecCCCCEE-EEeCC-----CeeEEEEecCChHHCEEEEEEE
Confidence 456778889999999999999999998 899998 466665433211 11111 1248999999999999999999
Q ss_pred ecCCcce-eEEEEEEc
Q psy10487 342 ENIRGNA-SGEISLDL 356 (610)
Q Consensus 342 ~N~~G~~-~~~~~L~V 356 (610)
.|..|.. .+++.|.+
T Consensus 76 ~N~~G~~~~~~i~l~~ 91 (92)
T cd05866 76 TDAKGQTQEATVVLEI 91 (92)
T ss_pred EcCCCcEEEEEEEEEE
Confidence 9999986 56777764
No 63
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.39 E-value=1.2e-12 Score=101.69 Aligned_cols=69 Identities=38% Similarity=0.566 Sum_probs=57.0
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
++|.|.+.|.|.|.+.|+|++..+..... . ....+.|.|.+++.+|+|.|+|.|.|..|....++.|.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~~~--~--------~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 69 (69)
T cd05725 1 VEFQCEVGGDPVPTVLWRKEDGELPKGRA--E--------ILDDKSLKIRNVTAGDEGSYTCEAENMVGKIEASASLTV 69 (69)
T ss_pred CEEEEECccCCCCEEEEEECCccCCCCcE--E--------EeeCCEEEECcCChhHCEEEEEEEEcCCCcEEEEEEEEC
Confidence 47999999999999999999876543221 1 112348999999999999999999999999999988875
No 64
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=99.38 E-value=1.7e-12 Score=104.57 Aligned_cols=79 Identities=28% Similarity=0.561 Sum_probs=64.4
Q ss_pred eEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCccee
Q psy10487 270 VIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNAS 349 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 349 (610)
+....|+.+.|.|.+.|.|.|.+.|++++..+........ ....+.|.|.+++.+|+|.|+|.|.|..|.++
T Consensus 4 ~~~~~G~~v~L~C~~~g~p~p~i~W~k~~~~~~~~~~~~~--------~~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~ 75 (82)
T cd05856 4 IARPVGSSVRLKCVASGNPRPDITWLKDNKPLTPTEIGES--------RKKKWTLSLKNLKPEDSGKYTCHVSNRAGEIN 75 (82)
T ss_pred eeccCCCeEEEEEEeeEeCCCcEEEEECCcCCcCCcccee--------cCceEEEEEccCChhhCEEEEEEEEcCCccEE
Confidence 3456799999999999999999999999987654332110 01235899999999999999999999999999
Q ss_pred EEEEEEc
Q psy10487 350 GEISLDL 356 (610)
Q Consensus 350 ~~~~L~V 356 (610)
+++.|.|
T Consensus 76 ~~~~v~v 82 (82)
T cd05856 76 ATYKVDV 82 (82)
T ss_pred EEEEEeC
Confidence 8888865
No 65
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=99.38 E-value=3e-12 Score=104.19 Aligned_cols=83 Identities=25% Similarity=0.414 Sum_probs=66.1
Q ss_pred eecceEeecCceEEEEEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecC
Q psy10487 266 KESMVIREAGGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 344 (610)
.|....+.+|+++.|.|.+ .|.|.|.+.|++++..+......... ...+.|.|.+++.+|+|.|+|.|.|.
T Consensus 2 ~p~~~~~~~G~~v~l~C~~~~g~p~p~i~W~k~g~~~~~~~~~~~~--------~~~~~L~I~~~~~~D~G~Y~C~a~N~ 73 (86)
T cd05724 2 EPSDTQVAVGEMAVLECSPPRGHPEPTVSWRKDGQPLNLDNERVRI--------VDDGNLLIAEARKSDEGTYKCVATNM 73 (86)
T ss_pred CCccEEEeCCCCEEEEEECCCCCCCCEEEEEECCEECCCCCCCEEE--------ccCCEEEEeECCcccCEEEEEEEEec
Confidence 3567788899999999998 79999999999999887654321111 11358999999999999999999999
Q ss_pred Ccce-eEEEEEEc
Q psy10487 345 RGNA-SGEISLDL 356 (610)
Q Consensus 345 ~G~~-~~~~~L~V 356 (610)
.|.. +..+.|.|
T Consensus 74 ~G~~~s~~~~l~V 86 (86)
T cd05724 74 VGERESAAARLSV 86 (86)
T ss_pred cCceeeeeEEEEC
Confidence 9986 45666654
No 66
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=99.38 E-value=2.4e-12 Score=102.22 Aligned_cols=72 Identities=29% Similarity=0.528 Sum_probs=55.9
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeE--EEEEE
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASG--EISLD 355 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~--~~~L~ 355 (610)
++|.|.+.|.|.|.|.|+|+|..+.......... . ..+.|.|.+++.+|+|.|+|.|.|.+|.... .++|.
T Consensus 1 v~L~C~~~g~P~p~v~W~k~g~~l~~~~~~~~~~-~------~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~~~l~ 73 (77)
T cd05760 1 VTLRCHIDGHPRPTYQWFRDGTPLSDGQGNYSVS-S------KERTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQNFTLS 73 (77)
T ss_pred CEEEEEeeecCCCcEEEEECCEECCCCCccEEEe-C------CCCEEEEeeCCcccCEEEEEEEEeCCCeEeeCceEEEE
Confidence 4799999999999999999999876543211111 1 1248999999999999999999999998754 55555
Q ss_pred c
Q psy10487 356 L 356 (610)
Q Consensus 356 V 356 (610)
|
T Consensus 74 v 74 (77)
T cd05760 74 I 74 (77)
T ss_pred E
Confidence 4
No 67
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=99.38 E-value=1.7e-12 Score=104.09 Aligned_cols=79 Identities=15% Similarity=0.292 Sum_probs=61.0
Q ss_pred ceEEEEEEEEec--CCCeEEEEeCCEEeccCCc--cceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEE
Q psy10487 276 GNVTMSCYVYGD--PEPTILWLLNGQVLHNSSF--DLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGE 351 (610)
Q Consensus 276 ~~v~l~C~~~g~--P~p~v~W~~~g~~l~~~~~--~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 351 (610)
+++.|.|.+.++ +++.+.|++||..+..... ........ ...+.|+|.+++..|+|.|+|.|.|.++..+++
T Consensus 1 ~~~~l~C~v~~d~~l~~~~~W~~dg~~i~~~~~~~~~~~~~~~----~~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a~ 76 (85)
T cd05853 1 ESIVLPCQVSHDHSLDIVFTWSFNGHLIDFQKDGDHFERVGGQ----DSAGDLMIRSIQLKHAGKYVCMVQTSVDKLSAA 76 (85)
T ss_pred CcEEEEEEeccCCCCCcEEEEEECCEECcccCCCccEEEeccC----CCCCcEEEecCCHHHCEEEEEEEEcccCceEEE
Confidence 468999999874 5788999999999963221 11111110 123589999999999999999999999999999
Q ss_pred EEEEcCc
Q psy10487 352 ISLDLPE 358 (610)
Q Consensus 352 ~~L~V~~ 358 (610)
+.|.|..
T Consensus 77 a~L~V~~ 83 (85)
T cd05853 77 ADLIVRG 83 (85)
T ss_pred EEEEEec
Confidence 9999853
No 68
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=99.38 E-value=2.1e-12 Score=100.78 Aligned_cols=69 Identities=28% Similarity=0.472 Sum_probs=57.4
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
+.|.|.+.|.|.|.+.|+|+|..+....+ .. ...+.|.|.+++.+|+|.|+|.|.|..|.....+.+.|
T Consensus 1 ~~l~c~v~g~P~p~v~W~k~g~~l~~~~~--~~--------~~~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~~ 69 (71)
T cd04976 1 VRLPVKVKAYPPPEIQWYKNGKLISEKNR--TK--------KSGHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFTL 69 (71)
T ss_pred CEEEeEEEEeCCCEEEEEECCEECCCCCE--EE--------cCCCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEEEE
Confidence 46999999999999999999998876532 11 12248999999999999999999999999887777765
No 69
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.38 E-value=3.1e-12 Score=100.85 Aligned_cols=73 Identities=34% Similarity=0.658 Sum_probs=59.1
Q ss_pred CceEEEEEEEEecCCCeEEEEe-CCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLL-NGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~-~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
|+.+.|.|.+.|.|.|.+.|++ ++..+....+ ... ...+.|.|.+++.+|+|.|+|.|.|..|.+++++.
T Consensus 1 G~~~~l~C~~~g~P~p~v~W~~~~~~~~~~~~~-~~~--------~~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 71 (74)
T cd05764 1 GQRATLRCKARGDPEPAIHWISPDGKLISNSSR-TLV--------YDNGTLDILITTVKDTGSFTCIASNAAGEATATVE 71 (74)
T ss_pred CCeEEEEEEccCcCCCEEEEEeCCCEEecCCCe-EEE--------ecCCEEEEEECChhhCEEEEEEEECCCCeEEEEEE
Confidence 6889999999999999999997 5555543321 111 22358999999999999999999999999999988
Q ss_pred EEc
Q psy10487 354 LDL 356 (610)
Q Consensus 354 L~V 356 (610)
|.|
T Consensus 72 l~v 74 (74)
T cd05764 72 LHI 74 (74)
T ss_pred EEC
Confidence 875
No 70
>KOG0618|consensus
Probab=99.37 E-value=2e-14 Score=155.25 Aligned_cols=184 Identities=25% Similarity=0.331 Sum_probs=151.1
Q ss_pred CCCCeeCccCCCcEEEcCCCCCCccCcccC--CCccEEEeecCCCCCCChhhhccc-----------------------C
Q psy10487 25 PDTCRCKWTLGKKSALCKDANFTALPSTLD--SDIQVLDLNNNKISYLTKEAFKSI-----------------------G 79 (610)
Q Consensus 25 p~~C~C~~~~~~~~~~C~~~~l~~lP~~l~--~~L~~L~L~~n~i~~l~~~~~~~~-----------------------~ 79 (610)
|..|.|.|. -..++|..+.++-+|..+. +.|++|+|+.|+|..+++..|... .
T Consensus 280 p~ri~~~~~--L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~ 357 (1081)
T KOG0618|consen 280 PLRISRITS--LVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENN 357 (1081)
T ss_pred HHHHhhhhh--HHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchh
Confidence 446667664 3567888889998987664 589999999999999988765431 1
Q ss_pred CCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEE
Q psy10487 80 LLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIE 159 (610)
Q Consensus 80 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 159 (610)
+..|+.|++.+|.++.-.-..|-+++.|+.|+|++|+|..++...+.+++.|++|+|++|.++.++ ....++..|+.|.
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp-~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLP-DTVANLGRLHTLR 436 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhh-HHHHhhhhhHHHh
Confidence 234677888888888765566888999999999999999999999999999999999999999997 5678889999999
Q ss_pred ccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCcc
Q psy10487 160 LQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPW 213 (610)
Q Consensus 160 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~ 213 (610)
..+|+|..++ .+..++.|+.+|++.|.|+...-......++|+.|+++||.+
T Consensus 437 ahsN~l~~fP--e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLLSFP--ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCceeech--hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999998885 678899999999999999876544444558999999999986
No 71
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=99.37 E-value=1.8e-12 Score=106.37 Aligned_cols=82 Identities=30% Similarity=0.408 Sum_probs=58.8
Q ss_pred CceEEEEEEEEecCCCeEEEEeCC----EEeccCCccc-eeecc--CCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNG----QVLHNSSFDL-LEEEE--GDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g----~~l~~~~~~~-~~~~~--~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
|+.++|.|.+.|.|.|+|+|+|++ ..+....... ..... ..........|.|.+++.+|+|.|+|.|.|..|.
T Consensus 1 G~~v~l~C~v~g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 80 (90)
T cd04974 1 GSDVEFHCKVYSDAQPHIQWLKHVEVNGSKYGPDGLPYVTVLKVAGINTTDNESEVLYLRNVSFDDAGEYTCLAGNSIGP 80 (90)
T ss_pred CCcEEEEEEEeCCCCCeEEEEEecccCCceeCCCCCceEEEEEecCCcccccccceEEEeccccccCcEEEEEeecccCc
Confidence 678999999999999999999963 3332111110 00000 0000012247999999999999999999999999
Q ss_pred eeEEEEEEc
Q psy10487 348 ASGEISLDL 356 (610)
Q Consensus 348 ~~~~~~L~V 356 (610)
..+++.|.|
T Consensus 81 ~~~sa~L~V 89 (90)
T cd04974 81 SHHSAWLTV 89 (90)
T ss_pred ccCCEEEEe
Confidence 999999987
No 72
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=99.37 E-value=2.4e-12 Score=102.75 Aligned_cols=76 Identities=20% Similarity=0.437 Sum_probs=60.6
Q ss_pred eeecceEeecCceEEEEEEEEecCCC-eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeec
Q psy10487 265 IKESMVIREAGGNVTMSCYVYGDPEP-TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 265 ~~~~~~~v~~G~~v~l~C~~~g~P~p-~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N 343 (610)
..|.++.+.+|+++.|.|.+.|.|.| +|.|+|+|.++..... ...+.|.|..+ .|+|.|+|+|.|
T Consensus 3 ~~P~~~~v~~G~~v~l~C~a~G~P~P~~I~W~k~g~~l~~~~~------------~~~s~L~i~~~--~d~g~Y~C~A~N 68 (81)
T cd05749 3 VEPEDLSVTANTPFNLTCQAVGPPEPVEILWWQGGSPLGDPPA------------PSPSVLNVPGL--NETSKFSCEAHN 68 (81)
T ss_pred CCCCceEEcCCCCEEEEEEeeeecCCeEEEEEECCEECCCCCC------------CCCCEEEEccc--cCCeEEEEEEEe
Confidence 45678889999999999999999999 7999999998764110 12247888887 488999999999
Q ss_pred CCcceeE-EEEE
Q psy10487 344 IRGNASG-EISL 354 (610)
Q Consensus 344 ~~G~~~~-~~~L 354 (610)
.+|...+ .+.|
T Consensus 69 ~~G~~~s~~a~~ 80 (81)
T cd05749 69 AKGVTTSRTGTV 80 (81)
T ss_pred ccCcEEeeeEEe
Confidence 9997654 5544
No 73
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=99.37 E-value=3e-12 Score=105.01 Aligned_cols=80 Identities=30% Similarity=0.430 Sum_probs=64.7
Q ss_pred ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
+.++.+.+|++++|.|.+.|. .|.|.|++++..+.... ..... ..+.|+|.+++.+|+|.|+|.|.|..|
T Consensus 10 ~~~~~v~~g~~v~l~C~a~g~-~p~i~W~kng~~l~~~~---~~~~~------~~~~L~I~~v~~~D~G~Y~C~a~N~~G 79 (91)
T cd05740 10 VGNQPPEDNQPVTLTCEAEGQ-ATYIWWVNNGSLLVPPR---LQLSN------DNRTLTFNNVTRSDTGHYQCEASNEVS 79 (91)
T ss_pred cCccccccCCcEEEEEEeCCC-CCEEEEEECCEECCCCC---EEEeC------CCCEEEECcCChhhCEEEEEEEEcCCC
Confidence 456789999999999999999 99999999998875432 11111 124899999999999999999999999
Q ss_pred ce-eEEEEEEc
Q psy10487 347 NA-SGEISLDL 356 (610)
Q Consensus 347 ~~-~~~~~L~V 356 (610)
.. +..+.|.|
T Consensus 80 ~~~S~~~~L~V 90 (91)
T cd05740 80 NMTSDPYILNV 90 (91)
T ss_pred CEEeeeEEEEe
Confidence 85 45777776
No 74
>KOG0617|consensus
Probab=99.37 E-value=9.8e-15 Score=127.91 Aligned_cols=166 Identities=26% Similarity=0.318 Sum_probs=138.9
Q ss_pred CCCCccCccc-CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCc
Q psy10487 44 ANFTALPSTL-DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQ 122 (610)
Q Consensus 44 ~~l~~lP~~l-~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~ 122 (610)
..+.++|.-+ .++++.|.|++|+++.+++..- .|.+|+.|++.+|+|.+++. +++.+++|+.|+++-|++..++
T Consensus 21 Ssf~~~~gLf~~s~ITrLtLSHNKl~~vppnia---~l~nlevln~~nnqie~lp~-~issl~klr~lnvgmnrl~~lp- 95 (264)
T KOG0617|consen 21 SSFEELPGLFNMSNITRLTLSHNKLTVVPPNIA---ELKNLEVLNLSNNQIEELPT-SISSLPKLRILNVGMNRLNILP- 95 (264)
T ss_pred ccHhhcccccchhhhhhhhcccCceeecCCcHH---HhhhhhhhhcccchhhhcCh-hhhhchhhhheecchhhhhcCc-
Confidence 3445566433 3589999999999999998765 48899999999999999975 5899999999999999998776
Q ss_pred ccccCCCCCcEEEeeCccccc-cCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCC
Q psy10487 123 DTFLGNDRLKVLYLNGNPITE-LRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTP 201 (610)
Q Consensus 123 ~~f~~l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 201 (610)
..|+.++.|+.|+|.+|++.. ..++.|-.+..|+.|+|++|.+.-+++ .++++.+|+.|.++.|.+-+++.+ ++.+.
T Consensus 96 rgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~-dvg~lt~lqil~lrdndll~lpke-ig~lt 173 (264)
T KOG0617|consen 96 RGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPP-DVGKLTNLQILSLRDNDLLSLPKE-IGDLT 173 (264)
T ss_pred cccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCCh-hhhhhcceeEEeeccCchhhCcHH-HHHHH
Confidence 569999999999999998875 334566678899999999999987754 578999999999999999888774 56788
Q ss_pred cccEEecCCCccccc
Q psy10487 202 NLKTLSLDGNPWCCD 216 (610)
Q Consensus 202 ~L~~l~l~~N~~~c~ 216 (610)
.|++|++++|.+.--
T Consensus 174 ~lrelhiqgnrl~vl 188 (264)
T KOG0617|consen 174 RLRELHIQGNRLTVL 188 (264)
T ss_pred HHHHHhcccceeeec
Confidence 999999999987643
No 75
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=99.36 E-value=1.8e-12 Score=100.59 Aligned_cols=68 Identities=34% Similarity=0.494 Sum_probs=56.8
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
+.|.|.+.|.|.|.+.|+|+|..+....+.. . ...+.|.|.+++.+|+|.|+|.|.|..|.++.++.|
T Consensus 1 v~L~C~~~g~P~p~i~W~k~g~~~~~~~~~~--~-------~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~L 68 (69)
T cd05746 1 VQIPCSAQGDPEPTITWNKDGVQVTESGKFH--I-------SPEGYLAIRDVGVADQGRYECVARNTIGYASVSMVL 68 (69)
T ss_pred CEeEecceEeCCCEEEEEECCEECCCCCCEE--E-------CCCCEEEECcCChhhCEEEEEEEECCCCcEEEEEEe
Confidence 4799999999999999999998876543211 1 123589999999999999999999999999988876
No 76
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=99.36 E-value=5.6e-12 Score=104.73 Aligned_cols=86 Identities=28% Similarity=0.439 Sum_probs=66.6
Q ss_pred eeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEec-----CCCCCeEEE
Q psy10487 264 TIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNV-----TDLDAGEYT 338 (610)
Q Consensus 264 ~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v-----~~~D~G~Y~ 338 (610)
...|.+..+.+|+++.|.|.+.|.|.|.+.|+|+|..+.......... ...+.|.|.++ +..|+|.|+
T Consensus 3 ~~~P~~~~~~~g~~v~l~C~v~g~P~p~i~W~k~g~~l~~~~~~~~~~-------~~~~~l~i~~v~~~~~~~~D~G~Y~ 75 (95)
T cd05722 3 LSEPSDIVAVRGGPVVLNCSAEGEPPPKIEWKKDGVLLNLVSDERRQQ-------LPNGSLLITSVVHSKHNKPDEGFYQ 75 (95)
T ss_pred EECCCCeEEcCCCCEEEeeecccCCCCEEEEEECCeECccccCcceEE-------ccCCeEEEeeeeccCCCCCcCEEEE
Confidence 456777888899999999999999999999999999886543211111 12246777776 589999999
Q ss_pred EEeecC-Ccce-eEEEEEEc
Q psy10487 339 CYAENI-RGNA-SGEISLDL 356 (610)
Q Consensus 339 C~a~N~-~G~~-~~~~~L~V 356 (610)
|.|.|. .|.. +..+.|.|
T Consensus 76 C~a~N~~~G~~~s~~~~l~v 95 (95)
T cd05722 76 CVAQNDSLGSIVSRTARLTV 95 (95)
T ss_pred EEEECCccCcEEEeeeEEeC
Confidence 999999 9986 56777765
No 77
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=99.36 E-value=3.5e-12 Score=104.73 Aligned_cols=82 Identities=32% Similarity=0.469 Sum_probs=59.8
Q ss_pred CceEEEEEEEEecCCCeEEEEeC----CEEeccCCccceee-ccCCcee--eeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLN----GQVLHNSSFDLLEE-EEGDALF--EKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~----g~~l~~~~~~~~~~-~~~~~~~--~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
|+.++|.|.+.|.|.|.|.|+|+ +..+.......... ....... ...+.|+|.+++.+|+|.|+|.|.|..|.
T Consensus 1 G~~v~L~C~~~g~P~P~i~W~k~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~A~N~~G~ 80 (90)
T cd05858 1 GSTVEFVCKVYSDAQPHIQWLKHVEKNGSKYGPDGLPYVTVLKTAGVNTTDKEMEVLYLRNVTFEDAGEYTCLAGNSIGI 80 (90)
T ss_pred CCeEEEEEEEecCCCCEEEEEEecccCCcEeCCCCCeeEEEeccCCceecCCceeEEEEccCCHHHCEEEEEEEEeCCCc
Confidence 67899999999999999999984 44443222111111 1110000 11258999999999999999999999999
Q ss_pred eeEEEEEEc
Q psy10487 348 ASGEISLDL 356 (610)
Q Consensus 348 ~~~~~~L~V 356 (610)
+.+++.|.|
T Consensus 81 ~~~~a~L~V 89 (90)
T cd05858 81 SHHSAWLTV 89 (90)
T ss_pred ccceEEEEE
Confidence 999999987
No 78
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.35 E-value=3.1e-12 Score=101.17 Aligned_cols=73 Identities=23% Similarity=0.425 Sum_probs=56.5
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccC-CccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNS-SFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~-~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
++|.|.+.|.|.|.++|+|++...... ...+.... ...+.|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 1 a~l~C~~~G~P~P~v~W~k~~~~~~~~~~~~~~~~~------~~~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V 74 (75)
T cd05763 1 ARLECAATGHPTPQIAWQKDGGTDFPAARERRMHVM------PEDDVFFIVDVKIEDTGVYSCTAQNTAGSISANATLTV 74 (75)
T ss_pred CEeEeecccccCCEEEEEeCCCccCCcccccceEEe------cCCCEEEEeeCCcccCEEEEEEEEcCCCEEEeeEEEEE
Confidence 479999999999999999988643221 11111111 11248999999999999999999999999999999887
No 79
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=99.35 E-value=9.4e-12 Score=102.50 Aligned_cols=88 Identities=26% Similarity=0.460 Sum_probs=66.6
Q ss_pred eeeeecceEeecCceEEEEEEEEecCCCeEEEEe-CCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEe
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVYGDPEPTILWLL-NGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYA 341 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~-~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a 341 (610)
+.+.|....+..|+++.|.|.+.|.| +.+.|++ ++..+......... ..+ ...+.|+|.+++.+|+|.|+|.|
T Consensus 3 v~v~p~~~~v~~G~~~~l~C~~~G~p-~~i~W~~~~~~~~~~~~~~~~~-~~~----~~~~~L~I~~v~~~D~G~Y~C~A 76 (92)
T cd04977 3 VDIVPSQGEISVGESKFFLCQVIGEP-KDISWFSPNGEKLVTQQQISVV-QND----DVRSTLTIYNANIEDAGIYKCVA 76 (92)
T ss_pred EEEecCcEEECCCCeEEEEEEeEeeC-CeEEEECCCCCEeccCCCEEEE-eCC----CCEEEEEEecCCcccCEEEEEEE
Confidence 45678888999999999999999997 5999998 56555443322111 111 12358999999999999999999
Q ss_pred ecCCc-ceeEEEEEEc
Q psy10487 342 ENIRG-NASGEISLDL 356 (610)
Q Consensus 342 ~N~~G-~~~~~~~L~V 356 (610)
.|..| ...+++.|.|
T Consensus 77 ~N~~g~~~~~sv~l~~ 92 (92)
T cd04977 77 TDAKGTESEATVNLKI 92 (92)
T ss_pred EcCCCCcceeEEEEEC
Confidence 99965 4677887764
No 80
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=99.35 E-value=3.7e-12 Score=101.75 Aligned_cols=79 Identities=16% Similarity=0.320 Sum_probs=64.7
Q ss_pred ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
|+...+.+|+.+.|.|.+.|. .|.+.|+|+|.++....+. . ...+.|.|.+++.+|+|.|+|.|.|..|
T Consensus 1 ~~~~~~~~G~~v~l~C~~~~~-~~~v~W~k~g~~l~~~~~~--~--------~~~~~L~I~~~~~~DsG~Y~C~a~n~~g 69 (79)
T cd04973 1 VESYSAHPGDLLQLRCRLRDD-VQSINWTKDGVQLGENNRT--R--------ITGEEVQIKDAVPRDSGLYACVTSSPSG 69 (79)
T ss_pred CCcEEecCCCCEEEEEEecCC-CceEEEeeCCcCCCCCceE--E--------EeCCEEEECCCChhhCEEEEEEEeCCCC
Confidence 345678899999999999996 6789999999888654321 1 1123799999999999999999999999
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.....+.|.|
T Consensus 70 ~~~~~~~v~V 79 (79)
T cd04973 70 SDTTYFSVNV 79 (79)
T ss_pred cccEEEEEeC
Confidence 9888887765
No 81
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=99.35 E-value=5.3e-12 Score=104.02 Aligned_cols=86 Identities=23% Similarity=0.339 Sum_probs=64.4
Q ss_pred CceeeeecceEeecC---ceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecC-CCCCeE
Q psy10487 261 PNVTIKESMVIREAG---GNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVT-DLDAGE 336 (610)
Q Consensus 261 P~i~~~~~~~~v~~G---~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~-~~D~G~ 336 (610)
|.+...|..+.+.++ +.+.|.|.+.|+|.|+++|+|++..+....... ....+.|.|.++. .+|+|.
T Consensus 2 P~f~~~P~~~~~~~~~~~~~v~l~C~a~G~P~P~i~W~k~~~~i~~~~~~~---------~~~~g~L~I~~~~~~~D~G~ 72 (93)
T cd05849 2 PVFEEQPIDTIYPEESTEGKVSVNCRARANPFPIYKWRKNNLDIDLTNDRY---------SMVGGNLVINNPDKYKDAGR 72 (93)
T ss_pred CEEEECCCCEEecCCccCCeEEEeCcCccCCCCEEEEEECCEEccCCCCeE---------EEECCEEEECcCCcCCCCEE
Confidence 555666666655543 479999999999999999999998875332211 1224589999985 689999
Q ss_pred EEEEeecCCcceeE-EEEEE
Q psy10487 337 YTCYAENIRGNASG-EISLD 355 (610)
Q Consensus 337 Y~C~a~N~~G~~~~-~~~L~ 355 (610)
|+|.|.|..|.+.. .+.|.
T Consensus 73 Y~C~A~N~~G~~~s~~a~l~ 92 (93)
T cd05849 73 YVCIVSNIYGKVRSREATLS 92 (93)
T ss_pred EEEEEEeCcceEEEccEEEe
Confidence 99999999998744 66553
No 82
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=99.35 E-value=4e-12 Score=100.16 Aligned_cols=72 Identities=28% Similarity=0.496 Sum_probs=57.2
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce-eEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA-SGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~L~V 356 (610)
++|.|.+.|.|.|.|.|+|++..+......+... ...+.|.|.+++.+|+|.|+|.|.|..|.. +..+.|.|
T Consensus 1 a~l~C~~~G~P~p~v~W~k~~~~~~~~~~~~~~~-------~~~g~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~l~v 73 (74)
T cd05738 1 ATMLCAASGNPDPEITWFKDFLPVDTTSNGRIKQ-------LRSGALQIENSEESDQGKYECVATNSAGTRYSAPANLYV 73 (74)
T ss_pred CEEEEEEeEecCCEEEEEECCEECccCCCCCEEE-------cCCcEEEECCCChhhCEEEEEEEECCCCceEcccEEEEE
Confidence 4799999999999999999998876432211211 123579999999999999999999999985 67788776
No 83
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=99.35 E-value=3.2e-12 Score=105.00 Aligned_cols=83 Identities=25% Similarity=0.469 Sum_probs=61.8
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISL 354 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L 354 (610)
|+.++|.|.+.|.|.|.+.|++++..+...... .............+.|+|.+++.+|+|.|+|.|.|..|...+.+.|
T Consensus 1 G~~v~L~C~~~g~P~p~v~W~k~g~~~~~~~~~-~~~~~~r~~v~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l 79 (90)
T cd05726 1 GRTVTFQCEATGNPQPAIFWQKEGSQNLLFSYQ-PPQSSSRFSVSQTGDLTITNVQRSDVGYYICQTLNVAGSILTKAYL 79 (90)
T ss_pred CCEEEEEEECCccCCCEEEEEeCCCcceeeccc-CCCCCCeEEECCCCeEEEeeCChhhCEEEEEEEEcCCCceEEEEEE
Confidence 688999999999999999999987643211000 0000111111224589999999999999999999999999999999
Q ss_pred EcCc
Q psy10487 355 DLPE 358 (610)
Q Consensus 355 ~V~~ 358 (610)
.|.+
T Consensus 80 ~V~~ 83 (90)
T cd05726 80 EVTD 83 (90)
T ss_pred EEee
Confidence 9954
No 84
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=99.35 E-value=4.2e-12 Score=103.06 Aligned_cols=81 Identities=22% Similarity=0.300 Sum_probs=61.5
Q ss_pred ceEEEEEEEEecCCC--eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 276 GNVTMSCYVYGDPEP--TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 276 ~~v~l~C~~~g~P~p--~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
++++|.|.+.|.|.| ++.|+++|..+........+.... .....+.|.|.+++..|+|.|+|.|.|..|..++++.
T Consensus 1 e~~~L~C~~~g~P~p~i~~~W~~~g~~i~~~~~~~~~~~~~--~~~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~ 78 (85)
T cd04970 1 ESITLQCHASHDPTLDLTFTWSFNGVPIDFDKDGGHYRRVG--GKDSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSASAD 78 (85)
T ss_pred CcEEEEEEEecCCCCCeEEEEEECCeEeeccCCCccEEEEe--cccccceEEEccCCHHhCeeeEEEEecCCCcEEEEEE
Confidence 468999999999988 569999999886433211000000 0012468999999999999999999999999999999
Q ss_pred EEcCc
Q psy10487 354 LDLPE 358 (610)
Q Consensus 354 L~V~~ 358 (610)
|.|.+
T Consensus 79 l~V~~ 83 (85)
T cd04970 79 LIVRG 83 (85)
T ss_pred EEEEC
Confidence 99853
No 85
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.34 E-value=4.2e-12 Score=141.95 Aligned_cols=160 Identities=25% Similarity=0.338 Sum_probs=124.0
Q ss_pred CcEEEcCCCCCCccCcccCCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCC
Q psy10487 36 KKSALCKDANFTALPSTLDSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDN 115 (610)
Q Consensus 36 ~~~~~C~~~~l~~lP~~l~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n 115 (610)
...+++.+.+++++|..++.+++.|+|++|+|+.++...+ .+|+.|+|++|+|+.++.. + ...|+.|+|++|
T Consensus 180 ~~~L~L~~~~LtsLP~~Ip~~L~~L~Ls~N~LtsLP~~l~-----~nL~~L~Ls~N~LtsLP~~-l--~~~L~~L~Ls~N 251 (754)
T PRK15370 180 KTELRLKILGLTTIPACIPEQITTLILDNNELKSLPENLQ-----GNIKTLYANSNQLTSIPAT-L--PDTIQEMELSIN 251 (754)
T ss_pred ceEEEeCCCCcCcCCcccccCCcEEEecCCCCCcCChhhc-----cCCCEEECCCCccccCChh-h--hccccEEECcCC
Confidence 4678899999999999899999999999999999987654 3899999999999988653 3 247899999999
Q ss_pred CCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcc
Q psy10487 116 QIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSES 195 (610)
Q Consensus 116 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 195 (610)
+|..++.... .+|+.|+|++|+++.++.. +. .+|+.|+|++|+|+.++.. + ..+|+.|++++|.++.++..
T Consensus 252 ~L~~LP~~l~---s~L~~L~Ls~N~L~~LP~~-l~--~sL~~L~Ls~N~Lt~LP~~-l--p~sL~~L~Ls~N~Lt~LP~~ 322 (754)
T PRK15370 252 RITELPERLP---SALQSLDLFHNKISCLPEN-LP--EELRYLSVYDNSIRTLPAH-L--PSGITHLNVQSNSLTALPET 322 (754)
T ss_pred ccCcCChhHh---CCCCEEECcCCccCccccc-cC--CCCcEEECCCCccccCccc-c--hhhHHHHHhcCCccccCCcc
Confidence 9998875432 5799999999999987653 32 5799999999999887532 2 13677788888887776543
Q ss_pred cccCCCcccEEecCCCcccc
Q psy10487 196 VFFPTPNLKTLSLDGNPWCC 215 (610)
Q Consensus 196 ~~~~~~~L~~l~l~~N~~~c 215 (610)
.. ++|+.|++++|.+.+
T Consensus 323 l~---~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 323 LP---PGLKTLEAGENALTS 339 (754)
T ss_pred cc---ccceeccccCCcccc
Confidence 32 456667777766554
No 86
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.33 E-value=4.8e-12 Score=140.74 Aligned_cols=161 Identities=21% Similarity=0.273 Sum_probs=117.7
Q ss_pred CCeeCccCCCcEEEcCCCCCCccCcccCCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCC
Q psy10487 27 TCRCKWTLGKKSALCKDANFTALPSTLDSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTI 106 (610)
Q Consensus 27 ~C~C~~~~~~~~~~C~~~~l~~lP~~l~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~ 106 (610)
.|.|-. .+...++|.+.+|+++|..++.+|+.|+|.+|+|+.++. .+++|++|+|++|+|+.++. ..++
T Consensus 195 ~~~Cl~-~~~~~LdLs~~~LtsLP~~l~~~L~~L~L~~N~Lt~LP~------lp~~Lk~LdLs~N~LtsLP~----lp~s 263 (788)
T PRK15387 195 MRACLN-NGNAVLNVGESGLTTLPDCLPAHITTLVIPDNNLTSLPA------LPPELRTLEVSGNQLTSLPV----LPPG 263 (788)
T ss_pred HHHHhc-CCCcEEEcCCCCCCcCCcchhcCCCEEEccCCcCCCCCC------CCCCCcEEEecCCccCcccC----cccc
Confidence 345654 335789999999999999999999999999999999874 25789999999999998863 2467
Q ss_pred CcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccccccccc
Q psy10487 107 LVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNG 186 (610)
Q Consensus 107 L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 186 (610)
|+.|+|++|.|..++. . ..+|+.|+|++|.++.++. .+++|+.|+|++|+|+.++. . ..+|+.|++++
T Consensus 264 L~~L~Ls~N~L~~Lp~-l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~ 331 (788)
T PRK15387 264 LLELSIFSNPLTHLPA-L---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYN 331 (788)
T ss_pred cceeeccCCchhhhhh-c---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC-C---ccccccccccc
Confidence 8888999988887764 2 2567788888888877654 23678888888888877642 1 23456666666
Q ss_pred ccccccCcccccCCCcccEEecCCCccc
Q psy10487 187 NRLKHLSESVFFPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 187 n~l~~~~~~~~~~~~~L~~l~l~~N~~~ 214 (610)
|.|+.++. + ..+|+.|++++|.+.
T Consensus 332 N~L~~LP~--l--p~~Lq~LdLS~N~Ls 355 (788)
T PRK15387 332 NQLTSLPT--L--PSGLQELSVSDNQLA 355 (788)
T ss_pred Cccccccc--c--ccccceEecCCCccC
Confidence 66666543 1 135666666666654
No 87
>KOG0472|consensus
Probab=99.32 E-value=4.5e-14 Score=139.19 Aligned_cols=178 Identities=25% Similarity=0.353 Sum_probs=133.9
Q ss_pred CCCCCCccCcccCC--CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCC
Q psy10487 42 KDANFTALPSTLDS--DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAW 119 (610)
Q Consensus 42 ~~~~l~~lP~~l~~--~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~ 119 (610)
.++++.++|..+.. .+..|++.+|+++.+++.... +..|++|+...|-+..++++ ++++.+|.-|+|..|+|..
T Consensus 145 ~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~---m~~L~~ld~~~N~L~tlP~~-lg~l~~L~~LyL~~Nki~~ 220 (565)
T KOG0472|consen 145 TNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIA---MKRLKHLDCNSNLLETLPPE-LGGLESLELLYLRRNKIRF 220 (565)
T ss_pred cccccccCchHHHHHHHHHHhhccccchhhCCHHHHH---HHHHHhcccchhhhhcCChh-hcchhhhHHHHhhhccccc
Confidence 34555566654432 455566666666666665553 66777777777777777654 6788888888888888888
Q ss_pred CCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccC
Q psy10487 120 LHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFP 199 (610)
Q Consensus 120 l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 199 (610)
++ .|.++..|.+|+++.|.|..++.....++++|..|||.+|+++++ |+.+..+.+|+.||+++|.|+.++. .+++
T Consensus 221 lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~-Pde~clLrsL~rLDlSNN~is~Lp~-sLgn 296 (565)
T KOG0472|consen 221 LP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV-PDEICLLRSLERLDLSNNDISSLPY-SLGN 296 (565)
T ss_pred CC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC-chHHHHhhhhhhhcccCCccccCCc-cccc
Confidence 87 488888888888888888888887777899999999999999999 5566788899999999999999977 4677
Q ss_pred CCcccEEecCCCcccc------cCCchhhHHHHhh
Q psy10487 200 TPNLKTLSLDGNPWCC------DCHLRSFRNWLLK 228 (610)
Q Consensus 200 ~~~L~~l~l~~N~~~c------~c~l~~~~~~l~~ 228 (610)
+ +|+.|.+.||++.- .|.-+....++.+
T Consensus 297 l-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs 330 (565)
T KOG0472|consen 297 L-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS 330 (565)
T ss_pred c-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH
Confidence 7 89999999999632 2555555555554
No 88
>KOG0472|consensus
Probab=99.31 E-value=3.5e-14 Score=139.95 Aligned_cols=170 Identities=26% Similarity=0.441 Sum_probs=127.3
Q ss_pred EEEcCCCCCCccCcccCC--CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCC
Q psy10487 38 SALCKDANFTALPSTLDS--DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDN 115 (610)
Q Consensus 38 ~~~C~~~~l~~lP~~l~~--~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n 115 (610)
.++|..+.++++|.++.. .+..|+..+|+|+.++++.+. +.+|..|.+.+|.+..+++.-+. ++.|++||...|
T Consensus 118 ~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~---~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N 193 (565)
T KOG0472|consen 118 KLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVN---LSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSN 193 (565)
T ss_pred hhhccccceeecCchHHHHhhhhhhhccccccccCchHHHH---HHHHHHhhccccchhhCCHHHHH-HHHHHhcccchh
Confidence 456667777777776654 566777777777777776663 66777777888888777776655 778888888888
Q ss_pred CCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcc
Q psy10487 116 QIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSES 195 (610)
Q Consensus 116 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 195 (610)
-+..++++ ++++.+|..|+|..|.+..++ .|..+..|..|+++.|+|.-++.....++.+|..|||+.|+++..+.+
T Consensus 194 ~L~tlP~~-lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde 270 (565)
T KOG0472|consen 194 LLETLPPE-LGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDE 270 (565)
T ss_pred hhhcCChh-hcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchH
Confidence 88877764 677888888888888888776 377888888888888888877666666788888888888888888775
Q ss_pred cccCCCcccEEecCCCcccc
Q psy10487 196 VFFPTPNLKTLSLDGNPWCC 215 (610)
Q Consensus 196 ~~~~~~~L~~l~l~~N~~~c 215 (610)
.. .+++|..||+++|.++.
T Consensus 271 ~c-lLrsL~rLDlSNN~is~ 289 (565)
T KOG0472|consen 271 IC-LLRSLERLDLSNNDISS 289 (565)
T ss_pred HH-HhhhhhhhcccCCcccc
Confidence 44 56677888888887643
No 89
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=99.30 E-value=7.5e-12 Score=97.78 Aligned_cols=70 Identities=31% Similarity=0.519 Sum_probs=57.3
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
+.|.|.+.|.|.|.+.|++++..+..... ... ...+.|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 1 v~l~C~~~g~P~p~v~W~k~~~~~~~~~~---~~~------~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05731 1 LLLECIAEGLPTPEISWIKIGGELPADRT---KFE------NFNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISVTV 70 (71)
T ss_pred CEEEEEeeEecCCeEEEEECCeECCCCce---eEe------cCCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEEEE
Confidence 47999999999999999999877643221 111 12248999999999999999999999999999998877
No 90
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=99.29 E-value=1.6e-11 Score=97.26 Aligned_cols=74 Identities=28% Similarity=0.398 Sum_probs=59.8
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcC
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
+.|.|.+.|.|.|.+.|+|++..+......+...... ...|.|.+++.+|.|.|+|.|.|..|.++.++.|.|.
T Consensus 1 ~~L~C~v~g~P~p~v~W~k~~~~l~~~~~~~~~~~~~------~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 74 (76)
T cd05736 1 ASLRCHAEGIPLPRLTWLKNGMDITPKLSKQLTLIAN------GSELHISNVRYEDTGAYTCIAKNEAGVDEDISSLFVE 74 (76)
T ss_pred CEeEeEeeecCCCEEEEEECCEECCCCCCccEEEeCC------CCEEEECcCCcccCEEEEEEEEcCCCCcceEEEEEEE
Confidence 4689999999999999999999876543322221111 1379999999999999999999999999999999883
No 91
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=99.28 E-value=1.2e-11 Score=99.30 Aligned_cols=78 Identities=27% Similarity=0.483 Sum_probs=57.9
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCE---EeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQ---VLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGE 351 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~---~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~ 351 (610)
|+.++|.|.+.|.|.|.+.|+|++. .+....... .........+.|.|.+++.+|+|.|+|.|.|.+|.+.+.
T Consensus 1 G~~v~l~C~~~g~P~p~v~W~k~~~~~~~~~~~~~~~----~~~~~~~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~ 76 (81)
T cd05765 1 GETASFHCDVTGRPPPEITWEKQVHGKENLIMRPNHV----RGNVVVTNIGQLVIYNAQPQDAGLYTCTARNSGGLLRAN 76 (81)
T ss_pred CCcEEEEeeccccCCCcEEEEecCCCCcceeecCCcc----cCCEEEccccEEEEccCCcccCEEEEEEEecCCceEEEE
Confidence 6889999999999999999999742 111000000 000011223589999999999999999999999999999
Q ss_pred EEEEc
Q psy10487 352 ISLDL 356 (610)
Q Consensus 352 ~~L~V 356 (610)
+.|.|
T Consensus 77 ~~l~v 81 (81)
T cd05765 77 FPLSV 81 (81)
T ss_pred EEEeC
Confidence 99876
No 92
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional
Probab=99.28 E-value=7.1e-12 Score=140.12 Aligned_cols=119 Identities=21% Similarity=0.352 Sum_probs=81.3
Q ss_pred CcEEEcCCCCCCccCcccCCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCC
Q psy10487 36 KKSALCKDANFTALPSTLDSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDN 115 (610)
Q Consensus 36 ~~~~~C~~~~l~~lP~~l~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n 115 (610)
-..++..+++++++|..+..+|++|+|++|+|+.++.... .+|+.|+|++|++..++.. +. .+|+.|+|++|
T Consensus 201 L~~L~Ls~N~LtsLP~~l~~nL~~L~Ls~N~LtsLP~~l~-----~~L~~L~Ls~N~L~~LP~~-l~--s~L~~L~Ls~N 272 (754)
T PRK15370 201 ITTLILDNNELKSLPENLQGNIKTLYANSNQLTSIPATLP-----DTIQEMELSINRITELPER-LP--SALQSLDLFHN 272 (754)
T ss_pred CcEEEecCCCCCcCChhhccCCCEEECCCCccccCChhhh-----ccccEEECcCCccCcCChh-Hh--CCCCEEECcCC
Confidence 3567888888999988888889999999998888875432 3678888888888877543 32 46788888888
Q ss_pred CCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCcccccc
Q psy10487 116 QIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSV 168 (610)
Q Consensus 116 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 168 (610)
+|..++.. +. .+|+.|+|++|.++.++.. +. .+|+.|+|++|++..+
T Consensus 273 ~L~~LP~~-l~--~sL~~L~Ls~N~Lt~LP~~-lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 273 KISCLPEN-LP--EELRYLSVYDNSIRTLPAH-LP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred ccCccccc-cC--CCCcEEECCCCccccCccc-ch--hhHHHHHhcCCccccC
Confidence 88776543 22 4677888888877766432 11 2344445555544444
No 93
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=99.27 E-value=1.6e-11 Score=97.42 Aligned_cols=77 Identities=25% Similarity=0.506 Sum_probs=62.1
Q ss_pred CceeeeecceEeecCceEEEEEEEEecCCC-eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEE
Q psy10487 261 PNVTIKESMVIREAGGNVTMSCYVYGDPEP-TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 261 P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p-~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C 339 (610)
|.+...|....+.+|++++|.|.+.|.|.+ .+.|+|||..+.... +.|.|.++ .+|+|.|+|
T Consensus 1 ~vv~~~P~~~~v~~G~~V~L~C~~~~~p~~~~~~W~kng~~l~~~~----------------~~l~i~~~-~~dsG~Y~C 63 (78)
T cd05752 1 AVVSLDPPWTTIFQGEKVTLTCNGFNSPEQNSTQWYHNGKLLETTT----------------NSYRIRAA-NNDSGEYRC 63 (78)
T ss_pred CeEEeCCCCeEeeCCCCEEEEEeCCCCCCCccEEEEECCEEeeccC----------------CeEEEeec-ccCCEEeEE
Confidence 456777888999999999999999998874 699999998873221 37999999 999999999
Q ss_pred EeecCCcceeEEEEEEc
Q psy10487 340 YAENIRGNASGEISLDL 356 (610)
Q Consensus 340 ~a~N~~G~~~~~~~L~V 356 (610)
.|.|. ..+..+.|+|
T Consensus 64 ~a~~~--~~S~~v~l~V 78 (78)
T cd05752 64 QTQGS--SLSDPVHLEV 78 (78)
T ss_pred ECCCC--cCCCCEEEeC
Confidence 99985 4444555543
No 94
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=99.27 E-value=3.9e-11 Score=98.75 Aligned_cols=82 Identities=28% Similarity=0.493 Sum_probs=61.3
Q ss_pred CceeeeecceEeec---CceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCC-CCCeE
Q psy10487 261 PNVTIKESMVIREA---GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTD-LDAGE 336 (610)
Q Consensus 261 P~i~~~~~~~~v~~---G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~-~D~G~ 336 (610)
|.|...+..+.+.+ |+.++|.|.+.|+|.|+++|++++..+......... ...+.|.|.++.. +|+|.
T Consensus 2 P~f~~~p~~~~~~~~~~~~~~~l~C~~~g~p~p~i~W~k~~~~l~~~~~~~~~--------~~~~~L~i~~~~~~~d~G~ 73 (91)
T cd04967 2 PVFEEQPDDTIFPEESDEGKVSLNCRARGSPPPTYRWLMNGTEIDDEPDSRYS--------LVGGNLVISNPSKAKDAGR 73 (91)
T ss_pred CeeEeCCCCEEccCCCCCCEEEEEEeeeEcCCCEEEEEECCEECCCCCCCCEE--------EECCEEEEecCCccCCCEE
Confidence 45555666665543 467999999999999999999999887433221111 2235899998874 89999
Q ss_pred EEEEeecCCcceeE
Q psy10487 337 YTCYAENIRGNASG 350 (610)
Q Consensus 337 Y~C~a~N~~G~~~~ 350 (610)
|+|+|.|..|.+..
T Consensus 74 Y~C~a~N~~G~~~S 87 (91)
T cd04967 74 YQCLASNIVGTVLS 87 (91)
T ss_pred EEEEEEcCCCEEEe
Confidence 99999999998654
No 95
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=99.25 E-value=2e-11 Score=96.47 Aligned_cols=72 Identities=24% Similarity=0.396 Sum_probs=56.8
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCcccee-eccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLE-EEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~-~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
++|.|.+.| .|.|++.|+|+|..+......... .... ...+.|.|.+++.+|+|.|+|.|.|..|.+..++.
T Consensus 1 ~~l~C~~~g~~P~p~~~W~k~g~~l~~~~~~~~~~~~~~----~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 74 (75)
T cd05750 1 LVLKCEATSEYPSLRFKWFKDGKELNRKNKPRNIKIRNK----KKNSELQINKAKLADSGEYTCVVENILGNDTVTAN 74 (75)
T ss_pred CEEEEEccCCCCCceEEEEcCCeeccccCCcceEEEEec----CceEEEEEccCCcccCeEEEEEEEEcCCceeEEEe
Confidence 369999999 999999999999988765432211 1111 12468999999999999999999999999887764
No 96
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=99.25 E-value=2.5e-11 Score=100.14 Aligned_cols=83 Identities=17% Similarity=0.226 Sum_probs=64.5
Q ss_pred cceEeecCceEEEEEEEEe-----cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEee
Q psy10487 268 SMVIREAGGNVTMSCYVYG-----DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAE 342 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g-----~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~ 342 (610)
....+.+|+.+.|.|.+.| .|.|.|.|+|++..+......... .....+.|.|.+++.+|+|.|+|.+.
T Consensus 7 ~~~~v~~G~~~~L~C~~~g~~~~~~p~~~v~Wyk~~~~~~~~~~~~~r------~~~~~~~L~I~~~~~~DsG~Y~C~~~ 80 (94)
T cd05756 7 KKSYVLEGEPVVIKCPLFYSYIAQSPGLNLTWYKSDGKTPIPTEERSR------MHQQKDLLWFLPAALEDSGLYTCVVR 80 (94)
T ss_pred eEEEEecCCCeEEECCCCCcccccCCCceEEEEEcCCCCcccccccce------eeecCCeEEEccCCcccCeEEEEEEc
Confidence 4566778999999999999 799999999998654322110000 01123589999999999999999999
Q ss_pred cCCcceeEEEEEEc
Q psy10487 343 NIRGNASGEISLDL 356 (610)
Q Consensus 343 N~~G~~~~~~~L~V 356 (610)
|..|.++..+.|.|
T Consensus 81 N~~g~~~~~~~L~v 94 (94)
T cd05756 81 NSTYCMKVSISLTV 94 (94)
T ss_pred CCCccEEEEEEEEC
Confidence 99999999998875
No 97
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional
Probab=99.24 E-value=2.4e-11 Score=135.23 Aligned_cols=161 Identities=22% Similarity=0.242 Sum_probs=100.4
Q ss_pred cEEEcCCCCCCccCcccCCCccEEEeecCCCCCCChhhh--ccc------------CCCCccEEEcccCCCcccchhhhc
Q psy10487 37 KSALCKDANFTALPSTLDSDIQVLDLNNNKISYLTKEAF--KSI------------GLLNLQRIYLKNSGIREVHRDTFK 102 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~~l~~~L~~L~L~~n~i~~l~~~~~--~~~------------~l~~L~~L~L~~n~l~~i~~~~f~ 102 (610)
..+++.+++++.+|. .+.+|+.|+|++|+|+.++.... ..+ ...+|+.|+|++|+|+.++..
T Consensus 285 ~~L~Ls~N~Lt~LP~-~p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~l--- 360 (788)
T PRK15387 285 CKLWIFGNQLTSLPV-LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTL--- 360 (788)
T ss_pred CEEECcCCccccccc-cccccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccCCCCCC---
Confidence 346667777777774 45678888888887777653110 000 001344555555555444321
Q ss_pred CCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccccc
Q psy10487 103 YLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESL 182 (610)
Q Consensus 103 ~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 182 (610)
..+|+.|++++|+|..++. ...+|+.|+|++|.++.++.. ..+|+.|++++|+|+.++. . ..+|+.|
T Consensus 361 -p~~L~~L~Ls~N~L~~LP~----l~~~L~~LdLs~N~Lt~LP~l----~s~L~~LdLS~N~LssIP~-l---~~~L~~L 427 (788)
T PRK15387 361 -PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTSLPVL----PSELKELMVSGNRLTSLPM-L---PSGLLSL 427 (788)
T ss_pred -CcccceehhhccccccCcc----cccccceEEecCCcccCCCCc----ccCCCEEEccCCcCCCCCc-c---hhhhhhh
Confidence 2234444555555554432 124677788888877766531 2578888888888887743 2 2467888
Q ss_pred ccccccccccCcccccCCCcccEEecCCCcccc
Q psy10487 183 NLNGNRLKHLSESVFFPTPNLKTLSLDGNPWCC 215 (610)
Q Consensus 183 ~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~c 215 (610)
++++|+|+.++.. +..+.+|..|++++|++.+
T Consensus 428 ~Ls~NqLt~LP~s-l~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 428 SVYRNQLTRLPES-LIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred hhccCcccccChH-HhhccCCCeEECCCCCCCc
Confidence 9999999888654 5678889999999999874
No 98
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=99.24 E-value=3e-11 Score=96.53 Aligned_cols=78 Identities=27% Similarity=0.364 Sum_probs=54.4
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce-eEEEEEEc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA-SGEISLDL 356 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~-~~~~~L~V 356 (610)
++|.|.+.|.|.|.+.|++++......... .....++......+.|.|.+++.+|+|.|+|.|.|..|.+ +..+.|+|
T Consensus 1 v~l~C~~~G~P~P~v~W~~~~~~~~~~~~~-~~~~~~r~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~s~~~~l~~ 79 (79)
T cd05734 1 VTLNCSAEGYPPPTIVWKHSKGRGHPQHTH-TCCLAGRIQLLSNGSLLIKHVLEEDSGYYLCKVSNDVGADASKSMVLTV 79 (79)
T ss_pred CEeEeeCeEeCCCEEEEEECCCcccccccc-ccccCCCEEEecCCeEEECcCCcccCEEEEEEEEeCCCCCCceEEEEeC
Confidence 479999999999999999964322111000 0001111112234689999999999999999999999987 56777764
No 99
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=99.23 E-value=3.6e-11 Score=95.44 Aligned_cols=71 Identities=31% Similarity=0.521 Sum_probs=53.0
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCC----CCCeEEEEEeecCCcceeE-EE
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTD----LDAGEYTCYAENIRGNASG-EI 352 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~----~D~G~Y~C~a~N~~G~~~~-~~ 352 (610)
++|.|.+.|+|.|+|+|+|++..+......+.... ...+.|.|.++.. +|+|.|+|+|.|..|.+.. .+
T Consensus 1 i~l~C~~~G~P~P~v~W~k~g~~l~~~~~~~~~~~------~~~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~~~ 74 (77)
T cd05733 1 IVIKCEAKGNPPPTFSWTRNGTHFDPEKDPRVTMK------PDSGTLVIDNMNGGRAEDYEGEYQCYASNELGTAISNEI 74 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCCCCCCEEEe------CCCCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEEcccc
Confidence 47999999999999999999998754432222211 1235899998864 7899999999999998644 44
Q ss_pred EE
Q psy10487 353 SL 354 (610)
Q Consensus 353 ~L 354 (610)
.|
T Consensus 75 ~l 76 (77)
T cd05733 75 HL 76 (77)
T ss_pred EE
Confidence 43
No 100
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.23 E-value=7e-12 Score=114.90 Aligned_cols=123 Identities=25% Similarity=0.363 Sum_probs=38.0
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
.+++|+|++|.|+.|..-. . .+.+|+.|+|++|.|+.+.. |..+..|++|++++|+|+.+.......+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~~Ie~L~-~--~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTIENLG-A--TLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELY 94 (175)
T ss_dssp ----------------S---T--T-TT--EEE-TTS--S--TT------TT--EEE--SS---S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccccccchh-h--hhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCccccchHHhCCcCCEEE
Confidence 5667777777777664211 1 25567777777777776653 56667777777777777766543223466677777
Q ss_pred eeCccccccCc-CcCCCCCCccEEEccCccccccCH---HHhhcCccccccc
Q psy10487 136 LNGNPITELRA-GQFPKLPYLKTIELQHCQIHSVHK---DALIHLTALESLN 183 (610)
Q Consensus 136 Ls~N~l~~l~~-~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~ 183 (610)
|++|+|..+.. ..+..+++|+.|+|.+|.+..... ..+..+++|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 77776666543 234455666666666666554321 1234445555544
No 101
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=99.22 E-value=5.8e-11 Score=94.15 Aligned_cols=71 Identities=23% Similarity=0.429 Sum_probs=51.9
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCC----CCCeEEEEEeecCCcceeE-EE
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTD----LDAGEYTCYAENIRGNASG-EI 352 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~----~D~G~Y~C~a~N~~G~~~~-~~ 352 (610)
+.|.|.+.|+|.|+|+|+|++..+........... ...+.|.|..+.. .|+|.|+|.|.|..|.+.+ .+
T Consensus 1 ~~l~C~a~G~P~P~i~W~k~g~~l~~~~~~~~~~~------~~~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~~~ 74 (77)
T cd05874 1 IVIQCEAKGKPPPSFSWTRNGTHFDIDKDPKVTMK------PNTGTLVINIMNGEKAEAYEGVYQCTARNERGAAVSNNI 74 (77)
T ss_pred CEEEeeCcccCCCeEEEEECCeECCCcCCCCEEEe------CCCceEEEeccccCCCCCCCEEEEEEEEcCCCeEEeeEE
Confidence 47999999999999999999988743322111111 1235888888764 3789999999999998755 44
Q ss_pred EE
Q psy10487 353 SL 354 (610)
Q Consensus 353 ~L 354 (610)
.|
T Consensus 75 ~~ 76 (77)
T cd05874 75 VI 76 (77)
T ss_pred EE
Confidence 43
No 102
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=99.22 E-value=6.3e-11 Score=95.89 Aligned_cols=79 Identities=22% Similarity=0.322 Sum_probs=60.6
Q ss_pred CceEEEEEEEEec--CCCeEEEEeCCEEeccCCccc--eeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeE
Q psy10487 275 GGNVTMSCYVYGD--PEPTILWLLNGQVLHNSSFDL--LEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASG 350 (610)
Q Consensus 275 G~~v~l~C~~~g~--P~p~v~W~~~g~~l~~~~~~~--~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~ 350 (610)
|+.++|.|.+.|. |.|.+.|.+++..+....... ...... ....+.|+|.+++.+|+|.|+|.|.|..|..++
T Consensus 1 Ge~~~L~C~~~g~~~~~~~i~W~~~~~~~~~~~~~~~~~~~~~~---~~~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~ 77 (84)
T cd05742 1 GETLVLNCTVLTELNEGVDFQWTYPGKKRGRGKSMVTRQSLSEA---TELSSTLTIPNATLKDSGTYTCAASSGTMDQKE 77 (84)
T ss_pred CCeEEEEEEEEeCCCccEEEEEecCCcccCCceEeecccccccc---eEEEEEEEECCCChhhCEEEEEEEccCCCceEE
Confidence 7889999999999 889999999887653321110 011111 134579999999999999999999999999988
Q ss_pred EEEEEc
Q psy10487 351 EISLDL 356 (610)
Q Consensus 351 ~~~L~V 356 (610)
++.|.|
T Consensus 78 s~~v~v 83 (84)
T cd05742 78 STKVNI 83 (84)
T ss_pred EEEEEE
Confidence 888865
No 103
>KOG0618|consensus
Probab=99.21 E-value=5.6e-13 Score=144.20 Aligned_cols=158 Identities=25% Similarity=0.328 Sum_probs=101.8
Q ss_pred cCCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccc----------------------hhhhcCCCCCcEE
Q psy10487 53 LDSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVH----------------------RDTFKYLTILVEV 110 (610)
Q Consensus 53 l~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~----------------------~~~f~~l~~L~~L 110 (610)
.|.+++++++++|+++.++ ++.. .+.+|+.|.+.+|.|..++ +....+++.|++|
T Consensus 239 ~p~nl~~~dis~n~l~~lp-~wi~--~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tL 315 (1081)
T KOG0618|consen 239 VPLNLQYLDISHNNLSNLP-EWIG--ACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTL 315 (1081)
T ss_pred ccccceeeecchhhhhcch-HHHH--hcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeee
Confidence 4557777777777777777 5544 4556666666655554332 1224557788888
Q ss_pred EccCCCCCCCCcccc-------------------------cCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccc
Q psy10487 111 DLSDNQIAWLHQDTF-------------------------LGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQI 165 (610)
Q Consensus 111 dLs~n~l~~l~~~~f-------------------------~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l 165 (610)
||..|+|..++...| ..+..|+.|+|.+|.+++-.-..+.+..+|+.|+|++|+|
T Consensus 316 dL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 316 DLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred eehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 888888877664332 1123466667777777766555666777888888888888
Q ss_pred cccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCccc
Q psy10487 166 HSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 166 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~ 214 (610)
..++...+.++..|+.|+|++|+++.++. ....+..|++|...+|.+.
T Consensus 396 ~~fpas~~~kle~LeeL~LSGNkL~~Lp~-tva~~~~L~tL~ahsN~l~ 443 (1081)
T KOG0618|consen 396 NSFPASKLRKLEELEELNLSGNKLTTLPD-TVANLGRLHTLRAHSNQLL 443 (1081)
T ss_pred ccCCHHHHhchHHhHHHhcccchhhhhhH-HHHhhhhhHHHhhcCCcee
Confidence 88877777888888888888888877763 2233444444444444433
No 104
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=99.20 E-value=5.7e-11 Score=92.21 Aligned_cols=67 Identities=22% Similarity=0.296 Sum_probs=52.0
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
+.|.|.+.|.|.|++.|+|++.++....... . .....|.|.+++.+|+|.|+|.|.|..+.......
T Consensus 1 ~~l~c~v~g~P~P~v~W~kdg~~l~~~~~~~-~--------~~~~~L~I~~v~~~D~G~YtC~a~~~~~~~~~~~~ 67 (72)
T cd07702 1 YRLTPKVKAFPAPEVIWLKDGLPAAEKCSRY-H--------VDGYSLVIKDVTEEDAGIYTILLGIKQYNLFKNLT 67 (72)
T ss_pred CeEEeeEEEcCCCeEEEEECCEECCCCCcEE-E--------eCCCEEEECcCCHHHCEEEEEEEEccccceEeeEE
Confidence 3689999999999999999999876543211 1 11237999999999999999999998766544433
No 105
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=99.19 E-value=1e-10 Score=92.78 Aligned_cols=67 Identities=25% Similarity=0.452 Sum_probs=49.5
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCC----CCCeEEEEEeecCCcceeE
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTD----LDAGEYTCYAENIRGNASG 350 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~----~D~G~Y~C~a~N~~G~~~~ 350 (610)
+.|.|.+.|+|.|.|+|+|++..+........... ...+.|.|.++.. +|+|.|+|.|.|..|.+.+
T Consensus 1 ~~l~C~~~G~P~P~v~W~k~g~~~~~~~~~~~~~~------~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05875 1 IIIECEAKGNPVPTFQWTRNGKFFNVAKDPRVSMR------RRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTALS 71 (77)
T ss_pred CEEEEeccccCCCEEEEEECCEEccCcCCCcEEEe------CCCceEEEeccCCCCCCCCCEEEEEEEEeccceEEE
Confidence 47999999999999999999987643222111111 1235899988752 4699999999999998754
No 106
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=99.19 E-value=1.4e-10 Score=95.68 Aligned_cols=93 Identities=24% Similarity=0.391 Sum_probs=69.2
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCCe-EEEEeCCEEeccCC-ccceeeccCCceeeeeeEEEEEecCCCC-CeE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEPT-ILWLLNGQVLHNSS-FDLLEEEEGDALFEKSVSITLFNVTDLD-AGE 336 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~-v~W~~~g~~l~~~~-~~~~~~~~~~~~~~~~~~L~I~~v~~~D-~G~ 336 (610)
||.| .....+.+.+|+.++|.|.+.+.|+|. |.|..++..+.... .++.+.... ......+.|.|.++...| .|.
T Consensus 2 pP~i-~~~~s~~~~~G~~~~L~C~~~s~P~P~~i~W~w~~~~i~~~~~~r~~I~~~~-~~~g~~S~L~I~~~~~~d~~g~ 79 (98)
T cd05898 2 PPII-SSEQVQYAVRGERGKVKCFIGSTPPPDRIAWAWKENVLESGTSERYTVERTS-TGSGVLSTLTINNIMEADFQTH 79 (98)
T ss_pred CCEE-ecCceEEEeCCCcEEEEEEEccCCCCcEEEEEEccccccCCCCCCEEEEEEc-cCCCcEEEEEECCCccccCCcE
Confidence 4444 667788889999999999999999884 78988887776542 222221110 001245689999998877 799
Q ss_pred EEEEeecCCcceeEEEEE
Q psy10487 337 YTCYAENIRGNASGEISL 354 (610)
Q Consensus 337 Y~C~a~N~~G~~~~~~~L 354 (610)
|.|.|.|.+|.+...++|
T Consensus 80 Y~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 80 YNCTAWNSFGSGTAIIQL 97 (98)
T ss_pred EEEEEEeCCccceEEEEe
Confidence 999999999999988876
No 107
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=99.15 E-value=1e-10 Score=94.95 Aligned_cols=77 Identities=23% Similarity=0.365 Sum_probs=63.2
Q ss_pred eecceEeecCceEEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecC
Q psy10487 266 KESMVIREAGGNVTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 344 (610)
.|....+.+|++++|.|.+.+ .|.|.+.|++++..+.... . ...+.|.|.+++.+|+|.|+|.|.|.
T Consensus 7 ~p~~~~v~~G~~v~L~C~~~~~~~~~~i~W~~~~~~~~~~~----~--------~~~~~L~I~~v~~~DsG~Y~C~a~n~ 74 (85)
T cd05754 7 EPRSQEVRPGADVSFICRAKSKSPAYTLVWTRVGGGLPSRA----M--------DFNGILTIRNVQLSDAGTYVCTGSNM 74 (85)
T ss_pred CCCceEEcCCCCEEEEEEcCCCCCCcEEEEEECCCcCCCcc----c--------ccCCEEEECCCCHHHCEEEEEEEecc
Confidence 456778899999999999975 7899999999886543211 0 12358999999999999999999999
Q ss_pred CcceeEEEEE
Q psy10487 345 RGNASGEISL 354 (610)
Q Consensus 345 ~G~~~~~~~L 354 (610)
.|...+.+.|
T Consensus 75 ~g~~~~~~~l 84 (85)
T cd05754 75 LDTDEATATL 84 (85)
T ss_pred CCeEeEEEEE
Confidence 9999988876
No 108
>KOG1259|consensus
Probab=99.15 E-value=4.6e-12 Score=120.70 Aligned_cols=131 Identities=31% Similarity=0.370 Sum_probs=81.2
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
.|++|||++|.|+.++... + -++.++.|++++|+|..+.. +..+.+|+.|||++|.+..+. +.-..+.+++.|.
T Consensus 285 ~LtelDLS~N~I~~iDESv-K--L~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~~~-Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESV-K--LAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAECV-GWHLKLGNIKTLK 358 (490)
T ss_pred hhhhccccccchhhhhhhh-h--hccceeEEeccccceeeehh--hhhcccceEeecccchhHhhh-hhHhhhcCEeeee
Confidence 4566677777776665432 2 25667777777777766653 556667777777777666554 2234456666777
Q ss_pred eeCccccccCcCcCCCCCCccEEEccCccccccCH-HHhhcCccccccccccccccccCc
Q psy10487 136 LNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHK-DALIHLTALESLNLNGNRLKHLSE 194 (610)
Q Consensus 136 Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~ 194 (610)
|++|.|..+.. +.+|-+|..||+++|+|.++.. ..+++++.|+++.|.+|.+..+..
T Consensus 359 La~N~iE~LSG--L~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 359 LAQNKIETLSG--LRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred hhhhhHhhhhh--hHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 77776666643 5566666677777776665532 345666666666666666665543
No 109
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=99.15 E-value=4e-10 Score=91.25 Aligned_cols=82 Identities=29% Similarity=0.470 Sum_probs=64.9
Q ss_pred eEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCccee
Q psy10487 270 VIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNAS 349 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 349 (610)
..+.+|+.+.|.|.+.|.|.|.+.|++++..+............ .....|.|.+++.+|+|.|+|.|.|..|..+
T Consensus 4 ~~~~~G~~~~l~C~~~~~p~~~v~W~k~~~~~~~~~~~~~~~~~-----~~~~~l~i~~~~~~d~g~Y~C~~~n~~g~~~ 78 (85)
T cd05729 4 HAVPAGSTVRLKCPASGNPRPTITWLKDGKPFKKEHRIGGYKVR-----KKKWTLILESVVPSDSGKYTCIVENKYGSIN 78 (85)
T ss_pred eEecCCCcEEEEEEcCCCCCCeEEEEECCEECcccCceeEEEcc-----CcEEEEEEeECCcccCEEEEEEEEECCceEE
Confidence 35668999999999999999999999999877644321111100 2235799999999999999999999999998
Q ss_pred EEEEEEc
Q psy10487 350 GEISLDL 356 (610)
Q Consensus 350 ~~~~L~V 356 (610)
.++.|.|
T Consensus 79 ~~~~l~v 85 (85)
T cd05729 79 HTYKVDV 85 (85)
T ss_pred EEEEEeC
Confidence 8888865
No 110
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A.
Probab=99.14 E-value=7.3e-11 Score=108.21 Aligned_cols=111 Identities=36% Similarity=0.532 Sum_probs=33.2
Q ss_pred CCCCCcEEEccCCCCCCCCccccc-CCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccc
Q psy10487 103 YLTILVEVDLSDNQIAWLHQDTFL-GNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALES 181 (610)
Q Consensus 103 ~l~~L~~LdLs~n~l~~l~~~~f~-~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 181 (610)
+..++++|+|++|.|..+.. +. .+.+|+.|+|++|.|+.+.. +..+++|+.|++++|+|+.+.......+++|+.
T Consensus 17 n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp -------------------S----TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred cccccccccccccccccccc--hhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 33445555555555555432 32 34555666666666655542 555666666666666666664322234666677
Q ss_pred cccccccccccCc-ccccCCCcccEEecCCCcccccC
Q psy10487 182 LNLNGNRLKHLSE-SVFFPTPNLKTLSLDGNPWCCDC 217 (610)
Q Consensus 182 L~L~~n~l~~~~~-~~~~~~~~L~~l~l~~N~~~c~c 217 (610)
|++++|+|..+.. ..+..+++|+.|++.+||++-..
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~ 129 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKK 129 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGST
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchh
Confidence 7777776665543 34556677777788888775443
No 111
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=99.13 E-value=4.2e-10 Score=90.89 Aligned_cols=79 Identities=19% Similarity=0.340 Sum_probs=58.2
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCCccc-eeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc--ceeEE
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDL-LEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG--NASGE 351 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~-~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G--~~~~~ 351 (610)
|++++|.|.+.|.|.|.+.|+++++......... ...... ....+.|.|.+++.+|+|.|+|.|.|..+ ....+
T Consensus 1 Ge~~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~~---~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~~s 77 (84)
T cd05861 1 GETITVNCIVQGNEVVDFSWTYPGKDIGKGIPEVEEVKVPA---TTLRSTLTFPHATVEDSGTYECAAHESTQDQKAFKK 77 (84)
T ss_pred CCcEEEEEEEECCCccEEEEEECCccCCCCceEEEEEecCC---cEEEEEEEECCCCcCCCEEEEEEEEECccCcceeEE
Confidence 7889999999999999999999776432111000 000011 12356999999999999999999999887 56777
Q ss_pred EEEEc
Q psy10487 352 ISLDL 356 (610)
Q Consensus 352 ~~L~V 356 (610)
+.|+|
T Consensus 78 v~i~V 82 (84)
T cd05861 78 VNITV 82 (84)
T ss_pred EEEEE
Confidence 87777
No 112
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=99.11 E-value=4.7e-10 Score=92.50 Aligned_cols=88 Identities=19% Similarity=0.240 Sum_probs=59.5
Q ss_pred ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCcee----eeeeEEEEEecCCCCCeEEEEEee
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALF----EKSVSITLFNVTDLDAGEYTCYAE 342 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~----~~~~~L~I~~v~~~D~G~Y~C~a~ 342 (610)
..++.+.+|+++.|.|.+.|.|.|.|.|++++..+........ ..+.+... .....|.|.+++.+|+|.|+|.+.
T Consensus 4 ~~~~tv~~G~tv~L~C~v~g~~~~~v~W~k~~~~~~~~~~~~~-~~~~r~~~~~~~~~~~~L~I~nV~~~D~G~YtC~~~ 82 (95)
T cd05882 4 TQDETVAVGGTVTLKCGVKEHDNSSLQWSNTAQQTLYFGEKRA-LRDNRIQLVKSTPTELIISISNVQLSDEGEYTCSIF 82 (95)
T ss_pred cccEEEecCCcEEEEEEEeCCCCCeEEEeccCccEEEeCCeEE-EeCCeEEEEeCCCceEEEEECCCCcccCEEEEEEEE
Confidence 4577899999999999999999999999998764321111000 00110000 123689999999999999999998
Q ss_pred cCCcceeEEEEEEc
Q psy10487 343 NIRGNASGEISLDL 356 (610)
Q Consensus 343 N~~G~~~~~~~L~V 356 (610)
. .-..++.++|.|
T Consensus 83 t-~~~~~~~~~~~v 95 (95)
T cd05882 83 T-MPVRTAKATVTV 95 (95)
T ss_pred e-eccccEEEEEEC
Confidence 7 223444555443
No 113
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=99.09 E-value=3.5e-10 Score=89.61 Aligned_cols=72 Identities=21% Similarity=0.391 Sum_probs=54.0
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCc--cceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSF--DLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~--~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
+.|.|.+.+ .|.|.+.|+++|..+..... ........ ...+.|.|.+++.+|+|.|+|.|.|..|..+.++.
T Consensus 1 ~~L~C~a~~~~p~~~~~W~~~g~~i~~~~~~~~~~~~~~~----~~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~~~ 75 (76)
T cd05895 1 LVLRCETVSEYPSLRFKWFKNGKEIGAKNKPDNKIKIRKK----KKSSELQISKASLADNGEYKCMVSSKLGNDSVTAN 75 (76)
T ss_pred CEEEEecccCCCCCceEEEECCcccccCCCCCceEEEEeC----CcEEEEEECcCCcccCEEEEEEEEeCCCceeEEEe
Confidence 479999875 68899999999988864321 11111111 12368999999999999999999999999888765
No 114
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=99.07 E-value=7.6e-10 Score=89.15 Aligned_cols=70 Identities=21% Similarity=0.403 Sum_probs=56.5
Q ss_pred eecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.|....+..|+++.|.|.+.+ |.|+|.|++||..+...... .. ...+.|.|.+++.+|+|.|+|.|.+..
T Consensus 2 ~P~~~~v~~G~~v~L~C~~~~-~~~~i~W~~ng~~i~~~~~r-~~--------~~~~~L~I~nv~~~DsG~Y~C~a~e~~ 71 (87)
T cd05873 2 DPRQRTFKLGNNAELKCSPKS-NLARVVWKFDGKVLTPESAK-YL--------LYRDGLLIFNASEADAGRYQCLSVEKS 71 (87)
T ss_pred CcceEEEECCCCEEEEEECCC-CCCeEEEEECCEECCCCCce-EE--------EECCcEEEeCCCHHHCEEEEEEEEecc
Confidence 356788899999999999865 78899999999998765321 11 223479999999999999999998864
No 115
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=99.04 E-value=9.2e-10 Score=90.11 Aligned_cols=82 Identities=23% Similarity=0.363 Sum_probs=63.1
Q ss_pred ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCc--cceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecC
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSF--DLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~--~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 344 (610)
+..+.+.+|+.+.|.|.+.+ |.+.+.|++++..+..... .... ...+.|.|.+++.+|+|.|+|.|.|.
T Consensus 3 ~~~~~v~~g~~v~L~C~~~~-p~~~i~W~k~~~~~~~~~~~~~~~~--------~~~~~L~I~~~~~~D~G~Y~C~a~~~ 73 (89)
T cd04979 3 EKVVTVVEGNSVFLECSPKS-NLASVVWLFQGGPLQRKEEPEERLL--------VTEDGLLIRSVSPADAGVYTCQSVEH 73 (89)
T ss_pred ceEEEEECCCcEEEEEeCCC-CCceEEEEECCcccccccCcCceEE--------EcCCCEEEccCCHHHCEEEEEEEecC
Confidence 45677889999999999988 8899999999987654321 1111 12236999999999999999999876
Q ss_pred C-cceeEEEEEEcC
Q psy10487 345 R-GNASGEISLDLP 357 (610)
Q Consensus 345 ~-G~~~~~~~L~V~ 357 (610)
. +...+++.|.|.
T Consensus 74 ~~~~~~~~~~l~V~ 87 (89)
T cd04979 74 GFKQTLATYSLNVL 87 (89)
T ss_pred ccceeEeEEEEEEe
Confidence 5 456778888873
No 116
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=99.02 E-value=1e-09 Score=89.98 Aligned_cols=78 Identities=19% Similarity=0.304 Sum_probs=60.9
Q ss_pred ceEeecCceEEEEEEEEe-----cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeec
Q psy10487 269 MVIREAGGNVTMSCYVYG-----DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~g-----~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N 343 (610)
...+.+|+.+.|.|...+ +|.|.+.|+|++.++....... ...+.|.|.+++.+|+|.|+|.|.|
T Consensus 4 ~~~~~~g~~~~l~Cp~~~~~~~~~~~p~i~Wyk~~~~i~~~~~~~----------~~~~~L~I~~v~~~DsG~YtC~~~n 73 (92)
T cd05757 4 KQILFSTKGGKIVCPDLDDFKNENTLPPVQWYKDCKLLEGDRKRF----------VKGSKLLIQNVTEEDAGNYTCKLTF 73 (92)
T ss_pred eEEEeeccCCEEECCChHHccCCCCCCcEEEeECCEECCCCccEE----------ecCCEEEEeeCChhhCEEEEEEEEe
Confidence 356788999999998753 3678999999999887544211 1235899999999999999999999
Q ss_pred CCcceeEEEEEEc
Q psy10487 344 IRGNASGEISLDL 356 (610)
Q Consensus 344 ~~G~~~~~~~L~V 356 (610)
..|.....++..+
T Consensus 74 ~~~~~~~~~t~t~ 86 (92)
T cd05757 74 THNGKQYNVTRTI 86 (92)
T ss_pred cCCCEEEEEEEEE
Confidence 9988766555544
No 117
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=99.01 E-value=2.2e-09 Score=88.80 Aligned_cols=88 Identities=18% Similarity=0.252 Sum_probs=59.6
Q ss_pred ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCcee----eeeeEEEEEecCCCCCeEEEEEee
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALF----EKSVSITLFNVTDLDAGEYTCYAE 342 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~----~~~~~L~I~~v~~~D~G~Y~C~a~ 342 (610)
+.++.+.+|+++.|.|.+.+.|.|.+.|++.+..+....... ...+++... ....+|.|.+++.+|+|.|+|.+.
T Consensus 4 ~~~v~v~eG~~v~L~C~~~~~p~~~v~W~~~~~~~l~~~~~~-~~~~~r~~~~~~~~~~~sL~I~~v~~~DsG~Y~C~~~ 82 (95)
T cd07701 4 TQNVTVVEGGTANLTCRVDQNDNTSLQWSNPAQQTLYFDDKK-ALRDNRIELVRASWHELSISISDVSLSDEGQYTCSLF 82 (95)
T ss_pred cceEEEecCCcEEEEEEEecCCceEEEEeCCCCeEEEEcCcc-cccCCCEEEEECCCCcEEEEECcCCcccCEEEEEEeE
Confidence 467889999999999999999999999997443211100000 000111000 123589999999999999999999
Q ss_pred cCCcceeEEEEEEc
Q psy10487 343 NIRGNASGEISLDL 356 (610)
Q Consensus 343 N~~G~~~~~~~L~V 356 (610)
+..+. ..++.|.|
T Consensus 83 t~~~~-~~~~~l~v 95 (95)
T cd07701 83 TMPVK-TSKAYLTV 95 (95)
T ss_pred eecCc-cEEEEEEC
Confidence 85433 66777665
No 118
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=98.97 E-value=3.2e-09 Score=86.10 Aligned_cols=80 Identities=23% Similarity=0.243 Sum_probs=58.2
Q ss_pred CceEEEEEEEEecCCC--eEEEEeCCEEeccCCccc---eeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCccee
Q psy10487 275 GGNVTMSCYVYGDPEP--TILWLLNGQVLHNSSFDL---LEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNAS 349 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p--~v~W~~~g~~l~~~~~~~---~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~ 349 (610)
|++++|.|.+.++|.+ .+.|.+++.......... ..... .....+.|.|.+++.+|+|.|+|.|.|..|...
T Consensus 1 Ge~~~L~C~~~~~~~~~~~~~W~~p~~~~~~~~~~~~~~~~~~~---~~~~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~ 77 (86)
T cd05862 1 GEKLVLNCTARTELNVGIDFQWDYPGKKEQRAKSVSENRRSLQE---HTELSSTLTIENVTLSDLGRYTCTASSGQMIAK 77 (86)
T ss_pred CCcEEEEEEEEeCCCCcEEEEEEcCCcccccceecccccccccc---cceeeeEEEEecCCcccCEEEEEEEeecceEec
Confidence 7889999999987655 679998776432111000 00000 113457999999999999999999999999998
Q ss_pred EEEEEEcC
Q psy10487 350 GEISLDLP 357 (610)
Q Consensus 350 ~~~~L~V~ 357 (610)
....|.|.
T Consensus 78 ~~t~~~V~ 85 (86)
T cd05862 78 NSTIVIVH 85 (86)
T ss_pred ccEEEEEe
Confidence 88888873
No 119
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=98.96 E-value=1.2e-09 Score=89.37 Aligned_cols=75 Identities=19% Similarity=0.222 Sum_probs=55.9
Q ss_pred cceEeecCceEEEEEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 268 SMVIREAGGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
..+.+.+|+.++|.|.. .|.|.|.+.|++++..+........+. ....|.|.|.+|+.+|+|.|+|.|+|.+.
T Consensus 11 ~~~~v~eG~~~~L~C~pP~g~P~p~~~W~k~~~~~~~~~d~r~~~------~~~~G~L~fs~v~~~D~g~Y~C~A~n~~~ 84 (96)
T cd05727 11 DEVKVKEGWGVVLFCDPPPHYPDLSYRWLLNEFPNFIPEDGRRFV------SQTNGNLYIAKVEASDRGNYSCFVSSPSS 84 (96)
T ss_pred CceeeeeCCcEEEeeCCCCCCCCCEEEEEECCcccccccCCCeEE------eCCCCcEEEeecCHhhCceeEEEEEeccc
Confidence 44668899999999976 689999999999986532111111111 11246999999999999999999999875
Q ss_pred ce
Q psy10487 347 NA 348 (610)
Q Consensus 347 ~~ 348 (610)
..
T Consensus 85 ~~ 86 (96)
T cd05727 85 TK 86 (96)
T ss_pred CC
Confidence 44
No 120
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=98.95 E-value=2.2e-09 Score=86.38 Aligned_cols=77 Identities=16% Similarity=0.254 Sum_probs=59.7
Q ss_pred eecceEeecCceEEEEEEEE-ecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecC
Q psy10487 266 KESMVIREAGGNVTMSCYVY-GDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~-g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 344 (610)
.+....+.+|++++|.|.+. +.+.+.+.|+|+|..+.... ..+.|.|.+++.+|+|.|+|.|.|.
T Consensus 5 ~~p~~~V~~G~~vtL~C~~~~~~~~~~~~w~k~g~~~~~~~--------------~~~~l~I~~~~~~dsG~Y~C~~~~~ 70 (83)
T cd05753 5 QVPSRVVFEGEPLVLRCHGWKNKPVYKVTYYRDGKAKKYSH--------------SNSNLSIPQATLSDSGSYHCSGIIG 70 (83)
T ss_pred ECCcceecCCCCEEEEeeCCCCCcceEEEEEECCeEccccC--------------CCceEEECccCHHHCEEEEEEEEeC
Confidence 34455788999999999985 46778899999997654211 1248999999999999999999999
Q ss_pred Ccce-eEEEEEEc
Q psy10487 345 RGNA-SGEISLDL 356 (610)
Q Consensus 345 ~G~~-~~~~~L~V 356 (610)
.|.. +..+.|+|
T Consensus 71 ~~~~~s~~~~i~~ 83 (83)
T cd05753 71 SYDYSSEPVSITV 83 (83)
T ss_pred CceecCCCEEEEC
Confidence 9864 44566554
No 121
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.93 E-value=6.6e-10 Score=83.79 Aligned_cols=59 Identities=32% Similarity=0.468 Sum_probs=28.8
Q ss_pred CccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCcc
Q psy10487 82 NLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNP 140 (610)
Q Consensus 82 ~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~ 140 (610)
+|++|++++|+|..+++++|.++++|++|+|++|+|..++++.|.++++|++|+|++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444444444444444455555555444444444444444444444444443
No 122
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=98.93 E-value=5.9e-09 Score=83.14 Aligned_cols=71 Identities=35% Similarity=0.645 Sum_probs=58.7
Q ss_pred eEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc-ce
Q psy10487 270 VIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG-NA 348 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G-~~ 348 (610)
..+.+|+.++|.|.+.|.|.+.+.|++++..+..... .+.+.+++.+|.|.|+|.|.|..| ..
T Consensus 9 ~~v~~g~~~~l~C~~~~~p~~~~~w~~~~~~~~~~~~----------------~~~~~~~~~~~~g~y~C~~~~~~~~~~ 72 (80)
T PF13895_consen 9 QSVEEGDSVTLTCSVSGNPPPQVQWYKNGSPINSSQN----------------GLFIPNVSPEDSGNYTCRASNGSGSNT 72 (80)
T ss_dssp SEEETTSEEEEEEEEESSSSSEEEEEETTEEEEEESS----------------EEEESSEEGGGTEEEEEEEEETTEEEE
T ss_pred eEEeCCCcEEEEEEEEcccceeeeeeeeeeeeeeeee----------------eeeeeeeccccCEEEEEEEEeCCCCeE
Confidence 6688999999999999999999999999877763321 377788999999999999999665 45
Q ss_pred eEEEEEEc
Q psy10487 349 SGEISLDL 356 (610)
Q Consensus 349 ~~~~~L~V 356 (610)
+.++.|+|
T Consensus 73 s~~~~v~V 80 (80)
T PF13895_consen 73 STSVNVTV 80 (80)
T ss_dssp EEEEEEEE
T ss_pred eeeEEeeC
Confidence 66777765
No 123
>PHA02826 IL-1 receptor-like protein; Provisional
Probab=98.90 E-value=2.1e-09 Score=103.54 Aligned_cols=100 Identities=16% Similarity=0.217 Sum_probs=69.0
Q ss_pred CCCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEEEEEE-----ecCCCeEEEEeCCEEeccCC
Q psy10487 231 LYSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMSCYVY-----GDPEPTILWLLNGQVLHNSS 305 (610)
Q Consensus 231 l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~C~~~-----g~P~p~v~W~~~g~~l~~~~ 305 (610)
.+.+.|.|.+.+..+... ..+.... ...+....+.+|++++|.|.+. |.|.|+|+|+|++..+....
T Consensus 108 ~DsG~Y~C~a~N~~~~~~-~~i~L~V-------~~~~~~~~~~~G~~v~L~C~~~~~~~~~~p~p~I~WyKng~~l~~~~ 179 (227)
T PHA02826 108 IDEGIYICTISSGNICEE-STIRLTF-------DSGTINYQFNSGKDSKLHCYGTDGISSTFKDYTLTWYKNGNIVLYTD 179 (227)
T ss_pred HHCEEEEEEEEECCcceE-EEEEEEE-------ecCCccceEecCCCEEEEeeCCCCccccCCCceEEEEECCEECCCCC
Confidence 467889999987553321 1121111 1122345677899999999986 34689999999999987544
Q ss_pred ccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 306 FDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
+... .. ..+.|.|.+++.+|+|.|+|.|....+
T Consensus 180 r~~~--~~------~~~~L~I~~V~~~DsG~YtC~a~~~~~ 212 (227)
T PHA02826 180 RIQL--RN------NNSTLVIKSATHDDSGIYTCNLRFNKN 212 (227)
T ss_pred CEEE--eC------CCCEEEECcCCHHhCEEEEEEEEEeEC
Confidence 3211 11 124899999999999999999998753
No 124
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=98.90 E-value=7.3e-09 Score=77.95 Aligned_cols=63 Identities=40% Similarity=0.666 Sum_probs=51.0
Q ss_pred cCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 274 AGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
+|+.++|.|.+.+.|.+.+.|++++..+.. .. .. ......|.|.+++..|+|.|+|.+.|..|
T Consensus 1 ~g~~~~l~C~~~~~~~~~v~W~~~~~~~~~--~~-~~-------~~~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 1 EGQSVTLTCPAEGDPVPNITWLKDGKPLPE--SN-RL-------SASGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred CCceEEEEeeCccCCCCeEEEEECCEECCC--CC-EE-------ecCCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 488999999999999999999999887761 11 11 12234899999999999999999999875
No 125
>KOG1259|consensus
Probab=98.89 E-value=2.5e-10 Score=109.07 Aligned_cols=131 Identities=28% Similarity=0.381 Sum_probs=110.0
Q ss_pred CCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEc
Q psy10487 81 LNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIEL 160 (610)
Q Consensus 81 ~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 160 (610)
..|+.|+|++|.|+.++ ++.+-++.++.|+++.|.|..+.. +..+.+|+.|+|++|.++.+... -.+|-+++.|.|
T Consensus 284 q~LtelDLS~N~I~~iD-ESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~~~Gw-h~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLITQID-ESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAECVGW-HLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchhhhh-hhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhHhhhhh-HhhhcCEeeeeh
Confidence 35888999999999986 457888999999999999988864 78899999999999999887653 235788999999
Q ss_pred cCccccccCHHHhhcCccccccccccccccccCc-ccccCCCcccEEecCCCcccccC
Q psy10487 161 QHCQIHSVHKDALIHLTALESLNLNGNRLKHLSE-SVFFPTPNLKTLSLDGNPWCCDC 217 (610)
Q Consensus 161 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~l~l~~N~~~c~c 217 (610)
+.|.|..+ ..+..+-+|..||+++|+|..+.. ..++.++.|+.+.|.+|++....
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 99998777 356778899999999999987764 46788999999999999986543
No 126
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A ....
Probab=98.89 E-value=1.7e-09 Score=81.50 Aligned_cols=61 Identities=28% Similarity=0.474 Sum_probs=50.8
Q ss_pred CCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccc
Q psy10487 105 TILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQI 165 (610)
Q Consensus 105 ~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l 165 (610)
++|++|+|++|+|..++++.|.++++|++|+|++|.++.+.+..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3678888888888888888888888888888888888888888888888888888888875
No 127
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=98.88 E-value=4e-09 Score=86.08 Aligned_cols=73 Identities=18% Similarity=0.221 Sum_probs=56.5
Q ss_pred ecceEeecCceEEEEEE-EEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCe-EEEEEeecC
Q psy10487 267 ESMVIREAGGNVTMSCY-VYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAG-EYTCYAENI 344 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~-~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G-~Y~C~a~N~ 344 (610)
...+.+.+|+.+.|.|. ..|.|.|.|.|++++..+...+. +..+...|+|.|.+|+.+|+| .|.|.|.|.
T Consensus 10 ~~~v~V~eG~~~~L~C~pP~g~P~P~i~W~~~~~~~i~~~~--------Ri~~~~~GnL~fs~v~~~D~g~~Y~C~a~~~ 81 (95)
T cd05845 10 IRPVEVEEGDSVVLPCNPPKSAVPLRIYWMNSDLLHITQDE--------RVSMGQNGNLYFANVEEQDSHPDYICHAHFP 81 (95)
T ss_pred cceeEEecCCCEEEEecCCCCCCCCEEEEECCCCccccccc--------cEEECCCceEEEEEEehhhCCCCeEEEEEcc
Confidence 36778999999999997 69999999999987654322211 112223479999999999999 799999998
Q ss_pred Ccc
Q psy10487 345 RGN 347 (610)
Q Consensus 345 ~G~ 347 (610)
+..
T Consensus 82 ~~~ 84 (95)
T cd05845 82 GLR 84 (95)
T ss_pred ccc
Confidence 643
No 128
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=98.86 E-value=3.1e-08 Score=81.10 Aligned_cols=88 Identities=18% Similarity=0.291 Sum_probs=70.9
Q ss_pred cceEeecCceEEEEEEEEecCCCe-EEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPEPT-ILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~p~-v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
..+.|.+|+++.|.|.+.+.|+|+ +.|.+++..+......... ........+.+.|.+..++.+|+|.|+|.|.|..+
T Consensus 11 ~~~~v~~gE~~~L~V~ieAYP~p~~~~W~~~~~~l~~~~~~~~~-~~~~~~~rY~S~L~L~Rlk~~E~G~YTf~a~N~~~ 89 (101)
T cd05860 11 TTIFVNAGENLDLIVEYEAYPKPEHQQWIYMNRTLTNTSDHYVK-SRNESNNRYVSELHLTRLKGTEGGTYTFLVSNSDA 89 (101)
T ss_pred ceEEEECCCCEEEEEEEEeCCCCeeeEEEcCCcccCccccceeE-EeccCceEEEEEEEEeecChhhCcEEEEEEECCCC
Confidence 456788999999999999999998 9999998876543332221 11112335778999999999999999999999999
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.++.++.|.|
T Consensus 90 ~~s~tF~l~v 99 (101)
T cd05860 90 SASVTFNVYV 99 (101)
T ss_pred eEEEEEEEEE
Confidence 9999999887
No 129
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=98.85 E-value=1.7e-08 Score=82.60 Aligned_cols=82 Identities=18% Similarity=0.344 Sum_probs=58.7
Q ss_pred ceEeecCceEEEEEEEEecCCCeEEEEeCCE--EeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEee-cCC
Q psy10487 269 MVIREAGGNVTMSCYVYGDPEPTILWLLNGQ--VLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAE-NIR 345 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~--~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~-N~~ 345 (610)
.+.+.+|+++.|.|.. +.|.|.+.|++.+. ...... ..........+.|.|.+++.+|+|.|+|.|. |..
T Consensus 5 ~~~~~eG~~v~L~C~~-~~p~p~v~Wykq~~g~~~~~~~------~~~~r~~~~~~~L~I~~~~~~DsG~Y~C~a~~~~~ 77 (91)
T cd05871 5 VVYGVENNSTFLECLP-KSPQASVKWLFQRGGDQRKEEV------KTEERLIHTERGLLLRSLQRSDAGVYTCTAVEHSF 77 (91)
T ss_pred EEEEecCCcEEEEEEC-CCCCceEEEEEECCCCCccccc------cccccEEEecCeEEEeeCChhHCEEEEEEEEccCC
Confidence 4567889999999996 58999999998332 211100 0001111233579999999999999999997 577
Q ss_pred cceeEEEEEEcC
Q psy10487 346 GNASGEISLDLP 357 (610)
Q Consensus 346 G~~~~~~~L~V~ 357 (610)
|.....++|+|.
T Consensus 78 ~~~~~~~~l~v~ 89 (91)
T cd05871 78 SQTLAKYTLHVI 89 (91)
T ss_pred eEEEEEEEEEEe
Confidence 777888888884
No 130
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=98.85 E-value=9.3e-10 Score=113.08 Aligned_cols=157 Identities=20% Similarity=0.204 Sum_probs=87.3
Q ss_pred CccEEEeecCCCCCCCh------hhhcccCCCCccEEEcccCCCcccchhhhcCCCC---CcEEEccCCCCCCCC----c
Q psy10487 56 DIQVLDLNNNKISYLTK------EAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTI---LVEVDLSDNQIAWLH----Q 122 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~------~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~---L~~LdLs~n~l~~l~----~ 122 (610)
+++.|+++++.+...+. ..+. .+.+|++|+|++|.+.......|..+.. |++|++++|++.... .
T Consensus 52 ~l~~l~l~~~~~~~~~~~~~~~~~~l~--~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~ 129 (319)
T cd00116 52 SLKELCLSLNETGRIPRGLQSLLQGLT--KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129 (319)
T ss_pred CceEEeccccccCCcchHHHHHHHHHH--hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence 46777777766653221 2233 3567777777777766444444444444 777777777665311 1
Q ss_pred ccccCC-CCCcEEEeeCccccccC----cCcCCCCCCccEEEccCccccccC----HHHhhcCccccccccccccccccC
Q psy10487 123 DTFLGN-DRLKVLYLNGNPITELR----AGQFPKLPYLKTIELQHCQIHSVH----KDALIHLTALESLNLNGNRLKHLS 193 (610)
Q Consensus 123 ~~f~~l-~~L~~L~Ls~N~l~~l~----~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~L~~n~l~~~~ 193 (610)
..+..+ ++|+.|+|++|.++... ...+..+.+|+.|+|++|.+.... ...+..+.+|+.|++++|.+....
T Consensus 130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 209 (319)
T cd00116 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG 209 (319)
T ss_pred HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHH
Confidence 233444 66777777777666211 123445566777777777666321 122334456777777777665332
Q ss_pred c----ccccCCCcccEEecCCCccc
Q psy10487 194 E----SVFFPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 194 ~----~~~~~~~~L~~l~l~~N~~~ 214 (610)
. ..+..+++|+.|++++|.+.
T Consensus 210 ~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 210 ASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred HHHHHHHhcccCCCCEEecCCCcCc
Confidence 1 23344566777777776654
No 131
>KOG0532|consensus
Probab=98.84 E-value=1.5e-10 Score=119.58 Aligned_cols=168 Identities=28% Similarity=0.369 Sum_probs=93.2
Q ss_pred EEEcCCCCCCccCcccC----CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEcc
Q psy10487 38 SALCKDANFTALPSTLD----SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLS 113 (610)
Q Consensus 38 ~~~C~~~~l~~lP~~l~----~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs 113 (610)
.+...+.+|+.+|..-. ......||+.|++.+++.+.-. +..|+.|.|..|.|..|+ .++..+..|+.|||+
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~~~~---f~~Le~liLy~n~~r~ip-~~i~~L~~lt~l~ls 129 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEEACA---FVSLESLILYHNCIRTIP-EAICNLEALTFLDLS 129 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccccCchHHHH---HHHHHHHHHHhccceecc-hhhhhhhHHHHhhhc
Confidence 45556667777764321 1345567778888777765432 334555555555555553 345555556666666
Q ss_pred CCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCc----------------
Q psy10487 114 DNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLT---------------- 177 (610)
Q Consensus 114 ~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~---------------- 177 (610)
.|+++.++...+. --|+.|.+++|+++.++.. ++.+.+|..|+.+.|.|..+++ .++.+.
T Consensus 130 ~NqlS~lp~~lC~--lpLkvli~sNNkl~~lp~~-ig~~~tl~~ld~s~nei~slps-ql~~l~slr~l~vrRn~l~~lp 205 (722)
T KOG0532|consen 130 SNQLSHLPDGLCD--LPLKVLIVSNNKLTSLPEE-IGLLPTLAHLDVSKNEIQSLPS-QLGYLTSLRDLNVRRNHLEDLP 205 (722)
T ss_pred cchhhcCChhhhc--CcceeEEEecCccccCCcc-cccchhHHHhhhhhhhhhhchH-HhhhHHHHHHHHHhhhhhhhCC
Confidence 6666555543321 2355555555555555442 3344455555555555544422 222222
Q ss_pred ------cccccccccccccccCcccccCCCcccEEecCCCccc
Q psy10487 178 ------ALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 178 ------~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~ 214 (610)
.|..||+++|+|..++- .|.+|+.|+.|.|.+|++.
T Consensus 206 ~El~~LpLi~lDfScNkis~iPv-~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 206 EELCSLPLIRLDFSCNKISYLPV-DFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HHHhCCceeeeecccCceeecch-hhhhhhhheeeeeccCCCC
Confidence 35556777777776655 4567777777777777763
No 132
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily. LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).
Probab=98.80 E-value=1.6e-09 Score=111.23 Aligned_cols=158 Identities=27% Similarity=0.328 Sum_probs=106.2
Q ss_pred CCccEEEeecCCCCCCChhhhcccCCC---CccEEEcccCCCcc----cchhhhcCC-CCCcEEEccCCCCCCCC----c
Q psy10487 55 SDIQVLDLNNNKISYLTKEAFKSIGLL---NLQRIYLKNSGIRE----VHRDTFKYL-TILVEVDLSDNQIAWLH----Q 122 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~~~~~~~l~---~L~~L~L~~n~l~~----i~~~~f~~l-~~L~~LdLs~n~l~~l~----~ 122 (610)
.+|+.|+|++|.+.......+. .+. +|++|++++|.+.. ....++..+ ++|++|+|++|+++... .
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~--~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~ 158 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLE--SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA 158 (319)
T ss_pred CceeEEEccCCCCChhHHHHHH--HHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence 4788899998888765555554 233 48999998888763 122345566 78899999998887321 2
Q ss_pred ccccCCCCCcEEEeeCccccccC----cCcCCCCCCccEEEccCccccccCHH----HhhcCccccccccccccccccCc
Q psy10487 123 DTFLGNDRLKVLYLNGNPITELR----AGQFPKLPYLKTIELQHCQIHSVHKD----ALIHLTALESLNLNGNRLKHLSE 194 (610)
Q Consensus 123 ~~f~~l~~L~~L~Ls~N~l~~l~----~~~~~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~L~~n~l~~~~~ 194 (610)
..|..+.+|++|+|++|.++... ...+..+++|+.|+|++|.+...... .+..+++|+.|++++|.+.+...
T Consensus 159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~ 238 (319)
T cd00116 159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGA 238 (319)
T ss_pred HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHH
Confidence 34666778889999888877421 12244557888899988888654332 34556788888998888775322
Q ss_pred ccc-----cCCCcccEEecCCCccc
Q psy10487 195 SVF-----FPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 195 ~~~-----~~~~~L~~l~l~~N~~~ 214 (610)
..+ .....|+.|++.+|.+.
T Consensus 239 ~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 239 AALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHHhccCCCceEEEccCCCCC
Confidence 111 12367888888888764
No 133
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=98.78 E-value=5.5e-08 Score=76.69 Aligned_cols=67 Identities=18% Similarity=0.234 Sum_probs=52.9
Q ss_pred EEEEEEEE-ecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce
Q psy10487 278 VTMSCYVY-GDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA 348 (610)
Q Consensus 278 v~l~C~~~-g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 348 (610)
+.|+|.+. |+|.++|+|++++.++..... . ...+..+...+.|.|.....+|.+.|+|+|.|.++..
T Consensus 2 ~~L~C~s~~skP~a~i~W~k~~~~l~~~~~---~-~~~~~~~t~~s~L~~~~~~~Ddg~~~~C~A~n~a~~~ 69 (80)
T cd05885 2 VELTCLSPRSKPAATLRWYRDRKELKGVIS---Q-QENGKTVSVSNTIRFPVDRKDDGAILSCEASHPALVS 69 (80)
T ss_pred EEEEEeCCCccCCCeEEEEECCEECCCCcc---c-ccCCceEEEEEEEEEEeeeccCCcEEEEEEEChhhCC
Confidence 68999985 789999999999999965321 1 1122234567789999999999999999999998864
No 134
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=98.76 E-value=2.9e-08 Score=81.26 Aligned_cols=80 Identities=16% Similarity=0.255 Sum_probs=57.7
Q ss_pred eEeecCceEEEEEEE-E----ecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecC
Q psy10487 270 VIREAGGNVTMSCYV-Y----GDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~-~----g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 344 (610)
..+.+|.+..|.|.- . .++.|++.|+||+.++...........+ .+.|.|.+|..+|+|.|+|+|.|.
T Consensus 5 ~~~~~~~~~~l~Cp~~~~f~~~~~~~~v~WYKd~~~l~~~~~~~~~~~~-------~~~L~I~~v~~~D~G~YtC~~~~~ 77 (95)
T cd05897 5 QILFTSTSGKLVCPDLSDFTINRTDVELQWYKDSVLLDKDNEKFYSLKG-------STYLHIIDVSLNDSGYYTCKLQFT 77 (95)
T ss_pred eEeccccCcEEECCCHHHcccCCCCCcEEEccCCEECcCCCcceEecCC-------CCEEEEEEcChhhCEEEEEEEEEe
Confidence 456788999999962 2 4577899999999988755432222111 237999999999999999999999
Q ss_pred Ccce----eEEEEEEc
Q psy10487 345 RGNA----SGEISLDL 356 (610)
Q Consensus 345 ~G~~----~~~~~L~V 356 (610)
+|.. ..++.|.|
T Consensus 78 ~~g~~y~vtr~~~l~v 93 (95)
T cd05897 78 HEGKKYNITRIIKLRI 93 (95)
T ss_pred eCCEEEEEEEEEEEEE
Confidence 7653 34444444
No 135
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=98.76 E-value=5.4e-08 Score=80.63 Aligned_cols=88 Identities=19% Similarity=0.285 Sum_probs=57.9
Q ss_pred ecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCcee----eeeeEEEEEecCCCCCeEEEEEee
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALF----EKSVSITLFNVTDLDAGEYTCYAE 342 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~----~~~~~L~I~~v~~~D~G~Y~C~a~ 342 (610)
...+.+.+|++++|.|.+.+.|.+.+.|++.+..+........ ..+.+... .....|+|.+++.+|+|.|+|.+.
T Consensus 4 ~~~~~v~~G~~v~L~C~~~~~~~~~v~W~~p~~~~~~~~~~~~-~~~~r~~~~~~~~~~~~L~I~~v~~~DsG~Y~C~~~ 82 (95)
T cd05717 4 TQDVTVVEGGTATLKCRVKNNDNSSLQWSNPNQQTLYFNDKRA-LRDNRIQLVNFSANELSISISNVSLSDEGRYTCSLY 82 (95)
T ss_pred CCcEEEcCCCCEEEEEEECCCCCceEEEeCCCCcEEEeccccc-cccCcEEEEcCCCCeeEEEEccCCcccCEEEEEEEe
Confidence 3567789999999999999999999999874332110000000 00000000 123579999999999999999999
Q ss_pred cCCcceeEEEEEEc
Q psy10487 343 NIRGNASGEISLDL 356 (610)
Q Consensus 343 N~~G~~~~~~~L~V 356 (610)
+... .++.+.|.|
T Consensus 83 ~~~~-~~~~~~~~v 95 (95)
T cd05717 83 TMPV-QTAKATVTV 95 (95)
T ss_pred cCCC-ceEEEEEEC
Confidence 8753 356666654
No 136
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=98.76 E-value=1.2e-07 Score=75.88 Aligned_cols=83 Identities=36% Similarity=0.600 Sum_probs=63.8
Q ss_pred cceEeecCceEEEEEEEEecCCCeEEEEeC-CEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPEPTILWLLN-GQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~-g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
..+.+..|+++.|.|.+.+.+.+.+.|+++ +..+.......... .. ....|.|.+++..|+|.|+|.+.+..|
T Consensus 2 ~~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~~~~~~~-~~-----~~~~l~i~~~~~~d~G~Y~C~v~~~~~ 75 (86)
T smart00410 2 PSVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESGRFSVSR-SG-----SNSTLTISNVTPEDSGTYTCAATNSSG 75 (86)
T ss_pred CcEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCCcEEEEE-cC-----CeeEEEEEeeccccCeEEEEEEEcCCC
Confidence 345678899999999999988999999998 77665222211111 11 135899999999999999999999998
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.....+.|.|
T Consensus 76 ~~~~~~~l~V 85 (86)
T smart00410 76 SASSTTTLTV 85 (86)
T ss_pred eEEEEEEEEE
Confidence 8877777765
No 137
>smart00409 IG Immunoglobulin.
Probab=98.76 E-value=1.2e-07 Score=75.88 Aligned_cols=83 Identities=36% Similarity=0.600 Sum_probs=63.8
Q ss_pred cceEeecCceEEEEEEEEecCCCeEEEEeC-CEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPEPTILWLLN-GQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~-g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
..+.+..|+++.|.|.+.+.+.+.+.|+++ +..+.......... .. ....|.|.+++..|+|.|+|.+.+..|
T Consensus 2 ~~~~~~~g~~~~l~C~~~~~~~~~~~W~~~~~~~v~~~~~~~~~~-~~-----~~~~l~i~~~~~~d~G~Y~C~v~~~~~ 75 (86)
T smart00409 2 PSVTVKEGESVTLSCEVSGSPPPEVTWYKQGGKLLAESGRFSVSR-SG-----SNSTLTISNVTPEDSGTYTCAATNSSG 75 (86)
T ss_pred CcEEEeCCCeEEEEEEEccCCCCeEEEEECCCEEcCCCCcEEEEE-cC-----CeeEEEEEeeccccCeEEEEEEEcCCC
Confidence 345678899999999999988999999998 77665222211111 11 135899999999999999999999998
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.....+.|.|
T Consensus 76 ~~~~~~~l~V 85 (86)
T smart00409 76 SASSTTTLTV 85 (86)
T ss_pred eEEEEEEEEE
Confidence 8877777765
No 138
>PLN03150 hypothetical protein; Provisional
Probab=98.76 E-value=2.4e-08 Score=111.27 Aligned_cols=107 Identities=21% Similarity=0.199 Sum_probs=75.9
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
.++.|+|++|.++...+..+. .|.+|+.|+|++|.+....+..|+.+++|+.|||++|++....+..+..+++|+.|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~--~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~ 496 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDIS--KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496 (623)
T ss_pred EEEEEECCCCCccccCCHHHh--CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEE
Confidence 477888888888766666666 677888888888888766666778888888888888888776667777777777777
Q ss_pred eeCccccccCcCcCCCC-CCccEEEccCcc
Q psy10487 136 LNGNPITELRAGQFPKL-PYLKTIELQHCQ 164 (610)
Q Consensus 136 Ls~N~l~~l~~~~~~~l-~~L~~L~L~~n~ 164 (610)
|++|.++...+..+..+ .++..+++.+|.
T Consensus 497 Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 497 LNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CcCCcccccCChHHhhccccCceEEecCCc
Confidence 77777776555444332 234455555543
No 139
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=98.75 E-value=2.2e-08 Score=82.14 Aligned_cols=79 Identities=16% Similarity=0.256 Sum_probs=53.8
Q ss_pred eEeecCceEEEEEEEEecCCCeEEEEeCCEEe-ccCCccceee----ccCCce------eeeeeEEEEEecCCCCCeEEE
Q psy10487 270 VIREAGGNVTMSCYVYGDPEPTILWLLNGQVL-HNSSFDLLEE----EEGDAL------FEKSVSITLFNVTDLDAGEYT 338 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l-~~~~~~~~~~----~~~~~~------~~~~~~L~I~~v~~~D~G~Y~ 338 (610)
+.+.+|++|+|.|.+.+.+.+.+.|++++... .......... ...+.. .....+|+|.+++.+|+|.|.
T Consensus 2 v~~~~G~~VtL~C~~s~~~~~~i~W~~~~~k~~~g~~~~l~~~~~~~~~~r~~~~~~~~~~g~~~L~I~~l~~sDsgtY~ 81 (94)
T cd07690 2 VLGKKGDTAELPCTASQKKSIQFHWKNSNQIKILGNQGSFLTKGPSKLNDRADSRRNLWDQGSFPLIIKNLKIEDSDTYI 81 (94)
T ss_pred eEeeCCCCEEEEEEeCCCCCcEEEEEECCcEEccCcCCEEEEecccccCCCCceecccCCCCeEEEEECCCCHHHCEEEE
Confidence 45788999999999999999999999876332 2111100000 000000 011247999999999999999
Q ss_pred EEeecCCcce
Q psy10487 339 CYAENIRGNA 348 (610)
Q Consensus 339 C~a~N~~G~~ 348 (610)
|.+.|..+..
T Consensus 82 C~v~~~~~~~ 91 (94)
T cd07690 82 CEVEDKKEEV 91 (94)
T ss_pred EEECCccceE
Confidence 9999987764
No 140
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=98.75 E-value=7.2e-08 Score=77.45 Aligned_cols=78 Identities=19% Similarity=0.403 Sum_probs=55.2
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc--eeEEEEE
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN--ASGEISL 354 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~--~~~~~~L 354 (610)
+.|.|.+.| .|.|.|+|+++|..+...........++ ..+...+.|.|.....+|.|.|+|.|.|.... ...+++|
T Consensus 2 ~~L~C~v~g~~P~~~v~W~~~g~~l~~~~~~~~~~~~~-~~~~~~s~L~i~~~~~~~~~~y~C~a~n~~l~~~~~~s~~l 80 (82)
T cd05759 2 YNLTCRARGAKPAAEIIWFRDGEVLDGATYSKELLKDG-KRETTVSTLPITPSDHDTGRTFTCRARNEALPTGKETSVTL 80 (82)
T ss_pred EEEEEEEeCccCCCEEEEEECCEEccCceeeeeEecCC-CeEEEEEEEEEeCceecCCCEEEEEEcCccCCCCcEEEEEE
Confidence 689999987 6999999999999886443222222222 22345578999888888999999999998754 3445555
Q ss_pred Ec
Q psy10487 355 DL 356 (610)
Q Consensus 355 ~V 356 (610)
.|
T Consensus 81 ~v 82 (82)
T cd05759 81 DV 82 (82)
T ss_pred cC
Confidence 43
No 141
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.75 E-value=6.4e-09 Score=110.33 Aligned_cols=169 Identities=28% Similarity=0.403 Sum_probs=91.8
Q ss_pred cEEEcCCCCCCccCccc--CC-CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEcc
Q psy10487 37 KSALCKDANFTALPSTL--DS-DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLS 113 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~~l--~~-~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs 113 (610)
..++..++.++.+|..+ .. +|+.|++++|+|..++... . .+++|+.|++++|++..+... ...+..|+.|+++
T Consensus 119 ~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~-~--~l~~L~~L~l~~N~l~~l~~~-~~~~~~L~~L~ls 194 (394)
T COG4886 119 TSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPL-R--NLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNLDLS 194 (394)
T ss_pred eEEecCCcccccCccccccchhhcccccccccchhhhhhhh-h--ccccccccccCCchhhhhhhh-hhhhhhhhheecc
Confidence 34455555555555433 21 4555555555555553111 1 355555555655555555432 1245555555666
Q ss_pred CCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccC
Q psy10487 114 DNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLS 193 (610)
Q Consensus 114 ~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 193 (610)
+|++..++.. ...+..|++|.+++|.+..... .+.++.++..|.+.+|++..+ +..+..+.+++.|++++|+++.+.
T Consensus 195 ~N~i~~l~~~-~~~~~~L~~l~~~~N~~~~~~~-~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~ 271 (394)
T COG4886 195 GNKISDLPPE-IELLSALEELDLSNNSIIELLS-SLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSIS 271 (394)
T ss_pred CCccccCchh-hhhhhhhhhhhhcCCcceecch-hhhhcccccccccCCceeeec-cchhccccccceeccccccccccc
Confidence 6655555542 1223345556666553222221 244555666666666666553 344556667777777777777776
Q ss_pred cccccCCCcccEEecCCCccc
Q psy10487 194 ESVFFPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 194 ~~~~~~~~~L~~l~l~~N~~~ 214 (610)
. +..+.+++.|++++|.+.
T Consensus 272 ~--~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 272 S--LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred c--ccccCccCEEeccCcccc
Confidence 6 556677777777777653
No 142
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.70 E-value=1e-07 Score=114.04 Aligned_cols=119 Identities=21% Similarity=0.307 Sum_probs=70.4
Q ss_pred cEEEcCCCCCCccCccc-CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCC-CcccchhhhcCCCCCcEEEccC
Q psy10487 37 KSALCKDANFTALPSTL-DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSG-IREVHRDTFKYLTILVEVDLSD 114 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~~l-~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~-l~~i~~~~f~~l~~L~~LdLs~ 114 (610)
+.+...+..++.+|..+ +.+|+.|+|.+|.|..+.... . .+.+|+.|+|+++. +..++ .+..+++|++|+|++
T Consensus 592 r~L~~~~~~l~~lP~~f~~~~L~~L~L~~s~l~~L~~~~-~--~l~~Lk~L~Ls~~~~l~~ip--~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 592 RLLRWDKYPLRCMPSNFRPENLVKLQMQGSKLEKLWDGV-H--SLTGLRNIDLRGSKNLKEIP--DLSMATNLETLKLSD 666 (1153)
T ss_pred EEEEecCCCCCCCCCcCCccCCcEEECcCcccccccccc-c--cCCCCCEEECCCCCCcCcCC--ccccCCcccEEEecC
Confidence 34555566677777655 457888888888777765443 2 46677777777654 44443 256667777777776
Q ss_pred CC-CCCCCcccccCCCCCcEEEeeCc-cccccCcCcCCCCCCccEEEccCc
Q psy10487 115 NQ-IAWLHQDTFLGNDRLKVLYLNGN-PITELRAGQFPKLPYLKTIELQHC 163 (610)
Q Consensus 115 n~-l~~l~~~~f~~l~~L~~L~Ls~N-~l~~l~~~~~~~l~~L~~L~L~~n 163 (610)
|. +..++ ..+..+.+|+.|+|++| .++.++.. + ++.+|+.|+|++|
T Consensus 667 c~~L~~lp-~si~~L~~L~~L~L~~c~~L~~Lp~~-i-~l~sL~~L~Lsgc 714 (1153)
T PLN03210 667 CSSLVELP-SSIQYLNKLEDLDMSRCENLEILPTG-I-NLKSLYRLNLSGC 714 (1153)
T ss_pred CCCccccc-hhhhccCCCCEEeCCCCCCcCccCCc-C-CCCCCCEEeCCCC
Confidence 53 33333 45666667777777664 34444332 1 3455555555544
No 143
>KOG0532|consensus
Probab=98.69 E-value=1.3e-09 Score=112.82 Aligned_cols=132 Identities=19% Similarity=0.221 Sum_probs=110.4
Q ss_pred cEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEee
Q psy10487 58 QVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLN 137 (610)
Q Consensus 58 ~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls 137 (610)
-+|.|++-+++..+..++. ++|..-...+|+.|++.+++. .+..+..|+.|.|..|.|..++. .+.++..|.+|+|+
T Consensus 53 g~l~Ls~rrlk~fpr~a~~-~~ltdt~~aDlsrNR~~elp~-~~~~f~~Le~liLy~n~~r~ip~-~i~~L~~lt~l~ls 129 (722)
T KOG0532|consen 53 GRLLLSGRRLKEFPRGAAS-YDLTDTVFADLSRNRFSELPE-EACAFVSLESLILYHNCIRTIPE-AICNLEALTFLDLS 129 (722)
T ss_pred cccccccchhhcCCCcccc-ccccchhhhhccccccccCch-HHHHHHHHHHHHHHhccceecch-hhhhhhHHHHhhhc
Confidence 4578888889999988887 688888889999999999864 45677788899999999998874 67889999999999
Q ss_pred CccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcc
Q psy10487 138 GNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSES 195 (610)
Q Consensus 138 ~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 195 (610)
.|.+..++.. ++.| -|+.|.+++|+++.++ ..++.+..|..||.+.|.|..++..
T Consensus 130 ~NqlS~lp~~-lC~l-pLkvli~sNNkl~~lp-~~ig~~~tl~~ld~s~nei~slpsq 184 (722)
T KOG0532|consen 130 SNQLSHLPDG-LCDL-PLKVLIVSNNKLTSLP-EEIGLLPTLAHLDVSKNEIQSLPSQ 184 (722)
T ss_pred cchhhcCChh-hhcC-cceeEEEecCccccCC-cccccchhHHHhhhhhhhhhhchHH
Confidence 9999999775 3344 4899999999999995 4567788999999999999887753
No 144
>PLN03150 hypothetical protein; Provisional
Probab=98.68 E-value=3.2e-08 Score=110.31 Aligned_cols=109 Identities=19% Similarity=0.248 Sum_probs=69.0
Q ss_pred CcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccccccccc
Q psy10487 107 LVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNG 186 (610)
Q Consensus 107 L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 186 (610)
++.|+|++|.+....+..|..+.+|+.|+|++|.+.+..+..+..+++|+.|+|++|++....+..+.++.+|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56667777777665556666677777777777776655555566667777777777777666566666777777777777
Q ss_pred ccccccCcccccCC-CcccEEecCCCcccc
Q psy10487 187 NRLKHLSESVFFPT-PNLKTLSLDGNPWCC 215 (610)
Q Consensus 187 n~l~~~~~~~~~~~-~~L~~l~l~~N~~~c 215 (610)
|.+.+..+..+... .++..+++.+|+..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCcccc
Confidence 76664444333321 234456666665544
No 145
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=98.65 E-value=5.8e-08 Score=73.83 Aligned_cols=63 Identities=37% Similarity=0.587 Sum_probs=46.0
Q ss_pred CceEEEEEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEe
Q psy10487 275 GGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYA 341 (610)
Q Consensus 275 G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a 341 (610)
|++++|.|.+ .+.+.+.+.|++++................ .....|.|.+++.+|+|.|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~W~~~~~~~~~~~~~~~~~~~~----~~~~~L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 1 GSSVTLTCSVSSGPPPTTVTWSKNGQSLPEGSTTNRSTNSV----SSTSRLTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp TSEEEEEEEEEESSSTSEEEEEETTTTTSEEEEEEEEETTT----EEEEEEEESSCTGGGTEEEEEEE
T ss_pred CCeEEEEeecCCCCCCcEEEEEECCccccCcceeEeecccc----eeeeEEEEccCCHHHCEEEEEEC
Confidence 7899999999 788889999999987655443222111111 11114999999999999999986
No 146
>PLN03210 Resistant to P. syringae 6; Provisional
Probab=98.63 E-value=2.3e-07 Score=111.06 Aligned_cols=96 Identities=19% Similarity=0.281 Sum_probs=65.3
Q ss_pred cEEEcCCCCCCccCccc--CCCccEEEeecCC-CCCCChhhhcccCCCCccEEEcccCC-CcccchhhhcCCCCCcEEEc
Q psy10487 37 KSALCKDANFTALPSTL--DSDIQVLDLNNNK-ISYLTKEAFKSIGLLNLQRIYLKNSG-IREVHRDTFKYLTILVEVDL 112 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~~l--~~~L~~L~L~~n~-i~~l~~~~~~~~~l~~L~~L~L~~n~-l~~i~~~~f~~l~~L~~LdL 112 (610)
..++..+.++..+|..+ ..+|+.|+|+++. +..++. +. .+++|+.|+|.+|. +..+ +..|..+.+|+.|+|
T Consensus 614 ~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls--~l~~Le~L~L~~c~~L~~l-p~si~~L~~L~~L~L 688 (1153)
T PLN03210 614 VKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LS--MATNLETLKLSDCSSLVEL-PSSIQYLNKLEDLDM 688 (1153)
T ss_pred cEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cc--cCCcccEEEecCCCCcccc-chhhhccCCCCEEeC
Confidence 45777777888887655 3478999998764 666653 33 57788889888875 4444 456788888888888
Q ss_pred cCC-CCCCCCcccccCCCCCcEEEeeCc
Q psy10487 113 SDN-QIAWLHQDTFLGNDRLKVLYLNGN 139 (610)
Q Consensus 113 s~n-~l~~l~~~~f~~l~~L~~L~Ls~N 139 (610)
++| .+..++... ++++|+.|+|++|
T Consensus 689 ~~c~~L~~Lp~~i--~l~sL~~L~Lsgc 714 (1153)
T PLN03210 689 SRCENLEILPTGI--NLKSLYRLNLSGC 714 (1153)
T ss_pred CCCCCcCccCCcC--CCCCCCEEeCCCC
Confidence 874 566655432 4556666666554
No 147
>KOG1859|consensus
Probab=98.59 E-value=1.4e-09 Score=115.20 Aligned_cols=129 Identities=22% Similarity=0.330 Sum_probs=101.6
Q ss_pred ccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccC
Q psy10487 83 LQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQH 162 (610)
Q Consensus 83 L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~ 162 (610)
|...+++.|.+..++ .++.-++.|+.|||+.|++.... .+..+.+|++|||++|.++.++.-....+ +|..|.|++
T Consensus 166 L~~a~fsyN~L~~mD-~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLVLMD-ESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHHhHH-HHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeeeecc
Confidence 445566666666664 56788888999999999998875 57889999999999999998876333333 499999999
Q ss_pred ccccccCHHHhhcCccccccccccccccccCc-ccccCCCcccEEecCCCcccccC
Q psy10487 163 CQIHSVHKDALIHLTALESLNLNGNRLKHLSE-SVFFPTPNLKTLSLDGNPWCCDC 217 (610)
Q Consensus 163 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~l~l~~N~~~c~c 217 (610)
|.++.+. .+.++.+|+.||+++|.|..... ..++.+..|+.|.|.||++.|.-
T Consensus 242 N~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 242 NALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9998873 46788999999999998876543 34556778889999999998853
No 148
>KOG3207|consensus
Probab=98.56 E-value=1.3e-08 Score=102.37 Aligned_cols=160 Identities=21% Similarity=0.267 Sum_probs=111.7
Q ss_pred CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchh-hhcCCCCCcEEEccCCCCCCCCc-ccccCCCCCc
Q psy10487 55 SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRD-TFKYLTILVEVDLSDNQIAWLHQ-DTFLGNDRLK 132 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~-~f~~l~~L~~LdLs~n~l~~l~~-~~f~~l~~L~ 132 (610)
.+++.|||+.|-|..+.+-.--.-.|++|+.|+|+.|.+...... .-..+..|+.|.|+.|.|+.-+- ......++|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 478999999998887765321111688999999999987643221 12356678888899988874322 2345568899
Q ss_pred EEEeeCccccccCcCcCCCCCCccEEEccCccccccCH-HHhhcCccccccccccccccccCccc------ccCCCcccE
Q psy10487 133 VLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHK-DALIHLTALESLNLNGNRLKHLSESV------FFPTPNLKT 205 (610)
Q Consensus 133 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~------~~~~~~L~~ 205 (610)
.|+|.+|....+.......+..|+.|+|++|++..+.. ...+.++.|+.|+++.+.|.++.... ...+++|+.
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~ 305 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY 305 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence 99999886444444445567888999999988877642 24567888888888888888765322 234678888
Q ss_pred EecCCCccc
Q psy10487 206 LSLDGNPWC 214 (610)
Q Consensus 206 l~l~~N~~~ 214 (610)
|++..|++.
T Consensus 306 L~i~~N~I~ 314 (505)
T KOG3207|consen 306 LNISENNIR 314 (505)
T ss_pred eecccCccc
Confidence 999888864
No 149
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=98.54 E-value=1.6e-07 Score=73.58 Aligned_cols=74 Identities=32% Similarity=0.618 Sum_probs=51.9
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecC-CCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDP-EPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYT 338 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P-~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~ 338 (610)
+|.|...+.......++ ++|.|.+.+.| .+.++|+ +....... .........+.|.|.++..+|.|.|+
T Consensus 1 kP~I~~~~~~~~~~~~~-~~l~C~~~~~~~~~~~~W~-~~~~~~~~--------~~~~~~~~~~~L~i~~v~~~~~g~y~ 70 (75)
T PF13927_consen 1 KPQISVPPPPVVTSGGS-VTLTCSAEGGPPPPSISWY-DSNPSFNS--------NSRGSSSSNSTLTISNVTRSDNGTYT 70 (75)
T ss_dssp ESEEEEESTSEEETTEE-EEEEEEESSEESSEEEEEE-TEEEEEEE--------EEEEEEEEEEEEEESSCCGGGTEEEE
T ss_pred CCEEEEcCCCcEeecee-EEEEEEEccccCCeEEEEE-ecCCceee--------eeeeccceeeEEEEccCCHHhCcEEE
Confidence 36666666666655555 99999999888 8899999 11111000 00112245679999999999999999
Q ss_pred EEeec
Q psy10487 339 CYAEN 343 (610)
Q Consensus 339 C~a~N 343 (610)
|+|.|
T Consensus 71 C~a~N 75 (75)
T PF13927_consen 71 CIASN 75 (75)
T ss_dssp EEEEE
T ss_pred EEEEC
Confidence 99987
No 150
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=98.52 E-value=5.4e-07 Score=74.10 Aligned_cols=86 Identities=19% Similarity=0.203 Sum_probs=59.6
Q ss_pred cceEeecCceEEEEEEEE-----------ecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeE
Q psy10487 268 SMVIREAGGNVTMSCYVY-----------GDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGE 336 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~-----------g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~ 336 (610)
....+.+|+.+.|.|... ......+.|+|++......... ..+ +.........|.|..+..+|+|.
T Consensus 8 ~~~~~~~GE~v~l~C~~~~~~~~~~~~~~~~~~~~v~WyK~~~~~~~~~~~--~~~-~~Ri~~~~~~Lwf~Pa~~eDSG~ 84 (104)
T cd05896 8 KKYMVLAGEPVRIKCALFYGYIRTNYSMAQSAGLSLMWYKSSGDGEEPIEI--IFD-GVRMSKEEDSIWFRPAELQDSGL 84 (104)
T ss_pred eeEEEcCCCeEEEECCCccccccccccccccCCceEEEEECCCCCCCCCcc--ccc-ceeEEEeCCEEEEEeCChhhCeE
Confidence 446788999999999861 1223489999997554433210 000 00112233489999999999999
Q ss_pred EEEEeecCCcceeEEEEEEc
Q psy10487 337 YTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 337 Y~C~a~N~~G~~~~~~~L~V 356 (610)
|+|++.|........+.|+|
T Consensus 85 Y~C~~rN~t~C~~~~i~l~V 104 (104)
T cd05896 85 YTCVLRNSTYCMKVSMSLTV 104 (104)
T ss_pred EEEEECCCCcceEEEEEEEC
Confidence 99999999888777777765
No 151
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=98.52 E-value=4.7e-07 Score=75.89 Aligned_cols=92 Identities=16% Similarity=0.117 Sum_probs=59.8
Q ss_pred eeecceEeecCceEEEEEEEEecCCCeEEEEeCCE-----EeccCCc-----cceeeccCCceeeeeeEEEEEecCCCCC
Q psy10487 265 IKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQ-----VLHNSSF-----DLLEEEEGDALFEKSVSITLFNVTDLDA 334 (610)
Q Consensus 265 ~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~-----~l~~~~~-----~~~~~~~~~~~~~~~~~L~I~~v~~~D~ 334 (610)
+.+....+.+|+++.|.|.........+.|+|... .+..... ...-...++.....+++|.|++++.+|+
T Consensus 3 ie~~p~~~~~G~~V~L~v~~~p~~~~~~~W~kg~~~~~~~~I~~y~~~~~~~~~gp~~~gR~~~~~ngSL~I~~v~~~D~ 82 (105)
T cd05774 3 IELVPPQVAEGENVLLLVHNLPENLLAYAWYKGKTVSPNFLIASYIISTNSSTPGPAYSGRETIYPNGSLLIQNVTQKDT 82 (105)
T ss_pred EeccCCcccCCCCEEEEecCCCCCceEEEEEcCCCCCCCEEEEEEECCCcccccCcccCCcEEEeCCCcEEEecCCcccC
Confidence 34455678899999999865433334899999632 1111110 0000112333445568999999999999
Q ss_pred eEEEEEeecCC-cceeEEEEEEc
Q psy10487 335 GEYTCYAENIR-GNASGEISLDL 356 (610)
Q Consensus 335 G~Y~C~a~N~~-G~~~~~~~L~V 356 (610)
|.|+|.+.|.. ......+.|.|
T Consensus 83 G~Y~~~v~~~~~~~~~~~v~l~V 105 (105)
T cd05774 83 GFYTLQTITTNFQVEQATVHLQV 105 (105)
T ss_pred EEEEEEEEeCCccEEEEEEEEEC
Confidence 99999999987 45566666654
No 152
>KOG3207|consensus
Probab=98.49 E-value=2.5e-08 Score=100.43 Aligned_cols=158 Identities=20% Similarity=0.242 Sum_probs=88.8
Q ss_pred CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccch-hhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcE
Q psy10487 55 SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHR-DTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKV 133 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~-~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~ 133 (610)
++|+.|+|+.|.+......... +-+.+|+.|.|+.|+|+.-+- ..+..+++|+.|+|..|....+....+.-+..|+.
T Consensus 172 p~Le~LNls~Nrl~~~~~s~~~-~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~ 250 (505)
T KOG3207|consen 172 PSLENLNLSSNRLSNFISSNTT-LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE 250 (505)
T ss_pred ccchhcccccccccCCccccch-hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence 3677777777766543332221 135667777777777664322 12345677777777777544344444555667777
Q ss_pred EEeeCccccccCc-CcCCCCCCccEEEccCccccccCHHH------hhcCccccccccccccccccCc-ccccCCCcccE
Q psy10487 134 LYLNGNPITELRA-GQFPKLPYLKTIELQHCQIHSVHKDA------LIHLTALESLNLNGNRLKHLSE-SVFFPTPNLKT 205 (610)
Q Consensus 134 L~Ls~N~l~~l~~-~~~~~l~~L~~L~L~~n~l~~~~~~~------~~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~ 205 (610)
|+|++|++-..+. .....++.|+.|+++.|.|..+..-. ...+.+|+.|++..|+|..+.. ..+..+.+|+.
T Consensus 251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~ 330 (505)
T KOG3207|consen 251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKH 330 (505)
T ss_pred ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhh
Confidence 7777777666542 12445677777777777766653211 2345677777777777765543 11222334444
Q ss_pred EecCCCcc
Q psy10487 206 LSLDGNPW 213 (610)
Q Consensus 206 l~l~~N~~ 213 (610)
|....|.+
T Consensus 331 l~~~~n~l 338 (505)
T KOG3207|consen 331 LRITLNYL 338 (505)
T ss_pred hhcccccc
Confidence 44444443
No 153
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]
Probab=98.49 E-value=8.7e-08 Score=101.66 Aligned_cols=150 Identities=29% Similarity=0.368 Sum_probs=86.3
Q ss_pred CccEEEeecCCCCCCChhhhcccCCC-CccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLL-NLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVL 134 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~-~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L 134 (610)
.++.|++.+|.++.+++.... +. +|+.|++++|++..+. ..++.++.|+.|++++|++..++.. ...+..|+.|
T Consensus 117 ~l~~L~l~~n~i~~i~~~~~~---~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~l~~l~~~-~~~~~~L~~L 191 (394)
T COG4886 117 NLTSLDLDNNNITDIPPLIGL---LKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNL 191 (394)
T ss_pred ceeEEecCCcccccCcccccc---chhhcccccccccchhhhh-hhhhccccccccccCCchhhhhhhh-hhhhhhhhhe
Confidence 466666666666666654431 32 6666666666666663 2356666666666666666666542 1245666666
Q ss_pred EeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCcc
Q psy10487 135 YLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPW 213 (610)
Q Consensus 135 ~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~ 213 (610)
++++|.++.++.. ...+..|+.|.+++|++..+ ...+..+.++..+.+.+|++..+. ..+..+..++.|++.+|.+
T Consensus 192 ~ls~N~i~~l~~~-~~~~~~L~~l~~~~N~~~~~-~~~~~~~~~l~~l~l~~n~~~~~~-~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 192 DLSGNKISDLPPE-IELLSALEELDLSNNSIIEL-LSSLSNLKNLSGLELSNNKLEDLP-ESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred eccCCccccCchh-hhhhhhhhhhhhcCCcceec-chhhhhcccccccccCCceeeecc-chhccccccceeccccccc
Confidence 6666666666552 12334466666666643333 234455566666666666665532 2344555566666666654
No 154
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=98.42 E-value=8.6e-07 Score=70.91 Aligned_cols=71 Identities=20% Similarity=0.392 Sum_probs=53.9
Q ss_pred cceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
..+.+.+|+++.|.|...+. .+.+.|+++|..+..+.+ .. .....|.|..++.+|+|.|.|.+. +.|-
T Consensus 4 ~~~tv~~g~~v~L~C~~~s~-~A~v~W~~ng~~l~~~~r--~~--------~~~~GLlI~~~~~~dsG~Y~C~s~-E~gf 71 (85)
T cd05872 4 KNRTVAPGADVVLPCQLRSN-LASPVWLFNGTPLNAQFS--YR--------VGTDGLLILVTSPEHSGTYRCYSE-EEGF 71 (85)
T ss_pred eEEEEecCCCEEEECCCCCC-CccEEEEECCcccCCCcc--eE--------EeCCCCEEEECCHhhCEEEEEEEe-cCCC
Confidence 45778899999999999885 669999999998865422 11 112258899999999999999986 4454
Q ss_pred eeE
Q psy10487 348 ASG 350 (610)
Q Consensus 348 ~~~ 350 (610)
...
T Consensus 72 ~~~ 74 (85)
T cd05872 72 QQL 74 (85)
T ss_pred eEE
Confidence 433
No 155
>cd05762 Ig8_MLCK Eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). Ig8_MLCK: the eighth immunoglobulin (Ig)-like domain of human myosin light-chain kinase (MLCK). MLCK is a key regulator of different forms of cell motility involving actin and myosin II. Agonist stimulation of smooth muscle cells increases cytosolic Ca2+, which binds calmodulin. This Ca2+-calmodulin complex in turn binds to and activates MLCK. Activated MLCK leads to the phosphorylation of the 20 kDa myosin regulatory light chain (RLC) of myosin II and the stimulation of actin-activated myosin MgATPase activity. MLCK is widely present in vertebrate tissues; it phosphorylates the 20 kDa RLC of both smooth and nonmuscle myosin II. Phosphorylation leads to the activation of the myosin motor domain and altered structural properties of myosin II. In smooth muscle MLCK it is involved in initiating contraction. In nonmuscle cells, MLCK may participate in cell division and cell motility; it has
Probab=98.41 E-value=4.3e-08 Score=81.60 Aligned_cols=42 Identities=10% Similarity=-0.012 Sum_probs=38.2
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCC
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQP 461 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~p 461 (610)
+....|.|.+++.+|+|.|+|.|.|..|+.+++++|.|.++|
T Consensus 53 ~~~s~L~I~~~~~~D~G~Ytc~a~N~~G~~~~~~~l~V~~~P 94 (98)
T cd05762 53 ENSSKLTITEGQQEHCGCYTLEVENKLGSRQAQVNLTVVDKP 94 (98)
T ss_pred CCeeEEEECCCChhhCEEEEEEEEcCCCceeEEEEEEEecCC
Confidence 445689999999999999999999999999999999998764
No 156
>KOG1644|consensus
Probab=98.39 E-value=3e-07 Score=83.67 Aligned_cols=102 Identities=33% Similarity=0.447 Sum_probs=50.9
Q ss_pred CcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCH-HHhhcCccccccccc
Q psy10487 107 LVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHK-DALIHLTALESLNLN 185 (610)
Q Consensus 107 L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~ 185 (610)
...+||++|.|..+. .|..+++|..|.|++|+|+.+.+..-.-+++|..|.|.+|+|..+.. +.+..++.|+.|.+-
T Consensus 44 ~d~iDLtdNdl~~l~--~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~~l~dl~pLa~~p~L~~Ltll 121 (233)
T KOG1644|consen 44 FDAIDLTDNDLRKLD--NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQELGDLDPLASCPKLEYLTLL 121 (233)
T ss_pred cceecccccchhhcc--cCCCccccceEEecCCcceeeccchhhhccccceEEecCcchhhhhhcchhccCCccceeeec
Confidence 334444444444432 24444445555555555555444333334445555555555544421 233445556666666
Q ss_pred cccccccC---cccccCCCcccEEecCC
Q psy10487 186 GNRLKHLS---ESVFFPTPNLKTLSLDG 210 (610)
Q Consensus 186 ~n~l~~~~---~~~~~~~~~L~~l~l~~ 210 (610)
+|.+++.. ..++..+++|+.||.+.
T Consensus 122 ~Npv~~k~~YR~yvl~klp~l~~LDF~k 149 (233)
T KOG1644|consen 122 GNPVEHKKNYRLYVLYKLPSLRTLDFQK 149 (233)
T ss_pred CCchhcccCceeEEEEecCcceEeehhh
Confidence 66555433 24556677777777654
No 157
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=98.38 E-value=4e-06 Score=68.77 Aligned_cols=72 Identities=19% Similarity=0.200 Sum_probs=50.9
Q ss_pred cceEeecCceEEEEEEEEecCCCeEEEEeCCEEecc-------CCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHN-------SSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~-------~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
.++++.+|++++|.|.+.+.....+.|++.+..+.. .+.+....... ....+|+|.+++.+|+|.|.|.
T Consensus 5 ~nvtv~~G~ta~L~C~v~~~~~~~v~w~~~~~~~i~~~~~~~~~d~Rf~~~~~~----~~~~tL~I~~vq~~D~G~Y~Cq 80 (95)
T cd05881 5 EDVTVVEGEVAIISCRVKNNDDSVIQLLNPNRQTIYFRDVRPLKDSRFQLVNFS----SNELRVSLSNVSLSDEGRYFCQ 80 (95)
T ss_pred CceEEcCCCcEEEEEEEccCCccEEEEEecCCcEEEecCccccCCcCEEEEeCC----CCEEEEEECcCCcccCEEEEEE
Confidence 567899999999999999988888999986644321 11111111101 1123799999999999999999
Q ss_pred eec
Q psy10487 341 AEN 343 (610)
Q Consensus 341 a~N 343 (610)
+..
T Consensus 81 v~t 83 (95)
T cd05881 81 LYT 83 (95)
T ss_pred EEc
Confidence 865
No 158
>KOG0531|consensus
Probab=98.37 E-value=7.5e-08 Score=102.55 Aligned_cols=108 Identities=31% Similarity=0.418 Sum_probs=46.3
Q ss_pred CCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEE
Q psy10487 80 LLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIE 159 (610)
Q Consensus 80 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 159 (610)
+.+|+.|++.+|.|..+... +..+.+|++|+|++|+|+.+.. +..+..|+.|++++|.|+.+.. |..+..|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~~~--~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDISG--LESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhhcccc-hhhhhcchheeccccccccccc--hhhccchhhheeccCcchhccC--Cccchhhhccc
Confidence 33444444444444444321 3344444444444444444432 3334444444444444444432 33344444444
Q ss_pred ccCccccccCHHHhhcCcccccccccccccccc
Q psy10487 160 LQHCQIHSVHKDALIHLTALESLNLNGNRLKHL 192 (610)
Q Consensus 160 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 192 (610)
+++|++..+.......+.+|+.+++.+|.+..+
T Consensus 169 l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i 201 (414)
T KOG0531|consen 169 LSYNRIVDIENDELSELISLEELDLGGNSIREI 201 (414)
T ss_pred CCcchhhhhhhhhhhhccchHHHhccCCchhcc
Confidence 444444444320023334444444444444433
No 159
>KOG1859|consensus
Probab=98.37 E-value=1.5e-08 Score=107.48 Aligned_cols=127 Identities=24% Similarity=0.365 Sum_probs=104.0
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
.|...++++|.+..++. +++ -++.|+.|+|++|+++.+. .++.++.|++|||+.|++..++.-...+. +|+.|+
T Consensus 165 ~L~~a~fsyN~L~~mD~-SLq--ll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLVLMDE-SLQ--LLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLN 238 (1096)
T ss_pred hHhhhhcchhhHHhHHH-HHH--HHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhh-hheeee
Confidence 57778888998877654 333 3678999999999999986 68999999999999999998876554554 499999
Q ss_pred eeCccccccCcCcCCCCCCccEEEccCccccccCH-HHhhcCcccccccccccccc
Q psy10487 136 LNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHK-DALIHLTALESLNLNGNRLK 190 (610)
Q Consensus 136 Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 190 (610)
|.+|.++.+.. +.+|.+|+.|||++|-|..... ..+..+..|..|.|.+|.+-
T Consensus 239 lrnN~l~tL~g--ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTTLRG--IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHhhhh--HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999999875 7789999999999998876533 24567788999999999875
No 160
>KOG0531|consensus
Probab=98.37 E-value=6e-08 Score=103.31 Aligned_cols=164 Identities=26% Similarity=0.319 Sum_probs=120.4
Q ss_pred cCCCCCCccCccc--CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCC
Q psy10487 41 CKDANFTALPSTL--DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIA 118 (610)
Q Consensus 41 C~~~~l~~lP~~l--~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~ 118 (610)
++.+.+..+-..+ ..+++.|++.+|.|..+... +. .+.+|++|+|++|.|..+.. +..+..|+.|++++|.|.
T Consensus 79 l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~--~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~ 153 (414)
T KOG0531|consen 79 LRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LS--SLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS 153 (414)
T ss_pred cchhhhhhhhcccccccceeeeeccccchhhcccc-hh--hhhcchheeccccccccccc--hhhccchhhheeccCcch
Confidence 4445555422212 35899999999999988762 22 47899999999999999975 677888999999999999
Q ss_pred CCCcccccCCCCCcEEEeeCccccccCc-CcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccc
Q psy10487 119 WLHQDTFLGNDRLKVLYLNGNPITELRA-GQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVF 197 (610)
Q Consensus 119 ~l~~~~f~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 197 (610)
.+.. |..+.+|+.+++++|.+..+.. . ...+.+|+.+.+.+|.+..+.. +..+..+..+++..|.++.+..-..
T Consensus 154 ~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~--~~~~~~l~~~~l~~n~i~~~~~l~~ 228 (414)
T KOG0531|consen 154 DISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG--LDLLKKLVLLSLLDNKISKLEGLNE 228 (414)
T ss_pred hccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc--hHHHHHHHHhhcccccceeccCccc
Confidence 8864 6668999999999999998876 2 4667889999999999887743 3334455556888888876654221
Q ss_pred cCCCcccEEecCCCccc
Q psy10487 198 FPTPNLKTLSLDGNPWC 214 (610)
Q Consensus 198 ~~~~~L~~l~l~~N~~~ 214 (610)
..+..|+.+++.+|++.
T Consensus 229 ~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 229 LVMLHLRELYLSGNRIS 245 (414)
T ss_pred chhHHHHHHhcccCccc
Confidence 11112677777777764
No 161
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=98.36 E-value=1.8e-06 Score=71.44 Aligned_cols=75 Identities=25% Similarity=0.363 Sum_probs=58.2
Q ss_pred ecCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 273 EAGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 273 ~~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
..|+.++|.|.+.|. |. +.|+|+++|..+.............++.+...+.|.|......|.|.|+|+|.+....
T Consensus 11 ~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~~~~~~~gt~~~~s~l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 11 LLGGSVTLTCLATGFYPPDITVTWLKNGKELTSGVTTTPPVPNSDGTYSVSSQLTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred HcCCCeEEEEEEeeEECCCcEEEEEECCEECCCceeccccccCCCCCEEEEEEEEECHHHhCCCCCEEEEEEeCCCC
Confidence 468899999999998 64 6899999999887655323334444556677788888887778999999999997654
No 162
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.35 E-value=8.1e-07 Score=78.05 Aligned_cols=126 Identities=18% Similarity=0.363 Sum_probs=65.8
Q ss_pred CChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcC
Q psy10487 70 LTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQF 149 (610)
Q Consensus 70 l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 149 (610)
++..+|. +..+|+.+.+.. .+..+...+|.++.+|+.|++.++ +..+....|.+..+|+.+.+.. .+..+....|
T Consensus 3 i~~~~F~--~~~~l~~i~~~~-~~~~I~~~~F~~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F 77 (129)
T PF13306_consen 3 IGNNAFY--NCSNLESITFPN-TIKKIGENAFSNCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAF 77 (129)
T ss_dssp E-TTTTT--T-TT--EEEETS-T--EE-TTTTTT-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTT
T ss_pred ECHHHHh--CCCCCCEEEECC-CeeEeChhhccccccccccccccc-ccccceeeeecccccccccccc-cccccccccc
Confidence 3445565 566777777764 577777777777777777777664 7777777777776777777754 6666666677
Q ss_pred CCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcc
Q psy10487 150 PKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNL 203 (610)
Q Consensus 150 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L 203 (610)
..+.+|+.+.+..+ +..+....|.+. +|+.+.+.. .+..+....|.++.+|
T Consensus 78 ~~~~~l~~i~~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l 128 (129)
T PF13306_consen 78 SNCTNLKNIDIPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKL 128 (129)
T ss_dssp TT-TTECEEEETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG-----
T ss_pred cccccccccccCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccC
Confidence 77777777777654 666666666665 777776665 4556666666666554
No 163
>cd05892 Ig_Myotilin_C C-terminal immunoglobulin (Ig)-like domain of myotilin. Ig_Myotilin_C: C-terminal immunoglobulin (Ig)-like domain of myotilin. Mytolin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to the latter family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Myotilin is most abundant in skeletal and cardiac muscle, and is involved in maintaining sarcomere integrity. It binds to alpha-actinin, filamin and actin. Mutations in myotilin lead to muscle disorders.
Probab=98.35 E-value=5.1e-07 Score=70.91 Aligned_cols=34 Identities=12% Similarity=-0.043 Sum_probs=32.1
Q ss_pred ceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 424 KLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 424 ~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
+|.|.+++.+|+|.|+|.|.|.+|++...++|.|
T Consensus 42 ~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05892 42 TLLIKNVNKKDAGWYTVSAVNEAGVATCHARLDV 75 (75)
T ss_pred EEEECCCChhhCEEEEEEEEcCcCeEEEEEEEeC
Confidence 7999999999999999999999999999998864
No 164
>KOG4579|consensus
Probab=98.33 E-value=5.1e-08 Score=83.06 Aligned_cols=133 Identities=15% Similarity=0.218 Sum_probs=81.1
Q ss_pred cEEEcccCCCcccchh--hhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEcc
Q psy10487 84 QRIYLKNSGIREVHRD--TFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQ 161 (610)
Q Consensus 84 ~~L~L~~n~l~~i~~~--~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~ 161 (610)
..|+|+.|.|-.+... .+.....|+.++|++|.+..+++..-...+.++.|+|++|.|..++.+ +..++.|+.|+++
T Consensus 30 h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 30 HFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLNLR 108 (177)
T ss_pred hhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhcccc
Confidence 3444555554443311 123333455556777777666655444455677777777777777665 6777777777777
Q ss_pred CccccccCHHHhhcCccccccccccccccccCcccccCCCcccEEecCCCcccccCCc
Q psy10487 162 HCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTLSLDGNPWCCDCHL 219 (610)
Q Consensus 162 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~c~c~l 219 (610)
.|.|... +..+..+.+|..|+..+|.+..++-..|.. ......++..++|...|+.
T Consensus 109 ~N~l~~~-p~vi~~L~~l~~Lds~~na~~eid~dl~~s-~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 109 FNPLNAE-PRVIAPLIKLDMLDSPENARAEIDVDLFYS-SLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cCccccc-hHHHHHHHhHHHhcCCCCccccCcHHHhcc-ccHHHHHhcCCcccccCcc
Confidence 7777666 444555777888888888877777654421 2223346677788776653
No 165
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.32 E-value=4.5e-06 Score=70.64 Aligned_cols=85 Identities=21% Similarity=0.293 Sum_probs=56.4
Q ss_pred cCceEEEEEEEEecC------CCeEEEEeCCE------E-eccCCccceeecc--CCcee----eeeeEEEEEecCCCCC
Q psy10487 274 AGGNVTMSCYVYGDP------EPTILWLLNGQ------V-LHNSSFDLLEEEE--GDALF----EKSVSITLFNVTDLDA 334 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P------~p~v~W~~~g~------~-l~~~~~~~~~~~~--~~~~~----~~~~~L~I~~v~~~D~ 334 (610)
.|++++|.|.....| ...|.|+|... . +............ ++..+ .....|.|.+++.+|+
T Consensus 1 ~G~~vtL~C~~~~~~~~~~~~~~~v~W~k~~~~~~~~~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~Ds 80 (106)
T cd05877 1 RGGNVTLPCRYHYEPELSAPRKIRVKWTKLESDYLKEEDVLVAIGTRHKSYGSYQGRVFLRRAHDLDASLVITDLRLEDY 80 (106)
T ss_pred CCCcEEEEeEeECCCcCCCCccceEEEEEecCCCCeeEEEEEEcCcEEEeccCccCcEEecCCCCCcEEEEEccCChHHC
Confidence 388999999987663 35699999531 1 1011000000000 11111 1235899999999999
Q ss_pred eEEEEEeecCCcceeEEEEEEcCc
Q psy10487 335 GEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 335 G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
|.|.|.+.+..|.....+.|.|..
T Consensus 81 G~Y~C~v~~~~~~~~~~~~l~v~~ 104 (106)
T cd05877 81 GRYRCEVIDGLEDESVVVALRLRG 104 (106)
T ss_pred EEEEEEEEecccceEEEEEEEEEE
Confidence 999999999999999999998853
No 166
>cd05854 Ig6_Contactin-2 Sixth Ig domain of contactin-2. Ig6_Contactin-2: Sixth Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=98.31 E-value=6.9e-07 Score=72.20 Aligned_cols=40 Identities=13% Similarity=0.026 Sum_probs=36.7
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecccccC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQ 460 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~ 460 (610)
..+.|.|.+++.+|+|.|+|.|.|..|+.++.++|.|..+
T Consensus 45 ~~~~L~I~~v~~~D~G~YtC~A~n~~g~~~~~~~L~V~~~ 84 (85)
T cd05854 45 TIGDLVIVNAQLSHAGTYTCTAQTVVDSASASATLVVRGP 84 (85)
T ss_pred eEeEEEEccCChhhCeEEEEEEecCCCCEEEEEEEEEECC
Confidence 4568999999999999999999999999999999988764
No 167
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=98.31 E-value=3.6e-06 Score=71.19 Aligned_cols=84 Identities=20% Similarity=0.312 Sum_probs=56.7
Q ss_pred cCceEEEEEEEEecC------CCeEEEEeCC-----E-Eecc-CCccceeeccCCcee------eeeeEEEEEecCCCCC
Q psy10487 274 AGGNVTMSCYVYGDP------EPTILWLLNG-----Q-VLHN-SSFDLLEEEEGDALF------EKSVSITLFNVTDLDA 334 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P------~p~v~W~~~g-----~-~l~~-~~~~~~~~~~~~~~~------~~~~~L~I~~v~~~D~ 334 (610)
.|++|+|.|...+.+ .+.|.|++.. . .+.. ..............+ ....+|+|.+++.+|+
T Consensus 1 ~G~~V~L~C~~~~~~~~~~~~~~~i~W~k~~~~~~~~~~v~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~~v~~sD~ 80 (106)
T cd05714 1 LGGNVTLPCRFHLEPALSAPHGPRIKWTKLESDGAKEVDVLVAIGGRVKVYGSGRVRVPLYPADPGDASLVITDLRLEDS 80 (106)
T ss_pred CCCCEEEeEEeECCcccCCCCCcEEEEEEeCCCCCceEEEEEEcCCEEEEcCCCceEEEeeCCCCCcceEEECCCCHHHC
Confidence 388999999988754 4689999962 1 1111 110000001111011 2346999999999999
Q ss_pred eEEEEEeecCCcceeEEEEEEcC
Q psy10487 335 GEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 335 G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
|.|.|.+.+..+.....+.|.|.
T Consensus 81 G~Y~C~v~~~~~~~~~~v~L~V~ 103 (106)
T cd05714 81 GRYRCEVIDGIEDEQDTVELEVR 103 (106)
T ss_pred EEEEEEEEcCCCceEEEEEEEEE
Confidence 99999999988888899999884
No 168
>KOG1909|consensus
Probab=98.31 E-value=1.7e-07 Score=92.02 Aligned_cols=111 Identities=19% Similarity=0.235 Sum_probs=57.4
Q ss_pred CccEEEeecCCCCCCChhhhccc--CCCCccEEEcccCCCcccchhh-------------hcCCCCCcEEEccCCCCCCC
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSI--GLLNLQRIYLKNSGIREVHRDT-------------FKYLTILVEVDLSDNQIAWL 120 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~--~l~~L~~L~L~~n~l~~i~~~~-------------f~~l~~L~~LdLs~n~l~~l 120 (610)
.|++||||.|.|..-....|..+ .+..|++|+|.+|.+....... ...-+.|++++.++|++..-
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc
Confidence 68888888887754333332211 4667778888777776443222 23345567777777766543
Q ss_pred Cc----ccccCCCCCcEEEeeCcccccc----CcCcCCCCCCccEEEccCcccc
Q psy10487 121 HQ----DTFLGNDRLKVLYLNGNPITEL----RAGQFPKLPYLKTIELQHCQIH 166 (610)
Q Consensus 121 ~~----~~f~~l~~L~~L~Ls~N~l~~l----~~~~~~~l~~L~~L~L~~n~l~ 166 (610)
+. ..|...+.|+.+.++.|.|..- ....|..+++|+.|||.+|-++
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 31 2233344455555555444321 1123334444455555444443
No 169
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=98.29 E-value=2.2e-06 Score=76.44 Aligned_cols=112 Identities=16% Similarity=0.208 Sum_probs=73.9
Q ss_pred CCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEEEEEEec-CC-CeEEEEeCCEEecc-----C
Q psy10487 232 YSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMSCYVYGD-PE-PTILWLLNGQVLHN-----S 304 (610)
Q Consensus 232 ~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~-----~ 304 (610)
+.+.|.|.+.+..+. .-..+.... ..+|.+...+......+|+.++|.|.+.|. |. ++|.|+++|..... .
T Consensus 12 D~G~Y~C~~~~~~~~-~~~~~~l~v-~~~P~v~~~~~~~~~~~~~~~~L~C~a~g~~P~~~~i~W~~~g~~~~~~~~~~~ 89 (139)
T cd05771 12 DEGTYICSVSTPPHQ-AQQIIQLSV-SEPPRVRLSLEKLVSMIEEPQTLICHIAGYYPLDVQVEWTREPPGDSPPPVSLS 89 (139)
T ss_pred HCEEEEEEEEccCcc-eeeEEEEEE-ecCCceEEeCCCceeecCCcEEEEEEECCCCCCCeEEEEEECCCCCccceeccC
Confidence 678899987554332 222233322 357888777766666688999999999986 54 48999999864221 1
Q ss_pred Ccc-ceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 305 SFD-LLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 305 ~~~-~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
... .....+.++.+..++.|.+..-...+.+.|+|++.+..
T Consensus 90 ~~~~~~~~~~~dgt~~~~s~L~v~~~~~~~g~~ytC~V~H~~ 131 (139)
T cd05771 90 NVSFSSHRQHQDGTYSLSSHLTLEPGTEDAGATYTCRVSHVS 131 (139)
T ss_pred CeEecceEeCCCCCEEEEEEEEecCCccCCCCEEEEEEEcCC
Confidence 111 11233455567778899987666666779999998754
No 170
>cd05863 Ig2_VEGFR-3 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). Ig2_VEGFR-3: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 3 (VEGFR-3). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-3 (Flt-4) binds two members of the VEGF family (VEGF-C and -D) and is involved in tumor angiogenesis and growth.
Probab=98.29 E-value=5.8e-07 Score=68.69 Aligned_cols=38 Identities=13% Similarity=-0.034 Sum_probs=32.0
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...+.|.|.++..+|+|.|+|+|+|+.|..+.+..+.+
T Consensus 28 ~~~~~L~i~~v~~~D~G~YtC~a~N~~g~~~~~~~~~l 65 (67)
T cd05863 28 HSQHSLQIKDVTEASAGTYTLVLWNSAAGLEKRISLEL 65 (67)
T ss_pred CCcCEEEECCCCHHHCEEEEEEEEECCccEEEEEEEEE
Confidence 34568999999999999999999999998777666543
No 171
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=98.28 E-value=6.8e-06 Score=70.34 Aligned_cols=91 Identities=20% Similarity=0.300 Sum_probs=55.5
Q ss_pred eecceEeecCceEEEEEEEEec----CCCeEEEEeCCE------EeccCCccceee-cc----CCce-----eeeeeEEE
Q psy10487 266 KESMVIREAGGNVTMSCYVYGD----PEPTILWLLNGQ------VLHNSSFDLLEE-EE----GDAL-----FEKSVSIT 325 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~----P~p~v~W~~~g~------~l~~~~~~~~~~-~~----~~~~-----~~~~~~L~ 325 (610)
.+..+.+..|+.++|.|..... +...|.|.+... .+......+.+. .. ++.. .....+|.
T Consensus 4 ~~~ev~a~~G~~v~L~C~f~~~~~~~~~~~v~W~~~~~~~~~~~~v~~y~~g~~~~~~~~~f~~Rv~f~g~~~~~daSI~ 83 (116)
T cd05879 4 TDREVYGTVGSDVTLSCSFWSSEWISDDISFTWHYQPDGSRDAISIFHYGKGQPYIDDVGPFKERIEWVGNPSRKDGSIV 83 (116)
T ss_pred ccceEEEEcCCcEEEEEEEecCCCCCCcEEEEEEEcCCCCCccEEEEEeCCCceecccccCccCceEEeCCCCcCeeEEE
Confidence 3456788899999999998763 346899954211 011010001110 00 0000 13446899
Q ss_pred EEecCCCCCeEEEEEeecCCcce--eEEEEEEc
Q psy10487 326 LFNVTDLDAGEYTCYAENIRGNA--SGEISLDL 356 (610)
Q Consensus 326 I~~v~~~D~G~Y~C~a~N~~G~~--~~~~~L~V 356 (610)
|.+++.+|.|.|+|.+.|.-+.. ...+.|.|
T Consensus 84 I~nv~~sD~G~Y~C~v~n~p~~~~~~~~~~l~v 116 (116)
T cd05879 84 IHNLDYTDNGTFTCDVKNPPDIVGKSSQVTLYV 116 (116)
T ss_pred EccCCcccCEEEEEEEEcCCCcCCceeEEEEEC
Confidence 99999999999999999986643 34455543
No 172
>cd05761 Ig2_Necl-1-4_like Second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-4 (also known as cell adhesion molecules CADM3, CADM1, CADM2, and CADM4, respectively). Ig2_Necl-1-4_like: domain similar to the second immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), Necl-3 (CADM2) and Necl-4 (CADM4). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cel
Probab=98.28 E-value=7.7e-06 Score=65.54 Aligned_cols=68 Identities=22% Similarity=0.355 Sum_probs=49.0
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
+.|.|.+.| .|.+.|+|++++..+.... . ......++.+...+.|.+......|.+.|+|+|.|....
T Consensus 2 ~~L~C~~~~~~P~~~v~W~~~~~~l~~~~-~-~~~~~~~~~~~~~s~l~~~~~~~d~g~~~~C~v~h~~l~ 70 (82)
T cd05761 2 VELTCTSSGSKPAATIRWFKGDKELKGVK-L-KEEDENGKTFTVTSSLRFQVDREDDGAPIICRVDHPALK 70 (82)
T ss_pred EEEEEEecCcCcCCeEEEEECCEEccCce-e-eEecCCCCEEEEEEEEEEEcchhhCCCEEEEEEeChhcC
Confidence 689999976 5999999999999886433 1 112222234556677887666666778999999998764
No 173
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=98.27 E-value=2.2e-06 Score=70.24 Aligned_cols=73 Identities=18% Similarity=0.210 Sum_probs=54.2
Q ss_pred CceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 261 PNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 261 P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
|.+...+. ..+.+|++|+|.|... .+...+.|+++|........ .. ....+.+.|.+|+.+|+|.|+|.
T Consensus 3 P~L~a~p~-~vV~~G~~VtL~C~~~-~~~~~f~l~k~g~~~~~~~~-----~~----~~~~~~f~i~~v~~~~~G~Y~C~ 71 (91)
T cd05751 3 PSLWAEPS-SVVPLGKPVTLRCQGP-YGAVEYRLYREGSTFAVKKP-----PE----PQNKAKFFIPSMKREHAGRYRCY 71 (91)
T ss_pred CEEEecCC-CccCCCCcEEEEEecC-CCCCEEEEEECCCCcccccc-----CC----CceeEEEEccCCChhHCEEEEEE
Confidence 55555554 4678999999999885 67788999999875332110 00 12345899999999999999999
Q ss_pred eecC
Q psy10487 341 AENI 344 (610)
Q Consensus 341 a~N~ 344 (610)
+.|.
T Consensus 72 ~~~~ 75 (91)
T cd05751 72 YRSG 75 (91)
T ss_pred EECC
Confidence 9986
No 174
>KOG1644|consensus
Probab=98.26 E-value=1.1e-06 Score=80.03 Aligned_cols=127 Identities=24% Similarity=0.275 Sum_probs=100.7
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
.=+.++|++.+|..+..-.. -+.+...++|++|.+..+. .|..+.+|.+|.|++|+|..|.+..-..+++|..|.
T Consensus 20 ~e~e~~LR~lkip~ienlg~---~~d~~d~iDLtdNdl~~l~--~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~ 94 (233)
T KOG1644|consen 20 RERELDLRGLKIPVIENLGA---TLDQFDAIDLTDNDLRKLD--NLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLI 94 (233)
T ss_pred cccccccccccccchhhccc---cccccceecccccchhhcc--cCCCccccceEEecCCcceeeccchhhhccccceEE
Confidence 45678888888877664111 3557889999999998875 488999999999999999999998777889999999
Q ss_pred eeCccccccCc-CcCCCCCCccEEEccCccccccCH---HHhhcCccccccccccc
Q psy10487 136 LNGNPITELRA-GQFPKLPYLKTIELQHCQIHSVHK---DALIHLTALESLNLNGN 187 (610)
Q Consensus 136 Ls~N~l~~l~~-~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~L~~n 187 (610)
|.+|.|..+.. .-+..+++|+.|.+-+|.+..... ..+..+++|+.||.+.-
T Consensus 95 LtnNsi~~l~dl~pLa~~p~L~~Ltll~Npv~~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 95 LTNNSIQELGDLDPLASCPKLEYLTLLGNPVEHKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred ecCcchhhhhhcchhccCCccceeeecCCchhcccCceeEEEEecCcceEeehhhh
Confidence 99999888654 346678999999999998876532 23456788998887653
No 175
>cd05852 Ig5_Contactin-1 Fifth Ig domain of contactin-1. Ig5_Contactin-1: fifth Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=98.25 E-value=1.2e-06 Score=68.54 Aligned_cols=37 Identities=16% Similarity=0.099 Sum_probs=33.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|.|.|..|+++.+++|.|
T Consensus 37 ~~g~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~~ 73 (73)
T cd05852 37 DDGSLEILNITKLDEGSYTCFAENNRGKANSTGVLSV 73 (73)
T ss_pred CCCEEEECcCChhHCEEEEEEEECCCCceeEEEEEEC
Confidence 4568999999999999999999999999999988764
No 176
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=98.25 E-value=5.8e-06 Score=69.12 Aligned_cols=82 Identities=20% Similarity=0.322 Sum_probs=52.0
Q ss_pred CceEEEEEEEEecCC---CeEEEEeCCE--EeccCCccce----eec--cCCcee------eeeeEEEEEecCCCCCeEE
Q psy10487 275 GGNVTMSCYVYGDPE---PTILWLLNGQ--VLHNSSFDLL----EEE--EGDALF------EKSVSITLFNVTDLDAGEY 337 (610)
Q Consensus 275 G~~v~l~C~~~g~P~---p~v~W~~~g~--~l~~~~~~~~----~~~--~~~~~~------~~~~~L~I~~v~~~D~G~Y 337 (610)
|++++|.|...+... ..+.|++... .+........ ... .++..+ ....+|.|.+++.+|+|.|
T Consensus 1 G~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~v~~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~sL~I~~v~~~D~G~Y 80 (100)
T cd05713 1 GEDAELPCHLSPKMSAEHMEVRWFRSQFSPAVHLYRDGQDQYGEQMPEYRGRTELLKDAIAEGSVALRIHNVRASDEGLY 80 (100)
T ss_pred CCcEEEEeEEcCCCCCCeeEEEEEECCCceeEEEEcCCcccccccCccccceEEeecccccCCcEEEEEEcCChhhCEEE
Confidence 688999999863322 3688988542 1111000000 000 011111 1235899999999999999
Q ss_pred EEEeecCCcceeEEEEEEc
Q psy10487 338 TCYAENIRGNASGEISLDL 356 (610)
Q Consensus 338 ~C~a~N~~G~~~~~~~L~V 356 (610)
+|.+.|..|..+..+.|+|
T Consensus 81 ~C~v~~~~~~~~~~i~l~v 99 (100)
T cd05713 81 TCFFQSDGFYEEATVELKV 99 (100)
T ss_pred EEEEecCCcEEEEEEEEEE
Confidence 9999998888888888876
No 177
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=98.25 E-value=3.5e-06 Score=69.16 Aligned_cols=82 Identities=18% Similarity=0.201 Sum_probs=54.4
Q ss_pred CceEEEEEEEEecCCCeEEEEeCCEEeccCC-------cccee--eccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 275 GGNVTMSCYVYGDPEPTILWLLNGQVLHNSS-------FDLLE--EEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~-------~~~~~--~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
|++|+|.|.........|.|+++........ ..... ...++......++|.|.+++.+|+|.|+|.+....
T Consensus 1 G~~VtL~c~~~~~~~~~i~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~sL~I~~l~~~DsG~Y~c~v~~~~ 80 (92)
T cd05741 1 GESVTLPVSNLPENLQEITWYKGKDKSVEAEIASYIATNSTVFGPAYSGRETIYPNGSLLIQNLTKEDSGTYTLQIISTN 80 (92)
T ss_pred CCcEEEEcccCCCCCEEEEEECCCCCCcceEEEEEecCCceeECCCcCCeEEEcCCceEEEccCCchhcEEEEEEEEcCC
Confidence 7899999998876777899999653321110 00000 00112223345799999999999999999999887
Q ss_pred cc-eeEEEEEEc
Q psy10487 346 GN-ASGEISLDL 356 (610)
Q Consensus 346 G~-~~~~~~L~V 356 (610)
|. ....+.|.|
T Consensus 81 ~~~~~~~~~l~v 92 (92)
T cd05741 81 GVTENAKFFLRV 92 (92)
T ss_pred CcEEEEEEEEEC
Confidence 54 455666654
No 178
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=98.23 E-value=8e-06 Score=69.36 Aligned_cols=85 Identities=14% Similarity=0.293 Sum_probs=55.4
Q ss_pred cCceEEEEEEEEecC------------CCeEEEEeC--CEE---eccC-Cccceeecc-CCcee------eeeeEEEEEe
Q psy10487 274 AGGNVTMSCYVYGDP------------EPTILWLLN--GQV---LHNS-SFDLLEEEE-GDALF------EKSVSITLFN 328 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P------------~p~v~W~~~--g~~---l~~~-~~~~~~~~~-~~~~~------~~~~~L~I~~ 328 (610)
.|++++|.|...... .+.|.|+|- |.. +... ...+...+. ++..+ ....+|+|.+
T Consensus 1 ~G~~VtLpC~~~~~~~~~~~~~~~~~~~~~I~W~k~~~g~~~~ii~~~~~~~~~~~~f~~R~sl~~~~~~~~~asL~I~n 80 (112)
T cd05900 1 LGSSLLIPCYFQDPIAKDPGAPTVAPLSPRIKWSFISKEKESVLLVATEGKVRVNTEYLDRVSLPNYPAIPSDATLEITE 80 (112)
T ss_pred CCCcEEEeeEEeCCcCccccccccCCCCCEEEEEEecCCCccEEEEEECCeEEECccccCeEEecccCCCCCCcEEEEee
Confidence 489999999987543 468999983 211 1111 100000000 01111 1346999999
Q ss_pred cCCCCCeEEEEEeecCCcceeEEEEEEcCc
Q psy10487 329 VTDLDAGEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 329 v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
++.+|+|.|.|.+.+.....+..+.|.|..
T Consensus 81 l~~sDsG~Y~C~V~~g~~~~~~~v~l~v~g 110 (112)
T cd05900 81 LRSNDSGTYRCEVMHGIEDNYDTVEVQVKG 110 (112)
T ss_pred cccccCEEEEEEEecCCCCceeEEEEEEEe
Confidence 999999999999998888888888888753
No 179
>cd05851 Ig3_Contactin-1 Third Ig domain of contactin-1. Ig3_Contactin-1: Third Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=98.22 E-value=2.7e-07 Score=75.15 Aligned_cols=37 Identities=19% Similarity=0.106 Sum_probs=33.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|.|+|.|.|..|..+..+.|.|
T Consensus 51 ~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 87 (88)
T cd05851 51 SGAVLKIFNIQPEDEGTYECEAENIKGKDKHQARVYV 87 (88)
T ss_pred CCCEEEECcCChhhCEEEEEEEEcCCCceEEEEEEEE
Confidence 4557999999999999999999999999999888765
No 180
>cd05723 Ig4_Neogenin Fourth immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig4_Neogenin: fourth immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=98.21 E-value=2.7e-06 Score=66.09 Aligned_cols=37 Identities=16% Similarity=0.196 Sum_probs=32.9
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|.|.|..|+++++++|.|
T Consensus 35 ~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 71 (71)
T cd05723 35 KEHNLQVLGLVKSDEGFYQCIAENDVGNVQASAQLII 71 (71)
T ss_pred ecCCEEEEcCCcccCEEEEEEEEcCCCEEEEEEEEEC
Confidence 4557899999999999999999999999999888754
No 181
>cd05876 Ig3_L1-CAM Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM: third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=98.21 E-value=2e-06 Score=66.90 Aligned_cols=38 Identities=16% Similarity=0.086 Sum_probs=33.6
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..++.|.|.+++.+|+|.|+|.|.|..|.++.++.|.|
T Consensus 33 ~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05876 33 NNNKTLQLDNVLESDDGEYVCTAENSEGSARHHYTVTV 70 (71)
T ss_pred cCCCEEEEcccCHHhCEEEEEEEEcCCCeEEEEEEEEE
Confidence 45678999999999999999999999999988877654
No 182
>cd05893 Ig_Palladin_C C-terminal immunoglobulin (Ig)-like domain of palladin. Ig_Palladin_C: C-terminal immunoglobulin (Ig)-like domain of palladin. Palladin belongs to the palladin-myotilin-myopalladin family. Proteins belonging to this family contain multiple Ig-like domains and function as scaffolds, modulating actin cytoskeleton. Palladin binds to alpha-actinin ezrin, vasodilator-stimulated phosphoprotein VASP, SPIN90 (DIP, mDia interacting protein), and Src. Palladin also binds F-actin directly, via its Ig3 domain. Palladin is expressed as several alternatively spliced isoforms, having various combinations of Ig-like domains, in a cell-type-specific manner. It has been suggested that palladin's different Ig-like domains may be specialized for distinct functions.
Probab=98.20 E-value=1.7e-06 Score=68.00 Aligned_cols=34 Identities=15% Similarity=-0.101 Sum_probs=31.7
Q ss_pred ceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 424 KLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 424 ~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.|.|.+++.+|+|.|+|.|.|..|+++.+++|.|
T Consensus 42 ~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 75 (75)
T cd05893 42 CLLIQGATKEDAGWYTVSAKNEAGIVSCTARLDV 75 (75)
T ss_pred EEEECCCCHHHCEEEEEEEEcCCCEEEEEEEEeC
Confidence 6999999999999999999999999999988864
No 183
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.19 E-value=5.4e-06 Score=70.47 Aligned_cols=81 Identities=22% Similarity=0.234 Sum_probs=54.0
Q ss_pred eeecceEeecCceEEEEEEEEecCCCeEEEEeCCE---E---eccCCccceeeccCCcee-----eeeeEEEEEecCCCC
Q psy10487 265 IKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQ---V---LHNSSFDLLEEEEGDALF-----EKSVSITLFNVTDLD 333 (610)
Q Consensus 265 ~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~---~---l~~~~~~~~~~~~~~~~~-----~~~~~L~I~~v~~~D 333 (610)
..+..+.+.+|++++|.|.+.+.+.+.+.|++... . +....... ....++... .....|.|.+++.+|
T Consensus 3 q~~~~v~~~~G~~v~L~C~~~~~~~~~v~W~k~~~~~~~~~l~~~~~~~~-~~~~~r~~~~~~~~~~~~~L~I~~~~~~D 81 (109)
T cd04983 3 QSPQSLSVQEGENVTLNCNYSTSTFYYLFWYRQYPGQGPQFLIYISSNGE-EKEKGRFSATLDKSRKSSSLHISAAQLSD 81 (109)
T ss_pred ecCCceEEcCCCCEEEEEEECCCCccEEEEEEECCCCCeEEEEEEecCCC-cccCCcEEEEEcccCCEEEEEECCCCHHH
Confidence 45667889999999999999988888999998431 1 00000000 000011111 123589999999999
Q ss_pred CeEEEEEeecCCc
Q psy10487 334 AGEYTCYAENIRG 346 (610)
Q Consensus 334 ~G~Y~C~a~N~~G 346 (610)
+|.|.|.+.+..+
T Consensus 82 sG~Y~C~~~~~~~ 94 (109)
T cd04983 82 SAVYFCALSESGG 94 (109)
T ss_pred CEEEEEEEecCCC
Confidence 9999999987653
No 184
>KOG4579|consensus
Probab=98.18 E-value=1.7e-07 Score=79.92 Aligned_cols=134 Identities=16% Similarity=0.242 Sum_probs=101.3
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
.+..|+|++++|-.+........+...|+..+|++|.+...++..-...+.++.|+|++|.|++++.+ |..++.|+.|+
T Consensus 28 E~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE-~Aam~aLr~lN 106 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEE-LAAMPALRSLN 106 (177)
T ss_pred HhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHH-HhhhHHhhhcc
Confidence 56778888888877665443323566788889999999998876556777899999999999999877 99999999999
Q ss_pred eeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccccccccccccccc
Q psy10487 136 LNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHL 192 (610)
Q Consensus 136 Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 192 (610)
++.|.+...+.- +..|.+|..|+..+|.+..++-+.|- -..+-..++.++.+.+-
T Consensus 107 l~~N~l~~~p~v-i~~L~~l~~Lds~~na~~eid~dl~~-s~~~al~~lgnepl~~~ 161 (177)
T KOG4579|consen 107 LRFNPLNAEPRV-IAPLIKLDMLDSPENARAEIDVDLFY-SSLPALIKLGNEPLGDE 161 (177)
T ss_pred cccCccccchHH-HHHHHhHHHhcCCCCccccCcHHHhc-cccHHHHHhcCCccccc
Confidence 999999877653 44588899999999999988766432 22333345555555443
No 185
>cd05853 Ig6_Contactin-4 Sixth Ig domain of contactin-4. Ig6_Contactin-4: sixth Ig domain of the neural cell adhesion molecule contactin-4. Contactins are neural cell adhesion molecules, and are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. Highest expresson of contactin-4 is in testes, thyroid, small intestine, uterus and brain. Contactin-4 plays a role in the response of neuroblastoma cells to differentiating agents, such as retinoids. The contactin 4 gene is associated with cerebellar degeneration in spinocerebellar ataxia type 16.
Probab=98.17 E-value=1.7e-06 Score=69.49 Aligned_cols=40 Identities=13% Similarity=0.057 Sum_probs=36.8
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecccccC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQ 460 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~ 460 (610)
..+.|.|.+++..|+|.|+|.|+|.+++...++.|+|..+
T Consensus 45 ~~~~L~I~nv~~~dsG~YtC~a~n~~~~~~a~a~L~V~~p 84 (85)
T cd05853 45 SAGDLMIRSIQLKHAGKYVCMVQTSVDKLSAAADLIVRGP 84 (85)
T ss_pred CCCcEEEecCCHHHCEEEEEEEEcccCceEEEEEEEEecC
Confidence 4568999999999999999999999999999999998864
No 186
>cd05735 Ig8_DSCAM Eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig8_DSCAM: the eight immunoglobulin (Ig) domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=98.17 E-value=5.9e-07 Score=73.15 Aligned_cols=39 Identities=26% Similarity=0.180 Sum_probs=35.6
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeecccccCC
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQP 461 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~p 461 (610)
..|.|.++..+|+|.|+|.|.|..|+.+..+.|.|.+.|
T Consensus 47 s~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~L~V~~~P 85 (88)
T cd05735 47 STLQILPTVREDSGFFSCHAINSYGEDRGIIQLTVQEPP 85 (88)
T ss_pred EEEEECCCCcccCEEEEEEEEcCCCcceEEEEEEEeCCC
Confidence 579999999999999999999999999999999988643
No 187
>cd07705 Ig2_Necl-1 Second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig2_Necl-1: second immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). These nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 and Necl-2 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue and is important to the formation of synapses, axon bundles, and myel
Probab=98.17 E-value=2.4e-05 Score=62.74 Aligned_cols=68 Identities=24% Similarity=0.350 Sum_probs=50.4
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCC-ceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGD-ALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~-~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
+.|.|.+.| +|.+.|+|+++|..+..... ....+++ +.+..++.|.|......|...|+|+|.+....
T Consensus 2 ~~LtC~a~g~~P~~~ItW~k~g~~l~~~~~--~~~~~~~~~t~~~~s~l~~~~~~~d~g~~~tC~v~h~~l~ 71 (83)
T cd07705 2 AKLRCTSSGSKPAANIKWRKGDQELEGAPT--SVLEDGNGKTFTVSSSVEFQVTREDDGAEITCSVGHESLH 71 (83)
T ss_pred EEEEEEecCccCCCEeEEEECCEECCCcce--eEEECCCCCEEEEEEEEEEEecchhCCCEEEEEEECcccC
Confidence 689999986 59999999999998865432 2222222 35566778888766777788999999998754
No 188
>cd05864 Ig2_VEGFR-2 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). Ig2_VEGF-2: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 2 (VEGFR-2). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-2 (KDR/Flk-1) is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF-A also interacts with VEGFR-1, which it binds more strongly than VEGFR-2. VEGFR-2 and -1 may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=98.15 E-value=2.1e-06 Score=66.35 Aligned_cols=35 Identities=11% Similarity=-0.082 Sum_probs=29.8
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
+..|.|.++..+|+|.|+|.|.|..|+.+....+.
T Consensus 33 ~~~L~I~~v~~~D~G~YtC~a~N~~G~~~~~~t~~ 67 (70)
T cd05864 33 GVHLTIYEVTEKDAGNYTVVLTNPITKEEQRHTFQ 67 (70)
T ss_pred CCEEEECcCCHHHCEEEEEEEEECCCceeeEEEEE
Confidence 45799999999999999999999999777655543
No 189
>cd05745 Ig3_Peroxidasin Third immunoglobulin (Ig)-like domain of peroxidasin. Ig3_Peroxidasin: the third immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells which have undergone programmed cell death, and protection of the organism against non-self.
Probab=98.14 E-value=2.9e-06 Score=66.54 Aligned_cols=37 Identities=14% Similarity=0.122 Sum_probs=33.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|.|.|..|+.+..++|.|
T Consensus 38 ~~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~L~V 74 (74)
T cd05745 38 SSGTLRISRVALHDQGQYECQAVNIVGSQRTVAQLTV 74 (74)
T ss_pred cCCeEEEeeCCHHhCEEEEEEEEeCCCceeEEEEEeC
Confidence 4568999999999999999999999999999888764
No 190
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=98.14 E-value=1.6e-05 Score=67.57 Aligned_cols=84 Identities=18% Similarity=0.353 Sum_probs=54.9
Q ss_pred cCceEEEEEEEEecC----------CCeEEEEeC--CEEec--cCCccce-eecc--CCcee------eeeeEEEEEecC
Q psy10487 274 AGGNVTMSCYVYGDP----------EPTILWLLN--GQVLH--NSSFDLL-EEEE--GDALF------EKSVSITLFNVT 330 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P----------~p~v~W~~~--g~~l~--~~~~~~~-~~~~--~~~~~------~~~~~L~I~~v~ 330 (610)
.|++++|.|.....+ ...|.|+|. +.... ....... .... ++..+ .....|+|.+++
T Consensus 1 ~G~~V~LpC~~~~~~~~~~~~~~~~~~~i~W~k~~~~~~~~v~~~~~~~~~~~~~f~gR~~~~~~~~~~~~asL~I~~l~ 80 (110)
T cd05878 1 LSSSVLLPCYFTLPPALPPPSNAPESPRIKWTKLSGQKEVTVLVAQDGVVKVGQEYQGRVSLPNYPENRGDASLEISRLR 80 (110)
T ss_pred CCCCEEEeeEeeCCccccccccCCCCCEEEEEEecCCCcEEEEEEECCEEEecccccCeEEeccCCCCCCcEEEEECCCC
Confidence 388999999997654 256999994 22211 0000000 0000 11011 133689999999
Q ss_pred CCCCeEEEEEeecCCcceeEEEEEEcC
Q psy10487 331 DLDAGEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 331 ~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
.+|+|.|.|.+....+..+..+.|.|.
T Consensus 81 ~sD~G~Y~C~v~~~~~~~~~~v~l~V~ 107 (110)
T cd05878 81 SSDSGVYRCEVMHGIEDEQDTVPLEVT 107 (110)
T ss_pred hhhCEEEEEEEEeCCCcceEEEEEEEE
Confidence 999999999999977788888888884
No 191
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=98.13 E-value=1.7e-05 Score=68.13 Aligned_cols=90 Identities=22% Similarity=0.395 Sum_probs=54.2
Q ss_pred ecceEeecCceEEEEEEEEecC----CCeEEEEeC----CEE--eccCCccceeecc----CCc-----eeeeeeEEEEE
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDP----EPTILWLLN----GQV--LHNSSFDLLEEEE----GDA-----LFEKSVSITLF 327 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P----~p~v~W~~~----g~~--l~~~~~~~~~~~~----~~~-----~~~~~~~L~I~ 327 (610)
+..+.+.+|++++|.|.....+ ...|.|++. +.. +............ ++. .......|.|.
T Consensus 5 ~~~v~~~~G~~v~L~C~~s~~~~~~~~~~i~W~~~~~~~~~~~~v~~~~~~~~~~~~~~f~~R~~~~~~~~~~~~sL~I~ 84 (115)
T cd05880 5 SKEVEAVNGTDVRLKCTFSSSAPIGDTLVITWNFRPLDGGREESVFYYHKRPYPPPDGRFKGRVVWDGNIMRRDASILIW 84 (115)
T ss_pred CceEEEEcCCCEEEEEEEEeCCCCCCcEEEEEEEECCCCCceeEEEEECCCccccCcccccCeEEEecCCcCCceEEEEe
Confidence 5677889999999999986543 246999751 211 1100000000000 000 00124579999
Q ss_pred ecCCCCCeEEEEEeecCCcce--eEEEEEEc
Q psy10487 328 NVTDLDAGEYTCYAENIRGNA--SGEISLDL 356 (610)
Q Consensus 328 ~v~~~D~G~Y~C~a~N~~G~~--~~~~~L~V 356 (610)
+++.+|+|.|+|.+.|..+.. ...+.|.|
T Consensus 85 ~v~~~D~G~Y~C~v~~~~~~~~~~~~~~~~~ 115 (115)
T cd05880 85 QLQPTDNGTYTCQVKNPPDVHGPIGEIRLRV 115 (115)
T ss_pred eCChhhCEEEEEEEEeCCCCCCCccEEEEeC
Confidence 999999999999999977642 34555543
No 192
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=98.12 E-value=1.5e-05 Score=66.24 Aligned_cols=81 Identities=19% Similarity=0.291 Sum_probs=51.9
Q ss_pred ceEEEEEEEEecC---CCeEEEEeCCEE----eccC--Cccceeecc--CCceee----eeeEEEEEecCCCCCeEEEEE
Q psy10487 276 GNVTMSCYVYGDP---EPTILWLLNGQV----LHNS--SFDLLEEEE--GDALFE----KSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 276 ~~v~l~C~~~g~P---~p~v~W~~~g~~----l~~~--~~~~~~~~~--~~~~~~----~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
++|+|.|...+.+ ...|.|+|.... +... ......... ++..+. ....|+|.+++.+|+|.|.|.
T Consensus 1 ~~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~R~~~~~~~~~~~sL~I~~v~~~D~G~Y~C~ 80 (98)
T cd05718 1 ESVTLECSFPVPGPVQITQVTWMKITGGSKQNIAVFHPQYGISIPPSYEGRVSFLNSSLEDATISISNLRLEDEGNYICE 80 (98)
T ss_pred CCEEEEeEeeCCCCceEEEEEEeeECCCCCEEEEEEecCCCcccCcCcCceEEEeCCCCCceEEEEccCCcccCEEEEEE
Confidence 4689999987754 447999995421 1000 000000000 000011 346999999999999999999
Q ss_pred eec-CCcceeEEEEEEc
Q psy10487 341 AEN-IRGNASGEISLDL 356 (610)
Q Consensus 341 a~N-~~G~~~~~~~L~V 356 (610)
+.+ ..|...+.+.|.|
T Consensus 81 v~~~~~g~~~~~~~l~V 97 (98)
T cd05718 81 FATFPQGNRQKVTTLTV 97 (98)
T ss_pred EEeCCCCcEEEEEEEEe
Confidence 875 6788888888877
No 193
>cd04974 Ig3_FGFR Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig3_FGFR: third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs.
Probab=98.12 E-value=3.1e-06 Score=69.26 Aligned_cols=36 Identities=14% Similarity=-0.039 Sum_probs=32.7
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.+++.+|+|.|+|.|.|+.|....++.|.|
T Consensus 54 ~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~sa~L~V 89 (90)
T cd04974 54 SEVLYLRNVSFDDAGEYTCLAGNSIGPSHHSAWLTV 89 (90)
T ss_pred cceEEEeccccccCcEEEEEeecccCcccCCEEEEe
Confidence 347899999999999999999999999999888876
No 194
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=98.12 E-value=2.2e-06 Score=104.26 Aligned_cols=78 Identities=23% Similarity=0.534 Sum_probs=69.5
Q ss_pred ccccccccccCcccccCCCcccEEecCCCcccccCCchhhHHHHhhccC---CCCCCCCCCCCccCCCcccccccccccC
Q psy10487 183 NLNGNRLKHLSESVFFPTPNLKTLSLDGNPWCCDCHLRSFRNWLLKSKL---YSHPLSCTEPGMLQTKHWDDVKAQEFAC 259 (610)
Q Consensus 183 ~L~~n~l~~~~~~~~~~~~~L~~l~l~~N~~~c~c~l~~~~~~l~~~~l---~~~~~~C~a~~~l~g~~~~~v~~~~~~c 259 (610)
||++|+|+.++...|..+.+|+.|+|++|+|.|||++.||..|++..+. ....+.|..|..++++.+.++...++.|
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~CDC~L~WL~~WL~~~~v~v~~~~~i~CasP~~LrG~~L~~l~~~d~~C 80 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFECDCGLARLPRWAEEKGVKVRQPEAALCAGPGALAGQPLLGIPLLDSGC 80 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccccccccHHHHHHHHhcCccccCCcccCCCCChHHCCCCcccCCcccCCC
Confidence 6889999999999999999999999999999999999999999987653 3456889999999999999998887777
Q ss_pred C
Q psy10487 260 P 260 (610)
Q Consensus 260 ~ 260 (610)
.
T Consensus 81 ~ 81 (2740)
T TIGR00864 81 D 81 (2740)
T ss_pred C
Confidence 5
No 195
>cd05725 Ig3_Robo Third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig3_Robo: domain similar to the third immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=98.10 E-value=3.3e-06 Score=65.21 Aligned_cols=37 Identities=22% Similarity=0.207 Sum_probs=33.1
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|.|+|.|.|..|..+..+.|.|
T Consensus 33 ~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 69 (69)
T cd05725 33 DDKSLKIRNVTAGDEGSYTCEAENMVGKIEASASLTV 69 (69)
T ss_pred eCCEEEECcCChhHCEEEEEEEEcCCCcEEEEEEEEC
Confidence 4567999999999999999999999999998887754
No 196
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=98.09 E-value=9.5e-06 Score=69.13 Aligned_cols=81 Identities=20% Similarity=0.260 Sum_probs=52.6
Q ss_pred eeecceEeecCceEEEEEEEEecCCCeEEEEeCC--EEec----cCCccceee---ccCCcee----eeeeEEEEEecCC
Q psy10487 265 IKESMVIREAGGNVTMSCYVYGDPEPTILWLLNG--QVLH----NSSFDLLEE---EEGDALF----EKSVSITLFNVTD 331 (610)
Q Consensus 265 ~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g--~~l~----~~~~~~~~~---~~~~~~~----~~~~~L~I~~v~~ 331 (610)
..|..+.+.+|++++|.|.+.+ +.+.+.|+|.. .... ......... ..++... .....|.|.+++.
T Consensus 3 Q~p~~~~v~~G~~v~l~C~~~~-~~~~v~Wykq~~g~~~~~l~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~L~I~~~~~ 81 (110)
T cd05899 3 QSPRYLIKGRGQSVTLRCSQTS-GHDNMYWYRQDPGKGLQLLFYSNGGSLNEEEGDPKDRFSASRPSLTRSSLTIKSAEP 81 (110)
T ss_pred ECCCceEEcCCCcEEEEEEECC-CCCEEEEEEECCCCCcEEEEEEcCCCceEecCccCCceEEECcCCCccEEEECCCCh
Confidence 4567788999999999999988 77899999842 1110 000000000 0010000 1235899999999
Q ss_pred CCCeEEEEEeecCCc
Q psy10487 332 LDAGEYTCYAENIRG 346 (610)
Q Consensus 332 ~D~G~Y~C~a~N~~G 346 (610)
+|+|.|.|.+.+..|
T Consensus 82 ~Dsg~Y~Ca~~~~~~ 96 (110)
T cd05899 82 EDSAVYLCASSLGGG 96 (110)
T ss_pred hhCEEEEEEeeCCCC
Confidence 999999999987543
No 197
>cd04970 Ig6_Contactin_like Sixth Ig domain of contactin. Ig6_Contactin_like: Sixth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=98.09 E-value=3.1e-06 Score=68.43 Aligned_cols=41 Identities=10% Similarity=0.072 Sum_probs=36.8
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccC
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQ 460 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~ 460 (610)
...+.|.|.+++.+|+|.|+|.|.|..|..+.++.|.|..+
T Consensus 44 ~~~~~L~I~~v~~~D~G~Y~C~a~n~~g~~~~~~~l~V~~p 84 (85)
T cd04970 44 DSNGDLMIRNAQLKHAGKYTCTAQTVVDSLSASADLIVRGP 84 (85)
T ss_pred cccceEEEccCCHHhCeeeEEEEecCCCcEEEEEEEEEECC
Confidence 34668999999999999999999999999999999988764
No 198
>cd05763 Ig_1 Subgroup of the immunoglobulin (Ig) superfamily. Ig_1: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=98.08 E-value=4.3e-06 Score=65.75 Aligned_cols=38 Identities=13% Similarity=0.165 Sum_probs=33.7
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..+..|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 37 ~~~~~L~I~~~~~~D~G~Y~C~A~N~~G~~~~~~~l~V 74 (75)
T cd05763 37 PEDDVFFIVDVKIEDTGVYSCTAQNTAGSISANATLTV 74 (75)
T ss_pred cCCCEEEEeeCCcccCEEEEEEEEcCCCEEEeeEEEEE
Confidence 34567999999999999999999999999998888866
No 199
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A.
Probab=98.07 E-value=9.1e-06 Score=71.29 Aligned_cols=117 Identities=21% Similarity=0.385 Sum_probs=76.8
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEE
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLY 135 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~ 135 (610)
+|+.+.+.. .+..+....|. ++.+|+.+.+.++ +..+...+|.++.+|+.+.+.+ .+..+....|....+|+.+.
T Consensus 13 ~l~~i~~~~-~~~~I~~~~F~--~~~~l~~i~~~~~-~~~i~~~~F~~~~~l~~i~~~~-~~~~i~~~~F~~~~~l~~i~ 87 (129)
T PF13306_consen 13 NLESITFPN-TIKKIGENAFS--NCTSLKSINFPNN-LTSIGDNAFSNCKSLESITFPN-NLKSIGDNAFSNCTNLKNID 87 (129)
T ss_dssp T--EEEETS-T--EE-TTTTT--T-TT-SEEEESST-TSCE-TTTTTT-TT-EEEEETS-TT-EE-TTTTTT-TTECEEE
T ss_pred CCCEEEECC-CeeEeChhhcc--ccccccccccccc-ccccceeeeecccccccccccc-cccccccccccccccccccc
Confidence 688888874 68889999998 7889999999875 9999999999998999999976 78888888999999999999
Q ss_pred eeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccc
Q psy10487 136 LNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALE 180 (610)
Q Consensus 136 Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 180 (610)
+..+ +..+....|.+. .|+.+.+.. .+..+....|.++.+|+
T Consensus 88 ~~~~-~~~i~~~~f~~~-~l~~i~~~~-~~~~i~~~~F~~~~~l~ 129 (129)
T PF13306_consen 88 IPSN-ITEIGSSSFSNC-NLKEINIPS-NITKIEENAFKNCTKLK 129 (129)
T ss_dssp ETTT--BEEHTTTTTT--T--EEE-TT-B-SS----GGG------
T ss_pred cCcc-ccEEchhhhcCC-CceEEEECC-CccEECCccccccccCC
Confidence 9876 888888889997 999999876 77778778888776663
No 200
>cd05867 Ig4_L1-CAM_like Fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig4_L1-CAM_like: fourth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM.
Probab=98.07 E-value=5.6e-06 Score=65.28 Aligned_cols=38 Identities=13% Similarity=0.178 Sum_probs=34.2
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAM 458 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 458 (610)
.++.|.|.+++.+|+|.|+|.|.|..|.....+.|.|+
T Consensus 39 ~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 76 (76)
T cd05867 39 SSGALILTDVQPSDTAVYQCEARNRHGNLLANAHVHVV 76 (76)
T ss_pred eCCEEEECCCChhhCEEEEEEEECCCCeEEEEEEEEEC
Confidence 45689999999999999999999999999998888763
No 201
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=98.05 E-value=3.3e-05 Score=66.46 Aligned_cols=91 Identities=22% Similarity=0.359 Sum_probs=54.4
Q ss_pred eecceEeecCceEEEEEEEEecC----CCeEEEEeCCE------EeccCCccceee-ccC----Cce-----eeeeeEEE
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDP----EPTILWLLNGQ------VLHNSSFDLLEE-EEG----DAL-----FEKSVSIT 325 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P----~p~v~W~~~g~------~l~~~~~~~~~~-~~~----~~~-----~~~~~~L~ 325 (610)
.|..+.+.+|++++|.|...... ...+.|++... .+.......... ..+ +.. ......|+
T Consensus 4 ~p~~v~v~~G~~vtL~C~~s~~~~~~~~~~v~W~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~sL~ 83 (116)
T cd05715 4 TPREVYAVNGSDVRLKCTFSSSEPISDDISVTWSFQPEGSGDTESIFHYHKGPYYPLKDGRFKDRVEWVGNPSRKDASIV 83 (116)
T ss_pred cCCeEEEEcCCCeEEEeEEeCCCCcCCceEEEEEEecCCCCCcEEEEEEcCCccccccCccccCcEEEecCCcCCeeEEE
Confidence 35677888999999999986532 25699987321 111000000000 000 000 01236899
Q ss_pred EEecCCCCCeEEEEEeecCCcce--eEEEEEEc
Q psy10487 326 LFNVTDLDAGEYTCYAENIRGNA--SGEISLDL 356 (610)
Q Consensus 326 I~~v~~~D~G~Y~C~a~N~~G~~--~~~~~L~V 356 (610)
|.+++.+|+|.|.|.+.|.-+.. ..++.|.|
T Consensus 84 I~~v~~~D~G~Y~C~v~~~~~~~~~~~~~~~~~ 116 (116)
T cd05715 84 IHNLQFTDNGTYTCDVKNPPDIVGKPGEIRLRV 116 (116)
T ss_pred EeeCCcccCEEEEEEEEeCCCCCCCccEEEEeC
Confidence 99999999999999999876542 23455543
No 202
>KOG4658|consensus
Probab=98.05 E-value=3e-06 Score=97.02 Aligned_cols=139 Identities=22% Similarity=0.288 Sum_probs=110.9
Q ss_pred CCCCccCccc-CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCC--CcccchhhhcCCCCCcEEEccCCC-CCC
Q psy10487 44 ANFTALPSTL-DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSG--IREVHRDTFKYLTILVEVDLSDNQ-IAW 119 (610)
Q Consensus 44 ~~l~~lP~~l-~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~--l~~i~~~~f~~l~~L~~LdLs~n~-l~~ 119 (610)
.++.++|... ...++.+.+.+|.+..+.... ..++|+.|-+..|. +..+....|..++.|+.|||++|. +..
T Consensus 511 ~~~~~~~~~~~~~~~rr~s~~~~~~~~~~~~~----~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~ 586 (889)
T KOG4658|consen 511 VGLSEIPQVKSWNSVRRMSLMNNKIEHIAGSS----ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSK 586 (889)
T ss_pred cCccccccccchhheeEEEEeccchhhccCCC----CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCc
Confidence 4666777544 347899999999988777544 45589999999996 788888889999999999999875 444
Q ss_pred CCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccccccccccc
Q psy10487 120 LHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNR 188 (610)
Q Consensus 120 l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 188 (610)
+ |..++.+-+|++|+|++..+.+++. .+.+|..|.+|++..+.-....+..+..+.+|+.|.+....
T Consensus 587 L-P~~I~~Li~LryL~L~~t~I~~LP~-~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 587 L-PSSIGELVHLRYLDLSDTGISHLPS-GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred C-ChHHhhhhhhhcccccCCCccccch-HHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 4 4678899999999999999998866 58889999999998876544546666778999999887654
No 203
>cd05869 Ig5_NCAM-1 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig5_NCAM-1: The fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM) and heterophilic (NCAM-non-NCAM) interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (tr
Probab=98.04 E-value=1e-06 Score=73.28 Aligned_cols=35 Identities=17% Similarity=-0.067 Sum_probs=31.8
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
+.|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 63 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 97 (97)
T cd05869 63 SSLTLKYIQYTDAGEYLCTASNTIGQDSQSMYLEV 97 (97)
T ss_pred EEEEEecCccCcCEEEEEEEecCCCCeeEEEEEEC
Confidence 57999999999999999999999999998887754
No 204
>cd07698 IgC_MHC_I_alpha3 Class I major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_I_alpha3; Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class I alpha chain. Class I MHC proteins bind antigenic peptide fragments and present them to CD8+ T lymphocytes. Class I molecules consist of a transmembrane alpha chain and a small chain called the beta2 microglobulin. The alpha chain contains three extracellular domains, two of which fold together to form the peptide-binding cleft (alpha1 and alpha2), and one which has an Ig fold (alpha3). Peptide binding to class I molecules occurs in the endoplasmic reticulum (ER) and involves both chaperones and dedicated factors to assist in peptide loading. Class I MHC molecules are expressed on most nucleated cells.
Probab=98.02 E-value=4.6e-05 Score=62.65 Aligned_cols=81 Identities=23% Similarity=0.394 Sum_probs=52.7
Q ss_pred CCceeeeecceEeecCceEEEEEEEEec-CCC-eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGD-PEP-TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEY 337 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~-P~p-~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y 337 (610)
+|.+.+...... ++.++|.|.+.|. |.. .++|.++|..............++++.+...+.|.|.. .|.+.|
T Consensus 2 pP~v~v~~~~~~---~~~~~L~C~a~gF~P~~i~v~W~~~g~~~~~~~~~~~~~~~~d~ty~~~s~l~v~~---~~~~~y 75 (93)
T cd07698 2 PPEVRVTRKRAP---DGSLTLSCHATGFYPRDIEVTWLRDGEDSVDDVESGEILPNGDGTYQLWVTLEVPP---EDKARY 75 (93)
T ss_pred CCEEEEEecCCC---CCcEEEEEEEEEEeCCCcEEEEEECCEECcccccccceEECCCCeEEEEEEEEECC---CCCCEE
Confidence 566665554332 6789999999996 544 89999999643332221222334444556666777654 478999
Q ss_pred EEEeecCCc
Q psy10487 338 TCYAENIRG 346 (610)
Q Consensus 338 ~C~a~N~~G 346 (610)
+|++.+..-
T Consensus 76 tC~V~H~~~ 84 (93)
T cd07698 76 SCRVEHSGL 84 (93)
T ss_pred EEEEEeCCC
Confidence 999987653
No 205
>cd05748 Ig_Titin_like Immunoglobulin (Ig)-like domain of titin and similar proteins. Ig_Titin_like: immunoglobulin (Ig)-like domain found in titin-like proteins. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic, depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone. It appears to function similarly to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching. Within the sarcomere, titin is also attached to or is associated with myosin binding protein C (MyBP-C). MyBP-C appears to contribute to the generation of passive tension by titin, and similar to titin has repeated Ig-like and FN-
Probab=98.00 E-value=8e-06 Score=64.01 Aligned_cols=38 Identities=5% Similarity=-0.073 Sum_probs=33.5
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
+....|.|.+++.+|+|.|+|.|.|..|+++..+.|.|
T Consensus 37 ~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 74 (74)
T cd05748 37 ASSTSLVIKNAERSDSGKYTLTLKNPAGEKSATINVKV 74 (74)
T ss_pred CCeEEEEECCCCcCcCEEEEEEEECCCccEEEEEEEEC
Confidence 34568999999999999999999999999998887754
No 206
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=98.00 E-value=5.7e-05 Score=64.12 Aligned_cols=38 Identities=26% Similarity=0.433 Sum_probs=34.6
Q ss_pred eeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCc
Q psy10487 321 SVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 321 ~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
..+|.|.+++.+|+|.|.|.+.+.......++.|.|..
T Consensus 78 ~asL~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V~G 115 (117)
T cd05901 78 DASLTIVKLRASDAGVYRCEVMHGIEDTQDTVSLDVSG 115 (117)
T ss_pred ceEEEEcccccccCEEEEEEEEECCcccEEEEEEEEEE
Confidence 46999999999999999999999998899999998853
No 207
>cd05755 Ig2_ICAM-1_like Second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ ICAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of intercellular cell adhesion molecule-1 (ICAM-1, CD54). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. ICAM-1 may be involved in organ targeted tumor metastasis. The interaction of ICAM-1 with leukocyte function-associated antigen-1 (LFA-1) plays a part in leukocyte-endothelial cell recognition. This group also contains ICAM-2, which also interacts with LFA-1. Transmigration of immature dendritic cells across resting endothelium is dependent on the interaction of ICAM-2 with, yet unidentified, ligand(s) on the dendritic cells. ICAM-1 has five Ig-like domains and ICAM-2 has two. ICAM-1 may also act as host receptor for viruses and parasites.
Probab=98.00 E-value=3.8e-05 Score=63.42 Aligned_cols=81 Identities=22% Similarity=0.344 Sum_probs=55.2
Q ss_pred ceeeeecceEeecCceEEEEEEEEe-cCCCe--EEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCe-EE
Q psy10487 262 NVTIKESMVIREAGGNVTMSCYVYG-DPEPT--ILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAG-EY 337 (610)
Q Consensus 262 ~i~~~~~~~~v~~G~~v~l~C~~~g-~P~p~--v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G-~Y 337 (610)
.+...+....+.+|+.++|.|.+.| .|.+. |.|++++..+....... ..........+|.+. +..+|.| .|
T Consensus 3 ~V~l~~~p~~~~eG~~~tL~C~v~g~~P~a~L~i~W~rG~~~l~~~~~~~----~~~~~~~~~stlt~~-~~r~D~g~~~ 77 (100)
T cd05755 3 SVELSPLPSWQPVGKNYTLQCDVPGVAPRQNLTVVLLRGNETLSRQPFGD----NTKSPVNAPATITIT-VDREDHGANF 77 (100)
T ss_pred eEEEecCCCcccCCCcEEEEEEEcCcCCCCcEEEEEeeCCEEcccceecc----ccCCCceeEEEEEEe-cchhhCCcEE
Confidence 3455566666789999999999975 68886 79999999886543211 001112344567765 4556655 89
Q ss_pred EEEeecCCcc
Q psy10487 338 TCYAENIRGN 347 (610)
Q Consensus 338 ~C~a~N~~G~ 347 (610)
+|+|++..+.
T Consensus 78 sC~A~l~l~~ 87 (100)
T cd05755 78 SCETELDLRP 87 (100)
T ss_pred EEEEEeccCc
Confidence 9999987654
No 208
>cd05884 Ig2_Necl-3 Second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig2_Necl-3: second immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-3 has been shown to accumulate in tissues of the central and peripheral nervous system, where it is expressed in ependymal cells and myelinated axons. It is observed at the interface between the axon shaft and the myelin sheath. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.99 E-value=4.4e-05 Score=61.14 Aligned_cols=69 Identities=20% Similarity=0.384 Sum_probs=50.0
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
++|.|.+.| +|...|+|++||..+..... .......++.+..++.|.+..-...|...|+|+|.+..-.
T Consensus 2 ~~LtC~a~gf~P~~~itW~kng~~l~~~~~-~~~~~~~~~t~~~~s~L~~~~~~~d~g~~ytC~v~h~~l~ 71 (83)
T cd05884 2 MQLTCKTSGSKPAADIRWFKNDKEIKDVKY-LKEEDANRKTFTVSSTLDFRVDRSDDGVAIICRVDHESLN 71 (83)
T ss_pred EEEEEEeCCccCCCEEEEEECCEECcCcee-eEeeCCCCCEEEEEEEEEEEcccccCCCEEEEEEechhcC
Confidence 689999986 78889999999999764332 1222233445667788888765566677999999987643
No 209
>cd05746 Ig4_Peroxidasin Fourth immunoglobulin (Ig)-like domain of peroxidasin. Ig4_Peroxidasin: the fourth immunoglobulin (Ig)-like domain in peroxidasin. Peroxidasin has a peroxidase domain and interacting extracellular motifs containing four Ig-like domains. It has been suggested that peroxidasin is secreted, and has functions related to the stabilization of the extracellular matrix. It may play a part in various other important processes such as removal and destruction of cells, which have undergone programmed cell death, and protection of the organism against non-self.
Probab=97.99 E-value=6.9e-06 Score=63.41 Aligned_cols=35 Identities=14% Similarity=0.006 Sum_probs=31.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeec
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 455 (610)
.++.|.|.+++.+|+|.|+|.|.|..|.++.+.+|
T Consensus 34 ~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~L 68 (69)
T cd05746 34 PEGYLAIRDVGVADQGRYECVARNTIGYASVSMVL 68 (69)
T ss_pred CCCEEEECcCChhhCEEEEEEEECCCCcEEEEEEe
Confidence 35689999999999999999999999999887776
No 210
>cd05730 Ig3_NCAM-1_like Third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). Ig3_NCAM-1_like: domain similar to the third immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1,and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the
Probab=97.99 E-value=1.7e-06 Score=71.56 Aligned_cols=39 Identities=10% Similarity=0.107 Sum_probs=34.7
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAM 458 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 458 (610)
.....|.|.+++.+|+|.|+|.|.|..|..+..++|.|.
T Consensus 55 ~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 93 (95)
T cd05730 55 EDGSEMTILDVDKLDEAEYTCIAENKAGEQEAEIHLKVF 93 (95)
T ss_pred CCCCEEEECCCChhhCEEEEEEEEcCCCeEEEEEEEEEE
Confidence 344579999999999999999999999999999988775
No 211
>cd05731 Ig3_L1-CAM_like Third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). Ig3_L1-CAM_like: domain similar to the third immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains the chicken neuron-glia cell adhesion molecule, Ng-CAM and human neurofascin.
Probab=97.99 E-value=8.3e-06 Score=63.24 Aligned_cols=38 Identities=16% Similarity=0.065 Sum_probs=32.9
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..+..|.|.+++.+|+|.|+|.|.|..|..+....+.|
T Consensus 33 ~~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 70 (71)
T cd05731 33 NFNKTLKIDNVSEEDDGEYRCTASNSLGSARHTISVTV 70 (71)
T ss_pred cCCCEEEECCCCHHHCEEEEEEEEeCCceEEEEEEEEE
Confidence 34568999999999999999999999999888777654
No 212
>cd05868 Ig4_NrCAM Fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). Ig4_ NrCAM: fourth immunoglobulin (Ig)-like domain of NrCAM (NgCAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six IG-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=97.98 E-value=8.8e-06 Score=64.18 Aligned_cols=38 Identities=5% Similarity=-0.007 Sum_probs=33.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAM 458 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 458 (610)
.++.|.|.+++.+|+|.|+|.|+|..|.+...+.|.|+
T Consensus 39 ~~~~l~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 76 (76)
T cd05868 39 DGDTIIFSKVQERSSAVYQCNASNEYGYLLANAFVNVL 76 (76)
T ss_pred cCCEEEECCCCHhhCEEEEEEEEcCCCEEEEEEEEEeC
Confidence 34578999999999999999999999999999888763
No 213
>cd05744 Ig_Myotilin_C_like Immunoglobulin (Ig)-like domain of myotilin, palladin, and myopalladin. Ig_Myotilin_like_C: immunoglobulin (Ig)-like domain in myotilin, palladin, and myopalladin. Myotilin, palladin, and myopalladin function as scaffolds that regulate actin organization. Myotilin and myopalladin are most abundant in skeletal and cardiac muscle; palladin is ubiquitously expressed in the organs of developing vertebrates and plays a key role in cellular morphogenesis. The three family members each interact with specific molecular partners: all three bind to alpha-actinin; in addition, palladin also binds to vasodilator-stimulated phosphoprotein (VASP) and ezrin, myotilin binds to filamin and actin, and myopalladin also binds to nebulin and cardiac ankyrin repeat protein (CARP).
Probab=97.98 E-value=9.2e-06 Score=63.87 Aligned_cols=34 Identities=12% Similarity=-0.090 Sum_probs=31.6
Q ss_pred ceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 424 KLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 424 ~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.|.|.+++.+|+|.|+|.|.|..|++...++|.|
T Consensus 42 ~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 75 (75)
T cd05744 42 CLLIQNANKEDAGWYTVSAVNEAGVVSCNARLDV 75 (75)
T ss_pred EEEECCCCcccCEEEEEEEEcCCCcEEEEEEEeC
Confidence 6999999999999999999999999999888754
No 214
>cd05747 Ig5_Titin_like M5, fifth immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins. Ig5_Titin_like: domain similar to the M5, fifth immunoglobulin (Ig)-like domain from the human titin C terminus. Titin (also called connectin) is a fibrous sarcomeric protein specifically found in vertebrate striated muscle. Titin is gigantic; depending on isoform composition it ranges from 2970 to 3700 kDa, and is of a length that spans half a sarcomere. Titin largely consists of multiple repeats of Ig-like and fibronectin type 3 (FN-III)-like domains. Titin connects the ends of myosin thick filaments to Z disks and extends along the thick filament to the H zone, and appears to function similar to an elastic band, keeping the myosin filaments centered in the sarcomere during muscle contraction or stretching.
Probab=97.98 E-value=1.6e-06 Score=71.23 Aligned_cols=35 Identities=9% Similarity=-0.070 Sum_probs=31.5
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
.+.|.|.++..+|+|.|+|.|+|..|..+..+.|+
T Consensus 58 ~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~ 92 (92)
T cd05747 58 KSTFEISKVQMSDEGNYTVVVENSEGKQEAQFTLT 92 (92)
T ss_pred eeEEEECCCCcccCEeEEEEEEcCCCCEeEEEEeC
Confidence 46899999999999999999999999998877763
No 215
>cd04978 Ig4_L1-NrCAM_like Fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). Ig4_L1-NrCAM_like: fourth immunoglobulin (Ig)-like domain of L1, Ng-CAM (Neuron-glia CAM cell adhesion molecule), and NrCAM (Ng-CAM-related). These proteins belong to the L1 subfamily of cell adhesion molecules (CAMs) and are comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. These molecules are primarily expressed in the nervous system. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=97.97 E-value=8.9e-06 Score=64.04 Aligned_cols=38 Identities=11% Similarity=0.020 Sum_probs=34.0
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..+..|.|.+++.+|+|.|+|.|.|..|.....+.|.|
T Consensus 38 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~V 75 (76)
T cd04978 38 VDGGTLILSNVQPNDTAVYQCNASNVHGYLLANAFVHV 75 (76)
T ss_pred ccCCEEEECCCChhhCEEEEEEEEccCCeEEEeEEEEE
Confidence 44578999999999999999999999999998888765
No 216
>cd04968 Ig3_Contactin_like Third Ig domain of contactin. Ig3_Contactin_like: Third Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=97.97 E-value=8.6e-06 Score=66.27 Aligned_cols=37 Identities=19% Similarity=0.042 Sum_probs=33.8
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|.|.|..|..+..+.|.|
T Consensus 51 ~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 87 (88)
T cd04968 51 SGAVLKIPNIQFEDEGTYECEAENIKGKDTHQGRIYV 87 (88)
T ss_pred eCCEEEECCCCcccCEEEEEEEEECCCcEEEEEEEEE
Confidence 4578999999999999999999999999999888865
No 217
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=97.96 E-value=6.7e-05 Score=62.21 Aligned_cols=36 Identities=25% Similarity=0.399 Sum_probs=32.9
Q ss_pred eeEEEEEecCCCCCeEEEEEeec-CCcceeEEEEEEc
Q psy10487 321 SVSITLFNVTDLDAGEYTCYAEN-IRGNASGEISLDL 356 (610)
Q Consensus 321 ~~~L~I~~v~~~D~G~Y~C~a~N-~~G~~~~~~~L~V 356 (610)
.++|.|.+++.+|+|.|+|.+.| ..|..++.+.|.|
T Consensus 62 daSi~i~nl~~~D~G~Y~C~v~t~P~g~~~~~~~L~V 98 (99)
T cd05886 62 DGTISLSRLELEDEGVYICEFATFPTGNRESQLNLTV 98 (99)
T ss_pred cceEEEcCCccccCEEEEEEEEeCCCCCeEEEEEEEE
Confidence 37999999999999999999999 7888888988887
No 218
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=97.96 E-value=7.4e-05 Score=59.19 Aligned_cols=76 Identities=18% Similarity=0.326 Sum_probs=51.6
Q ss_pred EEEEEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc-eeEEEEEE
Q psy10487 278 VTMSCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN-ASGEISLD 355 (610)
Q Consensus 278 v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~-~~~~~~L~ 355 (610)
+.|.|.+.| .|.+.|+|++++.++..... .....+ ..+...+.|.|..-...|...|+|+|.|..-. ......|.
T Consensus 2 ~~L~C~s~gSkP~A~I~W~k~~~~l~~~~~--~~~~~~-~~~t~~S~L~~~p~~eDdG~~~~C~a~~~~l~~~~~~~~L~ 78 (82)
T cd05883 2 IELNCTAMASKPAATIRWFKGNKELTGKST--VEETWS-RMFTVTSQLMLKVTKEDDGVPVICLVDHPAVKDLQTQRYLE 78 (82)
T ss_pred EEEEEEecCCCCCCEEEEEECCEECcCccc--ceeccC-CCcEEEEEEEEECchhhCCCEEEEEEcCcccCCceeeEEEE
Confidence 689999965 69999999999999865421 111111 12355678888666666666899999997532 34556665
Q ss_pred c
Q psy10487 356 L 356 (610)
Q Consensus 356 V 356 (610)
|
T Consensus 79 V 79 (82)
T cd05883 79 V 79 (82)
T ss_pred E
Confidence 5
No 219
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=97.96 E-value=2.4e-05 Score=66.63 Aligned_cols=94 Identities=21% Similarity=0.327 Sum_probs=59.0
Q ss_pred eeeeecceEeecCceEEEEEEEE-ecCCCeEEEEeCCE-----Eec-c-CCccc-eeecc--CCceee-----eeeEEEE
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVY-GDPEPTILWLLNGQ-----VLH-N-SSFDL-LEEEE--GDALFE-----KSVSITL 326 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~-g~P~p~v~W~~~g~-----~l~-~-~~~~~-~~~~~--~~~~~~-----~~~~L~I 326 (610)
+...+..+.+.+|+++.|.|... ......+.|++... .+. . ..... ..... ++..+. ...+|.|
T Consensus 4 vt~~~~~v~~~~G~~v~L~C~~~~~~~~~~v~W~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~i 83 (114)
T PF07686_consen 4 VTQPPSPVTVQEGESVTLPCSYSSSSNQSSVYWYRQSPGQGPQLIIRYSLSSTNETPTPSYSGRFTFSGNGSQNNFSLTI 83 (114)
T ss_dssp EEEEESEEEEETTSEEEEEEEEESSSSGSEEEEEEEETTSEEEEEEEEETTEEEEEEETTETTTEEEEEETTTTEEEEEE
T ss_pred EEEeCCeEEEecCCCEEEEEEEeCCCCcceEEEEEECccccceeeeeeccceeeeccccceeeeeeeeecccCCeEEEEE
Confidence 34457788999999999999998 55667899999322 111 0 00000 00000 111111 1347999
Q ss_pred EecCCCCCeEEEEEeecC-CcceeEEEEEEc
Q psy10487 327 FNVTDLDAGEYTCYAENI-RGNASGEISLDL 356 (610)
Q Consensus 327 ~~v~~~D~G~Y~C~a~N~-~G~~~~~~~L~V 356 (610)
.+++.+|+|.|.|.+... .+.....+.|.|
T Consensus 84 ~~l~~~DsG~Y~C~v~~~~~~~~~~~~~L~V 114 (114)
T PF07686_consen 84 KNLQPSDSGTYFCQVSTSNEQSFGNGTKLTV 114 (114)
T ss_dssp SSESGGGEEEEEEEEEESSEEEEEEEEEEEE
T ss_pred CCCCcCcCEEEEEEEEECCCCEECCcEEEEC
Confidence 999999999999999887 333445555554
No 220
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=97.95 E-value=3e-05 Score=64.34 Aligned_cols=84 Identities=20% Similarity=0.277 Sum_probs=55.1
Q ss_pred ecCceEEEEEEEEe-cCCCeEEEEeCCEEeccCCc----cceeeccC----Ccee-eeeeEEEEEecCCCCCeEEEEEee
Q psy10487 273 EAGGNVTMSCYVYG-DPEPTILWLLNGQVLHNSSF----DLLEEEEG----DALF-EKSVSITLFNVTDLDAGEYTCYAE 342 (610)
Q Consensus 273 ~~G~~v~l~C~~~g-~P~p~v~W~~~g~~l~~~~~----~~~~~~~~----~~~~-~~~~~L~I~~v~~~D~G~Y~C~a~ 342 (610)
..|++|+|.|.... .....+.|++....+..... ........ +..+ ...++|+|.+++.+|+|.|.|.+.
T Consensus 2 ~~G~sVtL~c~~~~~~~~~~v~W~~~~~~~i~~~~~~~~~~~~~~~~~f~~R~~~~~~~~sL~I~~~~~~DsG~Y~c~v~ 81 (97)
T cd05775 2 ILGGSVTLPLNIPDGTEIESITWSFNTSLAIITPGEETAPEIIVTDPSYKERVNFSQNDYSLQISNLKMEDAGSYRAEIN 81 (97)
T ss_pred ccCCeEEEeCCCCCCcEEEEEEEecCCEeEEEecCCCCCCccEEeCCCceeeEEecCCceeEEECCCchHHCEEEEEEEE
Confidence 36999999998754 45567999997543322111 11111111 1111 123689999999999999999999
Q ss_pred cCCcce-eEEEEEEc
Q psy10487 343 NIRGNA-SGEISLDL 356 (610)
Q Consensus 343 N~~G~~-~~~~~L~V 356 (610)
+..|.. ...+.|.|
T Consensus 82 ~~~~~~~~~~f~L~v 96 (97)
T cd05775 82 TKNGVTITKEFTLHI 96 (97)
T ss_pred cCCCCeEEEEEEEEe
Confidence 988764 56777765
No 221
>cd05855 Ig_TrkB_d5 Fifth domain (immunoglobulin-like) of Trk receptor TrkB. TrkB_d5: the fifth domain of Trk receptor TrkB, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors, which mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. The Trks are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkB shares significant sequence homology and domain organization with TrkA, and TrkC. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. In some cell systems NT-3 can activate TrkA and TrkB receptors. TrKB transcripts are found throughout multiple structures of the central and peripheral nervous systems.
Probab=97.95 E-value=4.1e-06 Score=66.23 Aligned_cols=34 Identities=12% Similarity=-0.181 Sum_probs=30.4
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeec
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 455 (610)
.+.|.|.+++.+|+|.|+|+|+|..|+++....+
T Consensus 43 ~~~L~i~~~~~~D~G~YtC~A~N~~G~~~~~~~~ 76 (79)
T cd05855 43 HGCLQLDNPTHLNNGIYTLVAKNEYGEDEKNVSA 76 (79)
T ss_pred EEEEEECCCCcccCEEEEEEEEcCCcccceEEEe
Confidence 4579999999999999999999999998877655
No 222
>cd05870 Ig5_NCAM-2 Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). Ig5_NCAM-2: the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-2 (also known as OCAM/mamFas II and RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=97.95 E-value=3e-06 Score=70.52 Aligned_cols=36 Identities=17% Similarity=0.027 Sum_probs=31.8
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 63 ~~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~~ 98 (98)
T cd05870 63 ESSLHIKDVKLSDSGRYDCEAASRIGGHQKSMYLDI 98 (98)
T ss_pred eeEEEEeeCCcCCCEEEEEEEeccCCcceeEEEEeC
Confidence 357999999999999999999999999888777653
No 223
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.93 E-value=2.2e-05 Score=66.08 Aligned_cols=76 Identities=24% Similarity=0.270 Sum_probs=49.4
Q ss_pred EeecCceEEEEEEEEec-CCCeEEEEeCCEE-----ecc-CCcc-c-eeeccCCcee-----eeeeEEEEEecCCCCCeE
Q psy10487 271 IREAGGNVTMSCYVYGD-PEPTILWLLNGQV-----LHN-SSFD-L-LEEEEGDALF-----EKSVSITLFNVTDLDAGE 336 (610)
Q Consensus 271 ~v~~G~~v~l~C~~~g~-P~p~v~W~~~g~~-----l~~-~~~~-~-~~~~~~~~~~-----~~~~~L~I~~v~~~D~G~ 336 (610)
.+.+|++++|.|.+.+. +...+.|++.... +.. .... . .....++... .....|+|.+++.+|+|.
T Consensus 2 ~v~~G~~v~L~C~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~r~~~~~~~~~~~~sL~I~~v~~~D~G~ 81 (105)
T cd00099 2 SVSEGESVTLSCTYSGSFSSYYIFWYRQKPGKGPELLIYISSNGSQYAGGVKGRFSGTRDSSKSSFTLTISSLQPEDSAV 81 (105)
T ss_pred eecCCCCEEEEEEEeCCcCcceEEEEEECCCCCCEEEEEEeCCCCccCccCCCcEEEEEeccCCEEEEEECCCCHHHCEE
Confidence 57789999999999886 7778999984321 110 0000 0 0000011001 123489999999999999
Q ss_pred EEEEeecCCc
Q psy10487 337 YTCYAENIRG 346 (610)
Q Consensus 337 Y~C~a~N~~G 346 (610)
|.|.+.+..+
T Consensus 82 Y~C~v~~~~~ 91 (105)
T cd00099 82 YYCAVSLSGG 91 (105)
T ss_pred EEEEEecCCC
Confidence 9999998775
No 224
>cd05773 Ig8_hNephrin_like Eighth immunoglobulin-like domain of nephrin. Ig8_hNephrin_like: domain similar to the eighth immunoglobulin-like domain in human nephrin. Nephrin is an integral component of the slit diaphragm, and is a central component of the glomerular ultrafilter. Nephrin plays a structural role, and has a role in signaling. Nephrin is a transmembrane protein having a short intracellular portion, and an extracellular portion comprised of eight Ig-like domains, and one fibronectin type III-like domain. The extracellular portions of nephrin, from neighboring foot processes of separate podocyte cells, may interact with each other, and in association with other components of the slit diaphragm, form a porous molecular sieve within the slit pore. The intracellular portion of nephrin is associated with linker proteins, which connect nephrin to the actin cytoskeleton. The intracellular portion is tyrosine phosphorylated, and mediates signaling from the slit diaphragm into the p
Probab=97.93 E-value=2.1e-06 Score=72.95 Aligned_cols=40 Identities=20% Similarity=0.191 Sum_probs=35.3
Q ss_pred ccceeeeeee-eccCcceeeeecCCCcceeeeeecccccCC
Q psy10487 422 EKKLLDVSIT-TTDRHTGSCEALGSQPDMELIEQSLAMEQP 461 (610)
Q Consensus 422 ~~~L~i~~v~-~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~p 461 (610)
.+.|.|.++. .+|.|.|+|.|.|..|.+++..+|.+.+.|
T Consensus 68 ~s~L~I~~v~~~~D~G~Y~C~A~N~~G~~~~~i~L~~~~~p 108 (109)
T cd05773 68 TSILTIINVSAALDYALFTCTAHNSLGEDSLDIQLVSTSRP 108 (109)
T ss_pred eeEEEECcCCccCCCEEEEEEEEeCCccCcEEEEEEecCCC
Confidence 3579999997 589999999999999999999999888754
No 225
>cd04971 Ig_TrKABC_d5 Fifth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d5: the fifth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrkB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor foun
Probab=97.92 E-value=1.3e-05 Score=63.89 Aligned_cols=35 Identities=9% Similarity=-0.223 Sum_probs=30.8
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
.+.|.|.+++.+|+|.|+|+|.|..|+++....+.
T Consensus 45 ~~~L~I~~~~~~D~G~YtC~A~N~~G~~~~~~~~~ 79 (81)
T cd04971 45 HGCLQFDNPTHVNNGNYTLVASNEYGQDSKSISAH 79 (81)
T ss_pred EEEEEECCCCcccCeEEEEEEEeCCCCeeeEEEee
Confidence 44799999999999999999999999988876653
No 226
>PF08205 C2-set_2: CD80-like C2-set immunoglobulin domain ; InterPro: IPR013162 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the C2-set type domains found in the T-cell antigen CD80, as well as in related proteins. CD80 (B7-1) is a glycoprotein expressed on antigen-presenting cells []. The shared ligands on CD80 and CD86 (B7-2) deliver the co-stimulatory signal through CD28 and CTLA-4 on T-cells, where CD28 augments the T-cell response and CTLA-4 attenuates it [].; PDB: 3S58_A 3O3U_N 3CJJ_A 3S59_A 2PF6_B 2PET_A 3ALP_A 3SKU_D 3U83_A 3U82_B ....
Probab=97.92 E-value=8.5e-05 Score=60.49 Aligned_cols=72 Identities=28% Similarity=0.437 Sum_probs=48.4
Q ss_pred CceEEEEEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 275 GGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 275 G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
|+.+.+.|.+ .|+|+|.|+|+.++..+...... ......++.+...+.|.+..-...+...++|.|.|..-.
T Consensus 14 ~~~~~~~C~s~~~~P~~~i~W~~~~~~~~~~~~~-~~~~~~~~~~~~~S~l~~~~~~~~~~~~~~C~~~~~~~~ 86 (89)
T PF08205_consen 14 GEEVTLTCSSSGGYPPPQITWYLDGGPVVASNTT-QSSSPDNGLFTVSSTLTLTPTREDHGKTLTCRASHPALS 86 (89)
T ss_dssp TEEEEEEEEEEEEBS-EEEEEEETTCEECEEEEE-EEEETTTTTEEEEEEEEEETTGGGTTEEEEEEEEETTCC
T ss_pred ceEEEEEEEeCCeECCeEEEEEECCCceeeeeee-eeeccCCCcceEEEEEEEEcChHHCCeEEEEEEECCccC
Confidence 7899999977 57899999999999887221111 112222334455567887655555667899999987644
No 227
>cd05726 Ig4_Robo Fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig4_Robo: domain similar to the fhird immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antagoni
Probab=97.92 E-value=1.1e-05 Score=65.95 Aligned_cols=39 Identities=13% Similarity=0.067 Sum_probs=35.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAME 459 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~ 459 (610)
.++.|.|.+++.+|+|.|+|.|.|..|.....+.|.|.+
T Consensus 45 ~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V~~ 83 (90)
T cd05726 45 QTGDLTITNVQRSDVGYYICQTLNVAGSILTKAYLEVTD 83 (90)
T ss_pred CCCeEEEeeCChhhCEEEEEEEEcCCCceEEEEEEEEee
Confidence 345799999999999999999999999999999988875
No 228
>smart00407 IGc1 Immunoglobulin C-Type.
Probab=97.92 E-value=7.6e-05 Score=58.59 Aligned_cols=68 Identities=26% Similarity=0.329 Sum_probs=48.5
Q ss_pred EEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 278 VTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 278 v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
++|.|.+.|. |+ ..++|++||..+...........++++.+..++.|.|......+...|+|++....
T Consensus 2 ~~L~C~a~gf~P~~i~v~W~k~g~~~~~~~~~~~~~~~~~gt~~~~s~L~v~~~~~~~~~~~tC~V~H~~ 71 (75)
T smart00407 2 ATLVCLVSGFYPPDITVTWLRNGQEVTSGVSTTDPLKNSDGTYFLSSYLTVSASTWESGDTYTCQVTHEG 71 (75)
T ss_pred eEEEEEEEeEeCCCCEEEEEECCEECCCCEEECceEECCCCCEEEEEEEEEccccCCCCCEEEEEEEEcC
Confidence 6899999986 54 58999999987543322211222345567778889887777777889999997654
No 229
>KOG1909|consensus
Probab=97.91 E-value=4.4e-06 Score=82.31 Aligned_cols=159 Identities=19% Similarity=0.225 Sum_probs=111.2
Q ss_pred CCccEEEeecCCCCCCChh----hhcccCCCCccEEEcccCCCc----cc------chhhhcCCCCCcEEEccCCCCCCC
Q psy10487 55 SDIQVLDLNNNKISYLTKE----AFKSIGLLNLQRIYLKNSGIR----EV------HRDTFKYLTILVEVDLSDNQIAWL 120 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~----~~~~~~l~~L~~L~L~~n~l~----~i------~~~~f~~l~~L~~LdLs~n~l~~l 120 (610)
..++.|+|++|.|..--.. .+. ..++|+..++++--.. ++ -..++.+.++|++||||+|.+..-
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~--~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLA--SKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHh--hcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 4789999999988642222 233 4557777777653211 11 134567778999999999988654
Q ss_pred Ccc----cccCCCCCcEEEeeCccccccCcC-------------cCCCCCCccEEEccCccccccCH----HHhhcCccc
Q psy10487 121 HQD----TFLGNDRLKVLYLNGNPITELRAG-------------QFPKLPYLKTIELQHCQIHSVHK----DALIHLTAL 179 (610)
Q Consensus 121 ~~~----~f~~l~~L~~L~Ls~N~l~~l~~~-------------~~~~l~~L~~L~L~~n~l~~~~~----~~~~~l~~L 179 (610)
... .+.....|++|+|++|.+...... ....-++|+.+...+|++-.... ..|...+.|
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 333 235568899999999987653322 23345789999999999877654 356667899
Q ss_pred ccccccccccccc----CcccccCCCcccEEecCCCcccc
Q psy10487 180 ESLNLNGNRLKHL----SESVFFPTPNLKTLSLDGNPWCC 215 (610)
Q Consensus 180 ~~L~L~~n~l~~~----~~~~~~~~~~L~~l~l~~N~~~c 215 (610)
+.+.++.|.|..- ....|..+++|+.|+|.+|.|+-
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~ 227 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTL 227 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhh
Confidence 9999999988632 23457788999999999998853
No 230
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=97.90 E-value=7.3e-05 Score=63.24 Aligned_cols=83 Identities=16% Similarity=0.213 Sum_probs=53.4
Q ss_pred CceEEEEEEEEecC-------CCeEEEEeCC-----EEe---ccCCccceeeccCCc--ee------eeeeEEEEEecCC
Q psy10487 275 GGNVTMSCYVYGDP-------EPTILWLLNG-----QVL---HNSSFDLLEEEEGDA--LF------EKSVSITLFNVTD 331 (610)
Q Consensus 275 G~~v~l~C~~~g~P-------~p~v~W~~~g-----~~l---~~~~~~~~~~~~~~~--~~------~~~~~L~I~~v~~ 331 (610)
|++++|.|...-.| .+.|.|.+-. ... ...+..........+ .+ ....+|.|.+++.
T Consensus 2 ~~~v~LpC~~~~~p~~~~~~~~~~I~W~k~~~~~~~~~~~v~v~~~~~~~~~~~y~gRvsl~~~~~~~~~asL~i~nv~~ 81 (110)
T cd05902 2 SSSVLLPCVFTLPPSASSPPEGPRIKWTKLRPASGQKQRPVLVARDNVVRVAKAFQGRVSLPGYPKNRYNASLVLSRLRY 81 (110)
T ss_pred CCcEEEeeEEEcCccccCCCCCCEEEEEEeCCCCCceEEEEEECCCCcEEEchhcccEEEeecCCCCCceEEEEECCCCH
Confidence 78899999976433 3789999841 111 001100001111111 11 1346999999999
Q ss_pred CCCeEEEEEeecCCcceeEEEEEEcC
Q psy10487 332 LDAGEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 332 ~D~G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
+|+|.|.|.+.......+..+.|.|.
T Consensus 82 ~D~G~Y~C~v~~g~~~~~~~v~L~V~ 107 (110)
T cd05902 82 SDSGTYRCEVVLGINDEQDTVPLEVT 107 (110)
T ss_pred HHCEEEEEEEEECCcccEEEEEEEEE
Confidence 99999999999977677888888874
No 231
>cd07699 IgC_L Immunoglobulin Constant domain. IgC_L: Immunoglobulin (Ig) light chain constant (C) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.90 E-value=4.3e-05 Score=63.69 Aligned_cols=86 Identities=23% Similarity=0.325 Sum_probs=57.5
Q ss_pred CCceeeeecce-EeecCceEEEEEEEEec-C-CCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeE
Q psy10487 260 PPNVTIKESMV-IREAGGNVTMSCYVYGD-P-EPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGE 336 (610)
Q Consensus 260 ~P~i~~~~~~~-~v~~G~~v~l~C~~~g~-P-~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~ 336 (610)
+|.+.+.+... ....++.++|.|.+.|. | ...|+|++||..+...........+.++.+..++.|.+..-...+...
T Consensus 1 pP~V~v~~p~~~~~~~~~~~~L~C~~~gfyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~ 80 (100)
T cd07699 1 APSVTIFPPSSEELEKSGKATLVCLINDFYPGFATVQWKVDGATVSSGVQTSTTEQQSDNTYSLSSYLTLTKSDWNKHKV 80 (100)
T ss_pred CCeEEEECCCHHHHccCCCcEEEEEEEeEECCCCEEEEEECCEECcccEeccccEECCCCCEEEEEEEEEcHHHhCCCCe
Confidence 35555544333 33457789999999984 5 457899999999864322222233345566777888876665556779
Q ss_pred EEEEeecCC
Q psy10487 337 YTCYAENIR 345 (610)
Q Consensus 337 Y~C~a~N~~ 345 (610)
|+|.+....
T Consensus 81 ~sC~V~H~~ 89 (100)
T cd07699 81 YTCEVTHEG 89 (100)
T ss_pred EEEEEEecC
Confidence 999998755
No 232
>cd05858 Ig3_FGFR-2 Third immunoglobulin (Ig)-like domain of fibroblast growth factor receptor 2 (FGFR2). Ig3_FGFR-2-like; domain similar to the third immunoglobulin (Ig)-like domain of human fibroblast growth factor receptor 2 (FGFR2). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for FGFs. FGFR2 is required for male sex determination.
Probab=97.90 E-value=1.1e-05 Score=65.98 Aligned_cols=35 Identities=17% Similarity=-0.063 Sum_probs=32.6
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..|.|.+++.+|+|.|+|+|.|..|....++.|.|
T Consensus 55 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~~~a~L~V 89 (90)
T cd05858 55 EVLYLRNVTFEDAGEYTCLAGNSIGISHHSAWLTV 89 (90)
T ss_pred eEEEEccCCHHHCEEEEEEEEeCCCcccceEEEEE
Confidence 57999999999999999999999999999888876
No 233
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=97.89 E-value=8.1e-05 Score=62.12 Aligned_cols=80 Identities=21% Similarity=0.386 Sum_probs=50.4
Q ss_pred eEEEEEEEEecC---CCeEEEEeC--CE---Eec--cCCccceeecc--CCcee-----eeeeEEEEEecCCCCCeEEEE
Q psy10487 277 NVTMSCYVYGDP---EPTILWLLN--GQ---VLH--NSSFDLLEEEE--GDALF-----EKSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 277 ~v~l~C~~~g~P---~p~v~W~~~--g~---~l~--~~~~~~~~~~~--~~~~~-----~~~~~L~I~~v~~~D~G~Y~C 339 (610)
+++|.|.....+ ...|.|+|. +. .+. ........... ++..+ ...+.|+|.+++.+|+|.|.|
T Consensus 2 ~v~L~C~~~~~~~~~~~~v~W~k~~~~~~~~~i~~~~~~~~~~~~~~~~~Rv~f~~~~~~~~~sL~I~nv~~sD~GtY~C 81 (100)
T cd05888 2 DTRLPCRYNVSDGETVVQVLWIRENAGGVEEEIALLHFKYGQTEFHAYEGRVRFETPNPIADGALILRNAVQADEGKYKC 81 (100)
T ss_pred CEEEEeEEecCCCCcEEEEEEEEccCCCCcEEEEEEeccCCcccCCCccCcEEEeCCCCCCceEEEEecCccccceEEEE
Confidence 589999986544 347999983 21 111 00000011111 11111 124689999999999999999
Q ss_pred Eeec-CCcceeEEEEEEc
Q psy10487 340 YAEN-IRGNASGEISLDL 356 (610)
Q Consensus 340 ~a~N-~~G~~~~~~~L~V 356 (610)
.+.+ ..|..++.+.|.|
T Consensus 82 ~v~~~p~g~~~~~~~L~V 99 (100)
T cd05888 82 RVITFPAGNFEAELVLTV 99 (100)
T ss_pred EEEeCCCCCeeeEEEEEe
Confidence 9998 6777777888876
No 234
>cd04969 Ig5_Contactin_like Fifth Ig domain of contactin. Ig5_Contactin_like: Fifth Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 week
Probab=97.88 E-value=1.7e-05 Score=61.90 Aligned_cols=37 Identities=14% Similarity=0.039 Sum_probs=33.0
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 37 ~~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~l~V 73 (73)
T cd04969 37 PDGSLEILNVTKSDEGKYTCFAENFFGKANSTGSLSV 73 (73)
T ss_pred CCCeEEEccCChhHCEEEEEEEECCCCceEEEEEEEC
Confidence 3457999999999999999999999999999888754
No 235
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.88 E-value=3.9e-05 Score=64.81 Aligned_cols=82 Identities=18% Similarity=0.208 Sum_probs=52.0
Q ss_pred eeeeecceEeecCceEEEEEEEEecC-CCeEEEEeCC--EE---eccCCccceeeccCCcee---eeeeEEEEEecCCCC
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVYGDP-EPTILWLLNG--QV---LHNSSFDLLEEEEGDALF---EKSVSITLFNVTDLD 333 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~g~P-~p~v~W~~~g--~~---l~~~~~~~~~~~~~~~~~---~~~~~L~I~~v~~~D 333 (610)
+...|..+.+.+|++++|.|.+.+.. ...+.|+|.. .. +................. .....|+|.+++.+|
T Consensus 3 v~Q~p~~~~v~~G~~v~L~C~~~~~~~~~~~~Wyrq~~g~~~~~l~~~~~~~~~~~~~r~~~~~~~~~~~L~I~~~~~~D 82 (106)
T cd04980 3 LTQSPATLSVSPGESATISCKASQSVSSNYLAWYQQKPGQAPKLLIYGASTLASGTPSRFSGSGSGTDFTLTISRVEPED 82 (106)
T ss_pred EEECCCcEEECCCCCEEEEEEECCCCCCCcEEEEEECCCCCcEEEEECccccCCCCCCCEEEeccCCEEEEEECCCChHH
Confidence 34556778899999999999998766 6789999832 11 110000000000000000 123479999999999
Q ss_pred CeEEEEEeecC
Q psy10487 334 AGEYTCYAENI 344 (610)
Q Consensus 334 ~G~Y~C~a~N~ 344 (610)
+|.|.|.+.+.
T Consensus 83 sg~Y~Ca~~~~ 93 (106)
T cd04980 83 AAVYYCQQYGT 93 (106)
T ss_pred CEEEEEEEeCC
Confidence 99999998764
No 236
>cd05894 Ig_C5_MyBP-C C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). Ig_C5_MyBP_C : the C5 immunoglobulin (Ig) domain of cardiac myosin binding protein C (MyBP-C). MyBP_C consists of repeated domains, Ig and fibronectin type 3, and various linkers. Three isoforms of MYBP_C exist and are included in this group: cardiac(c), and fast and slow skeletal muscle (s) MyBP_C. cMYBP_C has insertions between and inside domains and an additional cardiac-specific Ig domain at the N-terminus. For cMYBP_C an interaction has been demonstrated between this C5 domain and the Ig C8 domain.
Probab=97.87 E-value=1.6e-05 Score=64.29 Aligned_cols=37 Identities=3% Similarity=-0.170 Sum_probs=32.9
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
....|.|.++..+|+|.|+|.|.|..|+.+..+.|.|
T Consensus 50 ~~~~L~I~~~~~~D~G~Y~c~a~N~~G~~~~~~~l~V 86 (86)
T cd05894 50 DLSSFVIEGAEREDEGVYTITVTNPVGEDHASLFVKV 86 (86)
T ss_pred CeEEEEECCCccCcCEEEEEEEEeCCCcEEEEEEEEC
Confidence 3568999999999999999999999999988887754
No 237
>cd05771 IgC_Tapasin_R Tapasin-R immunoglobulin-like domain. IgC_Tapasin_R: Immunoglobulin-like domain on Tapasin-R. Tapasin is a V-C1 (variable-constant) immunoglobulin superfamily molecule present in the endoplasmic reticulum (ER), where it links MHC class I molecules to the transporter associated with antigen processing (TAP). Tapasin-R is a tapasin-related protein that contains similar structural motifs to Tapasin, with some marked differences, especially in the V domain, transmembrane and cytoplasmic regions. The majority of Tapasin-R is located within the ER; however, there may be some expression of Tapasin-R at the cell surface. Tapasin-R lacks an obvious ER retention signal.
Probab=97.86 E-value=9.7e-06 Score=72.30 Aligned_cols=36 Identities=33% Similarity=0.423 Sum_probs=33.0
Q ss_pred EEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCc
Q psy10487 323 SITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 323 ~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
.|+|.+++.+|+|.|+|.+.+..|.....+.|.|..
T Consensus 2 sL~i~~v~~~D~G~Y~C~~~~~~~~~~~~~~l~v~~ 37 (139)
T cd05771 2 SLTLPGLTVHDEGTYICSVSTPPHQAQQIIQLSVSE 37 (139)
T ss_pred eEEECCCCHHHCEEEEEEEEccCcceeeEEEEEEec
Confidence 699999999999999999999999999999998853
No 238
>cd05765 Ig_3 Subgroup of the immunoglobulin (Ig) superfamily. Ig_3: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.86 E-value=1.8e-05 Score=63.13 Aligned_cols=36 Identities=14% Similarity=-0.032 Sum_probs=32.7
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.+++.+|+|.|.|.|.|..|+....+.|.|
T Consensus 46 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 81 (81)
T cd05765 46 IGQLVIYNAQPQDAGLYTCTARNSGGLLRANFPLSV 81 (81)
T ss_pred ccEEEEccCCcccCEEEEEEEecCCceEEEEEEEeC
Confidence 467999999999999999999999999999888764
No 239
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=97.86 E-value=9.8e-05 Score=66.90 Aligned_cols=90 Identities=21% Similarity=0.265 Sum_probs=60.9
Q ss_pred cceEeecCceEEEEEEEE-ecCCCeEEEEeCCEEeccCCc-cceeeccCCceee------eeeEEEEEecCCCCCeEEEE
Q psy10487 268 SMVIREAGGNVTMSCYVY-GDPEPTILWLLNGQVLHNSSF-DLLEEEEGDALFE------KSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~-g~P~p~v~W~~~g~~l~~~~~-~~~~~~~~~~~~~------~~~~L~I~~v~~~D~G~Y~C 339 (610)
..+.|.+|++++|.|... +...+.|.|+|....+..... .....+...+.+. ..+.|+|.+|+.+|+|.|.|
T Consensus 23 ~~v~V~ege~VtLsCs~t~s~~~~qVtWkK~~~~IatY~~~g~~i~~~Fk~Rve~mS~s~~~StItIknVt~sDeGcY~C 102 (189)
T PHA02987 23 VKITVSEHVNVKISCNKTSSFNSILITWKKNNKTIAGYGPCGPVIVDKFKNKIEYLSKSFNESTILIKNVSLKDNGCYTC 102 (189)
T ss_pred EEEEEcCCCCEEEEEecCCCCccceEEEEEcCCCEEEEecCCcEEChhhcCeEEEeccCCCcceEEEEeCChhhCeEEEE
Confidence 356788999999999984 667788999996443322111 1111111111121 34799999999999999999
Q ss_pred Eeec-CCc-ceeEEEEEEcC
Q psy10487 340 YAEN-IRG-NASGEISLDLP 357 (610)
Q Consensus 340 ~a~N-~~G-~~~~~~~L~V~ 357 (610)
...- ..| ..+.++-|.|.
T Consensus 103 ~F~tfp~G~~~~gt~CLtVt 122 (189)
T PHA02987 103 IFNTLLSKNNEKGVVCLNVT 122 (189)
T ss_pred EEEecCCCCCceeEEEEEEE
Confidence 9754 356 67788888884
No 240
>cd05732 Ig5_NCAM-1_like Fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM) and similar proteins. Ig5_NCAM-1 like: domain similar to the fifth immunoglobulin (Ig)-like domain of Neural Cell Adhesion Molecule NCAM-1 (NCAM). NCAM plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-non-NCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves Ig1, Ig2, and Ig3. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM mole
Probab=97.84 E-value=3.2e-06 Score=70.04 Aligned_cols=36 Identities=17% Similarity=-0.015 Sum_probs=31.8
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.+++.+|+|.|+|.|.|..|..+.++.|.|
T Consensus 61 ~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~s~~l~v 96 (96)
T cd05732 61 VSSLTLKDVQLTDAGRYDCEASNRIGGDQQSMYLEV 96 (96)
T ss_pred EEEEEECcCCcCcCEEeEEEEEeCCCCcEEEEEEeC
Confidence 457999999999999999999999999988777653
No 241
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.83 E-value=6.7e-05 Score=64.54 Aligned_cols=78 Identities=26% Similarity=0.322 Sum_probs=50.8
Q ss_pred eecceEeecCceEEEEEEEEe--cCCCeEEEEeC--CEE----eccCCc-ccee---eccCCceee-----eeeEEEEEe
Q psy10487 266 KESMVIREAGGNVTMSCYVYG--DPEPTILWLLN--GQV----LHNSSF-DLLE---EEEGDALFE-----KSVSITLFN 328 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g--~P~p~v~W~~~--g~~----l~~~~~-~~~~---~~~~~~~~~-----~~~~L~I~~ 328 (610)
.+..+.+.+|++++|.|.+.+ .+.+.+.|++. +.. +..... .... ...++.... ....|+|.+
T Consensus 4 ~p~~~~~~~G~~v~l~C~~~~~~~~~~~v~Wyrq~~g~~~~~l~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~L~I~~ 83 (116)
T cd04982 4 PQLSITREESKSVTISCKVSGIDFSTTYIHWYRQKPGQALERLLYVSSTSTQRKLSGGTKNKFEARKDVGKSTSTLTIQN 83 (116)
T ss_pred cCCeEEeCCCCCEEEEEEEeCCCccccEEEEEEECCCCCCEEEEEEecCCCcEEeCcccCCCEEEEEECCCCEEEEEEEE
Confidence 456678889999999999987 68889999994 221 100000 0000 001111111 245899999
Q ss_pred cCCCCCeEEEEEeec
Q psy10487 329 VTDLDAGEYTCYAEN 343 (610)
Q Consensus 329 v~~~D~G~Y~C~a~N 343 (610)
++.+|+|.|.|.+..
T Consensus 84 ~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 84 LEKEDSATYYCAYWE 98 (116)
T ss_pred CCHHHCEEEEEEEec
Confidence 999999999999864
No 242
>cd05764 Ig_2 Subgroup of the immunoglobulin (Ig) superfamily. Ig_2: subgroup of the immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of the Ig superfamily are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.82 E-value=1.2e-05 Score=63.00 Aligned_cols=37 Identities=14% Similarity=0.037 Sum_probs=32.5
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|+|.|..|.++....|.|
T Consensus 38 ~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 74 (74)
T cd05764 38 DNGTLDILITTVKDTGSFTCIASNAAGEATATVELHI 74 (74)
T ss_pred cCCEEEEEECChhhCEEEEEEEECCCCeEEEEEEEEC
Confidence 4567999999999999999999999999988877654
No 243
>cd05736 Ig2_Follistatin_like Second immunoglobulin (Ig)-like domain of a follistatin-like molecule encoded by the Mahya gene and similar proteins. Ig2_Follistatin_like: domain similar to the second immunoglobulin (Ig)-like domain found in a follistatin-like molecule encoded by the CNS-related Mahya gene. Mahya genes have been retained in certain Bilaterian branches during evolution. They are conserved in Hymenoptera and Deuterostomes, but are absent from other metazoan species such as fruit fly and nematode. Mahya proteins are secretory, with a follistatin-like domain (Kazal-type serine/threonine protease inhibitor domain and EF-hand calcium-binding domain), two Ig-like domains, and a novel C-terminal domain. Mahya may be involved in learning and memory and in processing of sensory information in Hymenoptera and vertebrates. Follistatin is a secreted, multidomain protein that binds activins with high affinity and antagonizes their signaling.
Probab=97.82 E-value=2e-05 Score=62.05 Aligned_cols=39 Identities=15% Similarity=0.047 Sum_probs=34.5
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAM 458 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 458 (610)
..+..|.|.+++.+|.|.|+|.|.|..|..+.+++|.|.
T Consensus 36 ~~~~~l~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V~ 74 (76)
T cd05736 36 ANGSELHISNVRYEDTGAYTCIAKNEAGVDEDISSLFVE 74 (76)
T ss_pred CCCCEEEECcCCcccCEEEEEEEEcCCCCcceEEEEEEE
Confidence 334579999999999999999999999999999998764
No 244
>cd05865 Ig1_NCAM-1 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. Ig1_NCAM-1: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the surface of opposing cells (trans
Probab=97.82 E-value=2.8e-05 Score=64.30 Aligned_cols=36 Identities=11% Similarity=0.020 Sum_probs=32.2
Q ss_pred ccceeeeeeeeccCcceeeeecCCC-cceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQ-PDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~-G~~~~~~~l~v 457 (610)
.+.|.|.+++.+|+|.|+|.|+|.+ |+++.++.|.|
T Consensus 59 ~~~L~I~~v~~~D~G~YtC~A~N~~~g~~~~s~~l~v 95 (96)
T cd05865 59 SSTLTIYNANIDDAGIYKCVVSNEDEGESEATVNVKI 95 (96)
T ss_pred ceEEEEeccChhhCEEEEEEEEcCCCCcEEEEEEEEE
Confidence 3689999999999999999999997 99988888765
No 245
>cd05859 Ig4_PDGFR-alpha Fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. IG4_PDGFR-alpha: The fourth immunoglobulin (Ig)-like domain of platelet-derived growth factor receptor (PDGFR) alpha. PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFR alpha binds to all three PDGFs, whereas the PDGFR beta (not included in this group) binds only to PDGF-B. PDGF alpha is organized as an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFR alpha and PDGFR beta are essential for normal development.
Probab=97.79 E-value=2.9e-05 Score=64.87 Aligned_cols=36 Identities=11% Similarity=-0.112 Sum_probs=33.0
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.+++.+|+|.|+|.|.|..|+++.++.|.|
T Consensus 64 ~s~L~I~~v~~~D~G~Ytc~A~N~~g~~~~t~~l~V 99 (101)
T cd05859 64 VSKLKLIRAKEEDSGLYTALAQNEDAVKSYTFALQI 99 (101)
T ss_pred ccEEEEeeCCHHHCEEEEEEEEcCCceEEEEEEEEE
Confidence 357999999999999999999999999999888865
No 246
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=97.78 E-value=0.00012 Score=60.66 Aligned_cols=82 Identities=29% Similarity=0.376 Sum_probs=50.7
Q ss_pred CceEEEEEEEEecCCC-eEEEEeCCE----EeccC-C-ccceeecc-CCce-----eeeeeEEEEEecCCCCCeEEEEEe
Q psy10487 275 GGNVTMSCYVYGDPEP-TILWLLNGQ----VLHNS-S-FDLLEEEE-GDAL-----FEKSVSITLFNVTDLDAGEYTCYA 341 (610)
Q Consensus 275 G~~v~l~C~~~g~P~p-~v~W~~~g~----~l~~~-~-~~~~~~~~-~~~~-----~~~~~~L~I~~v~~~D~G~Y~C~a 341 (610)
|++++|.|........ .|.|+|... .+... . ........ .+.. .....+|+|.+++.+|+|.|.|..
T Consensus 1 G~~vtL~C~~~~~~~~~~v~W~k~~~~~~~~i~~~~~~~~~~~~~~~~~r~~~~~~~~~~~sL~I~nv~~~D~G~Y~C~~ 80 (97)
T cd05846 1 GGNVTLSCNLTLPEEVLQVTWQKIQGSSPENIATYSEKYGVKIQPSYFRRRSITSLGLNSTSITIWNVTLEDEGCYKCIF 80 (97)
T ss_pred CCcEEEEEEeCCCCeeEEEEEEEcCCCCceEEEEEcccCCcccCCCccCeEEEcCCCCCccEEEEeCCceeeeEEEEEEE
Confidence 7899999987654333 599998422 11100 0 00000000 0000 023468999999999999999997
Q ss_pred e-cCCcceeEEEEEEc
Q psy10487 342 E-NIRGNASGEISLDL 356 (610)
Q Consensus 342 ~-N~~G~~~~~~~L~V 356 (610)
. ...|.....+.|+|
T Consensus 81 ~~~p~g~~~~~~~L~v 96 (97)
T cd05846 81 NTFPDGSKSGTMCLTV 96 (97)
T ss_pred EeCCCCCeeeEEEEEE
Confidence 6 45777788888876
No 247
>cd05760 Ig2_PTK7 Second immunoglobulin (Ig)-like domain of protein tyrosine kinase (PTK) 7, also known as CCK4. Ig2_PTK7: domain similar to the second immunoglobulin (Ig)-like domain in protein tyrosine kinase (PTK) 7, also known as CCK4. PTK7 is a subfamily of the receptor protein tyrosine kinase family, and is referred to as an RPTK-like molecule. RPTKs transduce extracellular signals across the cell membrane, and play important roles in regulating cell proliferation, migration, and differentiation. PTK7 is organized as an extracellular portion having seven Ig-like domains, a single transmembrane region, and a cytoplasmic tyrosine kinase-like domain. PTK7 is considered a pseudokinase as it has several unusual residues in some of the highly conserved tyrosine kinase (TK) motifs; it is predicted to lack TK activity. PTK7 may function as a cell-adhesion molecule. PTK7 mRNA is expressed at high levels in placenta, melanocytes, liver, lung, pancreas, and kidney. PTK7 is overexpressed in s
Probab=97.78 E-value=2.7e-05 Score=61.55 Aligned_cols=35 Identities=17% Similarity=0.053 Sum_probs=29.4
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeee
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQ 454 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 454 (610)
..++.|.|.+++.+|+|.|.|.|.|..|+...++.
T Consensus 35 ~~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s~~~ 69 (77)
T cd05760 35 SKERTLTLRSAGPDDSGLYYCCAHNAFGSVCSSQN 69 (77)
T ss_pred CCCCEEEEeeCCcccCEEEEEEEEeCCCeEeeCce
Confidence 34568999999999999999999999998755433
No 248
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.78 E-value=3e-05 Score=53.60 Aligned_cols=38 Identities=29% Similarity=0.410 Sum_probs=17.8
Q ss_pred CccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCC
Q psy10487 82 NLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWL 120 (610)
Q Consensus 82 ~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l 120 (610)
+|++|+|++|+|+.+++ .|++|++|++|++++|+|+.+
T Consensus 2 ~L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp T-SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCSBE
T ss_pred cceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCCCC
Confidence 44555555555555433 245555555555555555443
No 249
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=97.77 E-value=0.00015 Score=57.34 Aligned_cols=76 Identities=13% Similarity=0.226 Sum_probs=51.8
Q ss_pred ceEeecCceEEEEEEEEec--CCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 269 MVIREAGGNVTMSCYVYGD--PEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~g~--P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
...+..|++++|.|+.... |.+.|.|.-.+....... . ....+|.+..++..|+|.|+|.+.-..-
T Consensus 8 ~~~lL~G~sLtLtl~~~s~s~p~~~i~w~~P~n~~~~~~-----~-------~~~ktL~~~qv~~qdSG~WtC~V~~~~k 75 (88)
T cd07694 8 SDHVLSGTNLTLTLHGSSNSLPAFKVEWRGPGNKSKQIL-----N-------QDKKTLNLVQLGPNDSGTWDCIVSVNSS 75 (88)
T ss_pred CCeeecCCcEEEEEecCCCCCCCccEEEeCCCCccceec-----c-------CCccEEEeceeCcccCCEEEEEEEECce
Confidence 3356789999999999654 455999998665432111 0 1113899999999999999999975533
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.....+.+.|
T Consensus 76 ~~~~~~~V~V 85 (88)
T cd07694 76 EKTLKLDIKV 85 (88)
T ss_pred EEEEEeeEEE
Confidence 3444444444
No 250
>cd04976 Ig2_VEGFR Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). Ig2_VEGFR: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor (VEGFR). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angiogenic and microvascular permeability-enhancing effects of VEGF-A. VEGFR-1 may play an inhibitory part in these processes by binding VEGF and interfering with its interaction with VEGFR-2. VEGFR-1 has a signa
Probab=97.77 E-value=3.1e-05 Score=60.11 Aligned_cols=37 Identities=14% Similarity=-0.006 Sum_probs=31.3
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
..+..|.|.+++.+|+|.|+|.|.|..|..+.+..+.
T Consensus 32 ~~~~~L~I~~v~~~D~G~YtC~a~N~~g~~~~~~~~~ 68 (71)
T cd04976 32 KSGHSLTIKDVTEEDAGNYTVVLTNKQAKLEKRLTFT 68 (71)
T ss_pred cCCCEEEECcCCHHHCEEEEEEEEcCCccEEEEEEEE
Confidence 3456899999999999999999999999877766554
No 251
>cd04975 Ig4_SCFR_like Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR) and similar proteins. Ig4_SCFR_like; fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). In addition to SCFR this group also includes the fourth Ig domain of platelet-derived growth factor receptors (PDGFR), alpha and beta, the fourth Ig domain of macrophage colony stimulating factor (M-CSF), and the Ig domain of the receptor tyrosine kinase KIT. SCFR and the PDGFR alpha and beta have similar organization: an extracellular component having five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR, this fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth SCFR_Ig-like domain abolishes
Probab=97.75 E-value=3.7e-05 Score=64.18 Aligned_cols=36 Identities=17% Similarity=0.044 Sum_probs=33.1
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.++..+|+|.|+|.|+|+.|+++..+.|.|
T Consensus 64 ~~~L~i~~v~~~D~G~Ytc~A~N~~G~~~~t~~L~V 99 (101)
T cd04975 64 VSELKLVRLKESEAGTYTFLASNSDASKSLTFELYV 99 (101)
T ss_pred EEEEEEeecCHhhCeeEEEEEECCCccEEEEEEEEE
Confidence 467999999999999999999999999999888865
No 252
>cd05767 IgC_MHC_II_alpha Class II major histocompatibility complex (MHC) alpha chain immunoglobulin domain. IgC_MHC_II_alpha: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II alpha chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosom
Probab=97.75 E-value=0.00035 Score=57.28 Aligned_cols=82 Identities=24% Similarity=0.362 Sum_probs=54.5
Q ss_pred CCceeeeecceEeecCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEE
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEY 337 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y 337 (610)
+|.+.+.... ....|+.++|.|.|.|. |. ..++|.+||..+..+........++|+.+..++.|.+.. .+...|
T Consensus 1 ~P~V~v~~~~-~~~~~~~~tL~C~a~gFyP~~I~v~W~~~g~~~~~~~~~~~~~~~~Dgty~~~s~L~v~~---~~~~~y 76 (94)
T cd05767 1 PPEVTVFSLK-PVELGEPNTLICFVDNFFPPVLNVTWLKNGVPVTDGVSETRYYPRQDLSFQKFSYLNFTP---EEGDIY 76 (94)
T ss_pred CCEEEEEeCC-cccCCCCeEEEEEEEEEECCcCEEEEEECCeEccCceEEeeeEeCCCCcEEEEEEEEEEC---CCCCeE
Confidence 3555554433 23346668999999995 53 468999999987654333333445566667777887754 455699
Q ss_pred EEEeecCC
Q psy10487 338 TCYAENIR 345 (610)
Q Consensus 338 ~C~a~N~~ 345 (610)
+|++....
T Consensus 77 tC~V~H~~ 84 (94)
T cd05767 77 SCIVEHWG 84 (94)
T ss_pred EEEEEeCC
Confidence 99997754
No 253
>cd05766 IgC_MHC_II_beta Class II major histocompatibility complex (MHC) beta chain immunoglobulin domain. IgC_MHC_II_beta: Immunoglobulin (Ig) domain of major histocompatibility complex (MHC) class II beta chain. MHC class II molecules play a key role in the initiation of the antigen-specific immune reponse. In both humans and in mice these molecules have been shown to be expressed constitutively on the cell surface of professional antigen-presenting cells (APCs), for example on B-lymphocytes, monocytes, and macrophages. The expression of these molecules has been shown to be induced in nonprofessional APCs such as keratinocyctes, and they are expressed on the surface of activated human T cells and on T cells from other species. The MHC II molecules present antigenic peptides to CD4(+) T-lymphocytes. These peptides derive mostly from protelytic processing via the endocytic pathway, of antigens internalized by the APC. These peptides bind to the MHC class II molecules in the endosome be
Probab=97.73 E-value=0.00041 Score=57.01 Aligned_cols=72 Identities=22% Similarity=0.307 Sum_probs=50.4
Q ss_pred ecCceEEEEEEEEec-CCC-eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 273 EAGGNVTMSCYVYGD-PEP-TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 273 ~~G~~v~l~C~~~g~-P~p-~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
..|+.++|.|.+.|. |.. +++|++||..+...........++++.+..++.|.+. ..+...|+|++......
T Consensus 12 ~~~~~~~L~C~~~gFyP~~i~v~W~~~g~~~~~~~~~~~~~~~~dgTy~~~s~L~~~---~~~~~~ysC~V~H~~l~ 85 (94)
T cd05766 12 SLSHPHLLVCHVWGFYPPEITVKWFKNGQEETEGVVSTELIPNGDWTYQILVMLETT---PSRGDTYTCVVEHSSLQ 85 (94)
T ss_pred cCCCCeEEEEEEeeecCCCCEEEEEECCeecCCCceecceEECCCCcEEEEEEEEEc---CCCCCEEEEEEEeCCCC
Confidence 357889999999985 543 6899999998776422223334555566677777664 34566899999876543
No 254
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B ....
Probab=97.73 E-value=3.4e-05 Score=53.36 Aligned_cols=38 Identities=39% Similarity=0.516 Sum_probs=22.2
Q ss_pred CCcEEEccCCCCCCCCcccccCCCCCcEEEeeCcccccc
Q psy10487 106 ILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITEL 144 (610)
Q Consensus 106 ~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l 144 (610)
+|++|+|++|+|+.+++ .|.++++|+.|+|++|+++.+
T Consensus 2 ~L~~L~l~~N~i~~l~~-~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPP-ELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp T-SEEEETSSS-SSHGG-HGTTCTTSSEEEETSSCCSBE
T ss_pred cceEEEccCCCCcccCc-hHhCCCCCCEEEecCCCCCCC
Confidence 46666666666666654 356666666666666666554
No 255
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=97.73 E-value=0.00021 Score=58.72 Aligned_cols=81 Identities=21% Similarity=0.203 Sum_probs=51.0
Q ss_pred ceEEEEEEEEecC-CCeEEEEeCCE----EeccCCc--cceeeccCCcee------eeeeEEEEEecCCCCCeEEEEEe-
Q psy10487 276 GNVTMSCYVYGDP-EPTILWLLNGQ----VLHNSSF--DLLEEEEGDALF------EKSVSITLFNVTDLDAGEYTCYA- 341 (610)
Q Consensus 276 ~~v~l~C~~~g~P-~p~v~W~~~g~----~l~~~~~--~~~~~~~~~~~~------~~~~~L~I~~v~~~D~G~Y~C~a- 341 (610)
++++|.|.....+ ...|+|.|... .+..... ...+.....+.+ ...++|.|.+++.+|+|.|+|.+
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~ia~y~~~~g~~~~~~y~~Rv~~~~~~~~d~sl~i~nv~~~D~G~Y~C~v~ 80 (96)
T cd05887 1 KNVTLKCRIQVNETITQSSWEKIHGKGSVTLAVHHPMYGISIQPDYQGRVSFKNYSLLDATIMLENVGFSDIGVYICKAV 80 (96)
T ss_pred CCEEEEEEecCCCcEEEEEEEEcCCCCcEEEEEEcccCCcccChhhCCcEEEcCCCCCccEEEEeCCCccccEEEEEEEE
Confidence 3689999986433 34799998421 2211110 000000000001 23579999999999999999996
Q ss_pred ecCCcceeEEEEEEc
Q psy10487 342 ENIRGNASGEISLDL 356 (610)
Q Consensus 342 ~N~~G~~~~~~~L~V 356 (610)
....|+.++++.|.|
T Consensus 81 tfP~G~~~~~~~l~~ 95 (96)
T cd05887 81 TFPLGNTQSSTTVTV 95 (96)
T ss_pred eCCCCCeeEEEEEEE
Confidence 557899999998887
No 256
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=97.71 E-value=0.0002 Score=54.09 Aligned_cols=68 Identities=40% Similarity=0.631 Sum_probs=48.3
Q ss_pred EEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc
Q psy10487 278 VTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN 347 (610)
Q Consensus 278 v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~ 347 (610)
+.|.|.+.+.+.+.+.|++++......... ..............|.|.+++..|.|.|.|.+.+..+.
T Consensus 1 ~~l~C~~~~~~~~~~~W~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~i~~~~~~d~g~y~C~~~~~~~~ 68 (74)
T cd00096 1 VTLTCLASGPPPPTITWLKNGKPLPSSVLT--RVRSSRGTSSGSSTLTISNVTLEDSGTYTCVASNSAGT 68 (74)
T ss_pred CEEEEEecCCCCCcEEEEECCEECCCcccE--EeccccCcceeEEEEEECccCcccCcEEEEEEecCcCc
Confidence 468999999888899999988765443321 00011112245568999999999999999999887633
No 257
>cd05739 Ig3_RPTP_IIa_LAR_like Third immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig3_RPTP_IIa_LAR_like: domain similar to the third immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple IG-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains. Included in this group is Drosophila LAR (DLAR).
Probab=97.70 E-value=6.8e-05 Score=57.77 Aligned_cols=32 Identities=22% Similarity=0.157 Sum_probs=27.2
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
..|.|.+++ |+|.|+|.|.|..|..+.+++|+
T Consensus 38 ~~L~i~~~~--d~G~Y~C~A~N~~G~~~~~a~l~ 69 (69)
T cd05739 38 NVLELTNIY--ESANYTCVAISSLGMIEATAQVT 69 (69)
T ss_pred cEEEEeccc--cCeeEEEEEEeCCCEEEEEEEEC
Confidence 468888874 89999999999999999887763
No 258
>cd05770 IgC_beta2m Class I major histocompatibility complex (MHC) beta2-microglobulin. IgC_beta2m: Immunoglobulin-like domain in beta2-Microglobulin (beta2m). Beta2m is the non-covalently bound light chain of the human class I major histocompatibility complex (MHC-I). Beta2m is structured as a beta-sandwich domain composed of two facing beta-sheets (four stranded and three stranded), that is typical of the C-type immunoglobulin superfamily. This structure is stabilized by an intramolecular disulfide bridge connecting two Cys residues in the facing beta -sheets. In vivo, MHC-I continuously exposes beta2m on the cell surface, where it may be released to plasmatic fluids, transported to the kidneys, degraded and then excreted.
Probab=97.68 E-value=0.00048 Score=56.27 Aligned_cols=80 Identities=24% Similarity=0.264 Sum_probs=53.6
Q ss_pred CceeeeecceEeecCceEEEEEEEEecCCC--eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEE
Q psy10487 261 PNVTIKESMVIREAGGNVTMSCYVYGDPEP--TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYT 338 (610)
Q Consensus 261 P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p--~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~ 338 (610)
|.+.+.... .+..|+..+|.|.|.|.-++ .++|.+||..+. .........++++.+..++.|.+. ..+...|+
T Consensus 2 P~v~v~~~~-~~~~g~~~~L~C~a~gFyP~~i~v~W~~dg~~~~-~~~~~~~~p~~d~tyq~~s~l~~~---~~~~~~ys 76 (93)
T cd05770 2 PKVQVYSRF-PAENGKPNVLNCYVTGFHPPDIEIRLLKNGVKIP-KVEQSDLSFSKDWTFYLLKSTEFT---PTKGDEYA 76 (93)
T ss_pred CEEEEEecC-CCcCCCceEEEEEEEEEeCCCCEEEEEECCEECC-CcEECcEEECCCCCEEEEEEEEEC---CCCCCeEE
Confidence 555544322 23457777999999996443 679999999987 433333445566666666777665 45777899
Q ss_pred EEeecCC
Q psy10487 339 CYAENIR 345 (610)
Q Consensus 339 C~a~N~~ 345 (610)
|++....
T Consensus 77 C~V~H~~ 83 (93)
T cd05770 77 CRVRHNS 83 (93)
T ss_pred EEEEECC
Confidence 9998743
No 259
>cd04972 Ig_TrkABC_d4 Fourth domain (immunoglobulin-like) of Trk receptors TrkA, TrkB and TrkC. TrkABC_d4: the fourth domain of Trk receptors TrkA, TrkB and TrkC, this is an immunoglobulin (Ig)-like domain which binds to neurotrophin. The Trk family of receptors are tyrosine kinase receptors. They are activated by dimerization, leading to autophosphorylation of intracellular tyrosine residues, and triggering the signal transduction pathway. TrkA, TrkB, and TrkC share significant sequence homology and domain organization. The first three domains are leucine-rich domains. The fourth and fifth domains are Ig-like domains playing a part in ligand binding. TrkA, Band C mediate the trophic effects of the neurotrophin Nerve growth factor (NGF) family. TrkA is recognized by NGF. TrKB is recognized by brain-derived neurotrophic factor (BDNF) and neurotrophin (NT)-4. TrkC is recognized by NT-3. NT-3 is promiscuous as in some cell systems it activates TrkA and TrkB receptors. TrkA is a receptor fo
Probab=97.68 E-value=7.3e-05 Score=61.06 Aligned_cols=36 Identities=19% Similarity=0.118 Sum_probs=32.1
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.++..+|.|.|+|.|.|..|++...+.|.+
T Consensus 55 ~~~L~I~~v~~~D~g~Y~C~A~N~~G~~~~~~~L~v 90 (90)
T cd04972 55 IYNLQLSNITSETQTTVTCTAENPVGQANVSVQVTV 90 (90)
T ss_pred EEEEEEecCCcccCEEEEEEEECCCCceeEEEEEeC
Confidence 457999999999999999999999999998887753
No 260
>cd05728 Ig4_Contactin-2-like Fourth Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig4_Contactin-2-like: fourth Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=97.67 E-value=6.4e-05 Score=60.66 Aligned_cols=37 Identities=11% Similarity=0.065 Sum_probs=32.8
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.++..+|+|.|+|.|.|..|.....+.|.|
T Consensus 49 ~~~~L~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~V 85 (85)
T cd05728 49 EAGDLRITKLSLSDSGMYQCVAENKHGTIYASAELAV 85 (85)
T ss_pred eCCEEEEeeCCHHHCEEEEEEEECCCCeEEEEEEEEC
Confidence 4557999999999999999999999999988887754
No 261
>cd05857 Ig2_FGFR Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. Ig2_FGFR: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three IG-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin sulfate proteoglycans.
Probab=97.65 E-value=4.9e-05 Score=61.28 Aligned_cols=37 Identities=14% Similarity=0.098 Sum_probs=32.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
....|.|.+++.+|+|.|+|.|.|..|+++..+.|.|
T Consensus 49 ~~~~l~i~~~~~~D~G~Y~C~a~N~~G~~~~~~~l~v 85 (85)
T cd05857 49 QHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDV 85 (85)
T ss_pred CceEEEEccCCcccCEEEEEEEEeCCCEEEEEEEEEC
Confidence 3457999999999999999999999999999887754
No 262
>PF07679 I-set: Immunoglobulin I-set domain; InterPro: IPR013098 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents I-set domains, which are found in several cell adhesion molecules, including vascular (VCAM), intercellular (ICAM), neural (NCAM) and mucosal addressin (MADCAM) cell adhesion molecules, as well as junction adhesion molecules (JAM). I-set domains are also present in several other diverse protein families, including several tyrosine-protein kinase receptors, the hemolymph protein hemolin, the muscle proteins titin, telokin, and twitchin, the neuronal adhesion molecule axonin-1 [], and the signalling molecule semaphorin 4D that is involved in axonal guidance, immune function and angiogenesis [].; PDB: 3MTR_A 2EDK_A 3DMK_B 1KOA_A 3NCM_A 2NCM_A 2V9Q_A 2CR3_A 3QQN_A 3QR2_A ....
Probab=97.65 E-value=3e-06 Score=69.18 Aligned_cols=38 Identities=18% Similarity=0.100 Sum_probs=33.8
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.....|.|.++..+|+|.|+|.|.|..|+.+..+.|.|
T Consensus 53 ~~~~~L~I~~v~~~D~G~Y~C~~~n~~g~~~~~~~l~V 90 (90)
T PF07679_consen 53 GGSSSLTIKNVTREDAGTYTCVASNSSGEATASVNLTV 90 (90)
T ss_dssp TTEEEEEESSESGGGSEEEEEEEEETTEEEEEEEEEEE
T ss_pred cceeEEccCCCChhhCEEEEEEEEECCCEEEEEEEEEC
Confidence 45668999999999999999999999999998887754
No 263
>cd05738 Ig2_RPTP_IIa_LAR_like Second immunoglobulin (Ig)-like domain of the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. Ig2_RPTP_IIa_LAR_like: domain similar to the second immunoglobulin (Ig)-like domain found in the receptor protein tyrosine phosphatase (RPTP)-F, also known as LAR. LAR belongs to the RPTP type IIa subfamily. Members of this subfamily are cell adhesion molecule-like proteins involved in central nervous system (CNS) development. They have large extracellular portions, comprised of multiple Ig-like domains and two to nine fibronectin type III (FNIII) domains, and a cytoplasmic portion having two tandem phosphatase domains.
Probab=97.65 E-value=6.5e-05 Score=58.84 Aligned_cols=36 Identities=14% Similarity=0.032 Sum_probs=29.2
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcce-eeeeecc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDM-ELIEQSL 456 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~-~~~~~l~ 456 (610)
.++.|.|.+++.+|+|.|+|.|.|..|.. ...+.|.
T Consensus 36 ~~g~L~i~~~~~~D~G~Y~C~a~N~~G~~~s~~a~l~ 72 (74)
T cd05738 36 RSGALQIENSEESDQGKYECVATNSAGTRYSAPANLY 72 (74)
T ss_pred CCcEEEECCCChhhCEEEEEEEECCCCceEcccEEEE
Confidence 45579999999999999999999999984 3444443
No 264
>cd05856 Ig2_FGFRL1-like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). Ig2_FGFRL1-like: second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor_like-1(FGFRL1). FGFRL1 is comprised of a signal peptide, three extracellular Ig-like modules, a transmembrane segment, and a short intracellular domain. FGFRL1 is expressed preferentially in skeletal tissues. Similar to FGF receptors, the expressed protein interacts specifically with heparin and with FGF2. FGFRL1 does not have a protein tyrosine kinase domain at its C terminus; neither does its cytoplasmic domain appear to interact with a signaling partner. It has been suggested that FGFRL1 may not have any direct signaling function, but instead acts as a decoy receptor trapping FGFs and preventing them from binding other receptors.
Probab=97.63 E-value=9.3e-05 Score=59.02 Aligned_cols=35 Identities=9% Similarity=0.049 Sum_probs=31.1
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
...|.|.+++.+|+|.|+|.|.|..|.++..+.+.
T Consensus 47 ~~~L~i~~v~~~D~G~Y~C~a~N~~G~~~~~~~v~ 81 (82)
T cd05856 47 KWTLSLKNLKPEDSGKYTCHVSNRAGEINATYKVD 81 (82)
T ss_pred eEEEEEccCChhhCEEEEEEEEcCCccEEEEEEEe
Confidence 45799999999999999999999999988877664
No 265
>cd05737 Ig_Myomesin_like_C C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Ig_Myomesin_like_C: domain similar to the C-temrinal immunoglobulin (Ig)-like domain of myomesin and M-protein. Myomesin and M-protein are both structural proteins localized to the M-band, a transverse structure in the center of the sarcomere, and are candidates for M-band bridges. Both proteins are modular, consisting mainly of repetitive Ig-like and fibronectin type III (FnIII) domains. Myomesin is expressed in all types of vertebrate striated muscle; M-protein has a muscle-type specific expression pattern. Myomesin is present in both slow and fast fibers; M-protein is present only in fast fibers. It has been suggested that myomesin acts as a molecular spring with alternative splicing as a means of modifying its elasticity.
Probab=97.63 E-value=5.6e-05 Score=62.04 Aligned_cols=35 Identities=6% Similarity=-0.128 Sum_probs=31.2
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..|.|.+++.+|+|.|+|.|.|..|+.+....+.|
T Consensus 58 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~v~v 92 (92)
T cd05737 58 ASLTIKGVSSEDSGKYGIVVKNKYGGETVDVTVSV 92 (92)
T ss_pred EEEEEccCChhhCEEEEEEEEECCCcceEEEEEeC
Confidence 47999999999999999999999999888777653
No 266
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=97.63 E-value=0.00023 Score=58.59 Aligned_cols=74 Identities=24% Similarity=0.319 Sum_probs=49.5
Q ss_pred CceeeeecceEeecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 261 PNVTIKESMVIREAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 261 P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
|.+...+ ...+..|++|+|.|+... +.-.+.|+|+|......... ....+ .....+.|..++.+|+|.|.|.
T Consensus 2 P~l~a~p-~~vV~~G~~VTL~C~~~~-~~~~f~l~k~g~~~~~~~~~--~~~~~----~~~a~f~I~~~~~~~~G~Y~C~ 73 (94)
T cd05711 2 PFLSAHP-SPVVPSGENVTLQCHSDI-RFDRFILYKEGRSKPVLHLY--EKHHG----GFQASFPLGPVTPAHAGTYRCY 73 (94)
T ss_pred CEEEecC-CCccCCCCeEEEEEecCC-CCCEEEEEECCCCCCceecc--cccCC----eEEEEEEecCCCcccCEEEEEE
Confidence 4444433 456778999999998765 55679999988653211000 00001 2345889999999999999999
Q ss_pred ee
Q psy10487 341 AE 342 (610)
Q Consensus 341 a~ 342 (610)
..
T Consensus 74 ~~ 75 (94)
T cd05711 74 GS 75 (94)
T ss_pred EE
Confidence 74
No 267
>KOG3515|consensus
Probab=97.62 E-value=4.9e-05 Score=83.33 Aligned_cols=80 Identities=19% Similarity=0.200 Sum_probs=57.3
Q ss_pred ecceEeecCceEEEEEEEEecCC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 267 ESMVIREAGGNVTMSCYVYGDPE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~g~P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.....+..|++|.|.|.+.|+|+ +.+.|++.++... .+. .. ....+|......+...++|.|+|.|..
T Consensus 14 ~l~~~~~~g~~v~l~C~v~~~pp~~~~eW~h~~~~~~--~~~-~~--------~~~~~~~~~~~~~~~~~~~~c~a~ns~ 82 (741)
T KOG3515|consen 14 SLTVGLRLGEDVPLPCRVNSNPPEIDVEWYHSTSGEH--GRY-AT--------IADPTLVTTGDVRDTVAELNCRAFNSV 82 (741)
T ss_pred CCChhhccCCcceeeeecCCCCCCcceEEEecCcccc--ccc-cc--------ccCCceeeecchhhhhhhhhhhhcccc
Confidence 33347889999999999987754 6899999876655 111 11 222377788888888899999999997
Q ss_pred cce-eEEEEEEcC
Q psy10487 346 GNA-SGEISLDLP 357 (610)
Q Consensus 346 G~~-~~~~~L~V~ 357 (610)
|.. .....+.|.
T Consensus 83 ~~~~~~~~~l~v~ 95 (741)
T KOG3515|consen 83 GMPSRCPMILDVD 95 (741)
T ss_pred cCceecceeeccc
Confidence 764 445666663
No 268
>KOG4658|consensus
Probab=97.61 E-value=7.1e-05 Score=85.92 Aligned_cols=124 Identities=19% Similarity=0.236 Sum_probs=98.0
Q ss_pred cEEEcCCCCCCccCccc-CCCccEEEeecCC--CCCCChhhhcccCCCCccEEEcccCC-CcccchhhhcCCCCCcEEEc
Q psy10487 37 KSALCKDANFTALPSTL-DSDIQVLDLNNNK--ISYLTKEAFKSIGLLNLQRIYLKNSG-IREVHRDTFKYLTILVEVDL 112 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~~l-~~~L~~L~L~~n~--i~~l~~~~~~~~~l~~L~~L~L~~n~-l~~i~~~~f~~l~~L~~LdL 112 (610)
..+.-.++.+..++... ..++++|-+..|. +..+..+.|. .++.|+.|+|++|. +..+ |..+++|-+|++|+|
T Consensus 526 rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~~l~~is~~ff~--~m~~LrVLDLs~~~~l~~L-P~~I~~Li~LryL~L 602 (889)
T KOG4658|consen 526 RRMSLMNNKIEHIAGSSENPKLRTLLLQRNSDWLLEISGEFFR--SLPLLRVLDLSGNSSLSKL-PSSIGELVHLRYLDL 602 (889)
T ss_pred eEEEEeccchhhccCCCCCCccceEEEeecchhhhhcCHHHHh--hCcceEEEECCCCCccCcC-ChHHhhhhhhhcccc
Confidence 34444555566666443 3379999999997 8888888888 79999999999875 5555 567899999999999
Q ss_pred cCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCcc
Q psy10487 113 SDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQ 164 (610)
Q Consensus 113 s~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~ 164 (610)
++..+..++. .+.++.+|.+|++..+......+.....|.+|++|.+-...
T Consensus 603 ~~t~I~~LP~-~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 603 SDTGISHLPS-GLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred cCCCccccch-HHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 9999998875 58999999999999887655556666678999999986543
No 269
>cd05847 IgC_CH2_IgE CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin E (IgE). IgC_CH2_IgE: The second constant domain of the heavy chain of immunoglobulin E (IgE). The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma, and mu, all consisting of a variable domain (VH) and three (in alpha, delta, and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). The different classes of antibodies vary in their heavy chains; the IgE class has the epsilon type. This domain (Cepsilon2) of IgE is in place of the flexible hinge region found in IgG.
Probab=97.61 E-value=0.00041 Score=56.96 Aligned_cols=75 Identities=17% Similarity=0.330 Sum_probs=50.0
Q ss_pred cCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce
Q psy10487 274 AGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA 348 (610)
Q Consensus 274 ~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 348 (610)
.++.++|.|.+.|. |. ..|+|.++|..+.............++.+..++.|.+..-...+...|+|++.......
T Consensus 13 ~~~~~~L~C~a~gFyP~~I~vtW~~dg~~~~~~~~~s~~~~~~~~Ty~~~S~L~v~~~~w~~~~~ytC~V~H~~~~~ 89 (94)
T cd05847 13 TSETIQLLCLISGYTPGTIEVEWLVDGQVATLVAASTAPQKEEGSTFSTTSELNVTQEDWKSGKTYTCKVTHQGTTF 89 (94)
T ss_pred CCCCEEEEEEEEeEECCCCEEEEEECCEECcCceeecccEECCCCcEEEEEEEEEchHHhcCCCeEEEEEEECCeee
Confidence 35668999999985 54 47899999998643322111122233356777888877555556679999998866443
No 270
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=97.61 E-value=0.00015 Score=60.24 Aligned_cols=74 Identities=15% Similarity=0.148 Sum_probs=45.7
Q ss_pred EeecCceEEEEEEEEec--CCCeEEEEeCC--EEe---ccCCccceeeccCCcee---eeeeEEEEEecCCCCCeEEEEE
Q psy10487 271 IREAGGNVTMSCYVYGD--PEPTILWLLNG--QVL---HNSSFDLLEEEEGDALF---EKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 271 ~v~~G~~v~l~C~~~g~--P~p~v~W~~~g--~~l---~~~~~~~~~~~~~~~~~---~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
.+.+|++++|.|...+. ....+.|++.. ... ............++... .....|+|.+++.+|+|.|.|.
T Consensus 2 ~v~~G~~v~l~C~~~~~~~~~~~i~Wy~q~~g~~~~~l~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~~Dsg~Y~C~ 81 (98)
T cd04984 2 SVSPGETVTITCTGSSGNISGNYVNWYQQKPGSAPRYLIYEDSDRPSGIPDRFSGSKSGNTASLTISGAQTEDEADYYCQ 81 (98)
T ss_pred ccCCCCCEEEEEEEcCCCcCCCCEEEEEECCCCCccEEEEeccccCCCCCCCEEEEccCCEEEEEECCCChhhCEEEEEE
Confidence 46789999999998775 56779999832 111 10000000000001000 1235799999999999999999
Q ss_pred eecC
Q psy10487 341 AENI 344 (610)
Q Consensus 341 a~N~ 344 (610)
+.+.
T Consensus 82 ~~~~ 85 (98)
T cd04984 82 VWDS 85 (98)
T ss_pred EccC
Confidence 8753
No 271
>KOG2982|consensus
Probab=97.60 E-value=3.4e-05 Score=74.54 Aligned_cols=159 Identities=19% Similarity=0.191 Sum_probs=80.4
Q ss_pred CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCc-ccccCCCCCcE
Q psy10487 55 SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQ-DTFLGNDRLKV 133 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~-~~f~~l~~L~~ 133 (610)
..++.|||.+|.|+.+..-.-..-+|+.|+.|+|+.|++.......=..+.+|++|-|.+..+..-.. ..+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 35677777777777665422111157777777777777664432110245567777777766653222 23455667777
Q ss_pred EEeeCccccccC--cCcCCCC-CCccEEEccCccccccC-HHHh-hcCccccccccccccccccCc-ccccCCCcccEEe
Q psy10487 134 LYLNGNPITELR--AGQFPKL-PYLKTIELQHCQIHSVH-KDAL-IHLTALESLNLNGNRLKHLSE-SVFFPTPNLKTLS 207 (610)
Q Consensus 134 L~Ls~N~l~~l~--~~~~~~l-~~L~~L~L~~n~l~~~~-~~~~-~~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~l~ 207 (610)
|+++.|.+..+. .+..... +.++.|++..|...-.. ...+ ..++++..+.+..|.|.+... ..+..++.+.-|+
T Consensus 151 lHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~Ln 230 (418)
T KOG2982|consen 151 LHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLN 230 (418)
T ss_pred hhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhh
Confidence 777777554432 1111111 24444444444322110 0111 123556666666666654432 2334444455556
Q ss_pred cCCCcc
Q psy10487 208 LDGNPW 213 (610)
Q Consensus 208 l~~N~~ 213 (610)
|+.|.+
T Consensus 231 L~~~~i 236 (418)
T KOG2982|consen 231 LGANNI 236 (418)
T ss_pred hccccc
Confidence 665554
No 272
>cd05734 Ig7_DSCAM Seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). Ig7_DSCAM: the seventh immunoglobulin (Ig)-like domain of Down Syndrome Cell Adhesion molecule (DSCAM). DSCAM is a cell adhesion molecule expressed largely in the developing nervous system. The gene encoding DSCAM is located at human chromosome 21q22, the locus associated with the mental retardation phenotype of Down Syndrome. DSCAM is predicted to be the largest member of the IG superfamily. It has been demonstrated that DSCAM can mediate cation-independent homophilic intercellular adhesion.
Probab=97.60 E-value=8.1e-05 Score=59.10 Aligned_cols=29 Identities=14% Similarity=0.052 Sum_probs=26.5
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcce
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDM 449 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~ 449 (610)
.++.|.|.++..+|+|.|.|.|.|..|..
T Consensus 42 ~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 70 (79)
T cd05734 42 SNGSLLIKHVLEEDSGYYLCKVSNDVGAD 70 (79)
T ss_pred cCCeEEECcCCcccCEEEEEEEEeCCCCC
Confidence 45789999999999999999999999976
No 273
>cd05895 Ig_Pro_neuregulin-1 Immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. Ig_Pro_neuregulin-1: immunoglobulin (Ig)-like domain found in neuregulin (NRG)-1. There are many NRG-1 isoforms which arise from the alternative splicing of mRNA. NRG-1 belongs to the neuregulin gene family, which is comprised of four genes. This group represents NRG-1. NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, and heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. The NRG-1 protein binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates process
Probab=97.57 E-value=6.9e-05 Score=58.99 Aligned_cols=34 Identities=9% Similarity=0.065 Sum_probs=29.9
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeee
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQ 454 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 454 (610)
..+.|.|.+++.+|+|.|+|.|+|..|..++.+.
T Consensus 42 ~~~~L~I~~~~~~DsG~Y~C~a~N~~g~~~~~~~ 75 (76)
T cd05895 42 KSSELQISKASLADNGEYKCMVSSKLGNDSVTAN 75 (76)
T ss_pred cEEEEEECcCCcccCEEEEEEEEeCCCceeEEEe
Confidence 3467999999999999999999999999887654
No 274
>cd05750 Ig_Pro_neuregulin Immunoglobulin (Ig)-like domain in neuregulins (NRGs). Ig_Pro_neuregulin: immunoglobulin (Ig)-like domain in neuregulins (NRGs). NRGs are signaling molecules, which participate in cell-cell interactions in the nervous system, breast, heart, and other organ systems, and are implicated in the pathology of diseases including schizophrenia, multiple sclerosis, and breast cancer. There are four members of the neuregulin gene family (NRG1, -2, -3, and -4). The NRG-1 protein, binds to and activates the tyrosine kinases receptors ErbB3 and ErbB4, initiating signaling cascades. The other NRGs proteins bind one or the other or both of these ErbBs. NRG-1 has multiple functions; for example, in the brain it regulates various processes such as radial glia formation and neuronal migration, dendritic development, and expression of neurotransmitters receptors; in the peripheral nervous system NRG-1 regulates processes such as target cell differentiation, and Schwann cell surv
Probab=97.56 E-value=4.2e-05 Score=59.91 Aligned_cols=34 Identities=9% Similarity=0.028 Sum_probs=29.9
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeee
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQ 454 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 454 (610)
....|.|.+++.+|+|.|+|.|.|..|++..+++
T Consensus 41 ~~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~ 74 (75)
T cd05750 41 KNSELQINKAKLADSGEYTCVVENILGNDTVTAN 74 (75)
T ss_pred ceEEEEEccCCcccCeEEEEEEEEcCCceeEEEe
Confidence 3468999999999999999999999999877654
No 275
>cd05866 Ig1_NCAM-2 First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2. Ig1_NCAM-2: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-2 (OCAM/mamFas II, RNCAM). NCAM-2 is organized similarly to NCAM , including five N-terminal Ig-like domains and two fibronectin type III domains. NCAM-2 is differentially expressed in the developing and mature olfactory epithelium (OE), and may function like NCAM, as an adhesion molecule.
Probab=97.56 E-value=0.00011 Score=60.21 Aligned_cols=28 Identities=14% Similarity=0.190 Sum_probs=25.8
Q ss_pred cceeeeeeeeccCcceeeeecCCCccee
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDME 450 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~ 450 (610)
..|.|.++..+|+|.|+|.|+|+.|+..
T Consensus 56 ~~L~I~~v~~~D~G~Y~C~A~N~~G~~~ 83 (92)
T cd05866 56 SRLTIYNANIEDAGIYRCQATDAKGQTQ 83 (92)
T ss_pred eEEEEecCChHHCEEEEEEEEcCCCcEE
Confidence 4799999999999999999999999863
No 276
>cd05743 Ig_Perlecan_D2_like Immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Ig_Perlecan_D2_like: the immunoglobulin (Ig)-like domain II (D2) of the human basement membrane heparan sulfate proteoglycan perlecan, also known as HSPG2. Perlecan consists of five domains. Domain I has three putative heparan sulfate attachment sites; domain II has four LDL receptor-like repeats, and one Ig-like repeat; domain III resembles the short arm of laminin chains; domain IV has multiple Ig-like repeats (21 repeats in human perlecan); and domain V resembles the globular G domain of the laminin A chain and internal repeats of EGF. Perlecan may participate in a variety of biological functions including cell binding, LDL-metabolism, basement membrane assembly and selective permeability, calcium binding, and growth- and neurite-promoting activities.
Probab=97.55 E-value=7.4e-05 Score=59.18 Aligned_cols=35 Identities=17% Similarity=0.168 Sum_probs=30.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeec
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 455 (610)
....|.|.+++.+|+|.|+|.|.|..|.....+.+
T Consensus 40 ~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~~ 74 (78)
T cd05743 40 GYGTLTIRDVKESDQGAYTCEAINTRGMVFGIPDG 74 (78)
T ss_pred CEEEEEECCCChHHCEEEEEEEEecCCEEEecccE
Confidence 34679999999999999999999999998776554
No 277
>cd05719 Ig2_PVR_like Second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig2_PVR_like: domain similar to the second immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), these result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus
Probab=97.53 E-value=0.00067 Score=55.77 Aligned_cols=77 Identities=16% Similarity=0.226 Sum_probs=48.3
Q ss_pred CceEEEEEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcc--eeEE
Q psy10487 275 GGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGN--ASGE 351 (610)
Q Consensus 275 G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~--~~~~ 351 (610)
.......|.+ .|.|.++|+|+++. .. ..........++.+...+.|.+.-....|.-.|+|+|.|..-. ...+
T Consensus 15 ~~~~va~C~s~~gkP~a~ItW~~~~---~~-~~~~~~~~~~~g~~tv~S~l~~~p~~~d~G~~~tC~v~h~~l~~~~~~~ 90 (95)
T cd05719 15 EPVTVATCVSANGKPPATISWETTL---GG-EAETQSKENPNGTVTVTSEYRLVPSREANGKELTCVVSHPTLQEPQRFS 90 (95)
T ss_pred CccEEEEEECCCCcCCCEEEEEeCC---CC-cceeEeecCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCCCeEEE
Confidence 3457889998 58999999999971 11 1111122223334556677877655555666899999998744 3444
Q ss_pred EEEE
Q psy10487 352 ISLD 355 (610)
Q Consensus 352 ~~L~ 355 (610)
+.|.
T Consensus 91 ~~L~ 94 (95)
T cd05719 91 VTLN 94 (95)
T ss_pred EEee
Confidence 4444
No 278
>cd05742 Ig1_VEGFR_like First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor (R) and similar proteins. Ig1_VEGFR_like: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R) related proteins. The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF-A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGF
Probab=97.51 E-value=0.00011 Score=59.07 Aligned_cols=37 Identities=19% Similarity=0.070 Sum_probs=32.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
....|.|.+++.+|+|.|+|.|.|..|+.+.++.+.|
T Consensus 47 ~~s~L~I~~v~~~DsG~Y~C~a~n~~~~~~~s~~v~v 83 (84)
T cd05742 47 LSSTLTIPNATLKDSGTYTCAASSGTMDQKESTKVNI 83 (84)
T ss_pred EEEEEEECCCChhhCEEEEEEEccCCCceEEEEEEEE
Confidence 3458999999999999999999999999888877754
No 279
>cd05772 IgC_SIRP Signal-regulatory protein (SIRP) immunoglobulin-like domain. IgC_SIRP: Immunoglobulin-like domain of signal-regulatory proteins (SIRP); the signal-regulatory proteins (SIRP) are Ig-like cell surface receptors detected in hematopoietic and non-hematopoietic cells. While their extracellular domains are similar, SIRP are classified as alpha or beta based on the length of the intracytoplasmic domain. Those having a 110- to 113-amino acid tail are classified as SIRP-alpha, and those having a 5-amino acid tail as SIRP-beta. SIRP-alpha and SIRP-beta molecules are thought to have complementary roles in signal regulation: SIRP-alpha inhibit signalling via their immunoreceptor tyrosine (IT)-based inhibition motifs while SIRP-beta are activating. SIRP-beta lack the cytoplasmic domainof SIRP-alpha, and associate with at least one other transmembrane protein (DAP-12 or KARAP). The IT-based activation motifs within DAP-12's cytoplasmic domain may link SIRP-beta to the activating
Probab=97.50 E-value=0.0016 Score=55.24 Aligned_cols=74 Identities=24% Similarity=0.363 Sum_probs=50.7
Q ss_pred EeecCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCC-ceeeeeeEEEEEecCCCCCe-EEEEEeecCCc
Q psy10487 271 IREAGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGD-ALFEKSVSITLFNVTDLDAG-EYTCYAENIRG 346 (610)
Q Consensus 271 ~v~~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~-~~~~~~~~L~I~~v~~~D~G-~Y~C~a~N~~G 346 (610)
....|+.++|.|.+.|. |. .+++|++||..+..... ....+++ +.+..++.|.+.. ...|.| .|+|.+.....
T Consensus 17 ~~~~g~~~tL~C~a~gF~P~~i~v~W~kng~~~~~~~~--~~~p~~d~~ty~~~S~L~~~~-~~~d~~~~ytC~V~H~~l 93 (111)
T cd05772 17 RANPGQSVNFTCSAHGFSPRDITVKWLKNGNELSAEQP--NITPEGDSVSYNVTSTVQVKL-TEDDVHSQVTCEVQHRTL 93 (111)
T ss_pred ccCCCCCEEEEEEEeeEeCCCCEEEEEECCEECccccc--ceeeCCCCCcEEEEEEEEEEC-ccccccCceEEEEEeCCC
Confidence 44568889999999875 54 58999999999864321 2222233 3566778888874 444544 59999998754
Q ss_pred c
Q psy10487 347 N 347 (610)
Q Consensus 347 ~ 347 (610)
.
T Consensus 94 ~ 94 (111)
T cd05772 94 Q 94 (111)
T ss_pred C
Confidence 3
No 280
>cd07693 Ig1_Robo First immunoglobulin (Ig)-like domain in Robo (roundabout) receptors and similar proteins. Ig1_Robo: domain similar to the first immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit res
Probab=97.50 E-value=3.5e-05 Score=64.03 Aligned_cols=27 Identities=15% Similarity=0.043 Sum_probs=21.2
Q ss_pred eeccCcceeeeecCCCcc-eeeeeeccc
Q psy10487 431 TTTDRHTGSCEALGSQPD-MELIEQSLA 457 (610)
Q Consensus 431 ~~~D~G~Y~C~A~N~~G~-~~~~~~l~v 457 (610)
+.+|+|.|+|.|.|..|. ....+.|.|
T Consensus 72 ~~~D~G~Y~C~a~N~~G~~~s~~~~l~v 99 (100)
T cd07693 72 GRSDEGVYVCVAHNSLGEAVSRNASLEV 99 (100)
T ss_pred CcCcCEEEEEEEEccccceecceEEEEe
Confidence 678999999999999998 444455443
No 281
>cd05740 Ig_CEACAM_D4 Fourth immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). Ig_CEACAM_D4: immunoglobulin (Ig)-like domain 4 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the
Probab=97.48 E-value=0.00012 Score=59.78 Aligned_cols=32 Identities=22% Similarity=0.302 Sum_probs=28.1
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceee
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
..++.|.|.+++.+|+|.|.|.|.|..|....
T Consensus 52 ~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~S 83 (91)
T cd05740 52 NDNRTLTFNNVTRSDTGHYQCEASNEVSNMTS 83 (91)
T ss_pred CCCCEEEECcCChhhCEEEEEEEEcCCCCEEe
Confidence 34568999999999999999999999998655
No 282
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=97.47 E-value=0.00048 Score=59.18 Aligned_cols=81 Identities=22% Similarity=0.281 Sum_probs=50.7
Q ss_pred eeeeecceEeecCceEEEEEEEEec-CCCeEEEEeC--CEE---eccCCccceeeccCCcee-----eeeeEEEEEecCC
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVYGD-PEPTILWLLN--GQV---LHNSSFDLLEEEEGDALF-----EKSVSITLFNVTD 331 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~g~-P~p~v~W~~~--g~~---l~~~~~~~~~~~~~~~~~-----~~~~~L~I~~v~~ 331 (610)
+...+..+.+.+|++++|.|...+. ....+.|++. +.. +............++... .....|+|.+++.
T Consensus 2 v~q~~~~v~~~~G~~v~L~C~~~~~~~~~~v~Wyrq~~~~~~~~l~~~~~~~~~~~~~R~~~~~~~~~~~~sL~I~~~~~ 81 (116)
T cd07706 2 VTQAQPDVSVQVGEEVTLNCRYETSWTNYYIFWYKQLPSGEMTFLIRQKSIYGNATKGRYSVNFQKAQKSISLTISALQL 81 (116)
T ss_pred cEEeCCceEEcCCCCEEEEEEEeCCCCceEEEEEEECCCCceEEEEEecCccCCccCCeEEEEEeccCCEEEEEECCCCH
Confidence 3455677889999999999998764 4567999983 221 100000000000011111 1134799999999
Q ss_pred CCCeEEEEEeec
Q psy10487 332 LDAGEYTCYAEN 343 (610)
Q Consensus 332 ~D~G~Y~C~a~N 343 (610)
+|+|.|.|.+..
T Consensus 82 ~Dsg~Y~C~~~~ 93 (116)
T cd07706 82 EDSAKYFCALST 93 (116)
T ss_pred HHCEEEEEEEEC
Confidence 999999999875
No 283
>cd05758 Ig5_KIRREL3-like Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2) and similar proteins. Ig5_KIRREL3-like: domain similar to the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=97.46 E-value=2.2e-05 Score=65.28 Aligned_cols=33 Identities=15% Similarity=0.018 Sum_probs=29.1
Q ss_pred cceeeeeeeec-cCcceeeeecCCCcceeeeeec
Q psy10487 423 KKLLDVSITTT-DRHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 423 ~~L~i~~v~~~-D~G~Y~C~A~N~~G~~~~~~~l 455 (610)
+.|.|.+++.+ |+|.|+|.|.|..|+++..++|
T Consensus 64 s~L~I~~v~~~d~~G~Y~C~A~N~~G~~~~~~~L 97 (98)
T cd05758 64 STLTISNTQESDFQTSYNCTAWNSFGSGTAIISL 97 (98)
T ss_pred EEEEECCccccccceeEEEEEEcCCCcccEEEEe
Confidence 47999999985 5999999999999999887765
No 284
>cd05850 Ig1_Contactin-2 First Ig domain of contactin-2. Ig1_Contactin-2: First Ig domain of the neural cell adhesion molecule contactin-2-like. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. It may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module by contacts between IG domains 1 and 4, and domains 2 and 3. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-2 is also expressed in retinal amacrine cells in the developing c
Probab=97.45 E-value=4.2e-05 Score=63.05 Aligned_cols=31 Identities=13% Similarity=0.054 Sum_probs=26.0
Q ss_pred cccceeeeeee-eccCcceeeeecCCCcceee
Q psy10487 421 QEKKLLDVSIT-TTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 421 ~~~~L~i~~v~-~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.++.|.|.++. ..|+|.|+|+|+|..|++.+
T Consensus 56 ~~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s 87 (94)
T cd05850 56 VAGNLVINNPQKARDAGSYQCLAINRCGTVVS 87 (94)
T ss_pred ECCeEEEccCCccCcCEEEEEEEEcCcCcEEE
Confidence 35678888865 58999999999999998765
No 285
>cd05768 IgC_CH4 CH4 domain (fourth constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH4: The fourth immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=97.43 E-value=0.00047 Score=57.59 Aligned_cols=74 Identities=20% Similarity=0.281 Sum_probs=48.8
Q ss_pred eecCceEEEEEEEEecCCC--eEEEEeCCEEeccCCccce-eecc--CCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 272 REAGGNVTMSCYVYGDPEP--TILWLLNGQVLHNSSFDLL-EEEE--GDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 272 v~~G~~v~l~C~~~g~P~p--~v~W~~~g~~l~~~~~~~~-~~~~--~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
+..|+.++|.|.|.|..++ .++|++||..+........ ...+ +++.+..++.|.|..-...+...|+|++....
T Consensus 13 ~~~~~~~tL~C~a~gFyP~~i~v~W~k~g~~~~~~~~~~~~~~~~~~~dgTy~~~s~L~v~~~~w~~~~~ytC~V~H~~ 91 (102)
T cd05768 13 LSLQETATLTCLVKGFSPSDIFVKWLQNGQPLSKQKYVTTAPMQEPGGNESYFLYSKLTVSAEDWNAGDVFTCVVGHEA 91 (102)
T ss_pred hCcCCceEEEEEEeeEeCCCCEEEEEECCEECCcccccccCcccccCCCCeEEEEEEEEEcHHHhcCCCcEEEEeEeCC
Confidence 3457789999999996444 5799999998764321111 1111 24566777888874444445668999997654
No 286
>cd05756 Ig1_IL1R_like First immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig1_IL1R_like: domain similar to the first immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=97.40 E-value=0.00014 Score=59.85 Aligned_cols=37 Identities=16% Similarity=0.043 Sum_probs=33.0
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.++.|.|.+++.+|+|.|+|.|+|..|..++.+.|.|
T Consensus 58 ~~~~L~I~~~~~~DsG~Y~C~~~N~~g~~~~~~~L~v 94 (94)
T cd05756 58 QKDLLWFLPAALEDSGLYTCVVRNSTYCMKVSISLTV 94 (94)
T ss_pred cCCeEEEccCCcccCeEEEEEEcCCCccEEEEEEEEC
Confidence 3568999999999999999999999999999887754
No 287
>PF07654 C1-set: Immunoglobulin C1-set domain; InterPro: IPR003597 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C1-set domains, which are classical Ig-like domains resembling the antibody constant domain. C1-set domains are found almost exclusively in molecules involved in the immune system, such as in immunoglobulin light and heavy chains, in the major histocompatibility complex (MHC) class I and II complex molecules [, ], and in various T-cell receptors.; PDB: 3BVN_D 3BXN_A 3PWV_E 3L9R_F 2XFX_B 1BMG_A 1K8I_A 3M1B_G 3M17_C 1EXU_A ....
Probab=97.39 E-value=0.0018 Score=51.90 Aligned_cols=70 Identities=27% Similarity=0.455 Sum_probs=51.3
Q ss_pred cCceEEEEEEEEec-CCC-eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 274 AGGNVTMSCYVYGD-PEP-TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 274 ~G~~v~l~C~~~g~-P~p-~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
.++.++|.|.+.|. |.. .|.|+++|..+...........++++.+...+.|.+. ..+...|+|++.....
T Consensus 7 ~~~~~~L~C~v~~f~P~~i~v~W~~~~~~~~~~~~~~~~~~~~dgty~~~s~l~v~---~~~~~~ysC~V~H~~l 78 (83)
T PF07654_consen 7 LGGSVTLTCLVSGFYPKDITVTWLKNGKEVTEGVETTPPPPNSDGTYSVTSSLTVT---WNSGDEYSCRVTHESL 78 (83)
T ss_dssp STSEEEEEEEEEEEBSSTEEEEEEETTEEETTTEEEEEEEEETTSEEEEEEEEEEE---TTTTGGEEEEEEETTS
T ss_pred CCCCEEEEEEEEEEECCCcEEEEEeccceeeeeeeecccccccccceeeeEEEEec---CCCCCEEEEEEEECCC
Confidence 47889999999985 544 6899999998876544333332456677778888887 5556689999987654
No 288
>cd05769 IgC_TCR_beta T cell receptor (TCR) beta chain constant immunoglobulin domain. IgC_TCR_beta: Constant domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the beta chain. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The antigen binding site is formed by the variable domains of the alpha and beta chains, located at the N-terminus of each chain. Alpha/beta TCRs recognize antigens differently from gamma/delta TCRs.
Probab=97.39 E-value=0.00096 Score=56.82 Aligned_cols=93 Identities=18% Similarity=0.319 Sum_probs=59.9
Q ss_pred CCceeeee-cceEeecCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccc-eeeccCCceeeeeeEEEEEecCCCC-C
Q psy10487 260 PPNVTIKE-SMVIREAGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDL-LEEEEGDALFEKSVSITLFNVTDLD-A 334 (610)
Q Consensus 260 ~P~i~~~~-~~~~v~~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~-~~~~~~~~~~~~~~~L~I~~v~~~D-~ 334 (610)
+|.+.+.+ ......+++.++|.|.+.|. |. .+|+|++||..+....... .....+++.+..++.|.|......| .
T Consensus 2 ~P~V~v~~ps~~e~~~~~~~tL~Cla~gFyP~~I~V~W~kng~~l~~g~~~~~~~~~~~~gTYs~~S~L~v~~~~w~~~~ 81 (115)
T cd05769 2 PPTVAIFPPSEAEIRNKRKATLVCLATGFYPDHVSLSWKVNGKEVTDGVATDPQALRENTSTYSISSRLRVSATEWFNPR 81 (115)
T ss_pred CCEEEEECcChHHhccCCCcEEEEEEEeEeCCCcEEEEEECCEECCCCcccccceecCCCCeEEEEEEEEEChHHhccCC
Confidence 35555543 33333456789999999985 54 3789999999876543211 1222223566778888887665544 5
Q ss_pred eEEEEEeecCCcceeEEE
Q psy10487 335 GEYTCYAENIRGNASGEI 352 (610)
Q Consensus 335 G~Y~C~a~N~~G~~~~~~ 352 (610)
..|+|.+...........
T Consensus 82 ~~ytC~V~H~g~~~~~~~ 99 (115)
T cd05769 82 NTFTCIVQFYGGTDTDKW 99 (115)
T ss_pred CeEEEEEEEeCCccceee
Confidence 689999988765554443
No 289
>cd04973 Ig1_FGFR First immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Ig1_FGFR: The first immunoglobulin (Ig)-like domain of fibroblast growth factor receptor (FGFR). Fibroblast growth factors (FGFs) participate in morphogenesis, development, angiogenesis, and wound healing. These FGF-stimulated processes are mediated by four FGFR tyrosine kinases (FGRF1-4). FGFRs are comprised of an extracellular portion consisting of three Ig-like domains, a transmembrane helix, and a cytoplasmic portion having protein tyrosine kinase activity. The highly conserved Ig-like domains 2 and 3, and the linker region between D2 and D3 define a general binding site for all FGFs.
Probab=97.39 E-value=0.00021 Score=56.76 Aligned_cols=36 Identities=6% Similarity=-0.089 Sum_probs=31.2
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
+..|.|.+++.+|+|.|+|.|.|..|.....+.+.|
T Consensus 44 ~~~L~I~~~~~~DsG~Y~C~a~n~~g~~~~~~~v~V 79 (79)
T cd04973 44 GEEVQIKDAVPRDSGLYACVTSSPSGSDTTYFSVNV 79 (79)
T ss_pred CCEEEECCCChhhCEEEEEEEeCCCCcccEEEEEeC
Confidence 347999999999999999999999999888776643
No 290
>cd05849 Ig1_Contactin-1 First Ig domain of contactin-1. Ig1_Contactin-1: First Ig domain of the neural cell adhesion molecule contactin-1. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-1 is differentially expressed in tumor tissues and may, through a RhoA mechanism, facilitate invasion and metastasis of human lung adenocarcinoma.
Probab=97.38 E-value=6.1e-05 Score=61.90 Aligned_cols=31 Identities=10% Similarity=-0.065 Sum_probs=26.5
Q ss_pred cccceeeeeee-eccCcceeeeecCCCcceee
Q psy10487 421 QEKKLLDVSIT-TTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 421 ~~~~L~i~~v~-~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.++.|.|.++. .+|+|.|+|.|.|..|.+..
T Consensus 55 ~~g~L~I~~~~~~~D~G~Y~C~A~N~~G~~~s 86 (93)
T cd05849 55 VGGNLVINNPDKYKDAGRYVCIVSNIYGKVRS 86 (93)
T ss_pred ECCEEEECcCCcCCCCEEEEEEEEeCcceEEE
Confidence 35689998885 58999999999999998755
No 291
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=97.37 E-value=0.00074 Score=56.00 Aligned_cols=75 Identities=24% Similarity=0.341 Sum_probs=47.1
Q ss_pred eEeecCceEEEEEEEEe-cCCCeEEEEeCCE-----EeccCCccceeeccCCcee-----eeeeEEEEEecCCCCCeEEE
Q psy10487 270 VIREAGGNVTMSCYVYG-DPEPTILWLLNGQ-----VLHNSSFDLLEEEEGDALF-----EKSVSITLFNVTDLDAGEYT 338 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g-~P~p~v~W~~~g~-----~l~~~~~~~~~~~~~~~~~-----~~~~~L~I~~v~~~D~G~Y~ 338 (610)
+.+.+|++++|.|.... .....+.|++... .+..... ......++... .....|+|.+++.+|+|.|.
T Consensus 2 v~~~~G~~vtl~C~~~~~~~~~~~~W~r~~~~~~~~~l~~~~~-~~~~~~~r~~~~~~~~~~~~~L~I~~v~~~DsG~Y~ 80 (98)
T cd05716 2 VTGELGGSVTIPCPYPPKNRSYEKYWCKWGSAGCCLIIVSEGS-VQSQYEGRVSLTDDPDNGVFTVTLNQLRKEDAGWYW 80 (98)
T ss_pred EEEEeCCeEEEEeeCCCCCCCcEeEeECCCCCCCCeEEECCCc-cccccCCCEEEEecCCCCEEEEEEcCCCHHHCEEEE
Confidence 46789999999998765 4567799998432 1110000 00000011011 12358999999999999999
Q ss_pred EEeecCC
Q psy10487 339 CYAENIR 345 (610)
Q Consensus 339 C~a~N~~ 345 (610)
|.+....
T Consensus 81 C~~~~~~ 87 (98)
T cd05716 81 CGVGDDG 87 (98)
T ss_pred EEcccCC
Confidence 9987654
No 292
>KOG3515|consensus
Probab=97.36 E-value=0.00027 Score=77.65 Aligned_cols=111 Identities=16% Similarity=0.137 Sum_probs=64.3
Q ss_pred ccCCCCCCCCCCCCccC--C-CcccccccccccCCCceeeee-cceEeecCceEEEEEEEE-ecCCCeEEEEeCCEEecc
Q psy10487 229 SKLYSHPLSCTEPGMLQ--T-KHWDDVKAQEFACPPNVTIKE-SMVIREAGGNVTMSCYVY-GDPEPTILWLLNGQVLHN 303 (610)
Q Consensus 229 ~~l~~~~~~C~a~~~l~--g-~~~~~v~~~~~~c~P~i~~~~-~~~~v~~G~~v~l~C~~~-g~P~p~v~W~~~g~~l~~ 303 (610)
.+.+.+.|+|.+.+... . ............|........ ......+|+.+.|.|.+. |+|.+.+.|+++...+..
T Consensus 171 Rka~~g~~tC~A~nr~s~~l~~~~~~~i~v~~~~~~~~~~~~~~~qsF~~g~~inlvc~~~gg~P~~~~~w~~~s~~~~~ 250 (741)
T KOG3515|consen 171 RKADNGNYTCPANNRNSPGLSFAKQLTIIVEAPCKGIGITGAQEQQSFTEGQTINLVCNAQGGNPSQQQTWYKDSRPQSE 250 (741)
T ss_pred EecCCceeEcccccccCccccccceeEeecccccccceecchhhcCcccccceEEEEehhhcCCcchhhhhccccccchh
Confidence 35677889999876422 1 111222222233443333333 346678899999999774 789999999998877665
Q ss_pred CCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeec
Q psy10487 304 SSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N 343 (610)
........ .+ .....++.+..-...+.-...|.|.|
T Consensus 251 ~sl~~~~~-sg---~~v~~~~~~~~~r~~~~~~~kc~a~n 286 (741)
T KOG3515|consen 251 SSLLSQEP-SG---DTVSSTLVLRVGRQDLQAQLKCKASN 286 (741)
T ss_pred hhcccCCC-CC---CcccccccccccccchhhhhhccccC
Confidence 41100000 11 12233455444444555567799999
No 293
>cd05875 Ig6_hNeurofascin_like Sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). Ig6_hNeurofascin_like: the sixth immunoglobulin (Ig)-like domain of human neurofascin (NF). NF belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and a cytoplasmic domain. NF has many alternatively spliced isoforms having different temporal expression patterns during development. NF participates in axon subcellular targeting and synapse formation, however little is known of the functions of the different isoforms.
Probab=97.34 E-value=0.00023 Score=56.15 Aligned_cols=33 Identities=9% Similarity=-0.174 Sum_probs=26.0
Q ss_pred ccccceeeeeeee----ccCcceeeeecCCCcceeee
Q psy10487 420 DQEKKLLDVSITT----TDRHTGSCEALGSQPDMELI 452 (610)
Q Consensus 420 ~~~~~L~i~~v~~----~D~G~Y~C~A~N~~G~~~~~ 452 (610)
..++.|.|..+.. +|+|.|+|.|.|..|++...
T Consensus 36 ~~~~~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s~ 72 (77)
T cd05875 36 RRSGTLVIDFSGGGRPEDYEGEYQCFARNNLGTALSN 72 (77)
T ss_pred CCCceEEEeccCCCCCCCCCEEEEEEEEeccceEEEE
Confidence 4567899887742 47999999999999986654
No 294
>cd07703 Ig2_Nectin-2_like Second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112) and similar proteins. Ig2_Nectin-2_like: domain similar to the second immunoglobulin (Ig) domain of nectin-2 (also known as poliovirus receptor related protein 2 or CD112). Nectin-2 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development.
Probab=97.34 E-value=0.0017 Score=53.28 Aligned_cols=71 Identities=18% Similarity=0.259 Sum_probs=45.7
Q ss_pred ceEEEEEEEE-ecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeE
Q psy10487 276 GNVTMSCYVY-GDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASG 350 (610)
Q Consensus 276 ~~v~l~C~~~-g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~ 350 (610)
....+.|.+. |.|.+.|+|+++.. . ..........++.+...+.|.+......|...|+|+|.|..-....
T Consensus 16 ~~~va~C~s~~gkPaa~IsW~~~~~---g-~~~~~~~~~~~gt~tv~S~l~~~P~~~d~Gk~ltC~v~h~al~~~~ 87 (95)
T cd07703 16 PVPVAKCVSANGRPPARISWSSTLG---G-NANTTSKENGDGTVTVTSEYSLVPTPEANGKEVTCKVEHETLQEPQ 87 (95)
T ss_pred ccEEEEEEcCCCCCCcEEEEEcCCC---C-CeeEEEEeCCCCCEEEEEEEEEecCHHHCCCEEEEEEeCcccCCCe
Confidence 3578999885 88999999999721 1 1111222222334455677877655556666899999998754333
No 295
>cd05724 Ig2_Robo Second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Ig2_Robo: domain similar to the second immunoglobulin (Ig)-like domain in Robo (roundabout) receptors. Robo receptors play a role in the development of the central nervous system (CNS), and are receptors of Slit protein. Slit is a repellant secreted by the neural cells in the midline. Slit acts through Robo to prevent most neurons from crossing the midline from either side. Three mammalian Robo homologs (robo1, -2, and -3), and three mammalian Slit homologs (Slit-1,-2, -3), have been identified. Commissural axons, which cross the midline, express low levels of Robo; longitudinal axons, which avoid the midline, express high levels of Robo. robo1, -2, and -3 are expressed by commissural neurons in the vertebrate spinal cord and Slits 1, -2, -3 are expressed at the ventral midline. Robo-3 is a divergent member of the Robo family which instead of being a positive regulator of slit responsiveness, antago
Probab=97.33 E-value=6e-05 Score=60.84 Aligned_cols=30 Identities=23% Similarity=0.212 Sum_probs=27.2
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceee
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
++.|.|.+++.+|+|.|+|.|.|..|....
T Consensus 50 ~~~L~I~~~~~~D~G~Y~C~a~N~~G~~~s 79 (86)
T cd05724 50 DGNLLIAEARKSDEGTYKCVATNMVGERES 79 (86)
T ss_pred CCEEEEeECCcccCEEEEEEEEeccCceee
Confidence 568999999999999999999999998654
No 296
>cd05891 Ig_M-protein_C C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). Ig_M-protein_C: the C-terminal immunoglobulin (Ig)-like domain of M-protein (also known as myomesin-2). M-protein is a structural protein localized to the M-band, a transverse structure in the center of the sarcomere, and is a candidate for M-band bridges. M-protein is modular consisting mainly of repetitive IG-like and fibronectin type III (FnIII) domains, and has a muscle-type specific expression pattern. M-protein is present in fast fibers.
Probab=97.32 E-value=0.00031 Score=57.59 Aligned_cols=35 Identities=11% Similarity=-0.075 Sum_probs=31.1
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..|.|.+++.+|+|.|+|.|.|..|.++.+..+.|
T Consensus 58 ~~L~I~~~~~~D~G~Y~C~a~N~~G~~~~~~~v~~ 92 (92)
T cd05891 58 ASLTIKGVTSEDSGKYSINVKNKYGGETVDVTVSV 92 (92)
T ss_pred EEEEECCCChhhCEEEEEEEEeCCCceeeEEEEEC
Confidence 37999999999999999999999999988777653
No 297
>cd05733 Ig6_L1-CAM_like Sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig6_L1-CAM_like: domain similar to the sixth immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth. This group also contains NrCAM [Ng(neuronglia)CAM-related cell adhesion molecule], which is primarily expressed in the nervous system, and human neurofascin.
Probab=97.31 E-value=0.00021 Score=56.39 Aligned_cols=32 Identities=9% Similarity=-0.053 Sum_probs=26.3
Q ss_pred ccccceeeeeeee----ccCcceeeeecCCCcceee
Q psy10487 420 DQEKKLLDVSITT----TDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 420 ~~~~~L~i~~v~~----~D~G~Y~C~A~N~~G~~~~ 451 (610)
..++.|.|.++.. +|+|.|+|.|.|..|++..
T Consensus 36 ~~~g~L~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05733 36 PDSGTLVIDNMNGGRAEDYEGEYQCYASNELGTAIS 71 (77)
T ss_pred CCCCEEEEeccCCCCCcCCCEEEEEEEEcCCCcEEc
Confidence 4567888888754 6999999999999998654
No 298
>cd05848 Ig1_Contactin-5 First Ig domain of contactin-5. Ig1_Contactin-5: First Ig domain of the neural cell adhesion molecule contactin-5. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains, anchored to the membrane by glycosylphosphatidylinositol. The different contactins show different expression patterns in the central nervous system. In rats, a lack of contactin-5 (NB-2) results in an impairment of the neuronal activity in the auditory system. Contactin-5 is expressed specifically in the postnatal nervous system, peaking at about 3 weeks postnatal. Contactin-5 is highly expressed in the adult human brain in the occipital lobe and in the amygdala; lower levels of expression have been detected in the corpus callosum, caudate nucleus, and spinal cord.
Probab=97.30 E-value=0.00032 Score=57.76 Aligned_cols=31 Identities=16% Similarity=0.094 Sum_probs=26.1
Q ss_pred cccceeeeeee-eccCcceeeeecCCCcceee
Q psy10487 421 QEKKLLDVSIT-TTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 421 ~~~~L~i~~v~-~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.++.|.|.++. .+|+|.|+|.|+|..|++..
T Consensus 56 ~~g~L~i~~~~~~~D~G~Y~C~A~N~~G~~~S 87 (94)
T cd05848 56 IDGNLIISNPSEVKDSGRYQCLATNSIGSILS 87 (94)
T ss_pred eCCeEEEccCCccCcCEEEEEEEEcCCCeEEe
Confidence 45678898875 68999999999999998754
No 299
>PRK15386 type III secretion protein GogB; Provisional
Probab=97.29 E-value=0.00073 Score=69.99 Aligned_cols=129 Identities=19% Similarity=0.300 Sum_probs=62.6
Q ss_pred cEEEcCCCCCCccCcccCCCccEEEeec-CCCCCCChhhhcccCCCCccEEEcccC-CCcccchhhhcCCCCCcEEEccC
Q psy10487 37 KSALCKDANFTALPSTLDSDIQVLDLNN-NKISYLTKEAFKSIGLLNLQRIYLKNS-GIREVHRDTFKYLTILVEVDLSD 114 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~~l~~~L~~L~L~~-n~i~~l~~~~~~~~~l~~L~~L~L~~n-~l~~i~~~~f~~l~~L~~LdLs~ 114 (610)
..++-.+..|+++| .+|.+|+.|.+++ +.++.++.. + ..+|++|.|.+| .+..++ ..|+.|+|+.
T Consensus 55 ~~L~Is~c~L~sLP-~LP~sLtsL~Lsnc~nLtsLP~~-L----P~nLe~L~Ls~Cs~L~sLP-------~sLe~L~L~~ 121 (426)
T PRK15386 55 GRLYIKDCDIESLP-VLPNELTEITIENCNNLTTLPGS-I----PEGLEKLTVCHCPEISGLP-------ESVRSLEIKG 121 (426)
T ss_pred CEEEeCCCCCcccC-CCCCCCcEEEccCCCCcccCCch-h----hhhhhheEccCcccccccc-------cccceEEeCC
Confidence 34555555677777 5677777777765 344444422 1 236677777766 444332 2456666665
Q ss_pred CCCCCCCcccccCCCCCcEEEeeCcc-ccccC-cCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccc
Q psy10487 115 NQIAWLHQDTFLGNDRLKVLYLNGNP-ITELR-AGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGN 187 (610)
Q Consensus 115 n~l~~l~~~~f~~l~~L~~L~Ls~N~-l~~l~-~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 187 (610)
+.+..+.. -.++|+.|.+.+++ ..... +..+ .++|+.|++++|....++ ..+ -.+|+.|.++.+
T Consensus 122 n~~~~L~~----LPssLk~L~I~~~n~~~~~~lp~~L--PsSLk~L~Is~c~~i~LP-~~L--P~SLk~L~ls~n 187 (426)
T PRK15386 122 SATDSIKN----VPNGLTSLSINSYNPENQARIDNLI--SPSLKTLSLTGCSNIILP-EKL--PESLQSITLHIE 187 (426)
T ss_pred CCCccccc----CcchHhheecccccccccccccccc--CCcccEEEecCCCcccCc-ccc--cccCcEEEeccc
Confidence 54433211 01345555554322 11000 0011 146677777666544332 111 135666666554
No 300
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=97.27 E-value=0.00024 Score=67.89 Aligned_cols=162 Identities=20% Similarity=0.241 Sum_probs=110.0
Q ss_pred CCCccEEEeecCCCCCCChhhhcc--cCCCCccEEEcccCCCcc----------cchhhhcCCCCCcEEEccCCCCCCCC
Q psy10487 54 DSDIQVLDLNNNKISYLTKEAFKS--IGLLNLQRIYLKNSGIRE----------VHRDTFKYLTILVEVDLSDNQIAWLH 121 (610)
Q Consensus 54 ~~~L~~L~L~~n~i~~l~~~~~~~--~~l~~L~~L~L~~n~l~~----------i~~~~f~~l~~L~~LdLs~n~l~~l~ 121 (610)
...+..++|++|.|..--..++.+ .+-.+|+..+++.--... .--.++.+++.|+.++||+|.+..-.
T Consensus 29 ~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~ 108 (388)
T COG5238 29 MDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEF 108 (388)
T ss_pred hcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCccc
Confidence 357899999999987544444432 134566666665432211 11345778999999999999886433
Q ss_pred c----ccccCCCCCcEEEeeCccccccCcCcC-------------CCCCCccEEEccCccccccCHH----HhhcCcccc
Q psy10487 122 Q----DTFLGNDRLKVLYLNGNPITELRAGQF-------------PKLPYLKTIELQHCQIHSVHKD----ALIHLTALE 180 (610)
Q Consensus 122 ~----~~f~~l~~L~~L~Ls~N~l~~l~~~~~-------------~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~ 180 (610)
+ +.++....|.+|.|++|.+..+...-+ ..-+.|+.+....|++...+.. .|..-.+|+
T Consensus 109 ~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~~lk 188 (388)
T COG5238 109 PEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHENLK 188 (388)
T ss_pred chHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhcCce
Confidence 2 345667899999999998776543222 2348899999999999876543 233335889
Q ss_pred cccccccccccc--Cc---ccccCCCcccEEecCCCcccc
Q psy10487 181 SLNLNGNRLKHL--SE---SVFFPTPNLKTLSLDGNPWCC 215 (610)
Q Consensus 181 ~L~L~~n~l~~~--~~---~~~~~~~~L~~l~l~~N~~~c 215 (610)
.+.+..|.|..- .. ..+.-+.+|+.|++++|.|+-
T Consensus 189 ~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~ 228 (388)
T COG5238 189 EVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTL 228 (388)
T ss_pred eEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhh
Confidence 999999987632 11 122346789999999999864
No 301
>cd05722 Ig1_Neogenin First immunoglobulin (Ig)-like domain in neogenin and similar proteins. Ig1_Neogenin: first immunoglobulin (Ig)-like domain in neogenin and related proteins. Neogenin is a cell surface protein which is expressed in the developing nervous system of vertebrate embryos in the growing nerve cells. It is also expressed in other embryonic tissues, and may play a general role in developmental processes such as cell migration, cell-cell recognition, and tissue growth regulation. Included in this group is the tumor suppressor protein DCC, which is deleted in colorectal carcinoma . DCC and neogenin each have four Ig-like domains followed by six fibronectin type III domains, a transmembrane domain, and an intracellular domain.
Probab=97.26 E-value=0.00016 Score=59.75 Aligned_cols=34 Identities=18% Similarity=0.136 Sum_probs=25.8
Q ss_pred ccceeeeee-----eeccCcceeeeecCC-Ccceee-eeec
Q psy10487 422 EKKLLDVSI-----TTTDRHTGSCEALGS-QPDMEL-IEQS 455 (610)
Q Consensus 422 ~~~L~i~~v-----~~~D~G~Y~C~A~N~-~G~~~~-~~~l 455 (610)
++.|.|.++ ...|+|.|+|.|.|. .|.+.. .++|
T Consensus 53 ~~~l~i~~v~~~~~~~~D~G~Y~C~a~N~~~G~~~s~~~~l 93 (95)
T cd05722 53 NGSLLITSVVHSKHNKPDEGFYQCVAQNDSLGSIVSRTARL 93 (95)
T ss_pred CCeEEEeeeeccCCCCCcCEEEEEEEECCccCcEEEeeeEE
Confidence 456777777 477999999999999 998733 3444
No 302
>cd07702 Ig2_VEGFR-1 Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). Ig2_VEGFR-1: Second immunoglobulin (Ig)-like domain of vascular endothelial growth factor receptor 1 (VEGFR-1). VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. VEGFRs bind VEGFs with high affinity at the Ig-like domains. VEGFR-1 binds VEGF-A strongly; VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-1 may play an inhibitory rolet in the function of VEGFR-2 by binding VEGF-A and interfering with its interaction with VEGFR-2. VEGFR-1 has a signaling role in mediating monocyte chemotaxis and may mediate a chemotactic and a survival signal in hematopoietic stem cells or leukemia cells.
Probab=97.24 E-value=0.00033 Score=54.27 Aligned_cols=31 Identities=13% Similarity=-0.120 Sum_probs=25.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceee
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.+..|.|.+++.+|+|.|+|.|+|..+....
T Consensus 34 ~~~~L~I~~v~~~D~G~YtC~a~~~~~~~~~ 64 (72)
T cd07702 34 DGYSLVIKDVTEEDAGIYTILLGIKQYNLFK 64 (72)
T ss_pred CCCEEEECcCCHHHCEEEEEEEEccccceEe
Confidence 3457999999999999999999997655433
No 303
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=97.22 E-value=0.002 Score=53.04 Aligned_cols=79 Identities=18% Similarity=0.344 Sum_probs=47.2
Q ss_pred ceEEEEEEEEe-cCCCeEEEEeCCE----EeccCC--ccceeecc--CCcee----eeeeEEEEEecCCCCCeEEEEEee
Q psy10487 276 GNVTMSCYVYG-DPEPTILWLLNGQ----VLHNSS--FDLLEEEE--GDALF----EKSVSITLFNVTDLDAGEYTCYAE 342 (610)
Q Consensus 276 ~~v~l~C~~~g-~P~p~v~W~~~g~----~l~~~~--~~~~~~~~--~~~~~----~~~~~L~I~~v~~~D~G~Y~C~a~ 342 (610)
++++|.|.... .....|+|.|... .+.... ....+... ++..+ ...++|.|.+++.+|+|.|+|.+.
T Consensus 1 ~~vtL~C~~~~~~~~~qV~W~k~~~~~~~~iavy~~~~g~~~~~~y~~Rv~f~~~~~~d~sI~i~nvt~~D~G~Y~C~~~ 80 (96)
T cd05889 1 EKMKLECVYPKTGVLIQVSWTKHNGSHKENIAVYHPIYGMHIEDKYRGRVYFLNSTREDMSLSFNNATEEDVGLYCCSLV 80 (96)
T ss_pred CCEEEEeEcCCCCcEEEEEEEEcCCCCCceEEEEECCCCCEECccccCeEEEecCCCCccEEEEcCCCcccCEEEEEEEE
Confidence 36889998753 2345789998432 121110 00011111 01001 134799999999999999999986
Q ss_pred cC-CcceeEEEEE
Q psy10487 343 NI-RGNASGEISL 354 (610)
Q Consensus 343 N~-~G~~~~~~~L 354 (610)
.- .|..++.+.+
T Consensus 81 t~P~g~~~~~i~~ 93 (96)
T cd05889 81 TYPQGSWEKVIEV 93 (96)
T ss_pred eCCCCCeEEEEEE
Confidence 64 7777777665
No 304
>cd04977 Ig1_NCAM-1_like First immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1 and similar proteins. Ig1_NCAM-1 like: first immunoglobulin (Ig)-like domain of neural cell adhesion molecule NCAM-1. NCAM-1 plays important roles in the development and regeneration of the central nervous system, in synaptogenesis and neural migration. NCAM mediates cell-cell and cell-substratum recognition and adhesion via homophilic (NCAM-NCAM), and heterophilic (NCAM-nonNCAM), interactions. NCAM is expressed as three major isoforms having different intracellular extensions. The extracellular portion of NCAM has five N-terminal Ig-like domains and two fibronectin type III domains. The double zipper adhesion complex model for NCAM homophilic binding involves the Ig1, Ig2, and Ig3 domains. By this model, Ig1 and Ig2 mediate dimerization of NCAM molecules situated on the same cell surface (cis interactions), and Ig3 domains mediate interactions between NCAM molecules expressed on the s
Probab=97.22 E-value=0.00049 Score=56.37 Aligned_cols=35 Identities=14% Similarity=0.060 Sum_probs=28.1
Q ss_pred ccceeeeeeeeccCcceeeeecCCCc-ceeeeeecc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQP-DMELIEQSL 456 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G-~~~~~~~l~ 456 (610)
...|+|.+++.+|+|.|+|.|.|..| ..+.+..|.
T Consensus 56 ~~~L~I~~v~~~D~G~Y~C~A~N~~g~~~~~sv~l~ 91 (92)
T cd04977 56 RSTLTIYNANIEDAGIYKCVATDAKGTESEATVNLK 91 (92)
T ss_pred EEEEEEecCCcccCEEEEEEEEcCCCCcceeEEEEE
Confidence 35799999999999999999999965 445555543
No 305
>KOG3665|consensus
Probab=97.22 E-value=0.00015 Score=81.06 Aligned_cols=131 Identities=16% Similarity=0.195 Sum_probs=84.0
Q ss_pred CccEEEeecCCC-C-CCChhhhcccCCCCccEEEcccCCCcccc-hhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCc
Q psy10487 56 DIQVLDLNNNKI-S-YLTKEAFKSIGLLNLQRIYLKNSGIREVH-RDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLK 132 (610)
Q Consensus 56 ~L~~L~L~~n~i-~-~l~~~~~~~~~l~~L~~L~L~~n~l~~i~-~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~ 132 (610)
+|+.||+++... . .++..... -|++|+.|.+.+-.+..-. ...+.++++|..||+|+.+++.+ ..++.+++|+
T Consensus 123 nL~~LdI~G~~~~s~~W~~kig~--~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl--~GIS~LknLq 198 (699)
T KOG3665|consen 123 NLQHLDISGSELFSNGWPKKIGT--MLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNL--SGISRLKNLQ 198 (699)
T ss_pred hhhhcCccccchhhccHHHHHhh--hCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCc--HHHhccccHH
Confidence 788888887642 1 22222222 4788898888876654332 12346788888999999888887 4577888888
Q ss_pred EEEeeCccccccC-cCcCCCCCCccEEEccCccccccC--HH----HhhcCcccccccccccccc
Q psy10487 133 VLYLNGNPITELR-AGQFPKLPYLKTIELQHCQIHSVH--KD----ALIHLTALESLNLNGNRLK 190 (610)
Q Consensus 133 ~L~Ls~N~l~~l~-~~~~~~l~~L~~L~L~~n~l~~~~--~~----~~~~l~~L~~L~L~~n~l~ 190 (610)
.|.+.+=.+..-. -..+-+|.+|+.||+|........ .. ....+++|+.||.+++.+.
T Consensus 199 ~L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi~ 263 (699)
T KOG3665|consen 199 VLSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDIN 263 (699)
T ss_pred HHhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcchh
Confidence 8887765554421 122446788888888876443332 11 1123678888888877654
No 306
>KOG2982|consensus
Probab=97.22 E-value=0.00038 Score=67.44 Aligned_cols=81 Identities=20% Similarity=0.238 Sum_probs=55.8
Q ss_pred cEEEcCCCCCCccCc--cc---CCCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCCCcccch-hhhcCCCCCcEE
Q psy10487 37 KSALCKDANFTALPS--TL---DSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSGIREVHR-DTFKYLTILVEV 110 (610)
Q Consensus 37 ~~~~C~~~~l~~lP~--~l---~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~l~~i~~-~~f~~l~~L~~L 110 (610)
+.+|..++++..... .| .+.|++|+|+.|.+..-....- +.+.+|+.|-|.+..+..-.. ..+..++.+++|
T Consensus 74 ~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp--~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtel 151 (418)
T KOG2982|consen 74 KELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP--LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTEL 151 (418)
T ss_pred hhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc--ccccceEEEEEcCCCCChhhhhhhhhcchhhhhh
Confidence 566777776654332 11 2479999999998865332221 247799999999988765433 345789999999
Q ss_pred EccCCCCCC
Q psy10487 111 DLSDNQIAW 119 (610)
Q Consensus 111 dLs~n~l~~ 119 (610)
.++.|++..
T Consensus 152 HmS~N~~rq 160 (418)
T KOG2982|consen 152 HMSDNSLRQ 160 (418)
T ss_pred hhccchhhh
Confidence 999996554
No 307
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=97.21 E-value=0.0026 Score=53.75 Aligned_cols=73 Identities=18% Similarity=0.254 Sum_probs=44.3
Q ss_pred EeecCceEEEEEEEEecC-CCeEEEEeC--C---EE----eccCCccceeec----cCCcee-----eeeeEEEEEecCC
Q psy10487 271 IREAGGNVTMSCYVYGDP-EPTILWLLN--G---QV----LHNSSFDLLEEE----EGDALF-----EKSVSITLFNVTD 331 (610)
Q Consensus 271 ~v~~G~~v~l~C~~~g~P-~p~v~W~~~--g---~~----l~~~~~~~~~~~----~~~~~~-----~~~~~L~I~~v~~ 331 (610)
.+.+|++++|.|.+.+.. ...+.|++- | .. +........... ...... .....|+|.+++.
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~~~~Wyrq~~g~~~~~~~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~~~~ 81 (107)
T cd07700 2 LVQTNNTVKLSCEAKGISENTRIYWLRWRQAPKDSHFEFLALWSPLGGATYGEEVSQEKFSIRVTSDSSRYRLHINRVKP 81 (107)
T ss_pred EEcCCCCEEEEEEEecCCCCCeEEEEEECCCCCCCccEEEEEEcCCCCeEEccccccCcEEEEEECCCCEEEEEECCCCH
Confidence 578899999999987643 457999983 2 10 000000000000 111111 1124699999999
Q ss_pred CCCeEEEEEeec
Q psy10487 332 LDAGEYTCYAEN 343 (610)
Q Consensus 332 ~D~G~Y~C~a~N 343 (610)
+|+|.|.|...+
T Consensus 82 ~Dsg~YyCa~~~ 93 (107)
T cd07700 82 EDSGTYFCMTVG 93 (107)
T ss_pred HHCEEEEEeEcC
Confidence 999999999854
No 308
>cd05874 Ig6_NrCAM Sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). Ig6_NrCAM: sixth immunoglobulin (Ig)-like domain of NrCAM (Ng (neuronglia) CAM-related cell adhesion molecule). NrCAM belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains and five fibronectin type III domains, a transmembrane region, and an intracellular domain. NrCAM is primarily expressed in the nervous system.
Probab=97.20 E-value=0.00039 Score=54.83 Aligned_cols=32 Identities=9% Similarity=-0.009 Sum_probs=25.5
Q ss_pred ccccceeeeeeee----ccCcceeeeecCCCcceee
Q psy10487 420 DQEKKLLDVSITT----TDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 420 ~~~~~L~i~~v~~----~D~G~Y~C~A~N~~G~~~~ 451 (610)
..++.|.|..+.. .|+|.|+|.|.|..|.+.+
T Consensus 36 ~~~g~l~i~~~~~~~~~~d~G~Y~C~A~N~~G~~~s 71 (77)
T cd05874 36 PNTGTLVINIMNGEKAEAYEGVYQCTARNERGAAVS 71 (77)
T ss_pred CCCceEEEeccccCCCCCCCEEEEEEEEcCCCeEEe
Confidence 3466788877764 3889999999999998655
No 309
>cd05861 Ig1_PDGFR-alphabeta Frst immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). Ig1_PDGFR-alphabeta: The first immunoglobulin (Ig)-like domain of platelet-derived growth factor (PDGF) receptors (R), alpha (CD140a), and beta (CD140b). PDGF is a potent mitogen for connective tissue cells. PDGF-stimulated processes are mediated by three different PDGFs (PDGF-A,-B, and C). PDGFRalpha binds to all three PDGFs, whereas the PDGFRbeta binds only to PDGF-B. PDGFRs alpha and beta have similar organization: an extracellular component with five Ig-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. In mice, PDGFRalpha and PDGFRbeta are essential for normal development.
Probab=97.19 E-value=0.00032 Score=56.40 Aligned_cols=38 Identities=18% Similarity=-0.015 Sum_probs=30.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCc--ceeeeeecccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQP--DMELIEQSLAM 458 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G--~~~~~~~l~v~ 458 (610)
....|.|.+++.+|+|.|+|.|+|..+ ..+.+..++|+
T Consensus 44 ~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~~sv~i~V~ 83 (84)
T cd05861 44 LRSTLTFPHATVEDSGTYECAAHESTQDQKAFKKVNITVH 83 (84)
T ss_pred EEEEEEECCCCcCCCEEEEEEEEECccCcceeEEEEEEEe
Confidence 356899999999999999999999876 55555555554
No 310
>cd04985 IgC_CH1 CH1 domain (first constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH1: The first immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fab antigen-binding fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=97.19 E-value=0.0031 Score=51.81 Aligned_cols=71 Identities=18% Similarity=0.262 Sum_probs=45.2
Q ss_pred cCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 274 AGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 274 ~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.++.++|.|.|.|. |. .+|+|.+||.. .............++.+..++.|++..-.-.....|+|++....
T Consensus 15 ~~~~~~L~C~a~gFyP~~i~vtW~k~g~~-~~~~~~~~~~~~~dgty~~~s~L~v~~~~w~~~~~ytC~V~H~~ 87 (95)
T cd04985 15 SSDSVTLGCLATGFLPEPVTFTWNSGSNS-TSGVKTYPAVLQSGGLYTASSQLTVPASEWKGKESFYCKVEHPS 87 (95)
T ss_pred CCCcEEEEEEEeeEECCCcEEEEeECCEE-CCCcEECCCEeCCCCCEEEEEEEEEeHHHcCCCCcEEEEEEeCC
Confidence 45679999999985 43 46899999998 33221111111224456667778766543333567999998754
No 311
>KOG2123|consensus
Probab=97.18 E-value=1.8e-05 Score=75.66 Aligned_cols=82 Identities=28% Similarity=0.376 Sum_probs=46.6
Q ss_pred CCCccEEEcccCCCcccchhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCc-CcCCCCCCccEE
Q psy10487 80 LLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRA-GQFPKLPYLKTI 158 (610)
Q Consensus 80 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~~L 158 (610)
|.+.++|++-+|.|..|. ...+|+.|+.|.|+-|+|+.+.+ |..+++|++|+|..|.|..+.. .-+.++++|+.|
T Consensus 18 l~~vkKLNcwg~~L~DIs--ic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~L 93 (388)
T KOG2123|consen 18 LENVKKLNCWGCGLDDIS--ICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRTL 93 (388)
T ss_pred HHHhhhhcccCCCccHHH--HHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhhH
Confidence 445566666666666653 23556666666666666666643 5555666666666666555543 223455555555
Q ss_pred EccCccc
Q psy10487 159 ELQHCQI 165 (610)
Q Consensus 159 ~L~~n~l 165 (610)
.|..|..
T Consensus 94 WL~ENPC 100 (388)
T KOG2123|consen 94 WLDENPC 100 (388)
T ss_pred hhccCCc
Confidence 5555543
No 312
>cd07697 IgC_TCR_gamma T cell receptor (TCR) gamma chain constant immunoglobulin domain. IgC_TCR_gamma; immunoglobulin (Ig) constant (C) domain of the gamma chain of gamma-delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha-beta TCRs but a small subset contain gamma-delta TCRs. Alpha-beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma-delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma-delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds.
Probab=97.18 E-value=0.0021 Score=52.86 Aligned_cols=69 Identities=12% Similarity=0.206 Sum_probs=46.3
Q ss_pred cCceEEEEEEEEec-CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 274 AGGNVTMSCYVYGD-PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 274 ~G~~v~l~C~~~g~-P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
.++.++|.|.|.|. |. -+++|.+||..+..+........+++ .+..++.|+|..-. ....|+|.+....
T Consensus 15 ~~~~~tL~C~a~gFyP~~I~v~W~kng~~~~~~~~~~~~~~~~d-ty~~~S~L~vt~~~--~~~~ysC~V~H~g 85 (96)
T cd07697 15 KQGQGIYLCLLENFFPDVIQVHWREGNSPSILGSQKSEKDKDND-VYSTTSWLTVTKDS--LGKKFRCIYKHEG 85 (96)
T ss_pred cCCCEEEEEEEEEEeCCCeEEEEEECCEECcCCeEeccEecCCC-EEEEEEEEEECchh--CCCeEEEEEEECC
Confidence 35678999999995 43 35799999998765433333344455 66677788765432 2335999998743
No 313
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=97.15 E-value=0.0027 Score=54.79 Aligned_cols=79 Identities=18% Similarity=0.153 Sum_probs=47.8
Q ss_pred eecceEeecCceEEEEEEEEecC------CCeEEEEeCCE-----E-eccCCcccee--eccCCc-----eeeeeeEEEE
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDP------EPTILWLLNGQ-----V-LHNSSFDLLE--EEEGDA-----LFEKSVSITL 326 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P------~p~v~W~~~g~-----~-l~~~~~~~~~--~~~~~~-----~~~~~~~L~I 326 (610)
.|..+.+.+|++++|.|...... ...+.|++... . +......... ...++. .......|.|
T Consensus 5 ~P~~v~~~~G~~VtL~C~f~~~~~~~~~~~~~~~Wykq~~g~~~~~~~~~~~~~~~~~~~f~gR~~~~~~~~~~~~sL~I 84 (119)
T cd05712 5 MPKSVSVQEGLCVLIPCSFSYPADWPVSNGVHGIWYKGHPYPKNRPPVATNNRSRLVHESTRGRFRLLGDLGKKNCSLLI 84 (119)
T ss_pred CCCEEEEeccccEEEEEEeeCcccccCCCceEEEEEeCCCCCCCCCcEEEcCCCccccccccccEEEecCCCCCEEEEEE
Confidence 35667889999999999865321 24589998421 1 1100000000 000110 0123458999
Q ss_pred EecCCCCCeEEEEEeecC
Q psy10487 327 FNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 327 ~~v~~~D~G~Y~C~a~N~ 344 (610)
.+++.+|+|.|.|.+...
T Consensus 85 ~~l~~~Dsg~Y~C~~~~~ 102 (119)
T cd05712 85 SDAQPEDSGKYFFRVELG 102 (119)
T ss_pred ccCChhhCeEEEEEEEcC
Confidence 999999999999988664
No 314
>cd05862 Ig1_VEGFR First immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). IG1_VEGFR: first immunoglobulin (Ig)-like domain of vascular endothelial growth factor (VEGF) receptor(R). The VEGFRs have an extracellular component with seven Ig-like domains, a transmembrane segment, and an intracellular tyrosine kinase domain interrupted by a kinase-insert domain. The VEGFR family consists of three members, VEGFR-1 (Flt-1), VEGFR-2 (KDR/Flk-1) and VEGFR-3 (Flt-4). VEGF_A interacts with both VEGFR-1 and VEGFR-2. VEGFR-1 binds strongest to VEGF, VEGF-2 binds more weakly. VEGFR-3 appears not to bind VEGF, but binds other members of the VEGF family (VEGF-C and -D). VEGFRs bind VEGFs with high affinity with the IG-like domains. VEGF-A is important to the growth and maintenance of vascular endothelial cells and to the development of new blood- and lymphatic-vessels in physiological and pathological states. VEGFR-2 is a major mediator of the mitogenic, angioge
Probab=97.14 E-value=0.00023 Score=57.55 Aligned_cols=39 Identities=18% Similarity=0.069 Sum_probs=33.8
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAME 459 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~ 459 (610)
....|.|.+++.+|+|.|+|.|.|..|.......+.|.|
T Consensus 48 ~~s~L~I~~~~~~DsG~Y~C~a~n~~~~~~~~t~~~V~~ 86 (86)
T cd05862 48 LSSTLTIENVTLSDLGRYTCTASSGQMIAKNSTIVIVHE 86 (86)
T ss_pred eeeEEEEecCCcccCEEEEEEEeecceEecccEEEEEeC
Confidence 346899999999999999999999999888877777653
No 315
>cd04967 Ig1_Contactin First Ig domain of contactin. Ig1_Contactin: First Ig domain of contactins. Contactins are neural cell adhesion molecules and are comprised of six Ig domains followed by four fibronectin type III(FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. The first four Ig domains form the intermolecular binding fragment, which arranges as a compact U-shaped module via contacts between Ig domains 1 and 4, and between Ig domains 2 and 3. Contactin-2 (TAG-1, axonin-1) may play a part in the neuronal processes of neurite outgrowth, axon guidance and fasciculation, and neuronal migration. This group also includes contactin-1 and contactin-5. The different contactins show different expression patterns in the central nervous system. During development and in adulthood, contactin-2 is transiently expressed in subsets of central and peripheral neurons. Contactin-5 is expressed specifically in the rat postnatal nervous system, peaking at about 3 weeks postnata
Probab=97.13 E-value=0.00064 Score=55.55 Aligned_cols=32 Identities=13% Similarity=-0.057 Sum_probs=26.5
Q ss_pred ccccceeeeeeee-ccCcceeeeecCCCcceee
Q psy10487 420 DQEKKLLDVSITT-TDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 420 ~~~~~L~i~~v~~-~D~G~Y~C~A~N~~G~~~~ 451 (610)
..++.|.|.++.. +|+|.|+|.|+|..|.+.+
T Consensus 55 ~~~~~L~i~~~~~~~d~G~Y~C~a~N~~G~~~S 87 (91)
T cd04967 55 LVGGNLVISNPSKAKDAGRYQCLASNIVGTVLS 87 (91)
T ss_pred EECCEEEEecCCccCCCEEEEEEEEcCCCEEEe
Confidence 3456789988875 8999999999999998654
No 316
>PF01462 LRRNT: Leucine rich repeat N-terminal domain; InterPro: IPR000372 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain and a C-terminal LRR domain (IPR000483 from INTERPRO). This entry represents the N-terminal LRR domain. ; PDB: 3E6J_A 1W8A_A 2V9S_C 2V9T_B 3TWI_D 3ZYN_A 3ZYO_A 1OOK_G 1QYY_G 1SQ0_B ....
Probab=97.13 E-value=0.00034 Score=42.97 Aligned_cols=28 Identities=36% Similarity=0.824 Sum_probs=22.4
Q ss_pred CCCCCCeeCccCCCcEEEcCCCCCCccCcccC
Q psy10487 23 DCPDTCRCKWTLGKKSALCKDANFTALPSTLD 54 (610)
Q Consensus 23 ~Cp~~C~C~~~~~~~~~~C~~~~l~~lP~~l~ 54 (610)
.||..|.|. ..+|+|++.+|+++|..||
T Consensus 1 ~CP~~C~C~----~~~V~C~~~~L~~vP~~lP 28 (28)
T PF01462_consen 1 ACPRPCTCS----GLTVDCSGRGLTAVPSDLP 28 (28)
T ss_dssp SSETTSEEE----TTEEEETTSS-SSS-STS-
T ss_pred CcCCCCEec----CCEeECCCCCCCccCCCCc
Confidence 499999999 4799999999999998765
No 317
>cd07696 IgC_CH3 CH3 domain (third constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH3: The third immunoglobulin constant domain (IgC) of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=97.11 E-value=0.0022 Score=52.87 Aligned_cols=75 Identities=13% Similarity=0.178 Sum_probs=48.8
Q ss_pred eEeecCceEEEEEEEEec--CC-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 270 VIREAGGNVTMSCYVYGD--PE-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 270 ~~v~~G~~v~l~C~~~g~--P~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
..+..|+.++|.|.+.|. |. ..|+|.||++...... ......+.++.+..++.|.+..-.-.+.-.|+|.+....
T Consensus 9 ~~l~~~~~~tLtC~v~gf~yP~~i~v~W~r~~~~~~~~~-~~~~~~~~dgty~~~s~l~v~~~~w~~g~~ysC~V~H~~ 86 (96)
T cd07696 9 KQLLLTKSVKLTCLVTNLTSPEGVNVTWTRGSGEPVKAS-IQPPESHNNATLSVTSTLNVSTDDWISGDTFQCKVTHPD 86 (96)
T ss_pred HHhccCCCeEEEEEEeCCCCCCCcEEEEEECCeEeeeEE-ecccccCCCCCEEEEEEEEeCHHHccCCCcEEEEEECCC
Confidence 334568899999999998 33 3579999875432211 112233445566777788776544444558999998765
No 318
>cd05754 Ig3_Perlecan_like Third immunoglobulin (Ig)-like domain found in Perlecan and similar proteins. Ig3_Perlecan_like: domain similar to the third immunoglobulin (Ig)-like domain found in Perlecan. Perlecan is a large multi-domain heparin sulfate proteoglycan, important in tissue development and organogenesis. Perlecan can be represented as 5 major portions; its fourth major portion (domain IV) is a tandem repeat of immunoglobulin-like domains (Ig2-Ig15), which can vary in size due to alternative splicing. Perlecan binds many cellular and extracellular ligands. Its domain IV region has many binding sites. Some of these have been mapped at the level of individual Ig-like domains, including a site restricted to the Ig5 domain for heparin/sulfatide, a site restricted to the Ig3 domain for nidogen-1 and nidogen-2, a site restricted to Ig4-5 for fibronectin, and sites restricted to Ig2 and to Ig13-15 for fibulin-2.
Probab=97.11 E-value=0.00062 Score=54.81 Aligned_cols=35 Identities=14% Similarity=-0.001 Sum_probs=31.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeec
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 455 (610)
.++.|.|.+++.+|+|.|.|.|.|..|..+..++|
T Consensus 50 ~~~~L~I~~v~~~DsG~Y~C~a~n~~g~~~~~~~l 84 (85)
T cd05754 50 FNGILTIRNVQLSDAGTYVCTGSNMLDTDEATATL 84 (85)
T ss_pred cCCEEEECCCCHHHCEEEEEEEeccCCeEeEEEEE
Confidence 35689999999999999999999999999888775
No 319
>cd05898 Ig5_KIRREL3 Fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). Ig5_KIRREL3: the fifth immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 protein (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1). These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development. Neph1 and 2 may mediate axonal guidance and synapse formation in certain areas of the CNS. In the kidney, they participate in the formation of the slit diaphragm.
Probab=97.10 E-value=0.00012 Score=60.51 Aligned_cols=35 Identities=23% Similarity=0.088 Sum_probs=30.0
Q ss_pred cccceeeeeeeecc-CcceeeeecCCCcceeeeeec
Q psy10487 421 QEKKLLDVSITTTD-RHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 421 ~~~~L~i~~v~~~D-~G~Y~C~A~N~~G~~~~~~~l 455 (610)
....|.|.++...| .|.|.|.|.|..|+.+...+|
T Consensus 62 ~~S~L~I~~~~~~d~~g~Y~C~a~N~~G~d~~~i~L 97 (98)
T cd05898 62 VLSTLTINNIMEADFQTHYNCTAWNSFGSGTAIIQL 97 (98)
T ss_pred cEEEEEECCCccccCCcEEEEEEEeCCccceEEEEe
Confidence 44589999998766 899999999999999887765
No 320
>KOG2739|consensus
Probab=97.10 E-value=0.0003 Score=67.24 Aligned_cols=86 Identities=28% Similarity=0.437 Sum_probs=43.8
Q ss_pred CCCccEEEcccCCCcccchhhhcCCCCCcEEEccCC--CCCCCCcccccCCCCCcEEEeeCccccccCc-CcCCCCCCcc
Q psy10487 80 LLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDN--QIAWLHQDTFLGNDRLKVLYLNGNPITELRA-GQFPKLPYLK 156 (610)
Q Consensus 80 l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n--~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~-~~~~~l~~L~ 156 (610)
+.+|+.|.+.+..++.+. .|-.|++|+.|+++.| ++..--.-....+++|++|+|++|+|..+.. ..+..+.+|.
T Consensus 42 ~~~le~ls~~n~gltt~~--~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL~ 119 (260)
T KOG2739|consen 42 FVELELLSVINVGLTTLT--NFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENLK 119 (260)
T ss_pred ccchhhhhhhccceeecc--cCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcchh
Confidence 445666666666665553 2556667777777777 3322111112333666666666666654321 1123344445
Q ss_pred EEEccCccccc
Q psy10487 157 TIELQHCQIHS 167 (610)
Q Consensus 157 ~L~L~~n~l~~ 167 (610)
.|++.+|..+.
T Consensus 120 ~Ldl~n~~~~~ 130 (260)
T KOG2739|consen 120 SLDLFNCSVTN 130 (260)
T ss_pred hhhcccCCccc
Confidence 55555544433
No 321
>smart00082 LRRCT Leucine rich repeat C-terminal domain.
Probab=97.08 E-value=0.00028 Score=50.66 Aligned_cols=49 Identities=35% Similarity=0.766 Sum_probs=38.3
Q ss_pred CcccccCCchhhHHHHhhcc--CCCCCCCCCCCCccCCCcccccccccccCC
Q psy10487 211 NPWCCDCHLRSFRNWLLKSK--LYSHPLSCTEPGMLQTKHWDDVKAQEFACP 260 (610)
Q Consensus 211 N~~~c~c~l~~~~~~l~~~~--l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~ 260 (610)
|+|.|||.+.||..|+.... .....+.|..+..+. ..+.++...++.|+
T Consensus 1 NP~~CdC~l~~~~~w~~~~~~~~~~~~~~C~~P~~~~-~~l~~~~~~~~~C~ 51 (51)
T smart00082 1 NPFICDCELRWLLRWLQANEHLQDPVSLRCASPSSLR-GPLLELLHSEFKCP 51 (51)
T ss_pred CCccCcCCchHHHHHHHhCCccCCCCCCEeCCcHHHH-hHHHcCCHhhCCCc
Confidence 89999999999999998732 234579999998877 55777776667664
No 322
>smart00013 LRRNT Leucine rich repeat N-terminal domain.
Probab=97.08 E-value=0.00065 Score=43.66 Aligned_cols=31 Identities=29% Similarity=0.745 Sum_probs=27.4
Q ss_pred CCCCCCeeCccCCCcEEEcCCCCCCccCcccCCCc
Q psy10487 23 DCPDTCRCKWTLGKKSALCKDANFTALPSTLDSDI 57 (610)
Q Consensus 23 ~Cp~~C~C~~~~~~~~~~C~~~~l~~lP~~l~~~L 57 (610)
.||..|.|. ...|+|.+.+|+++|..||.+.
T Consensus 1 ~CP~~C~C~----~~~V~C~~~~L~~vP~~iP~~t 31 (33)
T smart00013 1 ACPAPCNCS----GTAVDCSGRGLTEVPLDLPPDT 31 (33)
T ss_pred CcCCCCEEC----CCEeEeCCCCcCccCCCCCccc
Confidence 499999998 3689999999999999898754
No 323
>cd05749 Ig2_Tyro3_like Second immunoglobulin (Ig)-like domain of Axl/Tyro3 receptor tyrosine kinases (RTKs). Ig2_Tyro3_like: the second immunoglobulin (Ig)-like domain in the Axl/Tyro3 family of receptor tyrosine kinases (RTKs). This family includes Axl (also known as Ark, Ufo, and Tyro7), Tyro3 (also known as Sky, Rse, Brt, Dtk, and Tif), and Mer (also known as Nyk, c-Eyk, and Tyro12). Axl/Tyro3 family receptors have an extracellular portion with two Ig-like domains followed by two fibronectin-types III (FNIII) domains, a membrane-spanning single helix, and a cytoplasmic tyrosine kinase domain. Axl, Tyro3 and Mer are widely expressed in adult tissues, though they show higher expression in the brain, in the lymphatic and vascular systems, and in the testis. Axl, Tyro3, and Mer bind the vitamin K dependent protein Gas6 with high affinity, and in doing so activate their tyrosine kinase activity. Axl/Gas6 signaling may play a part in cell adhesion processes, prevention of apoptosis, and c
Probab=97.05 E-value=0.00074 Score=53.77 Aligned_cols=29 Identities=17% Similarity=0.103 Sum_probs=23.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceee
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
..+.|.|..+ .|.|.|.|+|+|..|....
T Consensus 47 ~~s~L~i~~~--~d~g~Y~C~A~N~~G~~~s 75 (81)
T cd05749 47 SPSVLNVPGL--NETSKFSCEAHNAKGVTTS 75 (81)
T ss_pred CCCEEEEccc--cCCeEEEEEEEeccCcEEe
Confidence 3456888776 4889999999999997765
No 324
>KOG3665|consensus
Probab=96.94 E-value=0.00056 Score=76.66 Aligned_cols=131 Identities=18% Similarity=0.236 Sum_probs=69.0
Q ss_pred CCccEEEcccCCCc-ccchhhh-cCCCCCcEEEccCCCCCCCC-cccccCCCCCcEEEeeCccccccCcCcCCCCCCccE
Q psy10487 81 LNLQRIYLKNSGIR-EVHRDTF-KYLTILVEVDLSDNQIAWLH-QDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKT 157 (610)
Q Consensus 81 ~~L~~L~L~~n~l~-~i~~~~f-~~l~~L~~LdLs~n~l~~l~-~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~ 157 (610)
.+|++|++++...- .-.+..+ ..++.|+.|.+++-.+..-. ...+.++++|..||+++.+++.+. .++.|.+|+.
T Consensus 122 ~nL~~LdI~G~~~~s~~W~~kig~~LPsL~sL~i~~~~~~~~dF~~lc~sFpNL~sLDIS~TnI~nl~--GIS~LknLq~ 199 (699)
T KOG3665|consen 122 QNLQHLDISGSELFSNGWPKKIGTMLPSLRSLVISGRQFDNDDFSQLCASFPNLRSLDISGTNISNLS--GISRLKNLQV 199 (699)
T ss_pred HhhhhcCccccchhhccHHHHHhhhCcccceEEecCceecchhHHHHhhccCccceeecCCCCccCcH--HHhccccHHH
Confidence 35666666664321 1111122 35666777776665443221 123455667777777777776662 3566666666
Q ss_pred EEccCccccc-cCHHHhhcCccccccccccccccccCc------ccccCCCcccEEecCCCcc
Q psy10487 158 IELQHCQIHS-VHKDALIHLTALESLNLNGNRLKHLSE------SVFFPTPNLKTLSLDGNPW 213 (610)
Q Consensus 158 L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~------~~~~~~~~L~~l~l~~N~~ 213 (610)
|.+.+=.+.. ..-..+.+|++|+.||+|..+...... +....+++|+.||.++...
T Consensus 200 L~mrnLe~e~~~~l~~LF~L~~L~vLDIS~~~~~~~~~ii~qYlec~~~LpeLrfLDcSgTdi 262 (699)
T KOG3665|consen 200 LSMRNLEFESYQDLIDLFNLKKLRVLDISRDKNNDDTKIIEQYLECGMVLPELRFLDCSGTDI 262 (699)
T ss_pred HhccCCCCCchhhHHHHhcccCCCeeeccccccccchHHHHHHHHhcccCccccEEecCCcch
Confidence 6655433332 111234566777777777654433321 1122356677777666543
No 325
>PRK15386 type III secretion protein GogB; Provisional
Probab=96.92 E-value=0.0035 Score=65.08 Aligned_cols=133 Identities=17% Similarity=0.255 Sum_probs=83.6
Q ss_pred CCccEEEeecCCCCCCChhhhcccCCCCccEEEcccCC-CcccchhhhcCCCCCcEEEccCC-CCCCCCcccccCCCCCc
Q psy10487 55 SDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNSG-IREVHRDTFKYLTILVEVDLSDN-QIAWLHQDTFLGNDRLK 132 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n~-l~~i~~~~f~~l~~L~~LdLs~n-~l~~l~~~~f~~l~~L~ 132 (610)
.+++.|++++|.|+.++ .+ ..+|+.|.+++|. +..++ +.+ ..+|++|++++| ++..++ .+|+
T Consensus 52 ~~l~~L~Is~c~L~sLP--~L----P~sLtsL~Lsnc~nLtsLP-~~L--P~nLe~L~Ls~Cs~L~sLP-------~sLe 115 (426)
T PRK15386 52 RASGRLYIKDCDIESLP--VL----PNELTEITIENCNNLTTLP-GSI--PEGLEKLTVCHCPEISGLP-------ESVR 115 (426)
T ss_pred cCCCEEEeCCCCCcccC--CC----CCCCcEEEccCCCCcccCC-chh--hhhhhheEccCcccccccc-------cccc
Confidence 47889999999999887 22 2379999998864 54443 333 357899999988 666554 4578
Q ss_pred EEEeeCccccccCcCcCCCCCCccEEEccCcc-ccccCHHHhhcC-ccccccccccccccccCcccccCCCcccEEecCC
Q psy10487 133 VLYLNGNPITELRAGQFPKLPYLKTIELQHCQ-IHSVHKDALIHL-TALESLNLNGNRLKHLSESVFFPTPNLKTLSLDG 210 (610)
Q Consensus 133 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l~l~~ 210 (610)
.|+|..|.+..+.. +. ++|+.|.+.+++ ....... ..+ .+|+.|++.+|....++.. +- ..|+.|.++.
T Consensus 116 ~L~L~~n~~~~L~~--LP--ssLk~L~I~~~n~~~~~~lp--~~LPsSLk~L~Is~c~~i~LP~~-LP--~SLk~L~ls~ 186 (426)
T PRK15386 116 SLEIKGSATDSIKN--VP--NGLTSLSINSYNPENQARID--NLISPSLKTLSLTGCSNIILPEK-LP--ESLQSITLHI 186 (426)
T ss_pred eEEeCCCCCccccc--Cc--chHhheeccccccccccccc--cccCCcccEEEecCCCcccCccc-cc--ccCcEEEecc
Confidence 88887776544321 11 467777775433 1111000 112 5789999998876554432 21 3677888766
Q ss_pred Cc
Q psy10487 211 NP 212 (610)
Q Consensus 211 N~ 212 (610)
|.
T Consensus 187 n~ 188 (426)
T PRK15386 187 EQ 188 (426)
T ss_pred cc
Confidence 53
No 326
>KOG2120|consensus
Probab=96.92 E-value=3.1e-05 Score=74.77 Aligned_cols=129 Identities=25% Similarity=0.279 Sum_probs=69.0
Q ss_pred CccEEEcccCCCcccc-hhhhcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCc-cccccCc-CcCCCCCCccEE
Q psy10487 82 NLQRIYLKNSGIREVH-RDTFKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGN-PITELRA-GQFPKLPYLKTI 158 (610)
Q Consensus 82 ~L~~L~L~~n~l~~i~-~~~f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N-~l~~l~~-~~~~~l~~L~~L 158 (610)
.|++|+|++..|+.-. ...++.+.+|+.|.|.++++.+-....+....+|+.|+|+.+ .++.... -.|..+..|..|
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~L 265 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDEL 265 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhc
Confidence 4667777666655321 133556666777777777776655556666677777777654 3332211 124456677777
Q ss_pred EccCccccccCHHH-hhcC-cccccccccccccc----ccCcccccCCCcccEEecCCC
Q psy10487 159 ELQHCQIHSVHKDA-LIHL-TALESLNLNGNRLK----HLSESVFFPTPNLKTLSLDGN 211 (610)
Q Consensus 159 ~L~~n~l~~~~~~~-~~~l-~~L~~L~L~~n~l~----~~~~~~~~~~~~L~~l~l~~N 211 (610)
+|+.|.+..-.... ..+. .+|..|+|++.+-. ++ ......+++|..|||++|
T Consensus 266 NlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~-~tL~~rcp~l~~LDLSD~ 323 (419)
T KOG2120|consen 266 NLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHL-STLVRRCPNLVHLDLSDS 323 (419)
T ss_pred CchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHH-HHHHHhCCceeeeccccc
Confidence 77776654432221 1222 35666666654211 11 011234566667777664
No 327
>cd04986 IgC_CH2 CH2 domain (second constant Ig domain of the heavy chain) in immunoglobulin. IgC_CH2: The second immunoglobulin constant domain (IgC), of immunoglobulin (Ig) heavy chains. This domain is found on the Fc fragment. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. There are two types of light chains: kappa and lambda; each composed of a constant domain and a variable domain. There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are modular proteins, in which the variable and constant domains have clear, conserved sequence patterns.
Probab=96.91 E-value=0.0033 Score=51.84 Aligned_cols=85 Identities=14% Similarity=0.297 Sum_probs=52.6
Q ss_pred CCCceeeee-cceEeecCceEEEEEEEEecC--C-CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCC
Q psy10487 259 CPPNVTIKE-SMVIREAGGNVTMSCYVYGDP--E-PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDA 334 (610)
Q Consensus 259 c~P~i~~~~-~~~~v~~G~~v~l~C~~~g~P--~-p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~ 334 (610)
+.|.+...+ .......++.++|.|.+.|.- . ..|+|.++|.. . ........+.++.+...+.|.+..-.-...
T Consensus 2 ~~PsV~l~pPs~e~l~~~~~atLtClV~~f~~P~~i~V~W~~~g~~-~--~~~t~~~~~~dgTys~~S~L~v~~~~W~~g 78 (99)
T cd04986 2 CKPSLSLQRPALEDLLLGSSASLTCTLSGLRDPEGAVFTWTPSGGK-E--AVQTSAESDQCGCYSVSSVLPGCAEEWNKG 78 (99)
T ss_pred CCCEEEEECcChHHhCcCCccEEEEEEeccCCCCCeEEEEEECCcc-C--cEEcCcccCCCCCEEEEEEEEeCHHHhcCC
Confidence 356666553 333344678899999999844 3 46999999876 1 111112223355667777888763332333
Q ss_pred eEEEEEeecCCc
Q psy10487 335 GEYTCYAENIRG 346 (610)
Q Consensus 335 G~Y~C~a~N~~G 346 (610)
..|+|++.....
T Consensus 79 ~~ytC~V~H~~l 90 (99)
T cd04986 79 EPFACTVTHPEG 90 (99)
T ss_pred CeEEEEEECCCc
Confidence 469999987653
No 328
>cd05753 Ig2_FcgammaR_like Second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig2_FcgammaR_like: domain similar to the second immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=96.86 E-value=0.00079 Score=53.94 Aligned_cols=28 Identities=18% Similarity=0.163 Sum_probs=25.2
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPD 448 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~ 448 (610)
....|.|.+++.+|+|.|+|.|.|..|+
T Consensus 46 ~~~~l~I~~~~~~dsG~Y~C~~~~~~~~ 73 (83)
T cd05753 46 SNSNLSIPQATLSDSGSYHCSGIIGSYD 73 (83)
T ss_pred CCceEEECccCHHHCEEEEEEEEeCCce
Confidence 4567999999999999999999999885
No 329
>cd05752 Ig1_FcgammaR_like Frst immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs) and similar proteins. Ig1_FcgammaR_like: domain similar to the first immunoglobulin (Ig)-like domain of Fcgamma-receptors (FcgammaRs). Interactions between IgG and FcgammaR are important to the initiation of cellular and humoral response. IgG binding to FcgammaR leads to a cascade of signals and ultimately to functions such as antibody-dependent-cellular-cytotoxicity (ADCC), endocytosis, phagocytosis, release of inflammatory mediators, etc. FcgammaR has two Ig-like domains. This group also contains FcepsilonRI, which binds IgE with high affinity.
Probab=96.82 E-value=0.0011 Score=52.34 Aligned_cols=24 Identities=17% Similarity=0.195 Sum_probs=21.3
Q ss_pred cccceeeeeeeeccCcceeeeecCC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
.+..|.|.++ .+|+|.|+|.|.|+
T Consensus 45 ~~~~l~i~~~-~~dsG~Y~C~a~~~ 68 (78)
T cd05752 45 TTNSYRIRAA-NNDSGEYRCQTQGS 68 (78)
T ss_pred cCCeEEEeec-ccCCEEeEEECCCC
Confidence 4568999999 99999999999985
No 330
>cd05757 Ig2_IL1R_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R) and similar proteins. Ig2_IL1R_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor (IL1R). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three IG-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta. This group also contains ILIR-like 1 (IL1
Probab=96.81 E-value=0.00082 Score=54.98 Aligned_cols=35 Identities=17% Similarity=0.154 Sum_probs=29.8
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeec
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQS 455 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l 455 (610)
.++.|.|.+++.+|+|.|+|.|+|..|........
T Consensus 50 ~~~~L~I~~v~~~DsG~YtC~~~n~~~~~~~~~t~ 84 (92)
T cd05757 50 KGSKLLIQNVTEEDAGNYTCKLTFTHNGKQYNVTR 84 (92)
T ss_pred cCCEEEEeeCChhhCEEEEEEEEecCCCEEEEEEE
Confidence 55689999999999999999999998876665544
No 331
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=96.76 E-value=0.0049 Score=52.94 Aligned_cols=78 Identities=17% Similarity=0.213 Sum_probs=47.3
Q ss_pred eecceEeecCceEEEEEEEEecC--CCeEEEEe--CCEE---ec-cCCc-cce-ee--ccCCceee-----eeeEEEEEe
Q psy10487 266 KESMVIREAGGNVTMSCYVYGDP--EPTILWLL--NGQV---LH-NSSF-DLL-EE--EEGDALFE-----KSVSITLFN 328 (610)
Q Consensus 266 ~~~~~~v~~G~~v~l~C~~~g~P--~p~v~W~~--~g~~---l~-~~~~-~~~-~~--~~~~~~~~-----~~~~L~I~~ 328 (610)
.|....+.+|++++|.|...+.- ...+.|++ .|+. +. .... ... .. ..++.... ....|+|.+
T Consensus 3 ~~~~~~v~~G~~vtL~C~~~~~~~~~~~~~WYkQ~~g~~p~~l~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~~~L~I~~ 82 (117)
T cd04981 3 ESGPGLVKPGQSLKLSCKASGFTFTSYGVNWVRQAPGKGLEWIGFINPGGGETYYADSVKGRFTITRDTSKSTVYLQLNS 82 (117)
T ss_pred cCCCeEEcCCCCEEEEEEEeCCCcccceEEEEEECCCCCcEEEEEEecCCCceEeCcccCCcEEEEEEccCCEEEEEECC
Confidence 35567789999999999876543 45699998 2221 10 0000 000 00 01111111 123799999
Q ss_pred cCCCCCeEEEEEeec
Q psy10487 329 VTDLDAGEYTCYAEN 343 (610)
Q Consensus 329 v~~~D~G~Y~C~a~N 343 (610)
++.+|+|.|.|.+..
T Consensus 83 ~~~~Dsa~YyCa~~~ 97 (117)
T cd04981 83 LTPEDTAVYYCARGL 97 (117)
T ss_pred CCHHHCEEEEEEEEc
Confidence 999999999998864
No 332
>cd05729 Ig2_FGFR_like Second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor and similar proteins. Ig2_FGFR_like: domain similar to the second immunoglobulin (Ig)-like domain of fibroblast growth factor (FGF) receptor. FGF receptors bind FGF signaling polypeptides. FGFs participate in multiple processes such as morphogenesis, development, and angiogenesis. FGFs bind to four FGF receptor tyrosine kinases (FGFR1, -2, -3, -4). Receptor diversity is controlled by alternative splicing producing splice variants with different ligand binding characteristics and different expression patterns. FGFRs have an extracellular region comprised of three Ig-like domains, a single transmembrane helix, and an intracellular tyrosine kinase domain. Ligand binding and specificity reside in the Ig-like domains 2 and 3, and the linker region that connects these two. FGFR activation and signaling depend on FGF-induced dimerization, a process involving cell surface heparin or heparin
Probab=96.75 E-value=0.0017 Score=51.95 Aligned_cols=34 Identities=12% Similarity=0.038 Sum_probs=30.2
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
..|.|.+++.+|+|.|.|.|.|..|..+.+.+|.
T Consensus 51 ~~l~i~~~~~~d~g~Y~C~~~n~~g~~~~~~~l~ 84 (85)
T cd05729 51 WTLILESVVPSDSGKYTCIVENKYGSINHTYKVD 84 (85)
T ss_pred EEEEEeECCcccCEEEEEEEEECCceEEEEEEEe
Confidence 4689999999999999999999999988877764
No 333
>KOG2739|consensus
Probab=96.73 E-value=0.00059 Score=65.25 Aligned_cols=102 Identities=26% Similarity=0.278 Sum_probs=57.3
Q ss_pred CCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccc--cccCcCcCCCCCCccEEEccCccccccCH-HHhhcCccc
Q psy10487 103 YLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPI--TELRAGQFPKLPYLKTIELQHCQIHSVHK-DALIHLTAL 179 (610)
Q Consensus 103 ~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l--~~l~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L 179 (610)
.+..|+.|.+.+..++.+. .|-.|++|+.|.++.|.+ ..--.-...++++|++|+|++|+|+-+.. ..+..+.+|
T Consensus 41 ~~~~le~ls~~n~gltt~~--~~P~Lp~LkkL~lsdn~~~~~~~l~vl~e~~P~l~~l~ls~Nki~~lstl~pl~~l~nL 118 (260)
T KOG2739|consen 41 EFVELELLSVINVGLTTLT--NFPKLPKLKKLELSDNYRRVSGGLEVLAEKAPNLKVLNLSGNKIKDLSTLRPLKELENL 118 (260)
T ss_pred cccchhhhhhhccceeecc--cCCCcchhhhhcccCCcccccccceehhhhCCceeEEeecCCccccccccchhhhhcch
Confidence 3445555666666665553 255567788888888733 32111123345778888888887764321 233455667
Q ss_pred cccccccccccccCc---ccccCCCcccEE
Q psy10487 180 ESLNLNGNRLKHLSE---SVFFPTPNLKTL 206 (610)
Q Consensus 180 ~~L~L~~n~l~~~~~---~~~~~~~~L~~l 206 (610)
..|++.+|..+.+.. .+|.-+++|+.|
T Consensus 119 ~~Ldl~n~~~~~l~dyre~vf~ll~~L~~L 148 (260)
T KOG2739|consen 119 KSLDLFNCSVTNLDDYREKVFLLLPSLKYL 148 (260)
T ss_pred hhhhcccCCccccccHHHHHHHHhhhhccc
Confidence 777777766555332 344444555544
No 334
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=96.73 E-value=0.0029 Score=53.08 Aligned_cols=73 Identities=23% Similarity=0.297 Sum_probs=44.7
Q ss_pred EeecCceEEEEEEEEecCCCeEEEEeCC----EE---ec-cCCcccee-ec----cCCcee---eeeeEEEEEecCCCCC
Q psy10487 271 IREAGGNVTMSCYVYGDPEPTILWLLNG----QV---LH-NSSFDLLE-EE----EGDALF---EKSVSITLFNVTDLDA 334 (610)
Q Consensus 271 ~v~~G~~v~l~C~~~g~P~p~v~W~~~g----~~---l~-~~~~~~~~-~~----~~~~~~---~~~~~L~I~~v~~~D~ 334 (610)
.+.+|++|+|.|...+.-...+.|++.. .. +. ........ .. ..+... .....|+|.+++.+|+
T Consensus 2 ~v~~G~~vtL~C~~~~~~~~~v~Wyrq~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~rf~~~~~~~~~~L~I~~~~~sDs 81 (104)
T cd05720 2 DAELGQKVELKCEVLNSSPTGCSWLFQPPGSAPQPTFLVYLSGSSKITWDEEELSSKRFSGSRSSNSFVLTLKNFQKENE 81 (104)
T ss_pred cccCCCeEEEEEEecCCCCCcEEEEEeCCCCCCCCEEEEEEeCCCCeeeccccCCCceEEEEecCCEEEEEECCCCHHHC
Confidence 4678999999999866555679999832 11 11 00000000 00 010000 1234799999999999
Q ss_pred eEEEEEeec
Q psy10487 335 GEYTCYAEN 343 (610)
Q Consensus 335 G~Y~C~a~N 343 (610)
|.|.|.+.+
T Consensus 82 gtY~Ca~~~ 90 (104)
T cd05720 82 GYYFCSVAS 90 (104)
T ss_pred EEEEEEEcc
Confidence 999998764
No 335
>KOG2123|consensus
Probab=96.70 E-value=0.00011 Score=70.43 Aligned_cols=101 Identities=25% Similarity=0.206 Sum_probs=64.7
Q ss_pred CCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHH-HhhcCccccc
Q psy10487 103 YLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKD-ALIHLTALES 181 (610)
Q Consensus 103 ~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~~ 181 (610)
.+.+.+.|++.++.|.+|. ....++.|+.|.|+-|.|+.+.+ |..+++|+.|+|..|.|..+..- -+.++++|+.
T Consensus 17 dl~~vkKLNcwg~~L~DIs--ic~kMp~lEVLsLSvNkIssL~p--l~rCtrLkElYLRkN~I~sldEL~YLknlpsLr~ 92 (388)
T KOG2123|consen 17 DLENVKKLNCWGCGLDDIS--ICEKMPLLEVLSLSVNKISSLAP--LQRCTRLKELYLRKNCIESLDELEYLKNLPSLRT 92 (388)
T ss_pred HHHHhhhhcccCCCccHHH--HHHhcccceeEEeeccccccchh--HHHHHHHHHHHHHhcccccHHHHHHHhcCchhhh
Confidence 3455667777777777764 35667777777887777777765 66777777777777777766432 2356677777
Q ss_pred cccccccccccCc-----ccccCCCcccEEe
Q psy10487 182 LNLNGNRLKHLSE-----SVFFPTPNLKTLS 207 (610)
Q Consensus 182 L~L~~n~l~~~~~-----~~~~~~~~L~~l~ 207 (610)
|-|..|.-.+-.. .++.-+++|+.||
T Consensus 93 LWL~ENPCc~~ag~nYR~~VLR~LPnLkKLD 123 (388)
T KOG2123|consen 93 LWLDENPCCGEAGQNYRRKVLRVLPNLKKLD 123 (388)
T ss_pred HhhccCCcccccchhHHHHHHHHcccchhcc
Confidence 7777765443322 2344456666553
No 336
>PHA03376 BARF1; Provisional
Probab=96.65 E-value=0.014 Score=52.89 Aligned_cols=80 Identities=23% Similarity=0.289 Sum_probs=49.3
Q ss_pred ceEeecCceEEEEEEEE---ecCCCeEEEEeCC----EEec-cCCccceeec-cCCcee-----eeeeEEEEEecCCCCC
Q psy10487 269 MVIREAGGNVTMSCYVY---GDPEPTILWLLNG----QVLH-NSSFDLLEEE-EGDALF-----EKSVSITLFNVTDLDA 334 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~---g~P~p~v~W~~~g----~~l~-~~~~~~~~~~-~~~~~~-----~~~~~L~I~~v~~~D~ 334 (610)
.+.+..|+.+.|.|.-. ..+.-.|.|+|.+ ..+. .......... ..++.. ..+-+|.|.+++.+|.
T Consensus 20 pVta~VGEda~LsC~lnp~ssa~~MrIrWqKs~p~~~~VvL~~~ggdVv~~QmEyRGrtD~~~~~gnvsLvI~~l~lSDd 99 (221)
T PHA03376 20 AVTAFLGERVTLTSYWRRVSLGPEIEVSWFKLGPGEEQVLIGRMHHDVIFIEWPFRGFFDIHRSANTFFLVVTAANISHD 99 (221)
T ss_pred chhheeCCcEEEEecccCccCCCceEEEEEecCCCCCCEEEEEcCCeeeeeeeccccEEEEEecCCeEEEEEEeeeecCC
Confidence 45567899999999864 3366789999942 2221 1111111111 111111 1245899999999999
Q ss_pred eEEEEEeecCCcce
Q psy10487 335 GEYTCYAENIRGNA 348 (610)
Q Consensus 335 G~Y~C~a~N~~G~~ 348 (610)
|.|+|..+-.....
T Consensus 100 GtY~C~fQkge~~~ 113 (221)
T PHA03376 100 GNYLCRMKLGETEV 113 (221)
T ss_pred ceEEEEEEcCCCce
Confidence 99999997755433
No 337
>cd07692 Ig_CD3_epsilon Immunoglobulin (Ig)-like domain of CD3 epsilon chain. Ig_CD3_epsilon; immunoglobulin (Ig)-like domain of CD3 epsilon chain. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=96.65 E-value=0.003 Score=47.02 Aligned_cols=52 Identities=35% Similarity=0.510 Sum_probs=35.4
Q ss_pred ecCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecC
Q psy10487 273 EAGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENI 344 (610)
Q Consensus 273 ~~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~ 344 (610)
..|.+|+|+|...+. .+.|.+|+..+..... .+.+.+-. ++.|.|+|.+.+.
T Consensus 5 isGTtVtlTCP~~~~---~i~W~~n~~~~~g~~~----------------~~~~~~~~-e~~G~Y~C~~~~~ 56 (65)
T cd07692 5 ISGTTVTVTCPLSGD---DIKWKKNDQVSQGSDE----------------KYLSLNHF-SSSGYYHCTADNA 56 (65)
T ss_pred EeccEEEEECCCCCC---CceEEeCCccCCCCCc----------------eEEeeccC-CCCceEEEEeCCC
Confidence 358899999965432 2999999865554221 33333444 8899999999653
No 338
>cd05871 Ig_Semaphorin_classIII Immunoglobulin (Ig)-like domain of class III semaphorin. Ig_Semaphorin_class III; Immunoglobulin (Ig)-like domain of class III semaphorins. Semaphorins are classified into various classes on the basis of structural features additional to the Sema domain. Class III semaphorins are a vertebrate class having a Sema domain, an Ig domain, a short basic domain, and are secreted. They have been shown to be axonal guidance cues and have a part in the regulation of the cardiovascular, immune and respiratory systems. Sema3A, the prototype member of this class III subfamily, induces growth cone collapse and is an inhibitor of axonal sprouting. In perinatal rat cortex as a chemoattractant, it functions to direct, for pyramidal neurons, the orientated extension of apical dendrites. It may play a role, prior to the development of apical dendrites, in signaling the radial migration of newborn cortical neurons towards the upper layers. Sema3A selectively inhibits vascula
Probab=96.56 E-value=0.0034 Score=51.24 Aligned_cols=39 Identities=23% Similarity=0.187 Sum_probs=32.5
Q ss_pred cccceeeeeeeeccCcceeeeec-CCCcceeeeeeccccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEAL-GSQPDMELIEQSLAME 459 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~-N~~G~~~~~~~l~v~~ 459 (610)
.++.|.|.+++.+|+|.|+|.|. |..|......+|.|++
T Consensus 51 ~~~~L~I~~~~~~DsG~Y~C~a~~~~~~~~~~~~~l~v~~ 90 (91)
T cd05871 51 TERGLLLRSLQRSDAGVYTCTAVEHSFSQTLAKYTLHVIE 90 (91)
T ss_pred ecCeEEEeeCChhHCEEEEEEEEccCCeEEEEEEEEEEec
Confidence 34569999999999999999998 5777777777887765
No 339
>smart00406 IGv Immunoglobulin V-Type.
Probab=96.52 E-value=0.0048 Score=48.65 Aligned_cols=65 Identities=25% Similarity=0.315 Sum_probs=37.6
Q ss_pred eEEEEEEEEecCCC--eEEEEeCCE----E-eccCC-ccceee---ccCCcee-----eeeeEEEEEecCCCCCeEEEEE
Q psy10487 277 NVTMSCYVYGDPEP--TILWLLNGQ----V-LHNSS-FDLLEE---EEGDALF-----EKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 277 ~v~l~C~~~g~P~p--~v~W~~~g~----~-l~~~~-~~~~~~---~~~~~~~-----~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
+++|.|.+.....+ .+.|++... . +.... ...... ..++..+ .....|.|.+++.+|+|.|.|.
T Consensus 1 ~v~l~C~~~~~~~~~~~v~W~~~~~~~~~~~l~~~~~~~~~~~~~~~~~R~~~~~~~~~~~~~L~i~~~~~~D~G~Y~C~ 80 (81)
T smart00406 1 SVTLSCKASGFTFSSYYVSWVRQPPGKGLEWLGYIGSSGSTYYQQSYKGRVTISKDTSKNDVSLTISNLRVEDTGTYYCA 80 (81)
T ss_pred CEEEEEEEeccccceeEEEEEEeCCCCCeEEEEEEcCCCcEEECcccCCcEEEEecCcCCEEEEEEcCCCHHHCEEEEEc
Confidence 37899998765554 799998432 1 11110 000000 0111111 1235799999999999999996
Q ss_pred e
Q psy10487 341 A 341 (610)
Q Consensus 341 a 341 (610)
+
T Consensus 81 v 81 (81)
T smart00406 81 V 81 (81)
T ss_pred C
Confidence 3
No 340
>KOG1026|consensus
Probab=96.49 E-value=0.003 Score=69.70 Aligned_cols=136 Identities=24% Similarity=0.306 Sum_probs=79.0
Q ss_pred ccEEecCCCcccccCCchhhHHHHhhc-cCCCCCCCCCCCCccCCCcccccccccccCCCceeeeecceEeecCceEEEE
Q psy10487 203 LKTLSLDGNPWCCDCHLRSFRNWLLKS-KLYSHPLSCTEPGMLQTKHWDDVKAQEFACPPNVTIKESMVIREAGGNVTMS 281 (610)
Q Consensus 203 L~~l~l~~N~~~c~c~l~~~~~~l~~~-~l~~~~~~C~a~~~l~g~~~~~v~~~~~~c~P~i~~~~~~~~v~~G~~v~l~ 281 (610)
+..+.+..|++.|.|...|...|.... ......+.|...... +..... .......+..........+..|..+++.
T Consensus 137 ~~~l~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~c~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~v~~~~~~~~~ 213 (774)
T KOG1026|consen 137 LTELSLVGNPFTCSCSIRWLDRYREDGFCVPYRGLACLNFLSN-GTVANE--SIQLCGEIENRIRAANLTVEEGSSITLK 213 (774)
T ss_pred cchhhhccCCCCcchhhhHHhhhcccCCCCCchhhHHHhhcCC-ceehhh--hhhhhcchhhhhhhhhhhhcccchheee
Confidence 344556669999999999877544333 122233455443331 110000 0001112222233335677889999999
Q ss_pred EEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcC
Q psy10487 282 CYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 282 C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
|.+.+.|.|.+.|+.+.............-. .-...+.+ ++|.++|..|....++.+.+.
T Consensus 214 c~~~~~~vp~~~~~~~~~~~~~~~~~~~~c~--------~~~~~~~~--------~~c~~E~~~~~~~~~v~~~~~ 273 (774)
T KOG1026|consen 214 CSQAGIPVPCHYWFPNCLASSNTNQTSSLCR--------SECEVLEN--------DLCIAENAVARSNPSILLVVD 273 (774)
T ss_pred eecccCCCcceeeecccccccCCCccccccc--------ccceeeec--------hhhHHHHhhhhcCceeeeEEe
Confidence 9999999999999987765544322111110 01222222 999999999998877777663
No 341
>cd07704 Ig2_Nectin-3-4_like Second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3), nectin-4 (poliovirus receptor related protein 4) and similar proteins. Ig2_Nectin-3-4_like: domain similar to the second immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and nectin-4 (poliovirus receptor related protein 4). Nectin-3 and nectin-4 belong to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectin-2 and nectin-3 localize at Sertoli-spermatid junctions where they form heterophilic trans-interactions between the cells that are essential for the formation and maintenance of the junctions and for spermatid development. Nect
Probab=96.43 E-value=0.025 Score=46.40 Aligned_cols=74 Identities=14% Similarity=0.232 Sum_probs=49.8
Q ss_pred ceEeecCceEEE-EEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 269 MVIREAGGNVTM-SCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 269 ~~~v~~G~~v~l-~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
...+.+|+.+.+ .|.+ .|.|.+.|+|+.+..-... . ......++.+...+.+.+..-...|.-.++|++....-
T Consensus 10 ~~~~~~g~~~~vA~C~sa~gkPaa~IsW~~~~~G~~~---~-~~~~~~ngT~TV~S~~~l~p~r~d~G~~vtC~V~H~al 85 (97)
T cd07704 10 SLLIDGGNGTTLAACCAAEGRPAADVTWETNVYGTSE---S-HSQEHPNGTTTVTSEYIWVPSRHANGHPLTCVVSHPAL 85 (97)
T ss_pred eeEeecCcceeEEEEEccCCccCCEeEEeCCCCCccc---e-eeecCCCCCEEEEEEEEEEeCHHHCCcEEEEEEeCccc
Confidence 445678888888 8987 5889999999986332111 1 11222233566777888866666677789999988743
No 342
>cd05727 Ig2_Contactin-2-like Second Ig domain of the neural cell adhesion molecule contactin-2 and similar proteins. Ig2_Contactin-2-like: second Ig domain of the neural cell adhesion molecule contactin-2. Contactins are comprised of six Ig domains followed by four fibronectin type III (FnIII) domains anchored to the membrane by glycosylphosphatidylinositol. Contactin-2 (aliases TAG-1, axonin-1) facilitates cell adhesion by homophilic binding between molecules in apposed membranes. The first four Ig domains form the intermolecular binding fragment which arranges as a compact U-shaped module by contacts between Ig domains 1 and 4, and domains 2 and 3. It has been proposed that a linear zipper-like array forms, from contactin-2 molecules alternatively provided by the two apposed membranes.
Probab=96.41 E-value=0.0025 Score=52.26 Aligned_cols=32 Identities=16% Similarity=0.213 Sum_probs=27.4
Q ss_pred ccccccceeeeeeeeccCcceeeeecCCCcce
Q psy10487 418 FNDQEKKLLDVSITTTDRHTGSCEALGSQPDM 449 (610)
Q Consensus 418 ~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~ 449 (610)
....++.|.|.+|+.+|+|.|+|.|+|.++..
T Consensus 55 ~~~~~G~L~fs~v~~~D~g~Y~C~A~n~~~~~ 86 (96)
T cd05727 55 VSQTNGNLYIAKVEASDRGNYSCFVSSPSSTK 86 (96)
T ss_pred EeCCCCcEEEeecCHhhCceeEEEEEecccCC
Confidence 34457899999999999999999999977654
No 343
>KOG2120|consensus
Probab=96.37 E-value=0.00042 Score=67.19 Aligned_cols=153 Identities=21% Similarity=0.156 Sum_probs=87.1
Q ss_pred CccEEEeecCCCCCCCh-hhhcccCCCCccEEEcccCCCcccchhhhcCCCCCcEEEccCC-CCCCCCc-ccccCCCCCc
Q psy10487 56 DIQVLDLNNNKISYLTK-EAFKSIGLLNLQRIYLKNSGIREVHRDTFKYLTILVEVDLSDN-QIAWLHQ-DTFLGNDRLK 132 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~-~~~~~~~l~~L~~L~L~~n~l~~i~~~~f~~l~~L~~LdLs~n-~l~~l~~-~~f~~l~~L~ 132 (610)
.++.|||++..|+.-.- ..+. .+.+|+.|.|.++++..-....+.+-.+|+.|+|+.+ .++.... -.|..++.|.
T Consensus 186 Rlq~lDLS~s~it~stl~~iLs--~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~ 263 (419)
T KOG2120|consen 186 RLQHLDLSNSVITVSTLHGILS--QCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLD 263 (419)
T ss_pred hhHHhhcchhheeHHHHHHHHH--HHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHh
Confidence 58999999888764322 2233 4678899999998888766666778888889998874 4554322 2356678888
Q ss_pred EEEeeCccccccCc-CcCCC-CCCccEEEccCcccc--ccCHHH-hhcCcccccccccccc-ccccCcccccCCCcccEE
Q psy10487 133 VLYLNGNPITELRA-GQFPK-LPYLKTIELQHCQIH--SVHKDA-LIHLTALESLNLNGNR-LKHLSESVFFPTPNLKTL 206 (610)
Q Consensus 133 ~L~Ls~N~l~~l~~-~~~~~-l~~L~~L~L~~n~l~--~~~~~~-~~~l~~L~~L~L~~n~-l~~~~~~~~~~~~~L~~l 206 (610)
.|+|+.+.+..-.- -...+ -++|..|+|++++-. .-+-.. ...+++|.+|||+.|. ++.-....|..++.|++|
T Consensus 264 ~LNlsWc~l~~~~Vtv~V~hise~l~~LNlsG~rrnl~~sh~~tL~~rcp~l~~LDLSD~v~l~~~~~~~~~kf~~L~~l 343 (419)
T KOG2120|consen 264 ELNLSWCFLFTEKVTVAVAHISETLTQLNLSGYRRNLQKSHLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFKFNYLQHL 343 (419)
T ss_pred hcCchHhhccchhhhHHHhhhchhhhhhhhhhhHhhhhhhHHHHHHHhCCceeeeccccccccCchHHHHHHhcchheee
Confidence 88888776543111 00111 145666666654211 111111 1345666666666542 322222233345555555
Q ss_pred ecCC
Q psy10487 207 SLDG 210 (610)
Q Consensus 207 ~l~~ 210 (610)
.++.
T Consensus 344 SlsR 347 (419)
T KOG2120|consen 344 SLSR 347 (419)
T ss_pred ehhh
Confidence 5544
No 344
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]
Probab=96.32 E-value=0.0051 Score=59.09 Aligned_cols=132 Identities=19% Similarity=0.201 Sum_probs=68.0
Q ss_pred CCCCccEEEcccCCCcccc----hhhhcCCCCCcEEEccCCCCCCCCcccc-------------cCCCCCcEEEeeCccc
Q psy10487 79 GLLNLQRIYLKNSGIREVH----RDTFKYLTILVEVDLSDNQIAWLHQDTF-------------LGNDRLKVLYLNGNPI 141 (610)
Q Consensus 79 ~l~~L~~L~L~~n~l~~i~----~~~f~~l~~L~~LdLs~n~l~~l~~~~f-------------~~l~~L~~L~Ls~N~l 141 (610)
+++.|++.+|++|-+..-- .+.++....|.+|.|++|.+.-+...-+ ..-+.|+.++...|++
T Consensus 90 kcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRl 169 (388)
T COG5238 90 KCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRL 169 (388)
T ss_pred cCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchh
Confidence 4566666666666544211 1234555666666666666543322111 2235666777766666
Q ss_pred cccCcC----cCCCCCCccEEEccCccccccCH-----HHhhcCccccccccccccccccCc----ccccCCCcccEEec
Q psy10487 142 TELRAG----QFPKLPYLKTIELQHCQIHSVHK-----DALIHLTALESLNLNGNRLKHLSE----SVFFPTPNLKTLSL 208 (610)
Q Consensus 142 ~~l~~~----~~~~l~~L~~L~L~~n~l~~~~~-----~~~~~l~~L~~L~L~~n~l~~~~~----~~~~~~~~L~~l~l 208 (610)
...+.. .|..-..|+.+.+..|.|..-.. ..+..+.+|+.|||+.|-++.... ..+..++.|+.|.+
T Consensus 170 engs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~l 249 (388)
T COG5238 170 ENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRL 249 (388)
T ss_pred ccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccc
Confidence 544321 11111456666666666653311 122345677777777776654332 23334555666665
Q ss_pred CC
Q psy10487 209 DG 210 (610)
Q Consensus 209 ~~ 210 (610)
.+
T Consensus 250 nD 251 (388)
T COG5238 250 ND 251 (388)
T ss_pred cc
Confidence 44
No 345
>cd05886 Ig1_Nectin-1_like First immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig1_Nectin-1_like: domain similar to the first immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. In addition nectins heterophilically trans-interact with other CAMs such as nectin-like molecules (Necls), nectin-1 for example, has been shown to trans-interact with Necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is
Probab=96.20 E-value=0.0036 Score=51.86 Aligned_cols=38 Identities=11% Similarity=0.019 Sum_probs=32.9
Q ss_pred cccceeeeeeeeccCcceeeeecC-CCcceeeeeecccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALG-SQPDMELIEQSLAM 458 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N-~~G~~~~~~~l~v~ 458 (610)
.+.+|.|.+++.+|+|.|.|...| ..|..+....|.|+
T Consensus 61 ~daSi~i~nl~~~D~G~Y~C~v~t~P~g~~~~~~~L~V~ 99 (99)
T cd05886 61 EDGTISLSRLELEDEGVYICEFATFPTGNRESQLNLTVY 99 (99)
T ss_pred CcceEEEcCCccccCEEEEEEEEeCCCCCeEEEEEEEEC
Confidence 556799999999999999999999 78888888877663
No 346
>PHA02633 hypothetical protein; Provisional
Probab=96.18 E-value=0.0079 Score=43.90 Aligned_cols=41 Identities=10% Similarity=-0.060 Sum_probs=35.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQP 461 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~p 461 (610)
....|.|.++..+|+|.|.|+.+|..=-.+++..+.|..++
T Consensus 16 ~~~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~~~~ 56 (63)
T PHA02633 16 NCNNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCICLRI 56 (63)
T ss_pred ccccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEeecc
Confidence 55579999999999999999999988888888888888654
No 347
>cd05882 Ig1_Necl-1 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molcule-1 (Necl-1, also known as cell adhesion molecule3 (CADM3)). Ig1_Necl-1: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-1, Necl-1 (also known as celll adhesion molecule 3 (CADM3), SynCAM2, IGSF4). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the format
Probab=96.13 E-value=0.0071 Score=49.75 Aligned_cols=23 Identities=13% Similarity=0.182 Sum_probs=21.4
Q ss_pred ccceeeeeeeeccCcceeeeecC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
+..|.|.+|+.+|+|.|+|.|..
T Consensus 61 ~~~L~I~nV~~~D~G~YtC~~~t 83 (95)
T cd05882 61 ELIISISNVQLSDEGEYTCSIFT 83 (95)
T ss_pred eEEEEECCCCcccCEEEEEEEEe
Confidence 46899999999999999999987
No 348
>cd04979 Ig_Semaphorin_C Immunoglobulin (Ig)-like domain of semaphorin. Ig_Semaphorin_C; Immunoglobulin (Ig)-like domain in semaphorins. Semaphorins are transmembrane protein that have important roles in a variety of tissues. Functionally, semaphorins were initially characterized for their importance in the development of the nervous system and in axonal guidance. Later they have been found to be important for the formation and functioning of the cardiovascular, endocrine, gastrointestinal, hepatic, immune, musculoskeletal, renal, reproductive, and respiratory systems. Semaphorins function through binding to their receptors and transmembrane semaphorins also serves as receptors themselves. Although molecular mechanism of semaphorins is poorly understood, the Ig-like domains may involve in ligand binding or dimerization.
Probab=96.03 E-value=0.0072 Score=49.02 Aligned_cols=38 Identities=18% Similarity=0.186 Sum_probs=28.9
Q ss_pred ccceeeeeeeeccCcceeeeecCCC-cceeeeeeccccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQ-PDMELIEQSLAME 459 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~-G~~~~~~~l~v~~ 459 (610)
...|.|.+++.+|+|.|.|.|.|.. +....+.+|.|++
T Consensus 50 ~~~L~I~~~~~~D~G~Y~C~a~~~~~~~~~~~~~l~V~~ 88 (89)
T cd04979 50 EDGLLIRSVSPADAGVYTCQSVEHGFKQTLATYSLNVLE 88 (89)
T ss_pred CCCEEEccCCHHHCEEEEEEEecCccceeEeEEEEEEec
Confidence 3469999999999999999999754 4445556666553
No 349
>KOG4597|consensus
Probab=95.88 E-value=0.0099 Score=60.96 Aligned_cols=90 Identities=14% Similarity=0.096 Sum_probs=67.2
Q ss_pred eeeeecceEeecCceEEEEEEEEecCCCeEEEEe---CCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEE
Q psy10487 263 VTIKESMVIREAGGNVTMSCYVYGDPEPTILWLL---NGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTC 339 (610)
Q Consensus 263 i~~~~~~~~v~~G~~v~l~C~~~g~P~p~v~W~~---~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C 339 (610)
+..-+....+-+|++..++|.+.|.|.+.|.|.+ |+..+... ..++. ++-.+.....|.|.+....|+|.|+|
T Consensus 199 l~~cpa~w~vg~wetcS~tCg~~G~q~r~V~c~qv~anr~~vv~~-~nq~~---e~p~vtstcql~ic~ewq~~a~w~tC 274 (560)
T KOG4597|consen 199 LVDCPAEWFVGDWETCSSTCGVQGRQYRVVTCEQVFANRENVVMR-PNQTV---ENPVVTSTCQLVICNEWQADAGWYTC 274 (560)
T ss_pred cccCcchhhcccchhhcccccccCCcCceeeeehhhccccceeec-Ccccc---CCcceeeeeeEEEcchhhcCCCceee
Confidence 3334455667889999999999999999999986 44333222 11111 11223556789999999999999999
Q ss_pred EeecCCcceeEEEEEEc
Q psy10487 340 YAENIRGNASGEISLDL 356 (610)
Q Consensus 340 ~a~N~~G~~~~~~~L~V 356 (610)
.|.|.+|...+.+.+.+
T Consensus 275 s~rcg~g~~~rdv~c~s 291 (560)
T KOG4597|consen 275 SARCGAGFLRRDVPCSS 291 (560)
T ss_pred ccccccceeeccceeee
Confidence 99999999988888876
No 350
>cd05713 Ig_MOG_like Immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). Ig_MOG_like: immunoglobulin (Ig)-like domain of myelin oligodendrocyte glycoprotein (MOG). MOG, a minor component of the myelin sheath, is an important CNS-specific autoantigen, linked to the pathogenesis of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). It is a transmembrane protein having an extracellular Ig domain. MOG is expressed in the CNS on the outermost lamellae of the myelin sheath, and on the surface of oligodendrocytes, and may participate in the completion, compaction, and/or maintenance of myelin. This group also includes butyrophilin (BTN). BTN is the most abundant protein in bovine milk-fat globule membrane (MFGM).
Probab=95.87 E-value=0.0058 Score=50.78 Aligned_cols=37 Identities=11% Similarity=-0.075 Sum_probs=31.1
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
....|.|.+++.+|+|.|.|.+.|..|..+....|.|
T Consensus 63 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~~~~~~i~l~v 99 (100)
T cd05713 63 GSVALRIHNVRASDEGLYTCFFQSDGFYEEATVELKV 99 (100)
T ss_pred CcEEEEEEcCChhhCEEEEEEEecCCcEEEEEEEEEE
Confidence 3458999999999999999999998887777666654
No 351
>PHA02633 hypothetical protein; Provisional
Probab=95.80 E-value=0.019 Score=41.99 Aligned_cols=36 Identities=22% Similarity=0.310 Sum_probs=31.9
Q ss_pred eEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcC
Q psy10487 322 VSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 322 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
..|.|.++..+|+|.|.|+..|..-....++.|.|.
T Consensus 18 ~nLwilpa~~sDSGiYiC~~rn~t~c~~~si~l~V~ 53 (63)
T PHA02633 18 NNMLILNPTQSDSGIYMCITKNETYSDMMKFDLCIC 53 (63)
T ss_pred ccEEEeccccccCcEEEEEEcCCCeeEEEEEEEEEe
Confidence 389999999999999999999988778888888874
No 352
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=95.79 E-value=0.023 Score=42.67 Aligned_cols=50 Identities=22% Similarity=0.421 Sum_probs=36.8
Q ss_pred cCceEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeec
Q psy10487 274 AGGNVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 274 ~G~~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N 343 (610)
..+.|.|.|.+ .-+|.|++ |..+.... ..+|.+-++..+-.|.|.|.+.+
T Consensus 5 ~~~~V~L~C~~----~tsi~W~k-G~~~~~~~---------------~~tlnLGs~~~DPRG~Y~C~~s~ 54 (69)
T cd07691 5 SEGKVFLKCNG----ATNITWKK-GKEILEVS---------------NTLLDLGSRINDPRGTYSCKESE 54 (69)
T ss_pred cCceEEEEecC----CCcEEEec-Cccccccc---------------ccEEeccCcccCCCcceEecCcc
Confidence 34578999975 25699999 65544321 12788888888889999999877
No 353
>smart00408 IGc2 Immunoglobulin C-2 Type.
Probab=95.76 E-value=0.0099 Score=43.74 Aligned_cols=28 Identities=21% Similarity=0.150 Sum_probs=24.5
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
.....|.|.+++..|+|.|+|.+.|..|
T Consensus 36 ~~~~~L~i~~~~~~d~G~Y~C~~~n~~g 63 (63)
T smart00408 36 ASGSTLTIKSVSLEDSGEYTCVAENSAG 63 (63)
T ss_pred cCCcEEEEeeCCcccCEEEEEEEecCCC
Confidence 4456899999999999999999999765
No 354
>cd07701 Ig1_Necl-3 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule-3 (Necl-3, also known as cell adhesion molecule 2 (CADM2)). Ig1_Necl-3: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-3, Necl-3 (also known as cell adhesion molecule 2 (CADM2), SynCAM2, IGSF4D). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-3 accumulates in central and peripheral nervous system tissue, and has been shown to selectively interact with oligodendrocytes.
Probab=95.69 E-value=0.015 Score=47.87 Aligned_cols=35 Identities=9% Similarity=0.043 Sum_probs=27.4
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
.+..|.|.+++.+|+|.|+|.+.+..+. ...+.|+
T Consensus 60 ~~~sL~I~~v~~~DsG~Y~C~~~t~~~~-~~~~~l~ 94 (95)
T cd07701 60 HELSISISDVSLSDEGQYTCSLFTMPVK-TSKAYLT 94 (95)
T ss_pred CcEEEEECcCCcccCEEEEEEeEeecCc-cEEEEEE
Confidence 4458999999999999999999985443 5555554
No 355
>cd05888 Ig1_Nectin-4_like Frst immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor) and similar proteins. Ig1_Nectin-4_like: domain similar to the first immunoglobulin (Ig) domain of nectin-4 (also known as poliovirus receptor related protein 4, or as LNIR receptor). Nectin-4 belongs to the nectin family, which is comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example nectin-4 trans-interacts with nectin-1. Nectin-4 has also been shown to interact with the actin filament-binding protein, afadin. Unlike the other nectins, which are widely expressed in adult tissues, nectin-4 is mainly expressed during embryogenesis, and is not detected in normal adult
Probab=95.56 E-value=0.0092 Score=49.65 Aligned_cols=37 Identities=11% Similarity=0.098 Sum_probs=30.7
Q ss_pred cccceeeeeeeeccCcceeeeecC-CCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALG-SQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N-~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|+|.|.+.+ ..|..+....|.|
T Consensus 62 ~~~sL~I~nv~~sD~GtY~C~v~~~p~g~~~~~~~L~V 99 (100)
T cd05888 62 ADGALILRNAVQADEGKYKCRVITFPAGNFEAELVLTV 99 (100)
T ss_pred CceEEEEecCccccceEEEEEEEeCCCCCeeeEEEEEe
Confidence 456799999999999999999998 7777766666654
No 356
>PHA03376 BARF1; Provisional
Probab=95.54 E-value=0.02 Score=51.96 Aligned_cols=48 Identities=10% Similarity=0.153 Sum_probs=38.3
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCCCcceeEecC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQPPVHITIESH 470 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~pp~~i~ie~~ 470 (610)
.+-.|.|.+++.+|.|+|+|...-..........|.++. |..+.|.+.
T Consensus 85 gnvsLvI~~l~lSDdGtY~C~fQkge~~~~k~ehLt~V~--~~~Lsv~a~ 132 (221)
T PHA03376 85 NTFFLVVTAANISHDGNYLCRMKLGETEVTKQEHLSVVK--PLTLSVHSE 132 (221)
T ss_pred CeEEEEEEeeeecCCceEEEEEEcCCCceeeeeeeeeee--cceEEEEec
Confidence 444799999999999999999988666666777888776 666777664
No 357
>cd07690 Ig1_CD4 First immunoglobulin (Ig) domain of CD4. Ig1_CD4; first immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=95.51 E-value=0.012 Score=48.23 Aligned_cols=28 Identities=21% Similarity=0.283 Sum_probs=25.3
Q ss_pred cceeeeeeeeccCcceeeeecCCCccee
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDME 450 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~ 450 (610)
..|.|.+++.+|+|+|.|.+.|..++.+
T Consensus 65 ~~L~I~~l~~sDsgtY~C~v~~~~~~~~ 92 (94)
T cd07690 65 FPLIIKNLKIEDSDTYICEVEDKKEEVE 92 (94)
T ss_pred EEEEECCCCHHHCEEEEEEECCccceEE
Confidence 4699999999999999999999888755
No 358
>cd05897 Ig2_IL1R2_like Second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). Ig2_IL1R2_like: domain similar to the second immunoglobulin (Ig)-like domain of interleukin-1 receptor-2 (IL1R2). IL-1 alpha and IL-1 beta are cytokines which participate in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds the type II (IL1R2) represented in this group. Mature IL1R2 consists of three IG-like domains, a transmembrane domain, and a short cytoplasmic domain. It lacks the large cytoplasmic domain of Mature IL1R1, and does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of IL-1 alpha and IL-1 beta.
Probab=95.51 E-value=0.0099 Score=48.74 Aligned_cols=28 Identities=11% Similarity=0.100 Sum_probs=24.4
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcce
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDM 449 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~ 449 (610)
...|.|.+|..+|+|.|+|+|+|..|..
T Consensus 54 ~~~L~I~~v~~~D~G~YtC~~~~~~~g~ 81 (95)
T cd05897 54 STYLHIIDVSLNDSGYYTCKLQFTHEGK 81 (95)
T ss_pred CCEEEEEEcChhhCEEEEEEEEEeeCCE
Confidence 3469999999999999999999987653
No 359
>KOG1480|consensus
Probab=95.31 E-value=0.0028 Score=68.59 Aligned_cols=86 Identities=19% Similarity=0.344 Sum_probs=64.5
Q ss_pred ceeeeecceEeecCceEEEEEEE-EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 262 NVTIKESMVIREAGGNVTMSCYV-YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 262 ~i~~~~~~~~v~~G~~v~l~C~~-~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
.+...+....|.++..+.+.|+. .|.|...+.|++++..++.... ... .....|++..+...|.|.|+|+
T Consensus 131 ~f~~~p~~q~V~~~s~~~l~cr~pe~~paae~~w~k~e~~~~pd~n-~~~--------~~d~~li~~~arlsd~~nytc~ 201 (909)
T KOG1480|consen 131 HFEQSPVGQEVQEETTLQLPCRPPEGDPKAEVEWLKNEVVIDPDAN-VIR--------ASDHNLIISQARLSDSGNYTCE 201 (909)
T ss_pred hhccChhhheecccccccccccCcccchhhhhhccccCCCCCcccc-chh--------hhcCCccccchhhhhcccceee
Confidence 34445566677888889999976 6899999999999988877322 111 2224799999999999999999
Q ss_pred eecCCcce---eEEEEEEc
Q psy10487 341 AENIRGNA---SGEISLDL 356 (610)
Q Consensus 341 a~N~~G~~---~~~~~L~V 356 (610)
|.|..+.. ..++.+.|
T Consensus 202 a~ni~~~r~~~~~~v~vyv 220 (909)
T KOG1480|consen 202 ATNIVAKRKSDPATVQVYV 220 (909)
T ss_pred eehhhccccccceEEEEEE
Confidence 99999864 34555555
No 360
>cd05896 Ig1_IL1RAPL-1_like First immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). Ig1_ IL1RAPL-1_like: domain similar to the first immunoglobulin (Ig)-like domain of X-linked interleukin-1 receptor accessory protein-like 1 (IL1RAPL-1). IL-1 alpha and IL-1 beta are cytokines which participates in the regulation of inflammation, immune responses, and hematopoiesis. These cytokines bind to the IL-1 receptor type 1 (IL1R1), which is activated on additional association with an accessory protein, IL1RAP. IL-1 also binds a second receptor designated type II (IL1R2). Mature IL1R1 consists of three Ig-like domains, a transmembrane domain, and a large cytoplasmic domain. Mature IL1R2 is organized similarly except that it has a short cytoplasmic domain. The latter does not initiate signal transduction. A naturally occurring cytokine IL-1RA (IL-1 receptor antagonist) is widely expressed and binds to IL-1 receptors, inhibiting the binding of
Probab=95.30 E-value=0.016 Score=47.94 Aligned_cols=37 Identities=14% Similarity=0.023 Sum_probs=31.2
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
..+..|.|..+..+|+|.|+|+++|+..-.++...|.
T Consensus 67 ~~~~~Lwf~Pa~~eDSG~Y~C~~rN~t~C~~~~i~l~ 103 (104)
T cd05896 67 KEEDSIWFRPAELQDSGLYTCVLRNSTYCMKVSMSLT 103 (104)
T ss_pred EeCCEEEEEeCChhhCeEEEEEECCCCcceEEEEEEE
Confidence 4566899999999999999999999887777766554
No 361
>cd05714 Ig_CSPGs_LP Immunoglobulin (Ig)-like domain of chondroitin sulfate proteoglycans (CSPGs), human cartilage link protein (LP) and similar proteins. Ig_CSPGs_LP: immunoglobulin (Ig)-like domain similar to that found in chondroitin sulfate proteoglycans (CSPGs) and human cartilage link protein (LP). Included in this group are the CSPGs aggrecan, versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue.
Probab=95.30 E-value=0.011 Score=49.74 Aligned_cols=39 Identities=13% Similarity=0.107 Sum_probs=32.2
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAM 458 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~ 458 (610)
..+..|.|.+++.+|+|+|.|.+.+..+..+...+|.|.
T Consensus 65 ~~~~sL~I~~v~~sD~G~Y~C~v~~~~~~~~~~v~L~V~ 103 (106)
T cd05714 65 PGDASLVITDLRLEDSGRYRCEVIDGIEDEQDTVELEVR 103 (106)
T ss_pred CCcceEEECCCCHHHCEEEEEEEEcCCCceEEEEEEEEE
Confidence 356689999999999999999999988776766666553
No 362
>cd05877 Ig_LP_like Immunoglobulin (Ig)-like domain of human cartilage link protein (LP). Ig_LP_like: immunoglobulin (Ig)-like domain similar to that that found in human cartilage link protein (LP). In cartilage, chondroitin-keratan sulfate proteoglycan (CSPG), aggrecan, forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=95.12 E-value=0.013 Score=49.29 Aligned_cols=36 Identities=14% Similarity=0.185 Sum_probs=31.5
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.+++.+|+|+|.|.+.+..|..+...+|.|
T Consensus 67 ~~sL~I~~v~~~DsG~Y~C~v~~~~~~~~~~~~l~v 102 (106)
T cd05877 67 DASLVITDLRLEDYGRYRCEVIDGLEDESVVVALRL 102 (106)
T ss_pred cEEEEEccCChHHCEEEEEEEEecccceEEEEEEEE
Confidence 457999999999999999999999988877777655
No 363
>cd05887 Ig1_Nectin-3_like First immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3) and similar proteins. Ig1_Nectin-3_like: domain similar to the first immunoglobulin (Ig) domain of nectin-3 (also known as poliovirus receptor related protein 3). Nectin-3 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through -4). Nectins are synaptic cell adhesion molecules (CAMs) which participate in adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. For example, during spermatid development, the nectin-3,-2 trans-interaction is required for the formation of Sertoli cell-spermatid junctions in testis, and during morphogenesis of the ciliary body, the nectin-3,-1 trans-interaction is important for apex-apex adhesion between the pigment and non-pigment layers of the ciliary epithelia. Nectins also
Probab=95.11 E-value=0.017 Score=47.46 Aligned_cols=38 Identities=8% Similarity=-0.026 Sum_probs=32.2
Q ss_pred ccccceeeeeeeeccCcceeeee-cCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEA-LGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A-~N~~G~~~~~~~l~v 457 (610)
..+.+|.|.+++.+|+|.|.|.. +...|+.+.+..|.|
T Consensus 57 ~~d~sl~i~nv~~~D~G~Y~C~v~tfP~G~~~~~~~l~~ 95 (96)
T cd05887 57 LLDATIMLENVGFSDIGVYICKAVTFPLGNTQSSTTVTV 95 (96)
T ss_pred CCccEEEEeCCCccccEEEEEEEEeCCCCCeeEEEEEEE
Confidence 45678999999999999999996 458899888877765
No 364
>PF00047 ig: Immunoglobulin domain The Prosite family only concerns antibodies and MHCs.; InterPro: IPR013151 Members of the immunoglobulin superfamily are found in hundreds of proteins of different functions. Examples include antibodies, the giant muscle kinase titin and receptor tyrosine kinases. Immunoglobulin-like domains may be involved in protein-protein and protein-ligand interactions. The Pfam alignments do not include the first and last strand of the immunoglobulin-like domain.; PDB: 1B6U_A 3O4O_C 3VH8_H 1BIH_A 2C9A_A 2V5Y_A 1BQH_K 2ATP_A 3B9K_A 1NEZ_H ....
Probab=95.08 E-value=0.022 Score=42.67 Aligned_cols=18 Identities=28% Similarity=0.320 Sum_probs=17.4
Q ss_pred eeeeeeeeccCcceeeee
Q psy10487 425 LLDVSITTTDRHTGSCEA 442 (610)
Q Consensus 425 L~i~~v~~~D~G~Y~C~A 442 (610)
|.|.+++.+|+|.|+|.|
T Consensus 47 L~i~~v~~~d~G~Y~C~v 64 (64)
T PF00047_consen 47 LTISNVTPEDSGTYTCVV 64 (64)
T ss_dssp EEESSCTGGGTEEEEEEE
T ss_pred EEEccCCHHHCEEEEEEC
Confidence 999999999999999986
No 365
>cd05717 Ig1_Necl-1-3_like First (N-terminal) immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 - Necl-3 (also known as cell adhesion molecules CADM3, CADM1, and CADM2 respectively). Ig1_Necl-1-3_like: N-terminal immunoglobulin (Ig)-like domain of the nectin-like molecules Necl-1 (also known as cell adhesion molecule 3 (CADM3)), Necl-2 (CADM1), and Necl-3 (CADM2). At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-1, Necl-2, and Necl-3 have Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is specifically expressed in neural tissue, and is important to the form
Probab=94.92 E-value=0.019 Score=47.12 Aligned_cols=34 Identities=9% Similarity=0.037 Sum_probs=26.4
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeecc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSL 456 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~ 456 (610)
+..|.|.+++.+|+|.|+|.+.+... .+..+.++
T Consensus 61 ~~~L~I~~v~~~DsG~Y~C~~~~~~~-~~~~~~~~ 94 (95)
T cd05717 61 ELSISISNVSLSDEGRYTCSLYTMPV-QTAKATVT 94 (95)
T ss_pred eeEEEEccCCcccCEEEEEEEecCCC-ceEEEEEE
Confidence 45799999999999999999998653 34444443
No 366
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=94.85 E-value=0.044 Score=47.23 Aligned_cols=83 Identities=16% Similarity=0.316 Sum_probs=48.9
Q ss_pred cCceEEEEEEEEe-----cCCCeEEEEeCCEEeccCCccceee-ccC------CceeeeeeEEEEEecCCCCCeEEEEEe
Q psy10487 274 AGGNVTMSCYVYG-----DPEPTILWLLNGQVLHNSSFDLLEE-EEG------DALFEKSVSITLFNVTDLDAGEYTCYA 341 (610)
Q Consensus 274 ~G~~v~l~C~~~g-----~P~p~v~W~~~g~~l~~~~~~~~~~-~~~------~~~~~~~~~L~I~~v~~~D~G~Y~C~a 341 (610)
-.++|.+.|.+.. .+...|.|.+++..+-..+...... ... ........+|.+.....- .|.|+|.+
T Consensus 26 CN~tV~IPC~v~n~~~~ni~~m~VkWk~~~~~If~~dg~~~~~~~~~f~sa~i~~l~kG~aSL~~~~~~a~-~GnYTCeV 104 (130)
T PF08204_consen 26 CNDTVVIPCFVNNLEANNISEMYVKWKFKNKDIFIFDGTNNKSTSDNFPSAKISELLKGNASLKMDKSDAV-EGNYTCEV 104 (130)
T ss_dssp T-SEEEE--BBSS---SSGGGEEEEEEETTEEEEEEETTTTEEEEGGGTT-BEGGGGGTB--EEEEHHHHH--EEEEEEE
T ss_pred cCCCEEEEeEeccccccccceEEEEEEECCeEEEEEcCccceecccCccccchhHhhCCCEEEEEcchhcc-ccceEEEE
Confidence 4788999999864 2445699999988764332211100 000 001122346888875555 89999999
Q ss_pred ecCCcceeEEEEEEcC
Q psy10487 342 ENIRGNASGEISLDLP 357 (610)
Q Consensus 342 ~N~~G~~~~~~~L~V~ 357 (610)
.......+..+.|...
T Consensus 105 t~~~~ege~~i~Lk~~ 120 (130)
T PF08204_consen 105 TELSREGETTIELKYR 120 (130)
T ss_dssp EETTEEEEEEEEEEE-
T ss_pred EecCCCceEEEEEEEE
Confidence 9998888888888773
No 367
>cd05775 Ig_SLAM-CD84_like_N N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. Ig_SLAM-CD84_like_N: The N-terminal immunoglobulin (Ig)-like domain of the signaling lymphocyte activation molecule (SLAM) family, CD84_like. The SLAM family is a group of immune-cell specific receptors that can regulate both adaptive and innate immune responses. Members of this group include proteins such as CD84, SLAM (CD150), Ly-9 (CD229), NTB-A (ly-108, SLAM6), 19A (CRACC), and SLAMF9. The genes coding for the SLAM family are nested on chromosome 1, in humans at 1q23, and in mice at 1H2. The SLAM family is a subset of the CD2 family, which also includes CD2 and CD58 located on chromosome 1 at 1p13 in humans. In mice, CD2 is located on chromosome 3, and there is no CD58 homolog. The SLAM family proteins are organized as an extracellular domain with either two or four Ig-like domains, a single transmembrane segment, and a cytoplasmic region
Probab=94.68 E-value=0.022 Score=47.07 Aligned_cols=42 Identities=12% Similarity=-0.025 Sum_probs=31.1
Q ss_pred ccccccccceeeeeeeeccCcceeeeecCCCcce-eeeeeccc
Q psy10487 416 VSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDM-ELIEQSLA 457 (610)
Q Consensus 416 ~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~-~~~~~l~v 457 (610)
+.+..++..|.|.+++.+|+|.|.|.+.+..|.. ...+.|.|
T Consensus 54 ~~~~~~~~sL~I~~~~~~DsG~Y~c~v~~~~~~~~~~~f~L~v 96 (97)
T cd05775 54 VNFSQNDYSLQISNLKMEDAGSYRAEINTKNGVTITKEFTLHI 96 (97)
T ss_pred EEecCCceeEEECCCchHHCEEEEEEEEcCCCCeEEEEEEEEe
Confidence 3344456789999999999999999999987754 33344443
No 368
>smart00409 IG Immunoglobulin.
Probab=94.65 E-value=0.059 Score=42.15 Aligned_cols=36 Identities=19% Similarity=0.153 Sum_probs=30.1
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.++...|+|.|.|.+.|..|.......|.|
T Consensus 50 ~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~~~l~V 85 (86)
T smart00409 50 NSTLTISNVTPEDSGTYTCAATNSSGSASSTTTLTV 85 (86)
T ss_pred eeEEEEEeeccccCeEEEEEEEcCCCeEEEEEEEEE
Confidence 467999999999999999999998888776655543
No 369
>smart00410 IG_like Immunoglobulin like. IG domains that cannot be classified into one of IGv1, IGc1, IGc2, IG.
Probab=94.65 E-value=0.059 Score=42.15 Aligned_cols=36 Identities=19% Similarity=0.153 Sum_probs=30.1
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.|.++...|+|.|.|.+.|..|.......|.|
T Consensus 50 ~~~l~i~~~~~~d~G~Y~C~v~~~~~~~~~~~~l~V 85 (86)
T smart00410 50 NSTLTISNVTPEDSGTYTCAATNSSGSASSTTTLTV 85 (86)
T ss_pred eeEEEEEeeccccCeEEEEEEEcCCCeEEEEEEEEE
Confidence 467999999999999999999998888776655543
No 370
>cd05718 Ig1_PVR_like First immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155) and similar proteins. Ig1_PVR_like: domain similar to the first immunoglobulin (Ig) domain of poliovirus receptor (PVR, also known as CD155). Poliovirus (PV) binds to its cellular receptor (PVR/CD155) to initiate infection. CD155 is a membrane-anchored, single-span glycoprotein; its extracellular region has three Ig-like domains. There are four different isotypes of CD155 (referred to as alpha, beta, gamma, and delta), that result from alternate splicing of the CD155 mRNA, and have identical extracellular domains. CD155-beta and - gamma, are secreted, CD155-alpha and delta are membrane-bound and function as PV receptors. The virus recognition site is contained in the amino-terminal domain, D1. Having the virus attachment site on the receptor distal from the plasma membrane, may be important for successful initiation of infection of cells by the virus. CD155 binds in the poliovirus "c
Probab=94.56 E-value=0.027 Score=46.42 Aligned_cols=37 Identities=11% Similarity=0.113 Sum_probs=30.7
Q ss_pred cccceeeeeeeeccCcceeeeecC-CCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALG-SQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N-~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|.|.|.+.+ ..|..+....|.|
T Consensus 60 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~g~~~~~~~l~V 97 (98)
T cd05718 60 EDATISISNLRLEDEGNYICEFATFPQGNRQKVTTLTV 97 (98)
T ss_pred CceEEEEccCCcccCEEEEEEEEeCCCCcEEEEEEEEe
Confidence 456899999999999999999875 6788777776655
No 371
>cd05774 Ig_CEACAM_D1 First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM). IG_CEACAM_D1: immunoglobulin (Ig)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surface. This family corresponds to the D
Probab=94.56 E-value=0.029 Score=47.01 Aligned_cols=36 Identities=11% Similarity=-0.019 Sum_probs=28.0
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCc-ceeeeeec
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQP-DMELIEQS 455 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G-~~~~~~~l 455 (610)
..+++|.|.+++.+|+|.|+|.+.|..+ ..+...+|
T Consensus 67 ~~ngSL~I~~v~~~D~G~Y~~~v~~~~~~~~~~~v~l 103 (105)
T cd05774 67 YPNGSLLIQNVTQKDTGFYTLQTITTNFQVEQATVHL 103 (105)
T ss_pred eCCCcEEEecCCcccCEEEEEEEEeCCccEEEEEEEE
Confidence 3467899999999999999999999763 44444443
No 372
>cd05873 Ig_Sema4D_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4D. Ig_Sema4D_like; Immunoglobulin (Ig)-like domain of Sema4D. Sema4D is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4D has extracellular Sema and Ig domains, a transmembrane domain, and a short cytoplasmic domain. Sema4D plays a part in the development of GABAergic synapses. Sema4D in addition is an immune semaphorin. It is abundant on resting T cells; its expression is weak on resting B cells and antigen presenting cells (APCs), but is upregulated by various stimuli. The receptor used by Sema4D in the immune system is CD72. Sem4D enhances the activation of B cells and DCs through binding CD72, perhaps by reducing CD72s inhibitory signals. The receptor used by Sema4D in the non-lymphatic tissues is plexin-B1. Sem4D is anchored to the cell surface but its extracellular domain can be released from the cell surface by a metalloproteas
Probab=94.54 E-value=0.021 Score=45.96 Aligned_cols=26 Identities=15% Similarity=0.185 Sum_probs=22.8
Q ss_pred cccceeeeeeeeccCcceeeeecCCC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQ 446 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~ 446 (610)
.++.|.|.+++.+|+|.|+|.|.+..
T Consensus 46 ~~~~L~I~nv~~~DsG~Y~C~a~e~~ 71 (87)
T cd05873 46 YRDGLLIFNASEADAGRYQCLSVEKS 71 (87)
T ss_pred ECCcEEEeCCCHHHCEEEEEEEEecc
Confidence 34579999999999999999999864
No 373
>cd05845 Ig2_L1-CAM_like Second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM) and similar proteins. Ig2_L1-CAM_like: domain similar to the second immunoglobulin (Ig)-like domain of the L1 cell adhesion molecule (CAM). L1 belongs to the L1 subfamily of cell adhesion molecules (CAMs) and is comprised of an extracellular region having six Ig-like domains, five fibronectin type III domains, a transmembrane region and an intracellular domain. L1 is primarily expressed in the nervous system and is involved in its development and function. L1 is associated with an X-linked recessive disorder, X-linked hydrocephalus, MASA syndrome, or spastic paraplegia type 1, that involves abnormalities of axonal growth.
Probab=94.49 E-value=0.047 Score=44.67 Aligned_cols=31 Identities=19% Similarity=0.115 Sum_probs=26.4
Q ss_pred ccccccceeeeeeeeccCc-ceeeeecCCCcc
Q psy10487 418 FNDQEKKLLDVSITTTDRH-TGSCEALGSQPD 448 (610)
Q Consensus 418 ~~~~~~~L~i~~v~~~D~G-~Y~C~A~N~~G~ 448 (610)
....++.|.|.+|+.+|+| .|.|.|+|....
T Consensus 53 ~~~~~GnL~fs~v~~~D~g~~Y~C~a~~~~~~ 84 (95)
T cd05845 53 SMGQNGNLYFANVEEQDSHPDYICHAHFPGLR 84 (95)
T ss_pred EECCCceEEEEEEehhhCCCCeEEEEEccccc
Confidence 4456799999999999999 799999997543
No 374
>PF13927 Ig_3: Immunoglobulin domain; PDB: 2D3V_A 1G0X_A 1VDG_A 1P7Q_D 3D2U_H 1UFU_A 1UGN_A 3VH8_H 3OQ3_B 4DKD_C ....
Probab=94.42 E-value=0.02 Score=44.12 Aligned_cols=25 Identities=24% Similarity=0.276 Sum_probs=22.3
Q ss_pred ccccceeeeeeeeccCcceeeeecC
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
.....|.+.++..+|.|.|+|+|.|
T Consensus 51 ~~~~~L~i~~v~~~~~g~y~C~a~N 75 (75)
T PF13927_consen 51 SSNSTLTISNVTRSDNGTYTCIASN 75 (75)
T ss_dssp EEEEEEEESSCCGGGTEEEEEEEEE
T ss_pred ceeeEEEEccCCHHhCcEEEEEEEC
Confidence 4566899999999999999999987
No 375
>PF13895 Ig_2: Immunoglobulin domain; PDB: 2V5R_B 2V5M_A 2V5S_B 2GI7_A 3LAF_A 4DEP_C 3O4O_B 2EC8_A 2E9W_A 1J87_A ....
Probab=94.30 E-value=0.046 Score=42.69 Aligned_cols=23 Identities=17% Similarity=0.271 Sum_probs=20.5
Q ss_pred eeeeeeeeccCcceeeeecCCCc
Q psy10487 425 LLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 425 L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
+.+.+++.+|+|.|+|.|.|..|
T Consensus 47 ~~~~~~~~~~~g~y~C~~~~~~~ 69 (80)
T PF13895_consen 47 LFIPNVSPEDSGNYTCRASNGSG 69 (80)
T ss_dssp EEESSEEGGGTEEEEEEEEETTE
T ss_pred eeeeeeccccCEEEEEEEEeCCC
Confidence 77889999999999999999655
No 376
>cd05721 IgV_CTLA-4 Immunoglobulin (Ig) domain of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). IgV_CTLA-4: domain similar to the variable(v)-type immunoglobulin (Ig) domain found in cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). CTLA-4 is involved in the regulation of T cell response, acting as an inhibitor of intracellular signalling. CTLA-4 is similar to CD28, a T cell co-receptor protein that recognizes the B7 proteins (CD80 and CD86). CD28 binding of the B7 proteins occurs after the presentation of antigen to the T cell receptor (TCR) via the peptide-MHC complex on the surface of an antigen presenting cell (APC). CTLA-4 also binds the B7 molecules with a higher affinity than does CD28. The B7/CTLA-4 interaction generates inhibitory signals down-regulating the response, and may prevent T cell activation by weak TCR signals. CD28 and CTLA-4 then elicit opposing signals in the regulation of T cell responsiveness and homeostasis. T cell activation leads to increased
Probab=94.26 E-value=0.23 Score=41.90 Aligned_cols=77 Identities=16% Similarity=0.138 Sum_probs=45.9
Q ss_pred eeecceEeecCceEEEEEEEEecCC---CeEEEEe--CCE-EeccC---CccceeeccCCce-----eeeeeEEEEEecC
Q psy10487 265 IKESMVIREAGGNVTMSCYVYGDPE---PTILWLL--NGQ-VLHNS---SFDLLEEEEGDAL-----FEKSVSITLFNVT 330 (610)
Q Consensus 265 ~~~~~~~v~~G~~v~l~C~~~g~P~---p~v~W~~--~g~-~l~~~---~~~~~~~~~~~~~-----~~~~~~L~I~~v~ 330 (610)
+.+....+..|+.++|.|.++|.-. -.++|+| +|. +.-.. ...+.....++.. ......|.|.+++
T Consensus 3 ~~~~~~lv~p~~sv~LsC~~sg~~~s~e~~~~wvRq~pg~lE~c~~~~~~g~~~~~~~~r~tcs~~~s~ntv~L~l~~L~ 82 (115)
T cd05721 3 VQQSPVLASSNGAASLVCEYTYNGFSKEFRASLLKGADSAVEVCAVTGNMSNQLQTSLDGFNCDGTLGNEQVNFTLQNLR 82 (115)
T ss_pred eecCCeEEcCCCCEEEEEEecCCccccEEEEEEEEeCCCCcEEEEEEeCCCccccccCCCeEEeEeCCCCEEEEEEcCCC
Confidence 3445667788899999999977543 3578998 331 11100 0001100011000 0123589999999
Q ss_pred CCCCeEEEEEe
Q psy10487 331 DLDAGEYTCYA 341 (610)
Q Consensus 331 ~~D~G~Y~C~a 341 (610)
.+|++.|.|..
T Consensus 83 a~DTa~Y~Ca~ 93 (115)
T cd05721 83 ANQTDIYFCKI 93 (115)
T ss_pred HHHCeEEEEEe
Confidence 99999999975
No 377
>cd05860 Ig4_SCFR Fourth immunoglobulin (Ig)-like domain of stem cell factor receptor (SCFR). Ig4_SCFR: The fourth Immunoglobulin (Ig)-like domain in stem cell factor receptor (SCFR). SCFR is organized as an extracellular component having five IG-like domains, a transmembrane segment, and a cytoplasmic portion having protein tyrosine kinase activity. SCFR and its ligand SCF are critical for normal hematopoiesis, mast cell development, melanocytes and gametogenesis. SCF binds to the second and third Ig-like domains of SCFR. This fourth Ig-like domain participates in SCFR dimerization, which follows ligand binding. Deletion of this fourth domain abolishes the ligand-induced dimerization of SCFR and completely inhibits signal transduction.
Probab=93.73 E-value=0.054 Score=44.65 Aligned_cols=36 Identities=11% Similarity=-0.023 Sum_probs=32.4
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
...|.+..+..+|+|.|+|.|.|+.+.++.++.|.+
T Consensus 64 ~S~L~L~Rlk~~E~G~YTf~a~N~~~~~s~tF~l~v 99 (101)
T cd05860 64 VSELHLTRLKGTEGGTYTFLVSNSDASASVTFNVYV 99 (101)
T ss_pred EEEEEEeecChhhCcEEEEEEECCCCeEEEEEEEEE
Confidence 357999999999999999999999999999888765
No 378
>cd05878 Ig_Aggrecan_like Immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG). Ig_Aggrecan_like: immunoglobulin (Ig)-like domain of the aggrecan-like chondroitin sulfate proteoglycan core protein (CSPG)s. Included in this group are the Ig domains of other CSPGs: versican, and neurocan. In CSPGs this Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with hyaluronan (HA). These aggregates contribute to the tissue's load bearing properties. Aggrecan and versican have a wide distribution in connective tissue and extracellular matrices. Neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substi
Probab=93.54 E-value=0.046 Score=46.31 Aligned_cols=38 Identities=13% Similarity=0.084 Sum_probs=30.3
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.....|.|.+++.+|+|+|.|.+....+..+.+..|.|
T Consensus 69 ~~~asL~I~~l~~sD~G~Y~C~v~~~~~~~~~~v~l~V 106 (110)
T cd05878 69 RGDASLEISRLRSSDSGVYRCEVMHGIEDEQDTVPLEV 106 (110)
T ss_pred CCcEEEEECCCChhhCEEEEEEEEeCCCcceEEEEEEE
Confidence 34567999999999999999999987666666555554
No 379
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=93.43 E-value=0.048 Score=31.29 Aligned_cols=12 Identities=42% Similarity=0.589 Sum_probs=4.8
Q ss_pred cEEEeeCccccc
Q psy10487 132 KVLYLNGNPITE 143 (610)
Q Consensus 132 ~~L~Ls~N~l~~ 143 (610)
++|+|++|.++.
T Consensus 3 ~~Ldls~n~l~~ 14 (22)
T PF00560_consen 3 EYLDLSGNNLTS 14 (22)
T ss_dssp SEEEETSSEESE
T ss_pred cEEECCCCcCEe
Confidence 334444444333
No 380
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....
Probab=93.38 E-value=0.042 Score=31.52 Aligned_cols=14 Identities=14% Similarity=0.373 Sum_probs=5.8
Q ss_pred ccEEEcccCCCccc
Q psy10487 83 LQRIYLKNSGIREV 96 (610)
Q Consensus 83 L~~L~L~~n~l~~i 96 (610)
|++|+|++|+|+.+
T Consensus 2 L~~Ldls~n~l~~i 15 (22)
T PF00560_consen 2 LEYLDLSGNNLTSI 15 (22)
T ss_dssp ESEEEETSSEESEE
T ss_pred ccEEECCCCcCEeC
Confidence 34444444444433
No 381
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=93.36 E-value=0.64 Score=36.67 Aligned_cols=52 Identities=19% Similarity=0.351 Sum_probs=35.7
Q ss_pred CCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEe-ecCCcceeEEEEEEc
Q psy10487 289 EPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYA-ENIRGNASGEISLDL 356 (610)
Q Consensus 289 ~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a-~N~~G~~~~~~~L~V 356 (610)
.|++.|.-.+....... ........+..|+|.++|.| .+..-.....+.|.|
T Consensus 26 ~~~~~l~~~~~k~~~~~----------------~~~~~~~~~~~d~G~w~C~a~~~~~k~~~s~~~i~v 78 (80)
T PF05790_consen 26 KPSLFLENPGKKSLETK----------------KLVSTFTPTTEDSGTWVCTASDNEPKERESKIEILV 78 (80)
T ss_dssp CEEEEEECSSCEEEEES----------------SEEEEESBTCGGSEEEEEEEEECTTEEEEEEEEEEE
T ss_pred ChhheeeccCccccccc----------------eEEEEecCCCCCCEEEEEEEcCCceEEEEEEEEEEc
Confidence 46677776665443322 26677788899999999999 666655666666655
No 382
>cd05900 Ig_Aggrecan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. Ig_Aggrecan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), aggrecan. These aggregates contribute to the tissue's load bearing properties. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, aggrecan forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Aggrecan has a wide distribution in connective tissue and extracellular matrices. Members of the vertebrate HPLN (hyaluronan/HA and proteoglycan binding link) protein family are physically linked adjacent to CSPG genes.
Probab=93.30 E-value=0.068 Score=45.36 Aligned_cols=37 Identities=16% Similarity=0.122 Sum_probs=29.6
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|+|.|.+.+.....+....|.|
T Consensus 72 ~~asL~I~nl~~sDsG~Y~C~V~~g~~~~~~~v~l~v 108 (112)
T cd05900 72 SDATLEITELRSNDSGTYRCEVMHGIEDNYDTVEVQV 108 (112)
T ss_pred CCcEEEEeecccccCEEEEEEEecCCCCceeEEEEEE
Confidence 5678999999999999999999987666555544443
No 383
>cd05741 Ig_CEACAM_D1_like First immunoglobulin (Ig)-like domain of carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) and similar proteins. Ig_CEACAM_D1_like : immunoglobulin (IG)-like domain 1 in carcinoembryonic antigen (CEA) related cell adhesion molecule (CEACAM) protein subfamily-like. The CEA family is a group of anchored or secreted glycoproteins, expressed by epithelial cells, leukocytes, endothelial cells and placenta. The CEA family is divided into the CEACAM and pregnancy-specific glycoprotein (PSG) subfamilies. This group represents the CEACAM subfamily. CEACAM1 has many important cellular functions, it is a cell adhesion molecule, and a signaling molecule that regulates the growth of tumor cells, it is an angiogenic factor, and is a receptor for bacterial and viral pathogens, including mouse hepatitis virus (MHV). In mice, four isoforms of CEACAM1 generated by alternative splicing have either two [D1, D4] or four [D1-D4] Ig-like domains on the cell surf
Probab=93.02 E-value=0.077 Score=43.02 Aligned_cols=29 Identities=21% Similarity=0.177 Sum_probs=25.3
Q ss_pred ccceeeeeeeeccCcceeeeecCCCccee
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDME 450 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~ 450 (610)
+..|.|.+++.+|+|.|.|......|...
T Consensus 56 ~~sL~I~~l~~~DsG~Y~c~v~~~~~~~~ 84 (92)
T cd05741 56 NGSLLIQNLTKEDSGTYTLQIISTNGVTE 84 (92)
T ss_pred CceEEEccCCchhcEEEEEEEEcCCCcEE
Confidence 37899999999999999999999876543
No 384
>cd05885 Ig2_Necl-4 Second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Ig2_Necl-4: second immunoglobulin (Ig)-like domain of nectin-like molecule-4 (Necl-4, also known as cell adhesion molecule 4 (CADM4)). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1-Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Ig domains are likely to participate in ligand binding and recognition. Necl-4 is expressed on Schwann cells, and plays a key part in initiating peripheral nervous system (PNS) myelination. In injured peripheral nerve cells, the mRNA signal for both Necl-4 and Necl-5 was observed to be elevated. Necl-4 participates in cell-cell adhesion and is proposed to play a role in tumor suppression.
Probab=93.02 E-value=0.18 Score=39.80 Aligned_cols=28 Identities=18% Similarity=-0.019 Sum_probs=23.6
Q ss_pred ccceeeeeeeeccCcceeeeecCCCcce
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQPDM 449 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G~~ 449 (610)
.+.|.+.-...+|.+.|+|+|.|.++..
T Consensus 42 ~s~L~~~~~~~Ddg~~~~C~A~n~a~~~ 69 (80)
T cd05885 42 SNTIRFPVDRKDDGAILSCEASHPALVS 69 (80)
T ss_pred EEEEEEEeeeccCCcEEEEEEEChhhCC
Confidence 4468888888889999999999988754
No 385
>cd05879 Ig_P0 Immunoglobulin (Ig)-like domain of Protein zero (P0). Ig_P0ex: immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin.
Probab=92.90 E-value=0.064 Score=45.84 Aligned_cols=29 Identities=14% Similarity=0.194 Sum_probs=25.1
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPD 448 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~ 448 (610)
..+.+|.|.+++.+|.|+|+|.+.|..+.
T Consensus 77 ~~daSI~I~nv~~sD~G~Y~C~v~n~p~~ 105 (116)
T cd05879 77 RKDGSIVIHNLDYTDNGTFTCDVKNPPDI 105 (116)
T ss_pred cCeeEEEEccCCcccCEEEEEEEEcCCCc
Confidence 45668999999999999999999996553
No 386
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=92.71 E-value=0.094 Score=31.40 Aligned_cols=21 Identities=43% Similarity=0.561 Sum_probs=11.7
Q ss_pred CCCcEEEccCCCCCCCCcccc
Q psy10487 105 TILVEVDLSDNQIAWLHQDTF 125 (610)
Q Consensus 105 ~~L~~LdLs~n~l~~l~~~~f 125 (610)
.+|++|+|++|+|..++...|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 345555666666655555544
No 387
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=92.71 E-value=0.094 Score=31.40 Aligned_cols=21 Identities=43% Similarity=0.561 Sum_probs=11.7
Q ss_pred CCCcEEEccCCCCCCCCcccc
Q psy10487 105 TILVEVDLSDNQIAWLHQDTF 125 (610)
Q Consensus 105 ~~L~~LdLs~n~l~~l~~~~f 125 (610)
.+|++|+|++|+|..++...|
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f 22 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAF 22 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHc
Confidence 345555666666655555544
No 388
>cd05901 Ig_Versican Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. Ig_Versican: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), versican. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Like aggrecan, versican has a wide distribution in connective tissue and extracellular matrices. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many different tissues. Members of the vertebrate HPLN (hyaluronan/HA
Probab=92.66 E-value=0.086 Score=44.87 Aligned_cols=37 Identities=16% Similarity=0.138 Sum_probs=31.1
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.+.+|.|.+++.+|+|.|.|...+.....+...+|.|
T Consensus 77 g~asL~i~~v~~sD~G~Y~C~V~~g~~~~~~~v~L~V 113 (117)
T cd05901 77 GDASLTIVKLRASDAGVYRCEVMHGIEDTQDTVSLDV 113 (117)
T ss_pred CceEEEEcccccccCEEEEEEEEECCcccEEEEEEEE
Confidence 4568999999999999999999998877777666654
No 389
>cd05889 Ig1_DNAM-1_like First immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226) and similar proteins. Ig1_DNAM-1_like: domain similar to the first immunoglobulin (Ig) domain of DNAX accessory molecule 1 (DNAM-1, also known as CD226). DNAM-1 is a transmembrane protein having two Ig-like domains. It is an adhesion molecule which plays a part in tumor-directed cytotoxicity and adhesion in natural killer (NK) cells and T lymphocytes. It has been shown to regulate the NK cell killing of several tumor types, including myeloma cells and ovarian carcinoma cells. DNAM-1 interacts specifically with poliovirus receptor (PVR; CD155) and nectin -2 (CD211), other members of the Ig superfamily. DNAM-1 is expressed in most peripheral T cells, NK cells, monocytes and a subset of B lymphocytes.
Probab=92.45 E-value=0.1 Score=42.84 Aligned_cols=34 Identities=18% Similarity=0.126 Sum_probs=27.7
Q ss_pred cccceeeeeeeeccCcceeeeecC-CCcceeeeee
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALG-SQPDMELIEQ 454 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N-~~G~~~~~~~ 454 (610)
.+.+|.|.+++.+|+|.|+|.... ..|..+....
T Consensus 58 ~d~sI~i~nvt~~D~G~Y~C~~~t~P~g~~~~~i~ 92 (96)
T cd05889 58 EDMSLSFNNATEEDVGLYCCSLVTYPQGSWEKVIE 92 (96)
T ss_pred CccEEEEcCCCcccCEEEEEEEEeCCCCCeEEEEE
Confidence 567899999999999999999876 5776655443
No 390
>cd05846 Ig1_MRC-OX-2_like First immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200) and similar proteins. Ig1_ MRC-OX-2_like: domain similar to the first immunoglobulin (Ig) domain of rat MRC OX-2 antigen (also known as CD200). MRC OX-2 is a membrane glycoprotein expressed in a variety of lymphoid and non-lymphoid cells in rats. It has a similar broad distribution pattern in humans. MRC OX-2 may regulate myeloid cell activity. The protein has an extracellular portion containing two Ig-like domains, a transmembrane portion, and a cytoplasmic portion.
Probab=92.40 E-value=0.11 Score=42.85 Aligned_cols=37 Identities=8% Similarity=-0.093 Sum_probs=30.0
Q ss_pred cccceeeeeeeeccCcceeeeecC-CCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALG-SQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N-~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|.|.|...+ ..|..+....|.|
T Consensus 59 ~~~sL~I~nv~~~D~G~Y~C~~~~~p~g~~~~~~~L~v 96 (97)
T cd05846 59 NSTSITIWNVTLEDEGCYKCIFNTFPDGSKSGTMCLTV 96 (97)
T ss_pred CccEEEEeCCceeeeEEEEEEEEeCCCCCeeeEEEEEE
Confidence 456799999999999999999764 6777777666655
No 391
>PHA03042 CD47-like protein; Provisional
Probab=92.22 E-value=0.56 Score=45.26 Aligned_cols=70 Identities=20% Similarity=0.293 Sum_probs=48.2
Q ss_pred cCceEEEEEEEEec-----CCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcce
Q psy10487 274 AGGNVTMSCYVYGD-----PEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNA 348 (610)
Q Consensus 274 ~G~~v~l~C~~~g~-----P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~ 348 (610)
-.+++.+.|.+..- -.-.+.|.+++..+...+.. ..++|.+.... .-.|.|+|+|.+...+.
T Consensus 30 CN~TV~IpC~v~n~~~~ni~~~~V~Wkf~~~~If~~n~t------------n~aSL~~~f~~-~l~GNYTCEv~~l~n~g 96 (286)
T PHA03042 30 CNKTIVIVCNLNLLIYYNISNIHINWKFNNKVIFKKNNT------------NTSSLKFNFSK-NLSGNYTCEAINKFNKI 96 (286)
T ss_pred cCceEEEEeecCChhhcCccceEEEEEeCCeeEEEecCC------------cceEEEEeccc-cCCCceeEEEeecccCc
Confidence 36778999988542 35669999999887544321 11356655433 34899999999877777
Q ss_pred eEEEEEEc
Q psy10487 349 SGEISLDL 356 (610)
Q Consensus 349 ~~~~~L~V 356 (610)
...+.|+-
T Consensus 97 k~~IeLk~ 104 (286)
T PHA03042 97 KNTIELQY 104 (286)
T ss_pred cEEEEEEE
Confidence 77777765
No 392
>cd05902 Ig_Neurocan Immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. Ig_Neurocan: immunoglobulin (Ig)-like domain of the chondroitin sulfate proteoglycan core protein (CSPG), neurocan. In CSPGs, the Ig-like domain is followed by hyaluronan (HA)-binding tandem repeats, and a C-terminal region with epidermal growth factor-like, lectin-like, and complement regulatory protein-like domains. Separating these N- and C-terminal regions is a nonhomologous glycosaminoglycan attachment region. In cartilage, the CSPG aggrecan (not included in this group) forms cartilage link protein stabilized aggregates with HA. These aggregates contribute to the tissue's load bearing properties. Unlike aggrecan which is widely distributed in connective tissue and extracellular matrices, neurocan is localized almost exclusively in nervous tissue. Aggregates having other CSPGs substituting for aggrecan may contribute to the structural integrity of many differen
Probab=92.17 E-value=0.082 Score=44.68 Aligned_cols=37 Identities=16% Similarity=0.058 Sum_probs=30.1
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
.+..|.|.+++.+|+|.|.|.........+....|.|
T Consensus 70 ~~asL~i~nv~~~D~G~Y~C~v~~g~~~~~~~v~L~V 106 (110)
T cd05902 70 YNASLVLSRLRYSDSGTYRCEVVLGINDEQDTVPLEV 106 (110)
T ss_pred ceEEEEECCCCHHHCEEEEEEEEECCcccEEEEEEEE
Confidence 4568999999999999999999986666666666554
No 393
>cd07689 Ig2_VCAM-1 Second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106) and intercellular cell adhesion molecule-1 (ICAM-1, CD54) and similar proteins. Ig2_ VCAM-1_like: domain similar to the second immunoglobulin (Ig)-like domain of vascular endothelial cell adhesion molecule-1 (VCAM-1, CD106). During the inflammation process, these molecules recruit leukocytes onto the vascular endothelium before extravasation to the injured tissues. The interaction of VCAM-1 binding to the beta1 integrin very late antigen (VLA-4) expressed by lymphocytes and monocytes mediates the adhesion of leucocytes to blood vessel walls, and regulates migration across the endothelium. During metastasis, some circulating cancer cells extravasate to a secondary site by a similar process. VCAM-1 may be involved in organ targeted tumor metastasis and may also act as host receptors for viruses and parasites. VCAM-1 contains seven Ig domains.
Probab=92.10 E-value=0.59 Score=38.26 Aligned_cols=70 Identities=30% Similarity=0.255 Sum_probs=41.6
Q ss_pred eecCceEEEEEEEEe-cCC--CeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCe-EEEEEeecC
Q psy10487 272 REAGGNVTMSCYVYG-DPE--PTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAG-EYTCYAENI 344 (610)
Q Consensus 272 v~~G~~v~l~C~~~g-~P~--p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G-~Y~C~a~N~ 344 (610)
+.+|..+++.|.+.+ .|. .+|.|++....+....+.... +.+........++|.- +.+|.| .|+|.|.=.
T Consensus 12 l~~G~~vtv~C~v~~v~P~~~l~v~LlkG~~~l~~~~f~~~~--~~ks~~~~~~~vtftp-treD~g~~fsC~A~L~ 85 (99)
T cd07689 12 LEEGKPVTVKCEVPDVYPFDRLEIELLKGETLLPSKSFLEDM--DKKSLETKSLEVTFTP-TIEDIGKVLVCRAKLH 85 (99)
T ss_pred ccCCceEEEEEEecCcccCCceEEEEecCcceeccccccccc--ccCCCCCcceeEEEec-chhhCCcEEEEEEEEe
Confidence 378999999999974 455 579999876665544321100 0000001123455554 477777 899998643
No 394
>cd05880 Ig_EVA1 Immunoglobulin (Ig)-like domain of epithelial V-like antigen 1 (EVA). Ig_EVA: immunoglobulin (Ig) domain of epithelial V-like antigen 1 (EVA). EVA is also known as myelin protein zero-like 2. EVA is an adhesion molecule, which may play a role in structural organization of the thymus and early lymphocyte development.
Probab=92.08 E-value=0.1 Score=44.65 Aligned_cols=28 Identities=18% Similarity=0.260 Sum_probs=24.1
Q ss_pred cccceeeeeeeeccCcceeeeecCCCcc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQPD 448 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G~ 448 (610)
.+..|.|.+++.+|+|+|.|.+.|..+.
T Consensus 77 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~~ 104 (115)
T cd05880 77 RDASILIWQLQPTDNGTYTCQVKNPPDV 104 (115)
T ss_pred CceEEEEeeCChhhCEEEEEEEEeCCCC
Confidence 4557999999999999999999996553
No 395
>smart00370 LRR Leucine-rich repeats, outliers.
Probab=91.84 E-value=0.14 Score=30.66 Aligned_cols=22 Identities=23% Similarity=0.410 Sum_probs=14.6
Q ss_pred CCccEEEcccCCCcccchhhhc
Q psy10487 81 LNLQRIYLKNSGIREVHRDTFK 102 (610)
Q Consensus 81 ~~L~~L~L~~n~l~~i~~~~f~ 102 (610)
.+|+.|+|.+|+|..+++++|.
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00370 2 PNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHcc
Confidence 4666777777777777666654
No 396
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily.
Probab=91.84 E-value=0.14 Score=30.66 Aligned_cols=22 Identities=23% Similarity=0.410 Sum_probs=14.6
Q ss_pred CCccEEEcccCCCcccchhhhc
Q psy10487 81 LNLQRIYLKNSGIREVHRDTFK 102 (610)
Q Consensus 81 ~~L~~L~L~~n~l~~i~~~~f~ 102 (610)
.+|+.|+|.+|+|..+++++|.
T Consensus 2 ~~L~~L~L~~N~l~~lp~~~f~ 23 (26)
T smart00369 2 PNLRELDLSNNQLSSLPPGAFQ 23 (26)
T ss_pred CCCCEEECCCCcCCcCCHHHcc
Confidence 4666777777777777666654
No 397
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D ....
Probab=91.27 E-value=0.13 Score=27.36 Aligned_cols=11 Identities=45% Similarity=0.755 Sum_probs=3.3
Q ss_pred CcEEEccCCCC
Q psy10487 107 LVEVDLSDNQI 117 (610)
Q Consensus 107 L~~LdLs~n~l 117 (610)
|+.|+|++|+|
T Consensus 3 L~~L~l~~n~L 13 (17)
T PF13504_consen 3 LRTLDLSNNRL 13 (17)
T ss_dssp -SEEEETSS--
T ss_pred cCEEECCCCCC
Confidence 33444444433
No 398
>cd05715 Ig_P0-like Immunoglobulin (Ig)-like domain of Protein zero (P0) and similar proteins. Ig_P0ex-like: domain similar to the immunoglobulin (Ig) domain of Protein zero (P0). P0 accounts for over 50% of the total protein in peripheral nervous system (PNS) myelin. P0 is a single-pass transmembrane glycoprotein with a highly basic intracellular domain and an extracellular Ig domain. The extracellular domain of P0 (P0-ED) is similar to the Ig variable domain, carrying one acceptor sequence for N-linked glycosylation. P0 plays a role in membrane adhesion in the spiral wraps of the myelin sheath. The intracellular domain is thought to mediate membrane apposition of the cytoplasmic faces and may, through electrostatic interactions, interact directly with lipid headgroups. It is thought that homophilic interactions of the P0 extracellular domain mediate membrane juxtaposition in the extracellular space of PNS myelin. This group also contains the Ig domain of Sodium channel subunit beta-2
Probab=91.24 E-value=0.15 Score=43.59 Aligned_cols=27 Identities=15% Similarity=0.278 Sum_probs=23.3
Q ss_pred cccceeeeeeeeccCcceeeeecCCCc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
.+..|.|.+++.+|+|.|.|.+.|..+
T Consensus 78 ~~~sL~I~~v~~~D~G~Y~C~v~~~~~ 104 (116)
T cd05715 78 KDASIVIHNLQFTDNGTYTCDVKNPPD 104 (116)
T ss_pred CeeEEEEeeCCcccCEEEEEEEEeCCC
Confidence 345799999999999999999998644
No 399
>KOG3864|consensus
Probab=90.88 E-value=0.053 Score=50.19 Aligned_cols=81 Identities=22% Similarity=0.305 Sum_probs=49.0
Q ss_pred CCcEEEccCCCCCCCCcccccCCCCCcEEEeeCcc-ccccCcCcCC-CCCCccEEEccCc-cccccCHHHhhcCcccccc
Q psy10487 106 ILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNP-ITELRAGQFP-KLPYLKTIELQHC-QIHSVHKDALIHLTALESL 182 (610)
Q Consensus 106 ~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~-l~~l~~~~~~-~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L 182 (610)
.++.+|.++..|..+.-+-+.++++|+.|.+.++. +.+..-+-++ ..++|+.|+|++| +|+.-.-..+..+++|+.|
T Consensus 102 ~IeaVDAsds~I~~eGle~L~~l~~i~~l~l~~ck~~dD~~L~~l~~~~~~L~~L~lsgC~rIT~~GL~~L~~lknLr~L 181 (221)
T KOG3864|consen 102 KIEAVDASDSSIMYEGLEHLRDLRSIKSLSLANCKYFDDWCLERLGGLAPSLQDLDLSGCPRITDGGLACLLKLKNLRRL 181 (221)
T ss_pred eEEEEecCCchHHHHHHHHHhccchhhhheeccccchhhHHHHHhcccccchheeeccCCCeechhHHHHHHHhhhhHHH
Confidence 46777777777776666666777777777776653 1111111111 2467888888876 5665544555666777766
Q ss_pred cccc
Q psy10487 183 NLNG 186 (610)
Q Consensus 183 ~L~~ 186 (610)
.|.+
T Consensus 182 ~l~~ 185 (221)
T KOG3864|consen 182 HLYD 185 (221)
T ss_pred HhcC
Confidence 6543
No 400
>PHA02865 MHC-like TNF binding protein; Provisional
Probab=90.70 E-value=1.1 Score=45.22 Aligned_cols=80 Identities=16% Similarity=0.238 Sum_probs=45.7
Q ss_pred CCCceeeeecceEeecCceEEEEEEEEecCCC--eEEEEeC---------C---EEeccCC--c------cceeeccCC-
Q psy10487 259 CPPNVTIKESMVIREAGGNVTMSCYVYGDPEP--TILWLLN---------G---QVLHNSS--F------DLLEEEEGD- 315 (610)
Q Consensus 259 c~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p--~v~W~~~---------g---~~l~~~~--~------~~~~~~~~~- 315 (610)
.+|.+.+.-.. ..+ .++|+|.|.|.-+. .++|.++ | ..+.... . ......++|
T Consensus 202 vpP~V~Vt~k~---~~~-~~tL~C~A~GFYP~~I~v~W~kd~~~~~~~~~g~e~~e~~~n~d~e~ge~~~~~~~~pn~Dg 277 (338)
T PHA02865 202 VTPTVKVTGEE---LGD-NTTLFCTFDSHYPSSVAAKWYNSEDFAPEYRYGRYYPELGRDTDYEPGEPGFPTNTKKDNDK 277 (338)
T ss_pred CCCceEEeccc---CCC-CceEEEEEEeEeCCccEEEEEecccccccccCCccccccccCCCccccccccccceeeCCCC
Confidence 35666553321 112 57999999997554 5789999 3 1111100 0 001333445
Q ss_pred ceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 316 ALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 316 ~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
+.+..+..++ +...+...|+|++....
T Consensus 278 gTfQ~~~~v~---v~~~~~~~Y~C~V~Hsg 304 (338)
T PHA02865 278 NTFSSTPSVR---VPTDMSNQIVCVVFHST 304 (338)
T ss_pred CeeEEEEEEE---eCCCCCCCcEEEEEeCC
Confidence 3666666664 44667778999987644
No 401
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=90.45 E-value=0.35 Score=46.48 Aligned_cols=49 Identities=22% Similarity=0.361 Sum_probs=35.3
Q ss_pred CCCeEEEEeCC-EEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCC
Q psy10487 288 PEPTILWLLNG-QVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIR 345 (610)
Q Consensus 288 P~p~v~W~~~g-~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~ 345 (610)
..|.+.|..++ +.+.+.... .....|.|.+.+...+++|.|+|...-..
T Consensus 11 iDP~y~W~GP~g~~l~gn~~~---------nIT~TG~L~~~~F~esmSG~YTCtLsYk~ 60 (271)
T PF07354_consen 11 IDPTYLWTGPNGKPLSGNSYV---------NITETGKLMFKNFQESMSGSYTCTLSYKP 60 (271)
T ss_pred CCCceEEECCCCcccCCCCeE---------EEccCceEEeeccccccCCceEEEEEEEe
Confidence 56899999954 444433221 22445799999999999999999986543
No 402
>cd05751 Ig1_LILRB1_like First immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1) and similar proteins. Ig1_LILRB1_like: domain similar to the first immunoglobulin (Ig)-like domain found in Leukocyte Ig-like receptors (LILR)B1 (also known as LIR-1). This group includes, LILRA5 (LIR9), an activating natural cytotoxicity receptor NKp46, and the immune-type receptor glycoprotein VI (GPVI). LILRs are a family of immunoreceptors expressed on expressed on T and B cells, on monocytes, dendritic cells, and subgroups of natural killer (NK) cells. The human LILR family contains nine proteins (LILRA1-3,and 5, and LILRB1-5). From functional assays, and as the cytoplasmic domains of various LILRs, for example LILRB1 (LIR-1), LILRB2 (LIR-2), and LILRB3 (LIR-3) contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) it is thought that LIR proteins are inhibitory receptors. Of the eight LIR family proteins, only LIR-1(LILRB1), and LIR-2 (LILRB2),
Probab=90.30 E-value=0.21 Score=40.51 Aligned_cols=26 Identities=12% Similarity=0.101 Sum_probs=22.8
Q ss_pred ccccceeeeeeeeccCcceeeeecCC
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
.....+.|.+|+.+|+|+|.|.+.|.
T Consensus 50 ~~~~~f~i~~v~~~~~G~Y~C~~~~~ 75 (91)
T cd05751 50 QNKAKFFIPSMKREHAGRYRCYYRSG 75 (91)
T ss_pred ceeEEEEccCCChhHCEEEEEEEECC
Confidence 34567999999999999999999986
No 403
>KOG0473|consensus
Probab=88.92 E-value=0.022 Score=53.68 Aligned_cols=84 Identities=18% Similarity=0.172 Sum_probs=51.9
Q ss_pred CCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCccccccccccccccccCcccccCCCcccEE
Q psy10487 127 GNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALESLNLNGNRLKHLSESVFFPTPNLKTL 206 (610)
Q Consensus 127 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~l 206 (610)
...+.+.|+|+.|++..+.. .|..++.|.+|+++.|++..+ +..+..+..+..+++..|.++.++. .+...++++.+
T Consensus 40 ~~kr~tvld~~s~r~vn~~~-n~s~~t~~~rl~~sknq~~~~-~~d~~q~~e~~~~~~~~n~~~~~p~-s~~k~~~~k~~ 116 (326)
T KOG0473|consen 40 SFKRVTVLDLSSNRLVNLGK-NFSILTRLVRLDLSKNQIKFL-PKDAKQQRETVNAASHKNNHSQQPK-SQKKEPHPKKN 116 (326)
T ss_pred ccceeeeehhhhhHHHhhcc-chHHHHHHHHHhccHhhHhhC-hhhHHHHHHHHHHHhhccchhhCCc-cccccCCcchh
Confidence 33445555555555544433 355566666777777777655 3445666667777777777766654 45666777777
Q ss_pred ecCCCcc
Q psy10487 207 SLDGNPW 213 (610)
Q Consensus 207 ~l~~N~~ 213 (610)
++.+|+|
T Consensus 117 e~k~~~~ 123 (326)
T KOG0473|consen 117 EQKKTEF 123 (326)
T ss_pred hhccCcc
Confidence 7777764
No 404
>KOG0473|consensus
Probab=88.32 E-value=0.0096 Score=56.00 Aligned_cols=86 Identities=15% Similarity=0.052 Sum_probs=53.7
Q ss_pred hcCCCCCcEEEccCCCCCCCCcccccCCCCCcEEEeeCccccccCcCcCCCCCCccEEEccCccccccCHHHhhcCcccc
Q psy10487 101 FKYLTILVEVDLSDNQIAWLHQDTFLGNDRLKVLYLNGNPITELRAGQFPKLPYLKTIELQHCQIHSVHKDALIHLTALE 180 (610)
Q Consensus 101 f~~l~~L~~LdLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 180 (610)
+......+.||++.|++..+.. .|+-+..|..|+|+.|.+..++. .+..+..+.++++..|++... |..+...++++
T Consensus 38 i~~~kr~tvld~~s~r~vn~~~-n~s~~t~~~rl~~sknq~~~~~~-d~~q~~e~~~~~~~~n~~~~~-p~s~~k~~~~k 114 (326)
T KOG0473|consen 38 IASFKRVTVLDLSSNRLVNLGK-NFSILTRLVRLDLSKNQIKFLPK-DAKQQRETVNAASHKNNHSQQ-PKSQKKEPHPK 114 (326)
T ss_pred hhccceeeeehhhhhHHHhhcc-chHHHHHHHHHhccHhhHhhChh-hHHHHHHHHHHHhhccchhhC-CccccccCCcc
Confidence 4445566667777776665553 35556666777777776666544 245555666666666666665 44566677777
Q ss_pred ccccccccc
Q psy10487 181 SLNLNGNRL 189 (610)
Q Consensus 181 ~L~L~~n~l 189 (610)
.+++..|.+
T Consensus 115 ~~e~k~~~~ 123 (326)
T KOG0473|consen 115 KNEQKKTEF 123 (326)
T ss_pred hhhhccCcc
Confidence 777766653
No 405
>cd04983 IgV_TCR_alpha_like Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) alpha chain and similar proteins. IgV_TCR_alpha: immunoglobulin (Ig) variable domain of the alpha chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group represents the variable domain of the alpha chain of TCRs and also includes the variable domain of delta chains of TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=88.05 E-value=0.28 Score=41.12 Aligned_cols=27 Identities=15% Similarity=0.047 Sum_probs=23.2
Q ss_pred cccceeeeeeeeccCcceeeeecCCCc
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
....|.|.+++.+|+|.|.|.+.+..|
T Consensus 68 ~~~~L~I~~~~~~DsG~Y~C~~~~~~~ 94 (109)
T cd04983 68 KSSSLHISAAQLSDSAVYFCALSESGG 94 (109)
T ss_pred CEEEEEECCCCHHHCEEEEEEEecCCC
Confidence 345799999999999999999998654
No 406
>cd05872 Ig_Sema4B_like Immunoglobulin (Ig)-like domain of the class IV semaphorin Sema4B. Ig_Sema4B_like; Immunoglobulin (Ig)-like domain of Sema4B_like. Sema4B is a Class IV semaphorin. Semaphorins are classified based on structural features additional to the Sema domain. Sema4B has extracellular Sema and Ig domains, a transmembrane domain and a short cytoplasmic domain. Sema4B has been shown to preferentially regulate the development of the postsynaptic specialization at the glutamatergic synapses. This cytoplasmic domain includes a PDZ-binding motif upon which the synaptic localization of Sem4B is dependent. Sema4B is a ligand of CLCP1, CLCP1 was identified in an expression profiling analysis, which compared a highly metastic lung cancer subline with its low metastic parental line. Sema4B was shown to promote CLCP1 endocytosis, and their interaction is a potential target for therapeutic intervention of metastasis.
Probab=87.51 E-value=0.67 Score=37.06 Aligned_cols=31 Identities=16% Similarity=0.145 Sum_probs=23.7
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeee
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQ 454 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~ 454 (610)
..|.|..++.+|+|.|.|.|. ..|-.+..++
T Consensus 47 ~GLlI~~~~~~dsG~Y~C~s~-E~gf~~~~~~ 77 (85)
T cd05872 47 DGLLILVTSPEHSGTYRCYSE-EEGFQQLVAS 77 (85)
T ss_pred CCCEEEECCHhhCEEEEEEEe-cCCCeEEEEE
Confidence 348899999999999999988 4465554443
No 407
>cd00099 IgV Immunoglobulin variable domain (IgV). IgV: Immunoglobulin variable domain (IgV). Members of the IgV family are components of immunoglobulin (Ig) and T cell receptors. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. Within the variable domain, there are regions of even more variability called the hypervariable or complementarity-determining regions (CDRs) which are responsible for antigen binding. A predominant feature of most Ig domains is the disulfide bridge connecting 2 beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=87.26 E-value=0.26 Score=40.92 Aligned_cols=26 Identities=19% Similarity=0.033 Sum_probs=23.2
Q ss_pred ccceeeeeeeeccCcceeeeecCCCc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
.-.|.|.+++.+|+|.|.|.+.+..+
T Consensus 66 ~~sL~I~~v~~~D~G~Y~C~v~~~~~ 91 (105)
T cd00099 66 SFTLTISSLQPEDSAVYYCAVSLSGG 91 (105)
T ss_pred EEEEEECCCCHHHCEEEEEEEecCCC
Confidence 44799999999999999999998765
No 408
>cd05890 Ig2_Nectin-1_like Second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111) and similar proteins. Ig2_Nectin-1_like: domain similar to the second immunoglobulin (Ig) domain of nectin-1 (also known as poliovirus receptor related protein 1, or as CD111). Nectin-1 belongs to the nectin family comprised of four transmembrane glycoproteins (nectins-1 through 4). Nectins are synaptic cell adhesion molecules (CAMs) which facilitate adhesion and signaling at various intracellular junctions. Nectins form homophilic cis-dimers, followed by homophilic and heterophilic trans-dimers involved in cell-cell adhesion. Nectins also heterophilically trans-interact with other CAMs such as nectin-like molecules (necls); nectin-1 for example, has been shown to trans-interact with necl-1. Nectins also interact with various other proteins, including the actin filament (F-actin)-binding protein, afadin. Mutation in the human nectin-1 gene is associ
Probab=87.06 E-value=3 Score=33.67 Aligned_cols=73 Identities=14% Similarity=0.312 Sum_probs=47.0
Q ss_pred eEEEEEE-EEecCCCeEEEEeC--CEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEE
Q psy10487 277 NVTMSCY-VYGDPEPTILWLLN--GQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEIS 353 (610)
Q Consensus 277 ~v~l~C~-~~g~P~p~v~W~~~--g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~ 353 (610)
.+.-.|. +.|.|+..|+|.-+ |.. ......+.++.+...+.+.+-.....|.-.-+|+++...-.....+.
T Consensus 22 v~VA~CiSa~GrPpa~ItW~t~l~G~~------etq~~~~~~GT~TV~S~y~lVPs~~~~gk~lTCvV~h~~~~~~~~~~ 95 (98)
T cd05890 22 MLVATCVSANGKPPSVVRWDTRLKGEA------EFQEIRNQNGTVTVISRYRLVPSREAHKQKLTCIVNYRNDRFTDSVT 95 (98)
T ss_pred EEEEEEEcCCCcCCcEeEEEccCCCce------eeeeeCCCCCCEEEEEEEEEeECHHHcCCEeEEEEEeccccccccEE
Confidence 3567898 57999999999853 221 01111222334556667777777777888999999876555555555
Q ss_pred EE
Q psy10487 354 LD 355 (610)
Q Consensus 354 L~ 355 (610)
|.
T Consensus 96 L~ 97 (98)
T cd05890 96 LN 97 (98)
T ss_pred ec
Confidence 54
No 409
>PF07686 V-set: Immunoglobulin V-set domain; InterPro: IPR013106 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents the V-set domains, which are Ig-like domains resembling the antibody variable domain. V-set domains are found in diverse protein families, including immunoglobulin light and heavy chains; in several T-cell receptors such as CD2 (Cluster of Differentiation 2), CD4, CD80, and CD86; in myelin membrane adhesion molecules; in junction adhesion molecules (JAM); in tyrosine-protein kinase receptors; and in the programmed cell death protein 1 (PD1).; PDB: 1PY9_A 2NXY_D 1U9K_B 3RNK_A 3BP6_A 3BIK_B 3SBW_A 1NPU_A 3BP5_A 3RNQ_A ....
Probab=86.98 E-value=0.36 Score=40.46 Aligned_cols=24 Identities=21% Similarity=0.159 Sum_probs=21.8
Q ss_pred ccceeeeeeeeccCcceeeeecCC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
...|.|.+++.+|+|.|.|.....
T Consensus 78 ~~sL~i~~l~~~DsG~Y~C~v~~~ 101 (114)
T PF07686_consen 78 NFSLTIKNLQPSDSGTYFCQVSTS 101 (114)
T ss_dssp EEEEEESSESGGGEEEEEEEEEES
T ss_pred eEEEEECCCCcCcCEEEEEEEEEC
Confidence 457999999999999999999886
No 410
>KOG3864|consensus
Probab=86.51 E-value=0.095 Score=48.55 Aligned_cols=34 Identities=24% Similarity=0.422 Sum_probs=17.3
Q ss_pred CccEEEeecCCCCCCChhhhcccCCCCccEEEcccC
Q psy10487 56 DIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLKNS 91 (610)
Q Consensus 56 ~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~~n 91 (610)
.++.+|-++..|....-+.+. ++..|+.|.+.+|
T Consensus 102 ~IeaVDAsds~I~~eGle~L~--~l~~i~~l~l~~c 135 (221)
T KOG3864|consen 102 KIEAVDASDSSIMYEGLEHLR--DLRSIKSLSLANC 135 (221)
T ss_pred eEEEEecCCchHHHHHHHHHh--ccchhhhheeccc
Confidence 355566665555554444444 4455555555444
No 411
>cd05759 Ig2_KIRREL3-like Second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). Ig2_KIRREL3-like: domain similar to the second immunoglobulin (Ig)-like domain of Kirrel (kin of irregular chiasm-like) 3 (also known as Neph2). This protein has five Ig-like domains, one transmembrane domain, and a cytoplasmic tail. Included in this group is mammalian Kirrel (Neph1), Kirrel2 (Neph3), and Drosophila RST (irregular chiasm C-roughest) protein. These proteins contain multiple Ig domains, have properties of cell adhesion molecules, and are important in organ development.
Probab=86.32 E-value=1 Score=35.49 Aligned_cols=25 Identities=16% Similarity=0.058 Sum_probs=19.1
Q ss_pred ceeeeeeeeccCcceeeeecCCCcc
Q psy10487 424 KLLDVSITTTDRHTGSCEALGSQPD 448 (610)
Q Consensus 424 ~L~i~~v~~~D~G~Y~C~A~N~~G~ 448 (610)
.|.+.....+|.|.|+|.|.|..-.
T Consensus 47 ~L~i~~~~~~~~~~y~C~a~n~~l~ 71 (82)
T cd05759 47 TLPITPSDHDTGRTFTCRARNEALP 71 (82)
T ss_pred EEEEeCceecCCCEEEEEEcCccCC
Confidence 5666666667889999999996543
No 412
>PHA02982 hypothetical protein; Provisional
Probab=86.24 E-value=1.6 Score=40.44 Aligned_cols=81 Identities=16% Similarity=0.260 Sum_probs=49.0
Q ss_pred cceEeecCceEEEEEEEE-ecCCCeEEEEeCCEE-eccCC-----ccc--eeeccCCc-----eeeeeeEEEEEecCCCC
Q psy10487 268 SMVIREAGGNVTMSCYVY-GDPEPTILWLLNGQV-LHNSS-----FDL--LEEEEGDA-----LFEKSVSITLFNVTDLD 333 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~-g~P~p~v~W~~~g~~-l~~~~-----~~~--~~~~~~~~-----~~~~~~~L~I~~v~~~D 333 (610)
.++....++.+.|.|... +.---+..|..+... +.... ... ........ ..-..++|+|.++..+.
T Consensus 32 ~dv~a~vd~~V~L~C~~~~~~~i~~~~W~~~~~~~la~~~~~~~~iN~~~y~~~~~kd~y~~sv~g~~STLTIkk~~i~N 111 (251)
T PHA02982 32 ADVNATVDQEVKLQCLFKDADEISRAMWKGDAGFMLAQEANGGTGINAFNYVPGPYKDKYALSVSGNSSTFTMKKPDPQN 111 (251)
T ss_pred hhhhccCCCcEEEEecCCCcchhhhheeeCCCCeEEEeeecCcceeccccccCCccceeEEEEEeccceeEEeccCCccc
Confidence 345566789999999852 333456789985432 22110 000 00000000 01124799999999999
Q ss_pred CeEEEEEeecCCcce
Q psy10487 334 AGEYTCYAENIRGNA 348 (610)
Q Consensus 334 ~G~Y~C~a~N~~G~~ 348 (610)
.|-|+|+|....|..
T Consensus 112 ~GCYtc~~ks~~~k~ 126 (251)
T PHA02982 112 LGCFTCEAKDAEGKE 126 (251)
T ss_pred CCceEEEEecCCCch
Confidence 999999999877654
No 413
>KOG1480|consensus
Probab=85.73 E-value=0.28 Score=53.83 Aligned_cols=31 Identities=16% Similarity=0.218 Sum_probs=25.8
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCccee
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDME 450 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~ 450 (610)
..+..+++..+...|.|.|+|+|.|.++..+
T Consensus 180 ~~d~~li~~~arlsd~~nytc~a~ni~~~r~ 210 (909)
T KOG1480|consen 180 ASDHNLIISQARLSDSGNYTCEATNIVAKRK 210 (909)
T ss_pred hhcCCccccchhhhhcccceeeeehhhcccc
Confidence 4556788999999999999999999777543
No 414
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=84.65 E-value=4.3 Score=33.55 Aligned_cols=35 Identities=14% Similarity=0.265 Sum_probs=27.6
Q ss_pred eEEEEEecCCCCCeEEEEEeecCCccee-EEEEEEc
Q psy10487 322 VSITLFNVTDLDAGEYTCYAENIRGNAS-GEISLDL 356 (610)
Q Consensus 322 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~-~~~~L~V 356 (610)
.+|.|..++..|+|.|.-+++|..|... +.+++.|
T Consensus 71 laLlIkaAq~qDSG~Y~LEvT~~sG~V~~~~FqVsV 106 (108)
T PF11465_consen 71 LALLIKAAQPQDSGLYCLEVTNESGKVCTKNFQVSV 106 (108)
T ss_dssp TEEEESS-SGGG-EEEEEEEEETTSCEEEEEEEEEE
T ss_pred ceEEEeecCcccCceEEEEEEcCCCcEEEEEEEEEe
Confidence 4899999999999999999999999873 3555544
No 415
>cd05881 Ig1_Necl-2 First (N-terminal) immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig1_Necl-2: domain similar to the N-terminal immunoglobulin (Ig)-like domain of nectin-like molecule-2, Necl-2 (also known as cell adhesion molecule 1 (CADM1), SynCAM1, IGSF4A, Tslc1, sgIGSF, and RA175). Nectin-like molecules have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). They all have an extracellular region containing three Ig-like domains, a transmembrane region, and a cytoplasmic region. The N-terminal Ig-like domain of the extracellular region, belongs to the V-type subfamily of Ig domains, is essential to cell-cell adhesion, and plays a part in the interaction with the envelope glycoprotein D of various viruses. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-2 is expressed in a wide variety of tissues, and is a
Probab=84.46 E-value=0.49 Score=38.75 Aligned_cols=24 Identities=13% Similarity=0.178 Sum_probs=20.9
Q ss_pred ccceeeeeeeeccCcceeeeecCC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
+-.|.|.+++.+|+|.|.|.+...
T Consensus 61 ~~tL~I~~vq~~D~G~Y~Cqv~t~ 84 (95)
T cd05881 61 ELRVSLSNVSLSDEGRYFCQLYTD 84 (95)
T ss_pred EEEEEECcCCcccCEEEEEEEEcc
Confidence 446999999999999999998763
No 416
>cd05899 IgV_TCR_beta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) bet a chain. IgV_TCR_beta: immunoglobulin (Ig) variable domain of the beta chain of alpha/beta T-cell antigen receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are composed of alpha and beta, or gamma and delta, polypeptide chains with variable (V) and constant (C) regions. This group includes the variable domain of the alpha chain of alpha/beta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. The variable domain of TCRs is responsible for antigen recognition, and is located at the N-terminus of the receptor. Gamma/delta TCRs recognize intact protein antigens; they recognize proteins antigens directly and without antigen processing, and MHC independently of the bound peptide.
Probab=83.30 E-value=0.72 Score=38.85 Aligned_cols=26 Identities=15% Similarity=0.010 Sum_probs=22.5
Q ss_pred ccceeeeeeeeccCcceeeeecCCCc
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
...|.|.+++.+|+|.|.|.+.+..|
T Consensus 71 ~~~L~I~~~~~~Dsg~Y~Ca~~~~~~ 96 (110)
T cd05899 71 RSSLTIKSAEPEDSAVYLCASSLGGG 96 (110)
T ss_pred ccEEEECCCChhhCEEEEEEeeCCCC
Confidence 45799999999999999999987543
No 417
>cd00096 Ig Immunoglobulin domain. Ig: immunoglobulin (Ig) domain found in the Ig superfamily. The Ig superfamily is a heterogenous group of proteins, built on a common fold comprised of a sandwich of two beta sheets. Members of this group are components of immunoglobulin, neuroglia, cell surface glycoproteins, such as, T-cell receptors, CD2, CD4, CD8, and membrane glycoproteins, such as, butyrophilin and chondroitin sulfate proteoglycan core protein. A predominant feature of most Ig domains is a disulfide bridge connecting the two beta-sheets with a tryptophan residue packed against the disulfide bond.
Probab=83.01 E-value=1.7 Score=31.62 Aligned_cols=28 Identities=25% Similarity=0.201 Sum_probs=23.4
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQP 447 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G 447 (610)
.....|.+.+++..|.|.|.|.+.+..+
T Consensus 40 ~~~~~l~i~~~~~~d~g~y~C~~~~~~~ 67 (74)
T cd00096 40 SGSSTLTISNVTLEDSGTYTCVASNSAG 67 (74)
T ss_pred eeEEEEEECccCcccCcEEEEEEecCcC
Confidence 4455788999999999999999998763
No 418
>PHA03270 envelope glycoprotein C; Provisional
Probab=82.06 E-value=15 Score=38.25 Aligned_cols=86 Identities=15% Similarity=0.202 Sum_probs=51.7
Q ss_pred CCCceeeeecceEeecCceEEEEEEEEecCCC---eEEEEeCCEEeccCCccce-eeccCCceeeeeeEEEEEecCCCCC
Q psy10487 259 CPPNVTIKESMVIREAGGNVTMSCYVYGDPEP---TILWLLNGQVLHNSSFDLL-EEEEGDALFEKSVSITLFNVTDLDA 334 (610)
Q Consensus 259 c~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p---~v~W~~~g~~l~~~~~~~~-~~~~~~~~~~~~~~L~I~~v~~~D~ 334 (610)
-+|.+.+.+. -+.+|+...-.|.+..+-+| .+.|+.|+.++........ .....++ +...++|++........
T Consensus 220 r~Psvsv~~~--PvL~Ge~Y~AtC~va~YYPp~Sv~lrWf~ng~~V~~~~~i~~~~~~~~dG-fs~vStvtsea~~~~~~ 296 (466)
T PHA03270 220 RRPSLSIRPH--AVLEGEPFGATCVAANYYPGDRAAFRWFEGGDEVFAPERVRTRVDAQRDG-FSATSTLTSEARAGLAP 296 (466)
T ss_pred cCCcccccCC--ccccCCCceEEEEeeeecCCCceEEEEEeCCccccCcceeeeeeEecCCC-eeEEEEEeccccccCCC
Confidence 3565554433 35679999999999776554 5899999998865333222 2222222 34555666554433222
Q ss_pred -eEEEEEeecCCcc
Q psy10487 335 -GEYTCYAENIRGN 347 (610)
Q Consensus 335 -G~Y~C~a~N~~G~ 347 (610)
-..+|.+.-..+.
T Consensus 297 PPsLrC~v~W~rd~ 310 (466)
T PHA03270 297 PRNLTCEFTWHRDS 310 (466)
T ss_pred CCCceEEEEEccCC
Confidence 3789998665444
No 419
>cd04984 IgV_L_lambda Immunoglobulin (Ig) lambda light chain variable (V) domain. IgV_L_lambda: Immunoglobulin (Ig) light chain, lambda type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=80.00 E-value=0.91 Score=37.28 Aligned_cols=25 Identities=20% Similarity=0.182 Sum_probs=21.4
Q ss_pred cccceeeeeeeeccCcceeeeecCC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
....|.|.+++.+|+|.|.|.+.+.
T Consensus 61 ~~~~L~I~~~~~~Dsg~Y~C~~~~~ 85 (98)
T cd04984 61 NTASLTISGAQTEDEADYYCQVWDS 85 (98)
T ss_pred CEEEEEECCCChhhCEEEEEEEccC
Confidence 3446999999999999999998763
No 420
>cd04980 IgV_L_kappa Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. IgV_L_kappa: Immunoglobulin (Ig) light chain, kappa type, variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which seem to be functionally identical, and can associate with any of the heavy chains.
Probab=79.47 E-value=0.84 Score=38.13 Aligned_cols=24 Identities=17% Similarity=0.261 Sum_probs=20.9
Q ss_pred ccceeeeeeeeccCcceeeeecCC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
...|.|.+++.+|+|.|.|.+.+.
T Consensus 70 ~~~L~I~~~~~~Dsg~Y~Ca~~~~ 93 (106)
T cd04980 70 DFTLTISRVEPEDAAVYYCQQYGT 93 (106)
T ss_pred EEEEEECCCChHHCEEEEEEEeCC
Confidence 346999999999999999999764
No 421
>KOG4308|consensus
Probab=78.63 E-value=0.093 Score=56.51 Aligned_cols=157 Identities=21% Similarity=0.279 Sum_probs=76.4
Q ss_pred ccEEEeecCCCCCCChhhhcc--cCCCCccEEEcccCCCcccch----hhhcCC-CCCcEEEccCCCCCCCCc----ccc
Q psy10487 57 IQVLDLNNNKISYLTKEAFKS--IGLLNLQRIYLKNSGIREVHR----DTFKYL-TILVEVDLSDNQIAWLHQ----DTF 125 (610)
Q Consensus 57 L~~L~L~~n~i~~l~~~~~~~--~~l~~L~~L~L~~n~l~~i~~----~~f~~l-~~L~~LdLs~n~l~~l~~----~~f 125 (610)
+..|.|.+|.+..-....+.. -....|+.|++++|.+..... ..+... ..|+.|++..|.+..... ..+
T Consensus 89 l~~L~L~~~~l~~~~~~~l~~~l~t~~~L~~L~l~~n~l~~~g~~~l~~~l~~~~~~l~~L~l~~c~l~~~g~~~l~~~L 168 (478)
T KOG4308|consen 89 LLHLSLANNRLGDRGAEELAQALKTLPTLGQLDLSGNNLGDEGARLLCEGLRLPQCLLQTLELVSCSLTSEGAAPLAAVL 168 (478)
T ss_pred HHHhhhhhCccccchHHHHHHHhcccccHhHhhcccCCCccHhHHHHHhhcccchHHHHHHHhhcccccccchHHHHHHH
Confidence 666777777766554433321 035566677777776663221 112222 445556666666554321 233
Q ss_pred cCCCCCcEEEeeCccccccC----cCcC----CCCCCccEEEccCccccccCHH----HhhcCcc-cccccccccccccc
Q psy10487 126 LGNDRLKVLYLNGNPITELR----AGQF----PKLPYLKTIELQHCQIHSVHKD----ALIHLTA-LESLNLNGNRLKHL 192 (610)
Q Consensus 126 ~~l~~L~~L~Ls~N~l~~l~----~~~~----~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~-L~~L~L~~n~l~~~ 192 (610)
.....|+.++++.|.+.... ...+ ....++++|.|++|.++...-. .+..... +..|++.+|++.+.
T Consensus 169 ~~~~~l~~l~l~~n~l~~~g~~~l~~~l~~~~~~~~~le~L~L~~~~~t~~~c~~l~~~l~~~~~~~~el~l~~n~l~d~ 248 (478)
T KOG4308|consen 169 EKNEHLTELDLSLNGLIELGLLVLSQALESAASPLSSLETLKLSRCGVTSSSCALLDEVLASGESLLRELDLASNKLGDV 248 (478)
T ss_pred hcccchhHHHHHhcccchhhhHHHhhhhhhhhcccccHHHHhhhhcCcChHHHHHHHHHHhccchhhHHHHHHhcCcchH
Confidence 33566666666666654211 1112 2345666666666665532211 2223333 44466666665533
Q ss_pred Cc----ccccCC-CcccEEecCCCcc
Q psy10487 193 SE----SVFFPT-PNLKTLSLDGNPW 213 (610)
Q Consensus 193 ~~----~~~~~~-~~L~~l~l~~N~~ 213 (610)
.. ..+..+ ..++.+++..|.+
T Consensus 249 g~~~L~~~l~~~~~~l~~l~l~~nsi 274 (478)
T KOG4308|consen 249 GVEKLLPCLSVLSETLRVLDLSRNSI 274 (478)
T ss_pred HHHHHHHHhcccchhhhhhhhhcCCc
Confidence 11 112222 3445566666654
No 422
>PHA02987 Ig domain OX-2-like protein; Provisional
Probab=78.04 E-value=4.6 Score=37.18 Aligned_cols=40 Identities=10% Similarity=-0.029 Sum_probs=32.0
Q ss_pred ccccceeeeeeeeccCcceeeeecC-CCc-ceeeeeeccccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALG-SQP-DMELIEQSLAME 459 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N-~~G-~~~~~~~l~v~~ 459 (610)
..+..|+|.+|+.+|+|.|.|...- ..| ..+....|.|..
T Consensus 82 ~~~StItIknVt~sDeGcY~C~F~tfp~G~~~~gt~CLtVt~ 123 (189)
T PHA02987 82 FNESTILIKNVSLKDNGCYTCIFNTLLSKNNEKGVVCLNVTT 123 (189)
T ss_pred CCcceEEEEeCChhhCeEEEEEEEecCCCCCceeEEEEEEEc
Confidence 4567899999999999999998754 456 677777777764
No 423
>PHA03273 envelope glycoprotein C; Provisional
Probab=78.01 E-value=21 Score=37.45 Aligned_cols=86 Identities=16% Similarity=0.174 Sum_probs=54.2
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCC---eEEEEeCCEEeccCCc-cceeeccCCceeeeeeEEEEEecCC-CCC
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEP---TILWLLNGQVLHNSSF-DLLEEEEGDALFEKSVSITLFNVTD-LDA 334 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p---~v~W~~~g~~l~~~~~-~~~~~~~~~~~~~~~~~L~I~~v~~-~D~ 334 (610)
+|.+.+.+. -+.+|+...-.|.+...-+| .+.|+.||.++....+ ........++.+...++|++.+... +..
T Consensus 237 ~Psvsv~~~--PvL~Ge~y~A~C~aa~YYPp~Sv~~rWf~dg~~V~~~~~~~~~~~~~~~gl~T~vStlt~~~~~~~~~P 314 (486)
T PHA03273 237 APLVDLSVH--PSLKGENYRAVCVVASYFPHSSVKLRWYKNAKEVDFTKYVTNASSVWVDGLITRISTLSIPVDPDEEYT 314 (486)
T ss_pred CCcccccCC--ccccCCCceEEEEeeeecCCCceEEEEEeCCeeccccccceeeEEEecCCceEEEEEEeccCcccCCCC
Confidence 455544433 35689999999999776544 5899999999883222 2122212233456667787766544 334
Q ss_pred eEEEEEeecCCcc
Q psy10487 335 GEYTCYAENIRGN 347 (610)
Q Consensus 335 G~Y~C~a~N~~G~ 347 (610)
-..+|.+.-..+.
T Consensus 315 P~lrC~v~W~rd~ 327 (486)
T PHA03273 315 PSLRCSIEWYRDE 327 (486)
T ss_pred CCceEEEEEccCC
Confidence 4799998665544
No 424
>smart00365 LRR_SD22 Leucine-rich repeat, SDS22-like subfamily.
Probab=77.57 E-value=1.8 Score=25.92 Aligned_cols=16 Identities=50% Similarity=0.567 Sum_probs=8.5
Q ss_pred CCCcEEEccCCCCCCC
Q psy10487 105 TILVEVDLSDNQIAWL 120 (610)
Q Consensus 105 ~~L~~LdLs~n~l~~l 120 (610)
.+|++|+|+.|+|..+
T Consensus 2 ~~L~~L~L~~NkI~~I 17 (26)
T smart00365 2 TNLEELDLSQNKIKKI 17 (26)
T ss_pred CccCEEECCCCcccee
Confidence 3455555555555443
No 425
>PF03921 ICAM_N: Intercellular adhesion molecule (ICAM), N-terminal domain; InterPro: IPR013768 Intercellular adhesion molecules (ICAMs) and vascular cell adhesion molecule-1 (VCAM-1) are part of the immunoglobulin superfamily. They are important in inflammation, immune responses and in intracellular signalling events []. The ICAM family consists of five members, designated ICAM-1 to ICAM-5. They are known to bind to leucocyte integrins CD11/CD18 during inflammation and in immune responses. In addition, ICAMs may exist in soluble forms in human plasma, due to activation and proteolysis mechanisms at cell surfaces. ICAM-1 (CD54) contains five Ig-like domains. It is expressed on leucocytes, endothelial and epithelial cells, and is upregulated in response to bacterial invasion. The protein is a ligand for lymphocyte-function associated (LFA) antigens and also a receptor for CD11a,b/CD18, fibrinogen, human rhinovirus and Plasmodium falciparum-infected erythrocytes. ICAM-1 binding sites for CD11a/CD18 and its other binding partners are located in the first domain and are overlapping. ICAM-1 domain 2 seems to play an important role in maintaining the conformation of domain 1 and particularly the structural integrity of the LFA-1 ligand-binding site []. The 3-dimensional atomic structure of the tandem N-terminal Ig-like domains (D1 and D2) of ICAM-1 has been determined to 2.2A resolution and fitted into a cryoelectron microscopy reconstruction of a rhinovirus-ICAM-1 complex []. Extensive charge interactions between ICAM-1 and human rhinovirusesare largely conserved in major and minor receptor groups of rhinoviruses. The interaction of ICAMs with LFA-1 is mediated by a divalent cation bound to the insertion (I)-domain on the alpha chain of LFA-1 and the carboxyl group of a conserved glutamic acid residue on ICAMs. ICAM-2 (CD102) has two Ig-like domains. It is expressed on endothelial cells, leucocytes and platelets, and binds to CD11a'b/CD18. The protein is refractory to proinflammatory cytokines, and plays an important role in the adhesion of leucocytes to the uninduced endothelium []. ICAM-3 (CD50) contains five Ig-like domains and binds to leucocyte integrins CD11a'd/CD18. The protein plays an important role in the immune response and perhaps in signal transduction []. ICAM-4 (LW blood group Ag) is red blood cell (RBC) specific and binds to CD11a'b/CD18. It is associated with the RBC Rh antigens and could be important in retaining immature red cells in the bone marrow, or in the uptake of senescent cells into the spleen []. ICAM-5 (telencephalin) has nine Ig-like domains and is confined to the telencephalon of the brain. The role of this CD11a/CD18 binding molecule is not yet known []. VCAM-1 was first described as a cytokine-inducible endothelial adhesion molecule. It can bind to leucocyte integrin VL-4 (very late antigen-4) to recruit leucocytes to sites of inflammation []. The predominant form of VCAM-1 in vivo has an N-terminal extracellular region comprising seven Ig-like domains []. A conserved integrin-binding motif has been identified in domains 1 and 4, variants of which are present in the N-terminal domain of all members of the integrin-binding subgroup of the immunoglobulin superfamily. The structure of a VLA-4-binding fragment comprising the first two domains of VCAM-1 has been determined to 1.8A resolution. The integrin-binding motif is exposed and forms the N-terminal region of the loop between beta-strands C and D of domain 1 []. VCAM-1 domains 1 and 2 are structurally similar to ICAM-1 and ICAM-2 []. This entry represents the N-terminal domain of ICAM proteins such as ICAM-2, ICAM-3 and ICAM-4.; PDB: 3BN3_B 1T0P_B 1ZXQ_A 3TCX_A 1MQ8_A 1Z7Z_I 1IC1_A 1IAM_A.
Probab=77.25 E-value=37 Score=27.47 Aligned_cols=80 Identities=21% Similarity=0.312 Sum_probs=50.7
Q ss_pred ceeeeecceEeecCceEEEEEEEEecCCCe-EEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEE
Q psy10487 262 NVTIKESMVIREAGGNVTMSCYVYGDPEPT-ILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCY 340 (610)
Q Consensus 262 ~i~~~~~~~~v~~G~~v~l~C~~~g~P~p~-v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~ 340 (610)
.+.+.|....+..|+++.+.|.. .-|.|. +.|...-. +...+.+ ..|..+.+.+|+. | ..-.|.
T Consensus 5 ~v~v~P~~~vV~~G~Sv~VNCSt-sC~~p~~~GLET~L~--------k~~~~~g----~~W~~f~LsnV~~-d-s~~~C~ 69 (91)
T PF03921_consen 5 EVRVSPEEPVVPPGGSVWVNCST-SCPQPEKIGLETSLS--------KTELDSG----PQWKAFQLSNVTE-D-SSPLCF 69 (91)
T ss_dssp -EEEESSEEEEETTEEEEEEEEE-SSSS-SEEEEESSSE--------EEEEEEE----TTEEEEEEEEE-S-C-EEEEEE
T ss_pred EEEEECCccEECCCCCEEEEEcC-CCCCCCcceEEEecC--------CcccCCC----CcEEEEEEEcccc-C-CeEEEE
Confidence 35677888999999999999997 445553 45543211 1111111 3467889999996 5 577899
Q ss_pred eecCCcceeEEEEEEc
Q psy10487 341 AENIRGNASGEISLDL 356 (610)
Q Consensus 341 a~N~~G~~~~~~~L~V 356 (610)
+.-......+++.++|
T Consensus 70 ~~C~g~Q~~~~~~ItV 85 (91)
T PF03921_consen 70 FNCSGEQSSASANITV 85 (91)
T ss_dssp EEETTEEEEEEEEEEE
T ss_pred EEcCCeEEEeEEeeEE
Confidence 8765444566777776
No 426
>smart00406 IGv Immunoglobulin V-Type.
Probab=76.63 E-value=0.95 Score=35.16 Aligned_cols=21 Identities=19% Similarity=0.229 Sum_probs=18.4
Q ss_pred cccceeeeeeeeccCcceeee
Q psy10487 421 QEKKLLDVSITTTDRHTGSCE 441 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~ 441 (610)
....|.|.+++.+|+|.|.|.
T Consensus 60 ~~~~L~i~~~~~~D~G~Y~C~ 80 (81)
T smart00406 60 NDVSLTISNLRVEDTGTYYCA 80 (81)
T ss_pred CEEEEEEcCCCHHHCEEEEEc
Confidence 345799999999999999996
No 427
>PHA03269 envelope glycoprotein C; Provisional
Probab=74.77 E-value=8.5 Score=40.47 Aligned_cols=87 Identities=20% Similarity=0.223 Sum_probs=55.4
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCC---eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCC--C
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEP---TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLD--A 334 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p---~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D--~ 334 (610)
+|.+.+.+ .-+.+|+...-.|.+..+-+| .+.|+.||..+.............++.+...++|.+......| -
T Consensus 329 ~PsVsV~p--~PVL~Ge~YkAtC~vA~YYPp~SvrlrWf~ng~~V~~~~it~t~~~~~dGlFSrVSTLtlp~~~~~d~~P 406 (566)
T PHA03269 329 RPNITVIG--DPVLLGNPYAAYCKVNKYYPPHSVIVKWTSNFGNIGKNFITDAIKENADGLFSSVSALHIPAQKNADYPP 406 (566)
T ss_pred CCCccccC--CccccCCCceEEEEeeeecCCCceEEEEEeCCcccCccccccceeecCCCceEEEEEEeccCccccCCCC
Confidence 35444433 346689999999999876544 5899999998875333332333445556777788765443333 3
Q ss_pred eEEEEEeecCCcce
Q psy10487 335 GEYTCYAENIRGNA 348 (610)
Q Consensus 335 G~Y~C~a~N~~G~~ 348 (610)
-..+|.+.-..+..
T Consensus 407 PsLrCeV~W~RDsV 420 (566)
T PHA03269 407 PAIQCNVLWIRDGV 420 (566)
T ss_pred CCceEEEEEccCCc
Confidence 46799986655443
No 428
>cd05716 Ig_pIgR Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). Ig_pIgR: Immunoglobulin (Ig)-like domain in the polymeric Ig receptor (pIgR). pIgR delivers dimeric IgA and pentameric IgM to mucosal secretions. Polymeric immunoglobulin (pIgs) are the first defense against pathogens and toxins. IgA and IgM can form polymers via an 18-residue extension at their c-termini referred to as the tailpiece. pIgR transports pIgs across mucosal epithelia into mucosal secretions. Human pIgR is a glycosylated type I transmembrane protein, comprised of a 620 residue extracellular region, a 23 residue transmembrane region, and a 103 residue cytoplasmic tail. The extracellular region contains five domains that share sequence similarity with Ig variable (v) regions.
Probab=74.69 E-value=1.3 Score=36.21 Aligned_cols=24 Identities=8% Similarity=-0.111 Sum_probs=21.2
Q ss_pred cceeeeeeeeccCcceeeeecCCC
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQ 446 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~ 446 (610)
-.|.|.+++.+|+|.|.|.+.+..
T Consensus 64 ~~L~I~~v~~~DsG~Y~C~~~~~~ 87 (98)
T cd05716 64 FTVTLNQLRKEDAGWYWCGVGDDG 87 (98)
T ss_pred EEEEEcCCCHHHCEEEEEEcccCC
Confidence 479999999999999999988753
No 429
>PF06832 BiPBP_C: Penicillin-Binding Protein C-terminus Family; InterPro: IPR009647 This conserved region of approximately 90 residues is found in a sub-group of bacterial Penicillin-Binding Proteins (PBPs). A variable length loop region separates this region from the transpeptidase unit (IPR001460 from INTERPRO). It is predicted to be a beta fold.
Probab=74.54 E-value=27 Score=27.96 Aligned_cols=56 Identities=14% Similarity=0.245 Sum_probs=37.4
Q ss_pred eEEEEEEEEecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeE
Q psy10487 277 NVTMSCYVYGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASG 350 (610)
Q Consensus 277 ~v~l~C~~~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~ 350 (610)
...|.+.+.|. .+.+.|+.||..+....... .+. ......|.|+-.+....|....
T Consensus 31 ~~~l~l~a~~~-~~~~~W~vdg~~~g~~~~~~--------------~~~---~~~~~~G~h~l~vvD~~G~~~~ 86 (89)
T PF06832_consen 31 RQPLVLKAAGG-RGPVYWFVDGEPLGTTQPGH--------------QLF---WQPDRPGEHTLTVVDAQGRSAS 86 (89)
T ss_pred cceEEEEEeCC-CCcEEEEECCEEcccCCCCC--------------eEE---eCCCCCeeEEEEEEcCCCCEEE
Confidence 56677777776 55999999999984333210 122 1234679999999888887544
No 430
>PF06328 Lep_receptor_Ig: Ig-like C2-type domain; InterPro: IPR010457 This entry represents a ligand-binding domain that displays similarity to C2-set immunoglobulin domains (antibody constant domain 2) []. The two cysteine residues form a disulphide bridge.; PDB: 3L5H_A 1P9M_A 1I1R_A 2D9Q_B.
Probab=74.14 E-value=11 Score=30.34 Aligned_cols=69 Identities=28% Similarity=0.421 Sum_probs=43.1
Q ss_pred eeeecceEeecCceEEEEEEEEe-----cCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEE
Q psy10487 264 TIKESMVIREAGGNVTMSCYVYG-----DPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYT 338 (610)
Q Consensus 264 ~~~~~~~~v~~G~~v~l~C~~~g-----~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~ 338 (610)
.+.+....+..|++++..|...- .....|.|..|+..+...... ...+. .+.+++.+.....+-.|-
T Consensus 7 ~i~p~~pvv~lGS~vtasC~l~~~c~~~~~a~~I~Wkln~~~iP~~qy~--~in~~------~SsVT~~~~~~~~~~L~c 78 (89)
T PF06328_consen 7 VISPPSPVVSLGSNVTASCVLKQNCSHSVNASQIVWKLNGEKIPGSQYR--VINDT------VSSVTLPNLNPTGATLFC 78 (89)
T ss_dssp EEECSSSEEETTS-EEEEEEE-CCCHCT-STTCEEEECSSCESTCGCEE--EESTT------EEEEEESS--SSEEEEEE
T ss_pred EEecCCCEEeCCCCEEEEEEEECCCCCCcccceEEEEECCEECChhHcc--eeCCe------EEEEEEccCCCCCceEEE
Confidence 45566777889999999999852 356689999999876655431 11111 146677666665556677
Q ss_pred EE
Q psy10487 339 CY 340 (610)
Q Consensus 339 C~ 340 (610)
|.
T Consensus 79 C~ 80 (89)
T PF06328_consen 79 CK 80 (89)
T ss_dssp EE
T ss_pred EE
Confidence 76
No 431
>PHA03052 Hypothetical protein; Provisional
Probab=72.85 E-value=8.7 Score=28.80 Aligned_cols=37 Identities=22% Similarity=0.561 Sum_probs=28.6
Q ss_pred ecceEeecCceEEEEEEEE-ec--CCCeEEEEeCCEEecc
Q psy10487 267 ESMVIREAGGNVTMSCYVY-GD--PEPTILWLLNGQVLHN 303 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~-g~--P~p~v~W~~~g~~l~~ 303 (610)
|..+.+..|..+++.|++. |. ..+.|.|.-|+..+..
T Consensus 4 P~~i~~slGs~ltI~Ckv~lg~g~~~a~V~W~~N~~~~e~ 43 (69)
T PHA03052 4 PEGIVTSLGSNLTITCKVSLRPPTTDADVFWISNGMYYEE 43 (69)
T ss_pred CccEEEEccCCceEeEEEEecCCCcceEEEEEeCCcEEec
Confidence 3556778899999999995 33 3567899999988743
No 432
>cd04982 IgV_TCR_gamma Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) gamma chain. IgV_TCR_gamma: immunoglobulin (Ig) variable (V) domain of the gamma chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=72.85 E-value=1.7 Score=36.83 Aligned_cols=23 Identities=17% Similarity=0.136 Sum_probs=20.4
Q ss_pred ccceeeeeeeeccCcceeeeecC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
...|.|.+++.+|+|.|.|.+..
T Consensus 76 ~~~L~I~~~~~~Dsg~Y~C~~~~ 98 (116)
T cd04982 76 TSTLTIQNLEKEDSATYYCAYWE 98 (116)
T ss_pred EEEEEEEECCHHHCEEEEEEEec
Confidence 34799999999999999999875
No 433
>PF13516 LRR_6: Leucine Rich repeat; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1DFJ_I 2BNH_A 3VQ1_A 3VQ2_A 2Z64_A 2OMX_A ....
Probab=72.56 E-value=1.9 Score=25.07 Aligned_cols=16 Identities=38% Similarity=0.584 Sum_probs=7.4
Q ss_pred CCccEEEccCcccccc
Q psy10487 153 PYLKTIELQHCQIHSV 168 (610)
Q Consensus 153 ~~L~~L~L~~n~l~~~ 168 (610)
++|+.|+|++|+|...
T Consensus 2 ~~L~~L~l~~n~i~~~ 17 (24)
T PF13516_consen 2 PNLETLDLSNNQITDE 17 (24)
T ss_dssp TT-SEEE-TSSBEHHH
T ss_pred CCCCEEEccCCcCCHH
Confidence 4555566665555443
No 434
>cd05720 Ig_CD8_alpha Immunoglobulin (Ig) like domain of CD8 alpha chain. Ig_CD8_alpha: immunoglobulin (Ig)-like domain in CD8 alpha. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alphaalpha or alphabeta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a v-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain. The Ig domain of CD8 alpha binds to antibodies.
Probab=72.54 E-value=1.6 Score=36.36 Aligned_cols=24 Identities=8% Similarity=-0.021 Sum_probs=20.6
Q ss_pred cccceeeeeeeeccCcceeeeecC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
....|.|.+++.+|+|+|.|.+.+
T Consensus 67 ~~~~L~I~~~~~sDsgtY~Ca~~~ 90 (104)
T cd05720 67 NSFVLTLKNFQKENEGYYFCSVAS 90 (104)
T ss_pred CEEEEEECCCCHHHCEEEEEEEcc
Confidence 334699999999999999999875
No 435
>smart00364 LRR_BAC Leucine-rich repeats, bacterial type.
Probab=71.48 E-value=2.4 Score=25.34 Aligned_cols=18 Identities=22% Similarity=0.538 Sum_probs=11.4
Q ss_pred CCccEEEeecCCCCCCCh
Q psy10487 55 SDIQVLDLNNNKISYLTK 72 (610)
Q Consensus 55 ~~L~~L~L~~n~i~~l~~ 72 (610)
.+|+.|++++|+++.++.
T Consensus 2 ~~L~~L~vs~N~Lt~LPe 19 (26)
T smart00364 2 PSLKELNVSNNQLTSLPE 19 (26)
T ss_pred cccceeecCCCccccCcc
Confidence 356667777776666653
No 436
>KOG0613|consensus
Probab=70.39 E-value=17 Score=43.09 Aligned_cols=37 Identities=11% Similarity=-0.030 Sum_probs=28.8
Q ss_pred cceeeeeeeeccCcceeeeecCCCcceeeeeeccccc
Q psy10487 423 KKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAME 459 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~ 459 (610)
..+.|..+...+.+.|.|.|.|..|.....+..++.+
T Consensus 393 ~~~~~~~~~~~e~~~~~~~a~n~~g~~~~~~~~~vs~ 429 (1205)
T KOG0613|consen 393 HTYTIKDAGPGEGYFTRVPAVNKGGTEQTIAESTVSE 429 (1205)
T ss_pred cchhhhhcCcccccccccceeccCCcccccchhhccc
Confidence 3566777778899999999999999877766655544
No 437
>cd07691 Ig_CD3_gamma_delta Immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. Ig_CD3_gamma_delta; immunoglobulin (Ig)-like domain of CD3 gamma and delta chains. CD3 is a T cell surface receptor that is associated with alpha/beta T cell receptors (TCRs). The CD3 complex consists of one gamma, one delta, two epsilon, and two zeta chains. The CD3 subunits form heterodimers as gamma/epsilon, delta/epsilon, and zeta/zeta. The gamma, delta, and epsilon chains each contain an extracellular Ig domain, whereas the extracellular domains of the zeta chains are very small and have unknown structure. The CD3 domain participates in intracellular signalling once the TCR has bound an MHC/antigen complex.
Probab=70.01 E-value=5.2 Score=30.28 Aligned_cols=23 Identities=26% Similarity=0.066 Sum_probs=20.8
Q ss_pred ccceeeeeeeeccCcceeeeecC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
+++|.+.++..+-+|.|.|.++|
T Consensus 32 ~~tlnLGs~~~DPRG~Y~C~~s~ 54 (69)
T cd07691 32 NTLLDLGSRINDPRGTYSCKESE 54 (69)
T ss_pred ccEEeccCcccCCCcceEecCcc
Confidence 67888999999999999999988
No 438
>KOG1947|consensus
Probab=69.92 E-value=1.3 Score=47.80 Aligned_cols=85 Identities=16% Similarity=0.121 Sum_probs=51.3
Q ss_pred CCccEEEeecC--CCCCCC---hhhhcccCCCCccEEEcccCC-Ccccchhhhc-CCCCCcEEEccCCC-CCCCCc-ccc
Q psy10487 55 SDIQVLDLNNN--KISYLT---KEAFKSIGLLNLQRIYLKNSG-IREVHRDTFK-YLTILVEVDLSDNQ-IAWLHQ-DTF 125 (610)
Q Consensus 55 ~~L~~L~L~~n--~i~~l~---~~~~~~~~l~~L~~L~L~~n~-l~~i~~~~f~-~l~~L~~LdLs~n~-l~~l~~-~~f 125 (610)
.+|+.|+++++ .+.... ..... .+.+|+.|+++.+. ++...-.++. .+++|++|.+.++. ++...- ...
T Consensus 214 ~~L~~L~l~~~~~~~~~~~~~~~~~~~--~~~~L~~l~l~~~~~isd~~l~~l~~~c~~L~~L~l~~c~~lt~~gl~~i~ 291 (482)
T KOG1947|consen 214 PNLEELDLSGCCLLITLSPLLLLLLLS--ICRKLKSLDLSGCGLVTDIGLSALASRCPNLETLSLSNCSNLTDEGLVSIA 291 (482)
T ss_pred chhheecccCcccccccchhHhhhhhh--hcCCcCccchhhhhccCchhHHHHHhhCCCcceEccCCCCccchhHHHHHH
Confidence 47888888863 222211 11112 46788888888887 6655444443 37788888877665 443221 223
Q ss_pred cCCCCCcEEEeeCccc
Q psy10487 126 LGNDRLKVLYLNGNPI 141 (610)
Q Consensus 126 ~~l~~L~~L~Ls~N~l 141 (610)
..+++|++|+|+++..
T Consensus 292 ~~~~~L~~L~l~~c~~ 307 (482)
T KOG1947|consen 292 ERCPSLRELDLSGCHG 307 (482)
T ss_pred HhcCcccEEeeecCcc
Confidence 4467799999987644
No 439
>KOG4308|consensus
Probab=69.74 E-value=0.22 Score=53.70 Aligned_cols=18 Identities=39% Similarity=0.553 Sum_probs=8.9
Q ss_pred hcCCCCCcEEEccCCCCC
Q psy10487 101 FKYLTILVEVDLSDNQIA 118 (610)
Q Consensus 101 f~~l~~L~~LdLs~n~l~ 118 (610)
+..+..|+.|++++|++.
T Consensus 111 l~t~~~L~~L~l~~n~l~ 128 (478)
T KOG4308|consen 111 LKTLPTLGQLDLSGNNLG 128 (478)
T ss_pred hcccccHhHhhcccCCCc
Confidence 344444555555555544
No 440
>cd07700 IgV_CD8_beta Immunoglobulin (Ig) like domain of CD8 beta chain. IgV_CD8_beta: immunoglobulin (Ig)-like domain in CD8 beta. The CD8 glycoprotein plays an essential role in the control of T-cell selection, maturation and the T-cell receptor (TCR)-mediated response to peptide antigen. CD8 is comprised of alpha and beta subunits and is expressed as either an alpha/alpha or alpha/beta dimer. Both dimeric isoforms can serve as a coreceptor for T cell activation and differentiation, however they have distinct physiological roles, different cellular distributions, unique binding partners etc. Each CD8 subunit is comprised of an extracellular domain containing a V-type Ig-like domain, a single pass transmembrane portion and a short intracellular domain.
Probab=69.70 E-value=2 Score=35.90 Aligned_cols=22 Identities=23% Similarity=0.259 Sum_probs=19.8
Q ss_pred cceeeeeeeeccCcceeeeecC
Q psy10487 423 KKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 423 ~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
..|.|.+++.+|+|.|.|...+
T Consensus 72 ~~L~I~~~~~~Dsg~YyCa~~~ 93 (107)
T cd07700 72 YRLHINRVKPEDSGTYFCMTVG 93 (107)
T ss_pred EEEEECCCCHHHCEEEEEeEcC
Confidence 3699999999999999999864
No 441
>cd05712 Ig_Siglec_N Immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Ig_Siglec_N: immunoglobulin (Ig) domain at the N terminus of Siglec (sialic acid-binding Ig-like lectins). Siglec refers to a structurally related protein family that specifically recognizes sialic acid in oligosaccharide chains of glycoproteins and glycolipids. Siglecs are type I transmembrane proteins, organized as an extracellular module composed of Ig-like domains (an N-terminal variable set of Ig-like carbohydrate recognition domains, and 1 to 16 constant Ig-like domains), followed by transmembrane and short cytoplasmic domains. Human siglecs are classified into two subgroups, one subgroup is comprised of sialoadhesin (Siglec-1), CD22 (Siglec-2), and MAG, the other subgroup is comprised of CD33-related Siglecs which include CD33 (Siglec-3) and human Siglecs 5-11.
Probab=66.96 E-value=3.2 Score=35.49 Aligned_cols=25 Identities=12% Similarity=-0.105 Sum_probs=21.3
Q ss_pred cccceeeeeeeeccCcceeeeecCC
Q psy10487 421 QEKKLLDVSITTTDRHTGSCEALGS 445 (610)
Q Consensus 421 ~~~~L~i~~v~~~D~G~Y~C~A~N~ 445 (610)
....|.|.+++.+|+|.|.|.....
T Consensus 78 ~~~sL~I~~l~~~Dsg~Y~C~~~~~ 102 (119)
T cd05712 78 KNCSLLISDAQPEDSGKYFFRVELG 102 (119)
T ss_pred CEEEEEEccCChhhCeEEEEEEEcC
Confidence 3457999999999999999987654
No 442
>KOG1947|consensus
Probab=66.92 E-value=2.4 Score=45.88 Aligned_cols=108 Identities=23% Similarity=0.240 Sum_probs=44.8
Q ss_pred CCCccEEEcccCC-Ccccc-hhhhcCCCCCcEEEccCC--CCCCCC---cccccCCCCCcEEEeeCcc-ccccCcCcCCC
Q psy10487 80 LLNLQRIYLKNSG-IREVH-RDTFKYLTILVEVDLSDN--QIAWLH---QDTFLGNDRLKVLYLNGNP-ITELRAGQFPK 151 (610)
Q Consensus 80 l~~L~~L~L~~n~-l~~i~-~~~f~~l~~L~~LdLs~n--~l~~l~---~~~f~~l~~L~~L~Ls~N~-l~~l~~~~~~~ 151 (610)
.++|+.|.+.++. +.... ......++.|++|+++++ .+.... ......+.+|+.|+|+.+. ++...-..+..
T Consensus 187 ~~~L~~l~l~~~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~L~~l~l~~~~~isd~~l~~l~~ 266 (482)
T KOG1947|consen 187 CPLLKRLSLSGCSKITDDSLDALALKCPNLEELDLSGCCLLITLSPLLLLLLLSICRKLKSLDLSGCGLVTDIGLSALAS 266 (482)
T ss_pred CchhhHhhhcccccCChhhHHHHHhhCchhheecccCcccccccchhHhhhhhhhcCCcCccchhhhhccCchhHHHHHh
Confidence 4555555555542 33211 122345556666666542 111110 1122334555556655554 33322211111
Q ss_pred -CCCccEEEccCcc-ccccCHHH-hhcCccccccccccc
Q psy10487 152 -LPYLKTIELQHCQ-IHSVHKDA-LIHLTALESLNLNGN 187 (610)
Q Consensus 152 -l~~L~~L~L~~n~-l~~~~~~~-~~~l~~L~~L~L~~n 187 (610)
+++|+.|.+.++. ++...-.. ...+++|+.|+|+.+
T Consensus 267 ~c~~L~~L~l~~c~~lt~~gl~~i~~~~~~L~~L~l~~c 305 (482)
T KOG1947|consen 267 RCPNLETLSLSNCSNLTDEGLVSIAERCPSLRELDLSGC 305 (482)
T ss_pred hCCCcceEccCCCCccchhHHHHHHHhcCcccEEeeecC
Confidence 4555555554443 33221111 123445555555544
No 443
>cd07706 IgV_TCR_delta Immunoglobulin (Ig) variable (V) domain of T-cell receptor (TCR) delta chain. IgV_TCR_delta: immunoglobulin (Ig) variable (V) domain of the delta chain of gamma/delta T-cell receptors (TCRs). TCRs mediate antigen recognition by T lymphocytes, and are heterodimers consisting of alpha and beta chains or gamma and delta chains. Each chain contains a variable (V) and a constant (C) region. The majority of T cells contain alpha/beta TCRs but a small subset contain gamma/delta TCRs. Alpha/beta TCRs recognize antigen as peptide fragments presented by major histocompatibility complex (MHC) molecules. Gamma/delta TCRs recognize intact protein antigens; they recognize protein antigens directly and without antigen processing, and MHC independently of the bound peptide. Gamma/delta T cells can also be stimulated by non-peptide antigens such as small phosphate- or amine-containing compounds. The variable domain of gamma/delta TCRs is responsible for antigen recognition and is
Probab=65.58 E-value=2.6 Score=35.75 Aligned_cols=23 Identities=13% Similarity=0.042 Sum_probs=20.7
Q ss_pred ccceeeeeeeeccCcceeeeecC
Q psy10487 422 EKKLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~N 444 (610)
...|.|.+++.+|+|.|.|.+..
T Consensus 71 ~~sL~I~~~~~~Dsg~Y~C~~~~ 93 (116)
T cd07706 71 SISLTISALQLEDSAKYFCALST 93 (116)
T ss_pred EEEEEECCCCHHHCEEEEEEEEC
Confidence 44799999999999999999985
No 444
>PF11465 Receptor_2B4: Natural killer cell receptor 2B4; InterPro: IPR024303 2B4 is a transmembrane receptor which is expressed primarily on natural killer (NK) cells. It plays a role in activating NK-mediated cytotoxicity through its interaction with CD48 on target cells in a subset of CD8 T cells []. The structure of 2B4 consists of an immunoglobulin variable domain fold and contains two beta-sheets. One of the beta-sheets, the six-stranded sheet, contains structural features that may have a role in ligand recognition and receptor function []. This entry represents the 2B4 immunoglobulin domain.; GO: 0005488 binding; PDB: 2PTU_D 2PTT_B 1Z2K_A.
Probab=64.54 E-value=5 Score=33.20 Aligned_cols=38 Identities=13% Similarity=0.075 Sum_probs=30.7
Q ss_pred ccccccccccceeeeeeeeccCcceeeeecCCCcceee
Q psy10487 414 QSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 414 ~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.++.+..++-.|.|..++..|+|.|.=+.+|..|....
T Consensus 62 ~r~~F~~enlaLlIkaAq~qDSG~Y~LEvT~~sG~V~~ 99 (108)
T PF11465_consen 62 NRFNFTSENLALLIKAAQPQDSGLYCLEVTNESGKVCT 99 (108)
T ss_dssp HHEEEETTTTEEEESS-SGGG-EEEEEEEEETTSCEEE
T ss_pred ceEeeeccCceEEEeecCcccCceEEEEEEcCCCcEEE
Confidence 34566678889999999999999999999999998754
No 445
>PHA02914 Immunoglobulin-like domain protein; Provisional
Probab=64.09 E-value=21 Score=36.72 Aligned_cols=89 Identities=18% Similarity=0.250 Sum_probs=53.7
Q ss_pred cceEeecCceEEEEEEEE--ecC-CCeEEEEeCCEEeccC------------Cc----cceeeccCC-ceeeeeeEEEEE
Q psy10487 268 SMVIREAGGNVTMSCYVY--GDP-EPTILWLLNGQVLHNS------------SF----DLLEEEEGD-ALFEKSVSITLF 327 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~--g~P-~p~v~W~~~g~~l~~~------------~~----~~~~~~~~~-~~~~~~~~L~I~ 327 (610)
..+.++.|..+.+.|..+ |+- --.+.|+--|-++..- ++ ..++....+ ..-...++|+|.
T Consensus 272 ~~~~~~~g~~v~~~c~~s~~~~e~i~~~~w~~t~~~~~~~~g~~~~~~~v~~~~~~~~~~~i~~~~~~s~dlk~STLTIk 351 (500)
T PHA02914 272 DEVMLEVGKRVDIECFFSMCGNENISNAKWIDTGFEIGPLIGTVKSKDIVEGDFAEDDDFMISAHANYSDDLKNSTLTIK 351 (500)
T ss_pred ceeEeccCcEEEEEEEEeecCCcccccceEEecCCcccceeEEEEecceeecccccCCceEEEEecccccchhhceEEee
Confidence 456777899999999876 443 3468898765544310 00 111111100 001234799999
Q ss_pred ecCCCCCeEEEEEeecCCcceeEEEEEEc
Q psy10487 328 NVTDLDAGEYTCYAENIRGNASGEISLDL 356 (610)
Q Consensus 328 ~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V 356 (610)
++..+.+|-|+|+|....-.....-=|.|
T Consensus 352 ka~I~N~GCY~~~a~~g~~~~ec~~Cl~V 380 (500)
T PHA02914 352 KAHINNAGCYEAQAFMGKFKEECRHCFKV 380 (500)
T ss_pred eEEEEcCCceEEEEecCcchhhhhhheEe
Confidence 99999999999999876433333333333
No 446
>KOG3763|consensus
Probab=62.89 E-value=3.8 Score=43.94 Aligned_cols=66 Identities=24% Similarity=0.386 Sum_probs=42.0
Q ss_pred CCCCccEEEccCccccccCHH-Hh-hcCccccccccccc--cccccCcccccCCCcccEEecCCCccccc
Q psy10487 151 KLPYLKTIELQHCQIHSVHKD-AL-IHLTALESLNLNGN--RLKHLSESVFFPTPNLKTLSLDGNPWCCD 216 (610)
Q Consensus 151 ~l~~L~~L~L~~n~l~~~~~~-~~-~~l~~L~~L~L~~n--~l~~~~~~~~~~~~~L~~l~l~~N~~~c~ 216 (610)
+.+.+..+.|++|+|..+..- .+ ...++|..|+|++| .+.....-.-.....|++|-+.||+++-+
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~Leel~l~GNPlc~t 285 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLPLEELVLEGNPLCTT 285 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCCHHHeeecCCccccc
Confidence 456777888889988777421 12 33578899999999 44433221111223567899999998544
No 447
>cd00098 IgC Immunoglobulin Constant domain. IgC: Immunoglobulin constant domain (IgC). Members of the IgC family are components of immunoglobulin, T-cell receptors, CD1 cell surface glycoproteins, secretory glycoproteins A/C, and Major Histocompatibility Complex (MHC) class I/II molecules. In immunoglobulins, each chain is composed of one variable domain (IgV) and one or more IgC domains. These names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. The IgV domain is responsible for antigen binding, and the IgC domain is involved in oligomerization and molecular interactions.
Probab=59.08 E-value=12 Score=29.98 Aligned_cols=24 Identities=13% Similarity=-0.015 Sum_probs=16.4
Q ss_pred eeeeeeeeccCcceeeeecCCCcc
Q psy10487 425 LLDVSITTTDRHTGSCEALGSQPD 448 (610)
Q Consensus 425 L~i~~v~~~D~G~Y~C~A~N~~G~ 448 (610)
|.+......|.|.|+|.|.+....
T Consensus 64 l~v~~~~~~~~~~y~C~v~h~~~~ 87 (95)
T cd00098 64 LTVSPSDWNSGDTYTCVVTHESLP 87 (95)
T ss_pred EEECHHHhCCCCCEEEEEEeCCCC
Confidence 333333344999999999996553
No 448
>PHA03271 envelope glycoprotein C; Provisional
Probab=58.75 E-value=49 Score=34.35 Aligned_cols=85 Identities=21% Similarity=0.142 Sum_probs=51.2
Q ss_pred CCceeeeecceEeecCceEEEEEEEEecCCC---eEEEEeCCEEeccCCccceee--ccCCceeeeeeEEEEEecCCCCC
Q psy10487 260 PPNVTIKESMVIREAGGNVTMSCYVYGDPEP---TILWLLNGQVLHNSSFDLLEE--EEGDALFEKSVSITLFNVTDLDA 334 (610)
Q Consensus 260 ~P~i~~~~~~~~v~~G~~v~l~C~~~g~P~p---~v~W~~~g~~l~~~~~~~~~~--~~~~~~~~~~~~L~I~~v~~~D~ 334 (610)
+|.+.+.+. -+.+|+...-.|.+...-+| .+.|+.||.++.......... .++...+...++|.+.+...+..
T Consensus 247 PPsVsV~a~--PVL~Ge~YkAtC~vAnYYPP~SvrlrWf~nG~~V~~~~~rdt~~~w~d~~~g~S~VSTltl~a~~~~~P 324 (490)
T PHA03271 247 PASVDVLAP--PVLSGENYKASCIVRHFYPPGSVYVSWRQNGNIATPRKDRDGSFWWFESGRGATLVSTITLGNSGIDPP 324 (490)
T ss_pred CCCccccCC--ccccCCCceEEEEeeeecCCCceEEEEEeCCccccCccccceeEEEecCCCceeEEEEEEcccccCCCC
Confidence 454554433 35679999999999876554 589999999886544322211 12222234445666655433333
Q ss_pred eEEEEEeecCCc
Q psy10487 335 GEYTCYAENIRG 346 (610)
Q Consensus 335 G~Y~C~a~N~~G 346 (610)
-..+|.+.-..+
T Consensus 325 PsLRCeV~W~rd 336 (490)
T PHA03271 325 PKISCLVAWKQG 336 (490)
T ss_pred CCceEEEEEccC
Confidence 479999866555
No 449
>PF02480 Herpes_gE: Alphaherpesvirus glycoprotein E; InterPro: IPR003404 Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation [].; GO: 0016020 membrane; PDB: 2GJ7_F 2GIY_B.
Probab=56.74 E-value=15 Score=39.22 Aligned_cols=21 Identities=14% Similarity=0.227 Sum_probs=16.2
Q ss_pred EEEEEecCCCCCeEEEEEeec
Q psy10487 323 SITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 323 ~L~I~~v~~~D~G~Y~C~a~N 343 (610)
.|++.++..+++|.|.|++.-
T Consensus 270 ~l~f~~a~~~~sGLYv~V~~~ 290 (439)
T PF02480_consen 270 DLQFTNAPESASGLYVFVVYY 290 (439)
T ss_dssp SEEESS--GGG-EEEEEEEEE
T ss_pred ceEecCCCcccCceEEEEEEE
Confidence 799999999999999999854
No 450
>PF02124 Marek_A: Marek's disease glycoprotein A; InterPro: IPR001038 Equid herpesvirus 1 (Equine herpesvirus 1, EHV-1) glycoprotein 13 (EHV-1 gp13) has the characteristic features of a membrane-spanning protein: an N-terminal signal sequence; a hydrophobic membrane anchor region; a charged C-terminal cytoplasmic tail; and an exterior domain with nine potential N-glycosylation sites []. EHV-1 gp13 is the structural homologue of the gC-like glycoproteins of the Human herpesvirus 1 (HHV-1) and Human herpesvirus 2 (HHV-2) (gC-1 and gC-2 respectively), Pseudorabies virus (strain Indiana-Funkhauser/Becker) (PRV) (gIII) and Human herpesvirus 3 (HHV-3) (gp66). Secretory glycoprotein GP57-65 precursor (glycoprotein A - GA) is similar to Herpesvirus glycoprotein C, and belongs to the immunoglobulin gene superfamily [, ]. GA is thought to play an immunoevasive role in the pathogenesis of Marek's disease. It is a candidate for causing the early-stage immunosuppression that occurs after MDHV infection.
Probab=56.19 E-value=60 Score=30.70 Aligned_cols=148 Identities=11% Similarity=0.097 Sum_probs=0.0
Q ss_pred eEEEEeCCEEeccCCccceeeccCCceeeeeeEEEE-EecCCCCCeEEEEEeecCCcceeEEEEEEcCccccccccccCC
Q psy10487 291 TILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITL-FNVTDLDAGEYTCYAENIRGNASGEISLDLPEINLATTLSKTD 369 (610)
Q Consensus 291 ~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I-~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~~~~~p~~~~~~ 369 (610)
.+.|+.||..+.............++.+...++|.+ .+...+-.-..+|.+.-..+....+-.... ..+-...+..
T Consensus 8 ~~~Wf~dg~~v~~~~~~~~~~~~~~G~~s~vStl~~~~~~~~~~pp~i~C~v~W~r~~v~~~r~~a~---~~P~Vy~~P~ 84 (211)
T PF02124_consen 8 RFRWFEDGNPVEPRFIRDSSQVWSDGLFSRVSTLTLPGNSADSPPPSIRCQVTWYRDSVSETRFNAT---ATPSVYPKPR 84 (211)
T ss_pred EEEEEECCEeCCccceeeEEEEecCCcEEEEEEEEecCCCCCCCCCcceEEEEEccCCCeeeEeecc---cccceecCCE
Q ss_pred cceeehhhhHHHHHHHHHhheeEEEEEEeeecccccccccCCccccccccccccceeeeeeeeccCc--ceeeeec
Q psy10487 370 SWYMLVLGISVCVVSVIVSIGMSFCVCRAHEHKNKRRKRKGKMKQSVSFNDQEKKLLDVSITTTDRH--TGSCEAL 443 (610)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~i~~v~~~D~G--~Y~C~A~ 443 (610)
.......+...|...-+--.. ..+.|+-+..+. .........+.-.....-..++-.---....| +|+|...
T Consensus 85 vsv~F~~g~AVC~A~CVP~~~-v~l~W~v~d~~~-~~~~~~~~~g~C~~~pglvnirs~~pls~~~~~~~YtC~l~ 158 (211)
T PF02124_consen 85 VSVRFEDGYAVCTARCVPRGN-VTLRWSVGDDPS-PAPAATEITGVCAEHPGLVNIRSRRPLSDEDGPVEYTCRLI 158 (211)
T ss_pred EEEEecCCEEEEEcceeeCCC-eEEEEEECCccC-CCCCceeecCcccCCcceeEeecccCCCccCCceeEEEEEe
No 451
>KOG4341|consensus
Probab=55.46 E-value=4.7 Score=41.82 Aligned_cols=37 Identities=19% Similarity=0.110 Sum_probs=16.5
Q ss_pred CCCCccEEEcccCC-Ccccchhhh-cCCCCCcEEEccCC
Q psy10487 79 GLLNLQRIYLKNSG-IREVHRDTF-KYLTILVEVDLSDN 115 (610)
Q Consensus 79 ~l~~L~~L~L~~n~-l~~i~~~~f-~~l~~L~~LdLs~n 115 (610)
++..|+.|..+++. +....-.++ .+..+|+.|-++.+
T Consensus 292 ~c~~lq~l~~s~~t~~~d~~l~aLg~~~~~L~~l~l~~c 330 (483)
T KOG4341|consen 292 GCHALQVLCYSSCTDITDEVLWALGQHCHNLQVLELSGC 330 (483)
T ss_pred hhhHhhhhcccCCCCCchHHHHHHhcCCCceEEEecccc
Confidence 44555555555543 222222222 24455555555554
No 452
>KOG4597|consensus
Probab=54.71 E-value=15 Score=38.65 Aligned_cols=50 Identities=10% Similarity=-0.065 Sum_probs=38.3
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeecccccCCCcceeEec
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLAMEQPPVHITIES 469 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v~~~pp~~i~ie~ 469 (610)
.+...|.|-+....|+|-|+|.|.|.+|.....+.+.++...+.....++
T Consensus 254 tstcql~ic~ewq~~a~w~tCs~rcg~g~~~rdv~c~s~~ge~a~daads 303 (560)
T KOG4597|consen 254 TSTCQLVICNEWQADAGWYTCSARCGAGFLRRDVPCSSVKGEGALDAADS 303 (560)
T ss_pred eeeeeEEEcchhhcCCCceeeccccccceeeccceeeeeccccccccccc
Confidence 45568999999999999999999999999888887776543333333333
No 453
>PF08204 V-set_CD47: CD47 immunoglobulin-like domain; InterPro: IPR013270 This family represents the CD47 leukocyte antigen V-set like Ig domain [, ].; PDB: 2VSC_B 2JJS_D 2JJT_C.
Probab=54.63 E-value=6.8 Score=33.93 Aligned_cols=37 Identities=11% Similarity=-0.035 Sum_probs=24.7
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceeeeeeccc
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMELIEQSLA 457 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~~~~l~v 457 (610)
..+.+|.+...+.. .|.|+|.+++...+.+....|..
T Consensus 83 kG~aSL~~~~~~a~-~GnYTCeVt~~~~ege~~i~Lk~ 119 (130)
T PF08204_consen 83 KGNASLKMDKSDAV-EGNYTCEVTELSREGETTIELKY 119 (130)
T ss_dssp GTB--EEEEHHHHH--EEEEEEEEETTEEEEEEEEEEE
T ss_pred CCCEEEEEcchhcc-ccceEEEEEecCCCceEEEEEEE
Confidence 34456777765554 89999999988777777666643
No 454
>KOG3763|consensus
Probab=54.46 E-value=7.7 Score=41.72 Aligned_cols=64 Identities=19% Similarity=0.155 Sum_probs=34.8
Q ss_pred CCCCCcEEEccCCCCCCCCc--ccccCCCCCcEEEeeCccccccCcCcCCC--CCCccEEEccCcccc
Q psy10487 103 YLTILVEVDLSDNQIAWLHQ--DTFLGNDRLKVLYLNGNPITELRAGQFPK--LPYLKTIELQHCQIH 166 (610)
Q Consensus 103 ~l~~L~~LdLs~n~l~~l~~--~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~--l~~L~~L~L~~n~l~ 166 (610)
+.+.+..+.|++|+|..+.. ..-...++|..|+|++|....-....+.+ ...|+.|-|.+|.+.
T Consensus 216 n~p~i~sl~lsnNrL~~Ld~~sslsq~apklk~L~LS~N~~~~~~~~el~K~k~l~Leel~l~GNPlc 283 (585)
T KOG3763|consen 216 NFPEILSLSLSNNRLYHLDALSSLSQIAPKLKTLDLSHNHSKISSESELDKLKGLPLEELVLEGNPLC 283 (585)
T ss_pred CCcceeeeecccchhhchhhhhHHHHhcchhheeecccchhhhcchhhhhhhcCCCHHHeeecCCccc
Confidence 45566777777777765542 11122367778888877222111111222 235667777777664
No 455
>PHA03189 UL14 tegument protein; Provisional
Probab=54.13 E-value=47 Score=32.95 Aligned_cols=85 Identities=22% Similarity=0.206 Sum_probs=42.9
Q ss_pred ecceEeecCceEEEEEEEE--ecCCCeEE-----EEeCCEEeccCCccceeec--------cC-----CceeeeeeEEEE
Q psy10487 267 ESMVIREAGGNVTMSCYVY--GDPEPTIL-----WLLNGQVLHNSSFDLLEEE--------EG-----DALFEKSVSITL 326 (610)
Q Consensus 267 ~~~~~v~~G~~v~l~C~~~--g~P~p~v~-----W~~~g~~l~~~~~~~~~~~--------~~-----~~~~~~~~~L~I 326 (610)
+..+.+.+|+.+++.|.+. .-|...|. |.-.+..+..+.......+ +. +......-+|++
T Consensus 59 pAP~l~pyGdrvtVpC~fp~H~WPevsIrarfCys~e~s~eLv~da~~G~~l~ndl~~~L~~~~W~Fedlg~aq~ltLtF 138 (348)
T PHA03189 59 PAPLLVPYGDRVTVPCTFPTHDWPEVSIRARFCYSPERSRELVVDADSGGELHNDLTYRLPEASWKFEDLGAAQRLTLTF 138 (348)
T ss_pred CCccccCCCceeeeeeeecCCCCceeeEEEEEeeccccceEEEEEcccCCEeccccceecccceeeeecccceeEEEEEE
Confidence 4556778899999999874 33555543 2112222211111000000 00 111111224554
Q ss_pred EecCCCCCeEEEEEeecCC-cceeEEE
Q psy10487 327 FNVTDLDAGEYTCYAENIR-GNASGEI 352 (610)
Q Consensus 327 ~~v~~~D~G~Y~C~a~N~~-G~~~~~~ 352 (610)
++..+-+|.|.|+-.|.. |.....+
T Consensus 139 -~v~t~taG~Y~CvLrN~tHglv~~rf 164 (348)
T PHA03189 139 -RVSTSTAGMYECVLRNETHGLVLQRF 164 (348)
T ss_pred -EEEecccceEEEEeccccceeeeEEe
Confidence 355667999999999974 4444433
No 456
>smart00368 LRR_RI Leucine rich repeat, ribonuclease inhibitor type.
Probab=53.30 E-value=11 Score=22.92 Aligned_cols=13 Identities=46% Similarity=0.700 Sum_probs=8.1
Q ss_pred CCcEEEccCCCCC
Q psy10487 106 ILVEVDLSDNQIA 118 (610)
Q Consensus 106 ~L~~LdLs~n~l~ 118 (610)
+|++|||++|.|.
T Consensus 3 ~L~~LdL~~N~i~ 15 (28)
T smart00368 3 SLRELDLSNNKLG 15 (28)
T ss_pred ccCEEECCCCCCC
Confidence 4666666666664
No 457
>KOG4341|consensus
Probab=52.81 E-value=8.9 Score=39.85 Aligned_cols=60 Identities=20% Similarity=0.130 Sum_probs=31.2
Q ss_pred CccEEEeecCC-CCCCChhhhcccCCCCccEEEcccCC-Ccccchhhh-cCCCCCcEEEccCCC
Q psy10487 56 DIQVLDLNNNK-ISYLTKEAFKSIGLLNLQRIYLKNSG-IREVHRDTF-KYLTILVEVDLSDNQ 116 (610)
Q Consensus 56 ~L~~L~L~~n~-i~~l~~~~~~~~~l~~L~~L~L~~n~-l~~i~~~~f-~~l~~L~~LdLs~n~ 116 (610)
.++.|+.++.. ++...-.++.. +..+|+.|.+..++ ++...-..+ ++...|+.+|+....
T Consensus 295 ~lq~l~~s~~t~~~d~~l~aLg~-~~~~L~~l~l~~c~~fsd~~ft~l~rn~~~Le~l~~e~~~ 357 (483)
T KOG4341|consen 295 ALQVLCYSSCTDITDEVLWALGQ-HCHNLQVLELSGCQQFSDRGFTMLGRNCPHLERLDLEECG 357 (483)
T ss_pred HhhhhcccCCCCCchHHHHHHhc-CCCceEEEeccccchhhhhhhhhhhcCChhhhhhcccccc
Confidence 34555555432 22222223321 56789999998885 433322222 345566666666543
No 458
>KOG1026|consensus
Probab=51.83 E-value=23 Score=40.11 Aligned_cols=67 Identities=16% Similarity=0.237 Sum_probs=42.9
Q ss_pred EecCCCeEEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcC
Q psy10487 285 YGDPEPTILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLP 357 (610)
Q Consensus 285 ~g~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~ 357 (610)
.++|.|...|..++..+............. ...+....-+..+.|.|+|.+.|..|.........+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~g~~~~t~s~~------~~C~~~~~~~h~~~~~~~~~~e~~~g~~~~r~~g~~~ 363 (774)
T KOG1026|consen 297 TANPGPALHWCYNGSGLNYRGTVCVTKSGK------EQCLPWNDPPHSHNGNYTLFPELPGGKNYCRNPGGFM 363 (774)
T ss_pred cCCCCCceeeeecCccceEecccccccccC------cCCcccCcCcccccCcceeeecccCccccccCcCccc
Confidence 367788889999887654433221111110 0234444447788999999999999988776665553
No 459
>cd04981 IgV_H Immunoglobulin (Ig) heavy chain (H), variable (V) domain. IgV_H: Immunoglobulin (Ig) heavy chain (H), variable (V) domain. The basic structure of Ig molecules is a tetramer of two light chains and two heavy chains linked by disulfide bonds. In Ig, each chain is composed of one variable domain (IgV) and one or more constant domains (IgC); these names reflect the fact that the variability in sequences is higher in the variable domain than in the constant domain. There are five types of heavy chains (alpha, gamma, delta, epsilon, and mu), which determine the type of immunoglobulin: IgA, IgG, IgD, IgE, and IgM, respectively. In higher vertebrates, there are two types of light chain, designated kappa and lambda, which can associate with any of the heavy chains. This family includes alpha, gamma, delta, epsilon, and mu heavy chains.
Probab=51.31 E-value=6.4 Score=33.53 Aligned_cols=21 Identities=24% Similarity=0.026 Sum_probs=19.3
Q ss_pred ceeeeeeeeccCcceeeeecC
Q psy10487 424 KLLDVSITTTDRHTGSCEALG 444 (610)
Q Consensus 424 ~L~i~~v~~~D~G~Y~C~A~N 444 (610)
.|.|.+++.+|+|.|.|.+..
T Consensus 77 ~L~I~~~~~~Dsa~YyCa~~~ 97 (117)
T cd04981 77 YLQLNSLTPEDTAVYYCARGL 97 (117)
T ss_pred EEEECCCCHHHCEEEEEEEEc
Confidence 699999999999999998865
No 460
>cd05711 Ig_FcalphaRI Immunoglobulin (IG)-like domain of of FcalphaRI. IG_FcalphaRI : immunoglobulin (IG)-like domain of of FcalphaRI. FcalphaRI (CD89) is an IgA-specific receptor that is expressed on monocytes, eosinophils, neutrophils and macrophages. FcalphaRI mediates IgA-induced immune effector responses such as phagocytosis, antibody-dependent cell-mediated cytotoxicity and respiratory burst. Both monomeric and dimeric IgA can bind to FcalphaRI, and monomeric or dimeric IgA immune complexes can activate phagocytosis and other immune responses through the clustering of FcalphaRI. The Fc RI ectodomain is comprised of two Ig-like domains oriented at about 90 degree to each another.
Probab=48.76 E-value=9.3 Score=31.04 Aligned_cols=22 Identities=14% Similarity=0.069 Sum_probs=19.1
Q ss_pred ccceeeeeeeeccCcceeeeec
Q psy10487 422 EKKLLDVSITTTDRHTGSCEAL 443 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A~ 443 (610)
...+.|..++.+|+|.|.|...
T Consensus 54 ~a~f~I~~~~~~~~G~Y~C~~~ 75 (94)
T cd05711 54 QASFPLGPVTPAHAGTYRCYGS 75 (94)
T ss_pred EEEEEecCCCcccCEEEEEEEE
Confidence 3468899999999999999975
No 461
>PF12355 Dscam_C: Down syndrome cell adhesion molecule C terminal ; InterPro: IPR021012 This entry is specific to the insecta, predominantly Drosophila spp. This entry is found in association with PF00047 from PFAM, PF07679 from PFAM and PF00041 from PFAM. The Down syndrome cell adhesion molecule (Dscam) belongs to a family of cell membrane molecules involved in the differentiation of the nervous system. This is the C-terminal cytoplasmic tail region of Dscam. In Drosophila melanogaster (Fruit fly) the gene has at least 59 different transcripts. Dscam may play a role in the nervous and immune systems [].
Probab=47.19 E-value=20 Score=29.45 Aligned_cols=21 Identities=38% Similarity=0.583 Sum_probs=12.9
Q ss_pred CCCCCCCCCeeeecccceecC
Q psy10487 561 GPKYDNMGPRVTAGGASILSL 581 (610)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~ 581 (610)
+-+|||.|-|-.++--|.+|.
T Consensus 35 g~PydhygSrgs~grrs~gs~ 55 (124)
T PF12355_consen 35 GAPYDHYGSRGSVGRRSVGSA 55 (124)
T ss_pred CCCccccccccccceeccccc
Confidence 346788888755444455555
No 462
>cd07694 Ig2_CD4 Second immunoglobulin (Ig) domain of CD4. Ig2_CD4; second immunoglobulin (Ig) domain of CD4. CD4 and CD8 are the two primary co-receptor proteins found on the surface of T cells, and the presence of either CD4 or CD8 determines the function of the T cell. CD4 is found on helper T cells, where it is required for the binding of MHC (major histocompatibility complex) class II molecules, while CD8 is found on cytotoxic T cells, where it is required for the binding of MHC class I molecules. CD4 contains four immunoglobulin domains, with the first three included in this hierarchy. The fourth domain has a general Ig architecture, but has slight topological changes in the arrangement of beta strands relative to the other structures in this family and is not specifically included in the hierarchy.
Probab=46.84 E-value=19 Score=28.91 Aligned_cols=32 Identities=22% Similarity=0.226 Sum_probs=24.3
Q ss_pred ccccceeeeeeeeccCcceeeeecCCCcceee
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQPDMEL 451 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~ 451 (610)
.+.++|...+++..|+|+.+|..+-..-+.+.
T Consensus 48 ~~~ktL~~~qv~~qdSG~WtC~V~~~~k~~~~ 79 (88)
T cd07694 48 QDKKTLNLVQLGPNDSGTWDCIVSVNSSEKTL 79 (88)
T ss_pred CCccEEEeceeCcccCCEEEEEEEECceEEEE
Confidence 35568899999999999999999754333333
No 463
>TIGR00864 PCC polycystin cation channel protein. Note: this model has been restricted to the amino half because for technical reasons.
Probab=46.54 E-value=13 Score=47.80 Aligned_cols=32 Identities=28% Similarity=0.435 Sum_probs=16.3
Q ss_pred EccCCCCCCCCcccccCCCCCcEEEeeCcccc
Q psy10487 111 DLSDNQIAWLHQDTFLGNDRLKVLYLNGNPIT 142 (610)
Q Consensus 111 dLs~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~ 142 (610)
||++|+|+.|+...|..+.+|+.|+|++|++.
T Consensus 1 DLSnN~LstLp~g~F~~L~sL~~LdLsgNPw~ 32 (2740)
T TIGR00864 1 DISNNKISTIEEGICANLCNLSEIDLSGNPFE 32 (2740)
T ss_pred CCCCCcCCccChHHhccCCCceEEEeeCCccc
Confidence 34455555555555555555555555555443
No 464
>PF05955 Herpes_gp2: Equine herpesvirus glycoprotein gp2; InterPro: IPR010278 This entry consists of a number of glycoprotein Gp2 sequences mainly found from equine herpesviruses [].; GO: 0016032 viral reproduction, 0016021 integral to membrane
Probab=43.96 E-value=53 Score=29.80 Aligned_cols=63 Identities=17% Similarity=0.233 Sum_probs=45.1
Q ss_pred EEEEEe-cCCCeEEEEeCCEEeccCCccceeeccCCce-eeeeeEEEEEecCCCCCeEEEEEeec
Q psy10487 281 SCYVYG-DPEPTILWLLNGQVLHNSSFDLLEEEEGDAL-FEKSVSITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 281 ~C~~~g-~P~p~v~W~~~g~~l~~~~~~~~~~~~~~~~-~~~~~~L~I~~v~~~D~G~Y~C~a~N 343 (610)
.|.++- .-.|.++|......+..+.+.+.+++-..+. ....+...|...+..|.-.|.|.+.-
T Consensus 113 vCitseL~s~PtitWsVgs~rl~n~gftqtwy~iqPGvCgilrS~v~~~R~~G~~~~~y~c~~~~ 177 (226)
T PF05955_consen 113 VCITSELVSQPTITWSVGSDRLRNDGFTQTWYGIQPGVCGILRSEVRIPRAEGRDNVDYLCEIRA 177 (226)
T ss_pred EEeeccccCCCeEEEEeccceeecCCccceeecccCcceeeEeeeeecccCCCCCcccEEecccc
Confidence 466643 4578999999988888888877755433221 13345778888888899999998754
No 465
>PF01463 LRRCT: Leucine rich repeat C-terminal domain; InterPro: IPR000483 Leucine-rich repeats (LRR, see IPR001611 from INTERPRO) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []. LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions []. Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response. LRRs are often flanked by cysteine-rich domains: an N-terminal LRR domain (IPR000372 from INTERPRO) and a C-terminal LRR domain. This entry represents the C-terminal LRR domain. ; PDB: 3RFE_B 3REZ_D 2WFH_A 2V70_B 2V9S_C 2V9T_B 1W8A_A.
Probab=42.14 E-value=11 Score=22.16 Aligned_cols=24 Identities=25% Similarity=0.571 Sum_probs=17.2
Q ss_pred CCCCCCCccCCCcccccccccccCC
Q psy10487 236 LSCTEPGMLQTKHWDDVKAQEFACP 260 (610)
Q Consensus 236 ~~C~a~~~l~g~~~~~v~~~~~~c~ 260 (610)
..|..|..++| .+.++...+|.|+
T Consensus 2 ~~Ca~P~~lrg-~l~~~~~~~f~C~ 25 (25)
T PF01463_consen 2 ARCASPPELRG-PLLDLPPSDFKCS 25 (25)
T ss_dssp -BEEESGGGTT-BGGGSSGGG----
T ss_pred CccCCChHHcC-cHhhCCcccCcCC
Confidence 57899999999 9999988888774
No 466
>PHA03282 envelope glycoprotein E; Provisional
Probab=41.40 E-value=1.2e+02 Score=32.14 Aligned_cols=21 Identities=19% Similarity=0.445 Sum_probs=19.1
Q ss_pred EEEEEecCCCCCeEEEEEeec
Q psy10487 323 SITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 323 ~L~I~~v~~~D~G~Y~C~a~N 343 (610)
.|+|.|+..+++|.|.|++.-
T Consensus 334 dL~F~nAp~saSGLYVfVl~y 354 (540)
T PHA03282 334 NLQLRDASEASGGLYVCVVYV 354 (540)
T ss_pred ceEecCCCcccCceEEEEEEE
Confidence 799999999999999999853
No 467
>PHA03273 envelope glycoprotein C; Provisional
Probab=39.57 E-value=5e+02 Score=27.77 Aligned_cols=18 Identities=22% Similarity=0.451 Sum_probs=12.9
Q ss_pred EEEEEecCC--CeEEEEeCC
Q psy10487 281 SCYVYGDPE--PTILWLLNG 298 (610)
Q Consensus 281 ~C~~~g~P~--p~v~W~~~g 298 (610)
.|.+.=-|. ..+.|..++
T Consensus 357 VCtA~CVP~egV~l~W~v~D 376 (486)
T PHA03273 357 VCTAKCVPSTGVFVSWSVND 376 (486)
T ss_pred EEecccccCCCeeEEEEccC
Confidence 477665565 678999866
No 468
>cd05883 Ig2_Necl-2 Second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Ig2_Necl-2: second immunoglobulin (Ig)-like domain of nectin-like molecule 2 (also known as cell adhesion molecule 1 (CADM1)). Nectin-like molecules (Necls) have similar domain structures to those of nectins. At least five nectin-like molecules have been identified (Necl-1 - Necl-5). These have an extracellular region containing three Ig-like domains, one transmembrane region, and one cytoplasmic region. Necl-2 has Ca(2+)-independent homophilic and heterophilic cell-cell adhesion activity. Necl-1 is expressed in a wide variety of tissues, and is a putative tumour suppressor gene, which is downregulated in aggressive neuroblastoma. Ig domains are likely to participate in ligand binding and recognition.
Probab=37.79 E-value=39 Score=26.75 Aligned_cols=22 Identities=18% Similarity=0.158 Sum_probs=14.6
Q ss_pred ceeeeeeeec-cCcceeeeecCCC
Q psy10487 424 KLLDVSITTT-DRHTGSCEALGSQ 446 (610)
Q Consensus 424 ~L~i~~v~~~-D~G~Y~C~A~N~~ 446 (610)
.|.+ .++.+ |...|+|.|.|.+
T Consensus 45 ~L~~-~p~~eDdG~~~~C~a~~~~ 67 (82)
T cd05883 45 QLML-KVTKEDDGVPVICLVDHPA 67 (82)
T ss_pred EEEE-ECchhhCCCEEEEEEcCcc
Confidence 4555 34444 5556999999965
No 469
>PF07354 Sp38: Zona-pellucida-binding protein (Sp38); InterPro: IPR010857 This family contains a number of zona-pellucida-binding proteins that seem to be restricted to mammals. These are sperm proteins that bind to the 90 kDa family of zona pellucida glycoproteins in a calcium-dependent manner []. These represent some of the specific molecules that mediate the first steps of gamete interaction, allowing fertilisation to occur [].; GO: 0007339 binding of sperm to zona pellucida, 0005576 extracellular region
Probab=37.14 E-value=23 Score=34.45 Aligned_cols=27 Identities=11% Similarity=0.076 Sum_probs=23.1
Q ss_pred ccccceeeeeeeeccCcceeeeecCCC
Q psy10487 420 DQEKKLLDVSITTTDRHTGSCEALGSQ 446 (610)
Q Consensus 420 ~~~~~L~i~~v~~~D~G~Y~C~A~N~~ 446 (610)
...++|.+.+....++|.|+|.-+-..
T Consensus 34 T~TG~L~~~~F~esmSG~YTCtLsYk~ 60 (271)
T PF07354_consen 34 TETGKLMFKNFQESMSGSYTCTLSYKP 60 (271)
T ss_pred ccCceEEeeccccccCCceEEEEEEEe
Confidence 455679999999999999999988754
No 470
>PF05725 FNIP: FNIP Repeat; InterPro: IPR008615 This repeat is approximately 22 residues long and is only found in Dictyostelium discoideum (Slime mould). It appears to be related to IPR001611 from INTERPRO. The alignment consists of two tandem repeats. It is termed the FNIP repeat after the pattern of conserved residues.
Probab=35.19 E-value=49 Score=22.44 Aligned_cols=34 Identities=9% Similarity=0.137 Sum_probs=20.1
Q ss_pred ccCCCccEEEeecCCCCCCChhhhcccCCCCccEEEcc
Q psy10487 52 TLDSDIQVLDLNNNKISYLTKEAFKSIGLLNLQRIYLK 89 (610)
Q Consensus 52 ~l~~~L~~L~L~~n~i~~l~~~~~~~~~l~~L~~L~L~ 89 (610)
.+|.+++.|.|.++.-..+..+.+. .+|++|.+.
T Consensus 9 ~iP~~l~~L~~g~~fn~~i~~~~lP----~sl~~L~fg 42 (44)
T PF05725_consen 9 SIPSSLKSLIFGSSFNQPIEPGSLP----NSLKSLSFG 42 (44)
T ss_pred eeCCCCeEEEECCccCccCCCCccC----CCceEEEee
Confidence 4667888888855544445444442 256666654
No 471
>PHA02982 hypothetical protein; Provisional
Probab=28.73 E-value=35 Score=31.95 Aligned_cols=58 Identities=14% Similarity=0.085 Sum_probs=41.1
Q ss_pred ccccccccccccceeeeeeeeccCcceeeeecCCCcceee-eeecccccCCCcceeEecC
Q psy10487 412 MKQSVSFNDQEKKLLDVSITTTDRHTGSCEALGSQPDMEL-IEQSLAMEQPPVHITIESH 470 (610)
Q Consensus 412 ~~~~~~~~~~~~~L~i~~v~~~D~G~Y~C~A~N~~G~~~~-~~~l~v~~~pp~~i~ie~~ 470 (610)
....++.....++|.|.++.....|-|+|+|....|..|. ..-|.+. ...+...++..
T Consensus 89 d~y~~sv~g~~STLTIkk~~i~N~GCYtc~~ks~~~k~E~c~kCl~V~-~~~V~~~W~e~ 147 (251)
T PHA02982 89 DKYALSVSGNSSTFTMKKPDPQNLGCFTCEAKDAEGKEETCEKCLEIQ-KEDILYVVEEH 147 (251)
T ss_pred eeEEEEEeccceeEEeccCCcccCCceEEEEecCCCchheeheeeeEe-cceEEEEEEec
Confidence 3445566677889999999999999999999987776655 4445442 12555566654
No 472
>PF05790 C2-set: Immunoglobulin C2-set domain; InterPro: IPR008424 The basic structure of immunoglobulin (Ig) molecules is a tetramer of two light chains and two heavy chains linked by disulphide bonds. There are two types of light chains: kappa and lambda, each composed of a constant domain (CL) and a variable domain (VL). There are five types of heavy chains: alpha, delta, epsilon, gamma and mu, all consisting of a variable domain (VH) and three (in alpha, delta and gamma) or four (in epsilon and mu) constant domains (CH1 to CH4). Ig molecules are highly modular proteins, in which the variable and constant domains have clear, conserved sequence patterns. The domains in Ig and Ig-like molecules are grouped into four types: V-set (variable; IPR013106 from INTERPRO), C1-set (constant-1; IPR003597 from INTERPRO), C2-set (constant-2; IPR008424 from INTERPRO) and I-set (intermediate; IPR013098 from INTERPRO) []. Structural studies have shown that these domains share a common core Greek-key beta-sandwich structure, with the types differing in the number of strands in the beta-sheets as well as in their sequence patterns [, ]. Immunoglobulin-like domains that are related in both sequence and structure can be found in several diverse protein families. Ig-like domains are involved in a variety of functions, including cell-cell recognition, cell-surface receptors, muscle structure and the immune system []. This entry represents C2-set domains, which are Ig-like domains resembling the antibody constant domain. C2-set domains are found primarily in the mammalian T-cell surface antigens CD2 (Cluster of Differentiation 2), CD4 and CD80, as well as in vascular (VCAM) and intercellular (ICAM) cell adhesion molecules. CD2 mediates T-cell adhesion via its ectodomain, and signal transduction utilising its 117-amino acid cytoplasmic tail []. CD2 displays structural and functional similarities with African swine fever virus (ASFV) LMW8-DR, a protein that is involved in cell-cell adhesion and immune response modulation, suggesting a possible role in the pathogenesis of ASFV infection []. CD4 is the primary receptor for HIV-1. CD4 has four immunoglobulin-like domains in its extracellular region that share the same structure, but can differ in sequence. Certain extracellular domains may be involved in dimerisation [].; GO: 0007155 cell adhesion, 0016021 integral to membrane; PDB: 1CID_A 1CDU_A 1WIQ_B 2NY4_B 2NY2_B 1WIP_B 1WIO_A 3S4S_G 1CDY_A 3S5L_G ....
Probab=28.63 E-value=56 Score=25.73 Aligned_cols=30 Identities=27% Similarity=0.209 Sum_probs=20.1
Q ss_pred ccceeeeeeeeccCcceeeee-cCCCcceee
Q psy10487 422 EKKLLDVSITTTDRHTGSCEA-LGSQPDMEL 451 (610)
Q Consensus 422 ~~~L~i~~v~~~D~G~Y~C~A-~N~~G~~~~ 451 (610)
.+.......+..|+|..+|.| .+..-..+.
T Consensus 42 ~~~~~~~~~~~~d~G~w~C~a~~~~~k~~~s 72 (80)
T PF05790_consen 42 KKLVSTFTPTTEDSGTWVCTASDNEPKERES 72 (80)
T ss_dssp SSEEEEESBTCGGSEEEEEEEEECTTEEEEE
T ss_pred ceEEEEecCCCCCCEEEEEEEcCCceEEEEE
Confidence 334456667778999999999 554443333
No 473
>PF02440 Adeno_E3_CR1: Adenovirus E3 region protein CR1; InterPro: IPR003471 Early region 3 (E3) of human adenoviruses (Ads) codes for proteins that appear to control viral interactions with the host []. This region called CR1 (conserved region 1) [] is found three times in Human adenovirus 19 (a subgroup D virus) 49 Kd protein in the E3 region. CR1 is also found in the 20.1 Kd protein of subgroup B adenoviruses. The function of this 80 amino acid region is unknown. This region is probably a divergent immunoglobulin domain.
Probab=26.37 E-value=1.8e+02 Score=21.69 Aligned_cols=21 Identities=33% Similarity=0.714 Sum_probs=14.2
Q ss_pred eecCceEEEEEEEEecCCCeEEEEe
Q psy10487 272 REAGGNVTMSCYVYGDPEPTILWLL 296 (610)
Q Consensus 272 v~~G~~v~l~C~~~g~P~p~v~W~~ 296 (610)
+..|++++| .|-|...|+|++
T Consensus 2 v~~G~N~TL----~Gp~~~~V~Wy~ 22 (63)
T PF02440_consen 2 VTVGSNVTL----VGPPDGPVTWYK 22 (63)
T ss_pred EeEcCcEEE----eCCCCCceEEEE
Confidence 456777776 454556799994
No 474
>PHA03240 envelope glycoprotein M; Provisional
Probab=26.33 E-value=91 Score=29.23 Aligned_cols=69 Identities=13% Similarity=0.047 Sum_probs=0.0
Q ss_pred ceEeecCceEEEEEEEEecCCCeEEEEe--------------------CCEEeccCCccceeeccCCceeeeeeEEEEEe
Q psy10487 269 MVIREAGGNVTMSCYVYGDPEPTILWLL--------------------NGQVLHNSSFDLLEEEEGDALFEKSVSITLFN 328 (610)
Q Consensus 269 ~~~v~~G~~v~l~C~~~g~P~p~v~W~~--------------------~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~ 328 (610)
.+.+.+|++|+|.=.-.-.|.-.+.|++ ..+.-.............-.....+++|.|.+
T Consensus 32 evt~r~G~nVTLga~~~lhpgq~v~Wy~~~c~~~~G~G~~~~plC~Ytppk~~r~ktl~~t~~nt~i~y~C~NstL~i~~ 111 (258)
T PHA03240 32 EHTTREGDPLLLGGGHGLGAGQKAHWYKHKCDGITGNGDKLHPICTYDPPKNGKGKTLDESAENSFILYECHNSTLIIAH 111 (258)
T ss_pred ecccccCCceeeCCcccCCCCCEEEEEeeecccccCCCCCCceeEEecCCccccccccccccCCCceEEEeccceEEEEE
Q ss_pred cCCCCCeEE
Q psy10487 329 VTDLDAGEY 337 (610)
Q Consensus 329 v~~~D~G~Y 337 (610)
|..+|.|+|
T Consensus 112 vn~sd~~nY 120 (258)
T PHA03240 112 LNLSDAGEY 120 (258)
T ss_pred EeecCcchh
No 475
>PHA03283 envelope glycoprotein E; Provisional
Probab=25.25 E-value=1.4e+02 Score=32.25 Aligned_cols=37 Identities=14% Similarity=0.012 Sum_probs=31.6
Q ss_pred eEEEEEecCCCCCeEEEEEeecCCcceeEEEEEEcCc
Q psy10487 322 VSITLFNVTDLDAGEYTCYAENIRGNASGEISLDLPE 358 (610)
Q Consensus 322 ~~L~I~~v~~~D~G~Y~C~a~N~~G~~~~~~~L~V~~ 358 (610)
+.|.|.+++.+++|.|+-...|..|.....+.|.|..
T Consensus 134 ~~l~I~~at~~~aGVYtly~r~d~~~~~~vflvtVk~ 170 (542)
T PHA03283 134 SVLQIQRATPNIAGVYTLHVSSDGMMKHSVFFVTVKK 170 (542)
T ss_pred CeeEEEecccccCeEEEEEecCCCceEEEEEEEEecC
Confidence 4899999999999999999999888556677777754
No 476
>PF12885 TORC_M: Transducer of regulated CREB activity middle domain; InterPro: IPR024784 This domain represents the region between the N and C terminus of TORC proteins. TORC (transducer of regulated CREB activity) is a protein family of coactivators that enhances the activity of CRE-dependent transcription via a phosphorylation-independent interaction with the bZIP DNA binding/dimerisation domain of CREB (cAMP Response Element-Binding) []. Although the C- and N- terminal domains of the TORC proteins have been well characterised [, ], no functional role has yet been assigned to the central region.
Probab=23.30 E-value=94 Score=27.42 Aligned_cols=23 Identities=26% Similarity=0.079 Sum_probs=15.7
Q ss_pred eeeecccceecCCCCCCCCCCCC
Q psy10487 570 RVTAGGASILSLPDATSTEDIPS 592 (610)
Q Consensus 570 ~~~~~~~~~~~~~~~~~~~~~~~ 592 (610)
++-|+-...+||||.|..+.+++
T Consensus 89 ~~p~~~nTGGSLPDLTnlhfpsP 111 (150)
T PF12885_consen 89 LIPAALNTGGSLPDLTNLHFPSP 111 (150)
T ss_pred ccccccCCCCcCcccccccCCCC
Confidence 44444444599999998886544
No 477
>PF15183 MRAP: Melanocortin-2 receptor accessory protein family
Probab=23.15 E-value=1.3e+02 Score=23.67 Aligned_cols=31 Identities=23% Similarity=0.531 Sum_probs=20.3
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-CCCeeCccC
Q psy10487 4 VVVILLAACLGTTGSPDWTDCP-DTCRCKWTL 34 (610)
Q Consensus 4 ~~~~l~~~~~~~~~~~~~~~Cp-~~C~C~~~~ 34 (610)
+++++.+...+.+|+++-..++ ..+.|.|..
T Consensus 51 ~~lF~iL~~ms~sgspq~~~~~k~~~~~p~~~ 82 (90)
T PF15183_consen 51 VFLFLILLYMSWSGSPQMRNSEKHHPMCPWSH 82 (90)
T ss_pred HHHHHHHHHHhccCCCCcCCccccCCCCCccc
Confidence 4455555777888877665665 367787753
No 478
>PHA03283 envelope glycoprotein E; Provisional
Probab=22.77 E-value=3.1e+02 Score=29.65 Aligned_cols=21 Identities=14% Similarity=0.120 Sum_probs=19.0
Q ss_pred EEEEEecCCCCCeEEEEEeec
Q psy10487 323 SITLFNVTDLDAGEYTCYAEN 343 (610)
Q Consensus 323 ~L~I~~v~~~D~G~Y~C~a~N 343 (610)
.|.+.++..+++|.|.|++.-
T Consensus 316 ~L~f~nap~~~SGLYVfVv~y 336 (542)
T PHA03283 316 DLLFKNAPASASGLYVFVLLY 336 (542)
T ss_pred ceEeccCCcccCceEEEEEEE
Confidence 799999999999999999853
No 479
>KOG0613|consensus
Probab=22.65 E-value=49 Score=39.39 Aligned_cols=85 Identities=16% Similarity=-0.001 Sum_probs=60.3
Q ss_pred cceEeecCceEEEEEEEEecCCCe-EEEEeCCEEeccCCccceeeccCCceeeeeeEEEEEecCCCCCeEEEEEeecCCc
Q psy10487 268 SMVIREAGGNVTMSCYVYGDPEPT-ILWLLNGQVLHNSSFDLLEEEEGDALFEKSVSITLFNVTDLDAGEYTCYAENIRG 346 (610)
Q Consensus 268 ~~~~v~~G~~v~l~C~~~g~P~p~-v~W~~~g~~l~~~~~~~~~~~~~~~~~~~~~~L~I~~v~~~D~G~Y~C~a~N~~G 346 (610)
..+.+..+..+++.|...|.+.|. +.|++++............ ..+. .....+.|..+...+.+.|.|.|.|..|
T Consensus 342 ~~v~a~d~~~v~m~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---~ts~~~~~~~~~~~e~~~~~~~a~n~~g 417 (1205)
T KOG0613|consen 342 LSVTARDNTLVEMPTALSGTQKPDEAQGYHGEEVSSESLGALPC-PVGT---VTSHTYTIKDAGPGEGYFTRVPAVNKGG 417 (1205)
T ss_pred ceeccccCcceeecccccCCcCCchheeeccccccccccccccc-cccc---ccCcchhhhhcCcccccccccceeccCC
Confidence 456667788899999999999998 9999987665543321111 1110 1223688889999999999999999999
Q ss_pred ceeEEEEEEc
Q psy10487 347 NASGEISLDL 356 (610)
Q Consensus 347 ~~~~~~~L~V 356 (610)
.........|
T Consensus 418 ~~~~~~~~~v 427 (1205)
T KOG0613|consen 418 TEQTIAESTV 427 (1205)
T ss_pred cccccchhhc
Confidence 8655544444
No 480
>PHA03282 envelope glycoprotein E; Provisional
Probab=20.53 E-value=1.6e+02 Score=31.34 Aligned_cols=39 Identities=15% Similarity=0.152 Sum_probs=27.8
Q ss_pred eeeeEEEEEecCCCCCeEEEEEeecCCc--ceeEEEEEEcC
Q psy10487 319 EKSVSITLFNVTDLDAGEYTCYAENIRG--NASGEISLDLP 357 (610)
Q Consensus 319 ~~~~~L~I~~v~~~D~G~Y~C~a~N~~G--~~~~~~~L~V~ 357 (610)
..+++|.|.+++.+|+|.|+-.+...-. ...+.+.|.|.
T Consensus 121 ~~n~tl~l~~a~~~DsG~Y~L~~~~~~~~~~~~~~v~l~V~ 161 (540)
T PHA03282 121 VVNGTLVLREARETDSGMYVLSVSRAPNSTAARAVVFLVVG 161 (540)
T ss_pred EecceEEEeeccccCCceEEEEecCCCCchhheEEEEEEec
Confidence 3456899999999999999998633222 23455667763
Done!